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1. Introduction  
1.1 Isomerization of Terminal Olefins to 2-Alkenes 
The isomerization of unsaturated substrates constitutes as an atom-economic alternative to 
conventional double bond forming processes, such as carbonyl olefination,1 alkyne reduction,2 
cross-coupling reactions,3 or olefin metathesis.4 The translocation of a terminal double bond 
can be considered as a formal 1,3-hydride shift, for which a defined stereocontrol of the 
resulting double bond is the biggest challenge. As depicted in Scheme 1, the E-configured olefin 
is the thermodynamically favored product, whereas the Z-configured isomer is predominantly 
formed under kinetic control.5 
 
 
Scheme 1: Energy diagram for the isomerization of terminal alkenes to the kinetic (Z-olefin, left) and 
thermodynamic product (E-olefin, right), (E = energy, G0 = Gibbs energy). 
Several different methods to realize an isomerization process have been described in the 
literature.6 This work focusses on the transition metal-catalyzed migration of a terminal double 
bond, which provides access to unsaturated target molecules with exactly defined double bond 
configuration and location. The double bond transposition can occur via different pathways.7 
The understanding of the mechanism for olefin isomerization is meaningful to illustrate the 
complexity of this supposedly simple reaction. 
1.1.1 Mechanistic Insights 
All steps corresponding to the movement of a double bond are reversible. Consequently, the 
thermodynamic ratio of alkenes is reached when the metal species remains active for an 
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adequate time.8 When an irreversible step occurs at a certain position, kinetic factors have to be 
considered. In the following, two mechanistic pathways will be presented in more detail: The 
allyl (1,3-hydride shift) and the alkyl (1,2-hydride shift) mechanism.9 
When the hydride transfer is provided from the substrate’s activated allylic position the allylic 
pathway occurs via formal 1,3-hydride shift through either an inner or an outer sphere 
mechanism. As depicted in Scheme 2, the inner sphere mechanism needs 14-electron metal 
complexes 2 with two vacant coordination sites.8,10 
 
Scheme 2: Allyl pathway of the 1,3-hydride shift with inner (top) and outer sphere mechanism (bottom).8 
After formation of the η3-allyl complex II through reversible oxidative addition and rotation, 
the reductive elimination provides the translocated olefin metal complex III. The hydride 
(highlighted in blue in Scheme 2) is transferred from the activated allylic position of alkene I. 
The outer sphere mechanism has to be considered when the ligand acts as base (with X = N or 
O) and enables deprotonation of the allylic position of IV.8,11,12  
Most reports in literature describe the isomerization proceeding through a metal hydride species 
4 formed by initial activation, for instance, through addition of a hydride salt or complex.13,14 
 
Scheme 3: Alkyl pathway of the 1,2-hydride shift.8 
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In the alkyl mechanism in Scheme 3, a metal hydride species 4 with a vacant coordination site 
is required for migratory insertion. The insertion of the olefin into the [M]−H bond usually takes 
place through a four-centered transition state leading to an alkyl metal species VIII. The 
following β-hydride elimination furnishes the isomerized olefin π-complex IX, which 
undergoes rotation and hydrometalation to X. The oxidation state of the metal does not change 
during the process. The Z/E ratio of the outcoming alkene typically depends on thermodynamic 
stability or nature and ligand sphere of the metal.15 In case of the hydride mechanism, another 
insertion can take place letting the metal hydride walk through the chain. Therefore, the biggest 
challenge is the realization of a double bond transposition over exactly one position without 
further chain-walking. Several approaches can be found in the literature.16−18,19 
Since these reactions are often catalyzed by precious metals, a growing demand in the 
utilization of first-row transition metals has increased. They are an attractive alternative to their 
higher homologues due to their high abundance, lower cost and high reactivity. In recent years, 
several first-row transition metal catalysts, especially iron-, nickel- and cobalt-based systems, 
have been described for a targeted isomerization over one position. The following chapter will 
thus be focused on the stereoselective isomerization of unfunctionalized alkenes as well as the 
double bond translocation in allylic systems through first-row transition metal catalysis. 
1.1.2 Isomerization of Unfunctionalized Alkenes via First-Row Transition 
Metal Catalysis 
Already in the 1970’s Miller and Lochow described the first nickel-based catalyst system 
comprising ethylenebis(tris-o-tolylphosphite)nickel(0) and HCl used for the isomerization of 
homoallylic ester 5 to a Z/E-mixture of crotylester 6 (Scheme 4, top). For skipped dienes 7 they 
used Ni(Bu3P)2Cl2 in combination with the Lewis acid iBu2AlCl (Scheme 4, bottom).
20  
 
Scheme 4: Nickel-catalyzed isomerization of simple 1-alkenes and diene structures. 
Another Z-selective isomerization of 1-pentene was described by Kanai in the early 1980’s. 
They explained the double bond transposition proceeding via metal hydride species. The 
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addition of the Lewis acid SnCl2 facilitated the reaction through halide abstraction from the 
catalyst precursor Ni(PPh3)3Br. They further suggested that the active catalyst species is a Ni(I) 
species formed by in situ reduction with Zn.21 
In a 2009 report, RajanBabu et al. observed the transposition of an exo-double bond as side 
reaction during their investigations on a nickel-catalyzed hydrovinylation of exocyclic alkenes 
of type 10 (Scheme 5) and ethylene to terminal alkenes (11) using a catalyst system comprising 
[(allyl)NiBr2] and triphenylphosphine. They wondered whether the hydrovinylation conditions 
could be modified towards a selective isomerization of the 2,2′-disubstituted alkene to 
trisubstituted alkene 12. After detailed optimization they could get access to products with an 
E-configured trisubstituted double bond. Compared to the nickel precursor, they found out that 
the neighboring palladium catalyst shows enhanced reactivity. Likewise, they propose a metal 
hydride mechanism for the isomerization using silver triflate for halide abstraction.22 
 
Scheme 5: Isomerization as side reaction observed by RajanBabu (Ar = 4-chlorophenyl, BARF = tetrakis[3,5-
bis(trifluoromethyl)-phenyl]borate). 
For substrates with an allylbenzene substructure the double bond migration is always limited to 
one position.23 If the (homo)allylic position of the carbon chain in the product is unsubstituted, 
another isomerization can take place. For linear substrates, for instance silyl ether 13, 
[(allyl)NiBr2] / PPh3 proved to be the more reactive catalyst, leading to mainly E-configured 2-
alkene 14. The reaction had to be performed at temperatures as low as −55 °C in order to 
suppress further 1,3-hydride shifts and to guarantee the stability of the nickel catalyst.22 
 
Scheme 6: Nickel-catalyzed isomerization to 2-alkenes by RajanBabu. 
Additionally to nickel, the iron-catalyzed isomerization is numerously presented in literature.24 
Mechanistically, the iron-mediated 1,3-hydride shift supposedly proceeds through an iron 
hydride intermediate.25 In 2011, Beller and Jacobi von Wangelin (JvW in Scheme 7) used an 
iron-based catalyst system for the isomerization of unfunctionalized 1-alkenes (1-octene, 15) 
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obtaining 2-octene (16) in moderate to good E-selectivity. Beller postulated a trinuclear iron 
hydride complex as active species. The selectivity is described by the high steric demand of the 
catalyst.26,27  
 
Scheme 7: Iron-catalyzed isomerization of simple terminal olefins to 2-alkenes (acac = acetyl acetonate). 
Jacobi von Wangelin et al. proposed an allylic pathway for their Grignard-assisted 
isomerization. They could prove it by deuterium labeling experiments figuring out that the 
allylic position of deuterated allylbenzene (17-d2) is the origin of the deuteride located at the 
methyl group in the product 18.26 Scheme 8 illustrates the experiment. 
 
Scheme 8: Deuterium labeling for the iron-catalyzed isomerization via allylic pathway. 
For a targeted isomerization of terminal olefins to 2-alkenes, the first cobalt-based catalyst was 
described by Oshima et al. in 2009 providing access to mainly E-configured alkenes (19 → 20 
in Scheme 9). Similar to Jacobi von Wangelin’s report, a Grignard reagent was necessary for 
the reduction of the Co(II)-precursor. Unfortunately, they did not mention whether the active 
catalyst is a Co(I) or Co(0)-species. Substrates with simple alkyl chains (20), ethers (21), silanes 
(22) and even a protected tertiary amine (23) were well-tolerated by the catalyst.28 
 
Scheme 9: Cobalt-catalyzed isomerization to 2-alkenes by Oshima (s.m. = starting material, IMes · HCl = 1,3-
bis(2,4,6-trimethylphenyl)imidazolium chloride. 
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For the formal 1,3-hydride shift, Oshima suggested a mechanistic pathway upon cobalt hydride 
formation, which could also be underlined by deuterium labeling experiments. Two deuterated 
substrates were subjected to the reaction. As can be seen in Scheme 10, terminally deuterated 
tridec-1-ene (24-d2) was isomerized leaving the isotopes untouched at the terminal position 
(25-d2) while the internally deuterated tridec-1-ene (26-d2) was isomerized with the expected 
transposition of one deuteride from the allylic to the terminal position of 27-d,d.28 
 
Scheme 10: Deuterium labeling to confirm the proposed 1,3-deuterium shift. 
Another cobalt-catalyzed isomerization of olefins 28 with an exo-double bond was described 
by Shenvi et al. in 2014. They proposed a radical isomerization via reversible hydrogen atom 
transfer (HAT) predominating hydrogenation as possible side reaction. They used a cobalt(III)-
salen precursor with phenylsilane as hydride donor gaining access to E-configured 2-alkenes 
29 with trisubstituted double bonds without defined stereoselectivity (Scheme 11).29 
 
Scheme 11: Cobalt-catalyzed isomerization of exo-double bonds to trisubstituted alkenes (saltBu/tBu = (R,R)-(−)-
N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamin). 
This year, Liu and coworkers could realize a Z-selective monoisomerization of either -
substituted terminal alkenes or 1,1-disubstituted olefins like tetracycle 30 using a cobalt-based 
catalyst system with NNP-pincer ligands shown in Scheme 12. Ammonia borane was used as 
reducing agent and hydride source. In case of non-cyclic olefins, an isomeric excess (ie) of up 
to 60% was possible. Besides utilization for a broad alkene scope, including a derivatization of 
testosterone, they used their method as key step for the total synthesis of the indole alkaloid 
minfiensine (31).30 
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Scheme 12: Liu’s cobalt-catalyzed isomerization as key step in the synthesis of minfiensine  
(i.r. = isomeric ratio). 
In 2014, Weix and Holland found a high-spin Co(II)-catalyst suitable for the double bond 
transposition over exactly one position in linear substrates without adjacent functional group. 
They suggested the bulky β-diketiminate ligand having the appropriate kinetic selectivity for 
the formation of predominantly Z-configured 2-alkenes, for instance 2-octene (16), with a Z/E 
ratio of 88:12. Their approach, shown in Scheme 13, is the first Z-selective isomerization by a 
cobalt catalyst reported in literature achieving Z/E-stereoselectivity of up to 92:8 in good 
yield.31 
 
Scheme 13: Cobalt-catalyzed Z-selective isomerization by Weix (s.m. = starting material). 
Due to the metal hydride walking through the chain, the formation of undesired higher 
homologues was also observed (up to 13% in case of 2-alkene 32). Weix et al. explained that 
the amount of E-configured 2-alkene increased over time, so that the reaction had to be 
quenched when the amount of 2-Z-isomer has reached its maximum. The Z-selectivity is 
determined by insertion product XI in Scheme 14. Elimination of the Z-alkene occurs more 
rapidly than the reversible Z to E isomerization (Z-36 to E-36) which indicates that this step is 
kinetically controlled.31 
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Scheme 14: Origin of the Z-selectivity of the isomerization by Weix. 
The same year, our group developed a similar Z-selective isomerization where the double bond 
migration is limited to only one position (37 → 38 in Scheme 15, bottom). The sum of other 
internal isomers for most of the substrates was less than 1%.  Our cobalt catalyst system consists 
of the Co(II)-precursor with a bidentate phosphine ligand, Zn powder as the reducing agent and 
the Lewis acid ZnI2 for halide abstraction from the active Co(I)-species XIV (Scheme 15, top). 
The addition of diphenylphosphine is crucial in terms of Z-selectivity as well as reactivity.32  
 
Scheme 15: Formation of the proposed active Co(I) species (top) and cobalt-catalyzed Z-selective isomerization 
by Hilt et al. (bottom). 
As already mentioned, the specialty of our method is that selectively one 1,3-hydride shift 
occurs in the isomerization process. This can be explained that diphenylphosphine, the co-
ligand and isomerization promoter, takes part in the isomerization process, transferring the 
hydrogen atom directly to the substrate. This could be verified by deuterium labeling 
experiments. As a result, Hilt et al. proposed the mechanism depicted in Scheme 16 for the 
transformation.32,33 
The hydrogen atom is reversibly transferred to the terminal position of the alkene from the 
HPPh2 co-ligand coordinating to the active Co(I)-species XV. -Hydride elimination of one of 
the allylic hydrides generates cobalt hydride XVII, which releases the Z-configured alkene. The 
active catalyst species has a higher affinity to the terminal alkene. A reinsertion of the 2-alkene 
Z-36 is suppressed this way.32 
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Scheme 16: Proposed mechanistic pathway for the diphenylphosphine-assisted isomerization by Hilt.32 
The reaction must be quenched at the point where a further conversion lowers the excess of the 
Z-configured product 36, otherwise thermodynamic factors have to be taken into consideration, 
since the amount of E-isomer of 36 increased. 
During her studies on the Z-selective isomerization, Anastasia Schmidt found a broad spectrum 
of -alkenes 37 suitable for the reaction. Best results were obtained by varying the ligand and 
reaction time for each substrate guaranteeing optimal conversion of the starting material and 
excess of the Z-configured product.32 
 
Scheme 17: Selected substrates of Hilt’s cobalt-catalyzed Z-selective isomerization. 
Several functional groups were well-tolerated by the catalyst, such as aliphatic and branched 
alkyl chains, ethers, ketones and even a protic hydroxyl group as well as heteroatom-containing 
functional groups like silane 22, silyl ether 14 or boronic ester 41. On the downside, bulky 
groups and those with inherent coordinating abilities lead to inhibition of the catalyst. No 
conversion could be detected for the substrates shown in Figure 1.33 
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Figure 1: Substrates which do not work. 
Especially amines like 44 and amides, not suitable for our group’s cobalt-catalyzed 
isomerization, are of special interest, due to their high applicability in relevant follow-up 
reactions. Catalytic systems containing first-row transition metals other than cobalt can be 
found in the literature. Especially nickel and iron catalysts are able to induce the double bond 
transposition in O- and N-allyl systems. 
1.1.3 Isomerization of O- and N-Allyl Compounds 
The second category of olefinic substrates are the ones with an adjacent functional group, so-
called “2-point binding substrates”, which can coordinate to the catalyst and exert a direct 
influence on the catalyst’s reactivity and selectivity.14 Many 1,2-isomerizations of terminal 
alkenes are described for substrates substituted in the allylic position in which the chain walking 
is limited to one position. The allylic substituent (typically an ether, ester, or amide group) acts 
as -acceptor and stabilizes the vinylic position, due to the conjugation of the double bond.34 
Moreover, allylic alcohols or ethers can serve as latent enol(ether) synthons.35  
The double bond migration is a good alternative to the 2-step synthetic sequence of double bond 
reduction and alcohol oxidation (45 → 46 → 47 in Scheme 18). In the last years, the catalyst 
development has given rise to efficient methods including enantioselective variants mainly 
catalyzed by precious transition metals, such as ruthenium, rhodium, or iridium.36  
 
Scheme 18: Mechanism of the isomerization of allylic alcohols. [M]: typically Ru, Rh or Ir catalyst. 
1. Introduction 
11 
 
With focus on selected examples about first-row transition metal catalysis, Goetz et al. 
evaluated the potential of [HCo(CO)4] serving for the isomerization of allylic alcohols during 
their investigations on olefin hydroformylation.37 Furthermore, iron carbonyl complexes and 
nickel hydrides bear the potential of enolate formation by double bond transposition.38 
A recent article by de Vries et al. describes the iron-catalyzed isomerization of allylic alcohol 
49 to saturated ketone 50 (Scheme 19).39 
 
Scheme 19: Iron-catalyzed isomerization of substituted allylic alcohols by de Vries. 
The isomerization of allylic alcohols is also applicable in one-pot sequences which are of 
special interest for my own work. One of the first examples shown in Scheme 20 was reported 
by Grée who used iron carbonyl catalysts for a moderately diastereoselective tandem 
isomerization/aldol reaction of benzaldehyde (51) and allylic alcohol 52.40 
 
Scheme 20: Iron-catalyzed one-pot isomerization/aldol-reaction sequence. 
Furthermore, they presented a nickel pre-catalyst which was activated with a Grignard reagent 
and applied for a dia- and enantioselective isomerization/Mannich-type reaction sequence.41  
 
Scheme 21: Nickel-catalyzed asymmetric one-pot isomerization/Mannich reaction sequence. 
Frauenrath used LiBHEt3 as reducing agent and hydride donor for his nickel precursor 
Ni(dppb)Cl2 (dppb = bis(diphenylphosphino)butane) to achieve the isomerization of diallylic 
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ethers 58 followed by a Claisen rearrangement of enolether 59 to the resulting -unsaturated 
aldehyde 60. The method provides an excellent Z/E ratio of 95:5 and is shown in Scheme 22. It 
is restricted to allylic ethers, though, in which the transposition of the double bond is limited to 
a single 1,3-hydride shift.13 
 
Scheme 22: Z-Selective isomerization of allyl ethers and subsequent Claisen rearrangement. 
Frauenrath’s modified catalyst system with the Me-DuPHOS ligand (L* in Scheme 23) could 
be further applied for an elegant kinetic resolution (KR) of acetal 61 via desymmetrization 
giving enantiomeric excesses (ees) up to 98%.42 
 
Scheme 23: KR by desymmetrization with a chiral nickel catalyst by Frauenrath. 
Additionally, Frauenrath used his Ni(dppb)Cl2/LiBHEt3 catalyst systems for the isomerization 
of N-allyl acetals of type 63 obtaining excellent Z-selectivities up to 99:1.42 
 
Scheme 24: Isomerization of N-allyl acetals by Frauenrath. 
For the isomerization of N-allylic systems to enamides and enamines several transition metal 
catalysts are described in the literature.18,43–46,45,46  
The Tagasako menthol process is a noteworthy industrial process illustrating the usefulness of 
a rhodium-catalyzed stereoconvergent isomerization to an enantiomerically enriched enamine 
(cf. chapter 1.2.1). 
In case of first-row transition metals, there are several approaches to obtain enamides via 
isomerization of the corresponding allylic compounds. Starting with iron, Stille reported the 
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isomerization of substituted N-allyl amide 65 obtaining enamide 66  in good yield (95%), but 
poor selectivity (Scheme 25).47  
 
Scheme 25: Initial isomerization of N-allylic amides with iron carbonyl complexes. 
20 years later, Hesse et al. used Fe(CO)5 for a broader substrate scope and obtain E/Z-mixtures 
of the corresponding enamide 68 under neat conditions.48  
 
Scheme 26: Isomerization of N-allylic amides by Hesse. 
As depicted in Scheme 27, they proposed the E-isomer being formed by coordination of the 
carbonyl moiety to the iron center (XXIII) and subsequent cis-elimination. Due to steric 
demand in intermediate complex XXII an elimination to the corresponding Z-isomer 69 is 
hindered.48 They further describe long distance migration for their catalyst at somewhat higher 
temperatures (neat, 120 °C) to obtain enamides in a moderate Z/E ratio of 1:2 up to 1:3.49 
 
Scheme 27: Proposed mechanistic pathway for the iron-catalyzed isomerization of N-allyl amides explaining the 
stereochemical outcome. 
For the nickel-catalyzed isomerization of N-allyl amides and carbamates 71 there are two 
methods described by Manolikakes50 as well as Liu.51 Both authors described the high reactivity 
of their catalyst systems giving mainly E-configured enamides or mixtures of E/Z-isomers in 
good yield. Scheme 28 depicts a comparison of both methods. 
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Scheme 28: Comparison of the isomerization of N-allylic amides and carbamates by Liu and Manolikakes. 
A mechanistically divergent reaction sequence combining a nickel-catalyzed isomerization of 
N-allyl carbamates of type 73 with a subsequent enantioselective double bond functionalization 
could be achieved by the Moran group in 2016 and is shown in Scheme 29. The in situ generated 
imines or enecarbamates gave opposingly functionalized products. Formal -functionalization 
of imine 74 provided -arylamine 76 upon enantioselective Friedel-Crafts reaction, whereas 
the -functionalization was achieved in an enantioselective Povarov cycloaddition to 77.52 
 
Scheme 29: Mechanistically divergent nickel-catalyzed isomerization/functionalization sequence by Moran 
triphos = (bis(diphenylphosphinoethyl)phenylphosphine, 1,2-DCE = 1,2-dichloroethane, dme = dimethoxy-
ethane, Boc = tert-butoxy carbamate, Cbz = Carboxybenzyl). 
The previous chapters described a targeted isomerization to achieve the double bond migration 
over exactly one position. Especially in allylic systems, multiple double bond migration is not 
possible. Chain walking of a metal hydride is a common phenomenon in substrates without 
adjacent functional group. 
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1.2 Remote Functionalization Through Double Bond Isomerization 
As explained before, a double bond migration is not always limited to one position. Most of the 
mechanisms proceed via metal hydride species allowing multiple 1,3-hydride shifts along an 
aliphatic carbon chain through chain walking.53 A recent example is Grotjahn’s “alkene zipper” 
ruthenium catalyst, which is able to let the double bond “walk” 30 positions through an aliphatic 
chain.54 Chain walking brings new possibilities to direct a follow-up reaction to a desired 
location in the molecule. A double bond transposition can be further seen as a remote 
functionalization leading to a selective reaction at a different position, the remote site.8 Scheme 
30 illustrates the concept of remote functionalization in comparison with the direct 
transformation of a molecule’s most reactive site.  
 
Scheme 30: Direct versus remote functionalization (LG = leaving group, FG = functional group).11 
Taking advantage of a double bond’s reactivity to generate another reactive site in a molecule 
is an ongoing challenge,8 especially in academic and industrial research. 
1.2.1 Relevance of Remote Functionalization for Chemical Industry 
The transition metal-catalyzed olefin isomerization is of great value for industrial processes, 
since the double bond acts as popular group for further functionalizations. An asymmetric 
isomerization is used as key step in the Tagasako menthol process from myrcene (78) in which 
a chiral rhodium/(S)-BINAP catalyst established its first industrial usage. Scheme 31 illustrates 
the enantioselective isomerization of allylic amine 79 to the resulting enamine 80 in greater 
than 98% enantiomeric excess (ee). Subsequent functionalization allows the conversion of 80 
to aldehyde 81 with final Lewis acid-assisted cyclization to (−)-menthol (82) in greater than 
98% diastereomeric excess (de).55,56 
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Scheme 31: Enantioselective isomerization as key step in the Tagasako menthol process (BINAP = 2,2′-
bis(diphenylphosphino)-1,1′-binaphthyl, cod = cycloocta-1,4-diene). 
Especially tandem reactions are typical methods for the preparation of fine chemicals from 
petrochemicals. The DuPont adiponitrile process in Scheme 32 is a major success for industrial 
homogeneous catalysis involving a nickel(0)tetrakis(phosphite) catalyst for the three-step 
industrial synthesis of adiponitrile from 1,3-butadiene (83). The catalyst reacts with 83 in the 
presence of HCN and a Lewis acid to afford two mononitrile isomers 85 and 86. 85 undergoes 
a skeletal rearrangement providing the desired linear product, crotylnitrile 86.57,58 
 
Scheme 32: DuPont adiponitrile process (simplified). 
The subsequent nickel-catalyzed isomerization of crotylnitrile (86) is the crucial key step for 
formation of adiponitrile (89) by an anti-Markownikow hydrocyanation. Surprisingly, a kinetic 
preference of 86 compared to the thermodynamically favored vinylnitrile 87 occurs.58 
Another remarkable industrial process is the Shell Higher Olefin Process (SHOP) comprising 
an oligomerization/isomerization/cross-metathesis sequence for the synthesis of fatty alcohols 
for detergents and surfactants. The homogeneous nickel phosphine complex 91 is used for the 
preparation of terminal alkenes of preferred length by ethylene oligomerization.56,59  
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Scheme 33: Shell Higher Olefin Process (SHOP) for the preparation of long-chain alcohols.56 
From all known examples of remote functionalization induced by transitions metals, the most  
common application with relevance in chemical industry is the isomerization/hydroformylation 
sequence convergently producing one defined product out of an isomeric mixture of the 
unsaturated starting material 94. The treatment of an olefin 95 with syngas, a mixture of CO 
and H2, leads to the formation of versatile carbonyl compounds 96/97 as Scheme 34 
illustrates.8,60 The formation of linear aldehydes 96 is only reached when the isomerization 
occurs faster than the CO insertion. 
 
Scheme 34: Schematic tandem isomerization/hydroformylation process. 
The observation that ethylene, H2, and CO were converted into propanal in the cobalt-catalyzed 
Fischer-Tropsch reaction, marked the beginning of hydroformylation catalysis.61 Since then, 
the cobalt-catalyzed isomerization/hydroformylation process has a high industrial relevance 
and is numerously presented in literature.60,62 
The isomerization reaction proceeds via chain walking of the metal hydride to give all possible 
isomers. The observation, that a general tendency for the formation of linear aldehydes is 
independent of the starting molecule, indicates a strong kinetic preference for the irreversible 
formation of a (n-alkyl)acyl-cobalt intermediate XXIV in the hydroformylation step.63 
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Scheme 35: Disproportionation of a (n-alkyl)acyl-Co species. 
Large-scale technical processes usually operate at high temperatures (120−175 °C) and high 
CO pressure (270−300 bar) providing 60−70% n-aldehydes. A modification of the catalyst with 
bulky phosphine ligands generally increases thermal stability and favors the formation of linear 
aldehydes. The regioselectivity can be increased to 75−90%. As a drawback, alcohols are 
preferentially formed due to the enhanced hydrogenation activities of [HCo(CO)3PR3].
58 An 
isomerization and subsequent hydrogenation is also known for nickel-containing catalyst 
systems.64 Besides hydroformylation, there are also other reactions suitable for remote 
functionalization in a one-pot fashion. They will be presented in the following chapter. 
1.2.2 One-pot Isomerization Sequences 
Nickel-catalyzed double bond migration is nowadays used as attractive remote strategy to form 
bonds between otherwise unactivated carbon centers.65,66 Zhu and co-workers described several 
approaches using dual nickel catalysis for isomerization and a subsequent cross-coupling 
reaction to form C−C bonds between sp2/sp3 and sp3/sp3-hybridized carbon atoms.65,67,68 This 
year, the Zhu group presented a nickel hydride-species, formed upon reduction of the Ni(II)-
precursor with triethoxysilane, catalyzing the isomerization of unrefined olefin mixtures 100 
and the subsequent remote hydroalkylation for the construction of C(sp3)−C(sp3) bonds.67 The 
reaction is illustrated in Scheme 36. 
 
Scheme 36: Remote reductive hydroalkylation of terminal alkenes (DMF = N,N-dimethylformamide). 
Similar to the SHOP, Grotjahn and Schrock published an elegant isomerization/cross-
metathesis sequence catalyzed by a co-catalyst system comprising Grotjahn’s “alkene-zipper” 
(ruthenium catalyst 105) and tungsten catalyst 106, which had a strong preference for terminal 
olefins to give Z-configured internal alkenes as 104 in olefin metathesis (Scheme 37).69 
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Scheme 37: Isomerization/cross-metathesis sequence with “alkene-zipper”/tungsten co-catalysis. 
An application of the Grubbs II catalyst for ring closing metathesis (RCM) and subsequent 
isomerization of the corresponding cyclic allyl urethane 109 was described by Schmidt (Scheme 
38).70 A similar approach for the one-pot synthesis of indoles by an isomerization/enamide-ene 
metathesis reaction sequence was reported by Shuto in 2011.71 
 
Scheme 38: Tandem RCM/isomerization sequence by Schmidt. 
The Carboni group upgraded the isomerization/metathesis sequence with a subsequent 
allylboration step after metathesis of vinyl boronic ester 110 and allylbenzene (17) with 
Grubbs I catalyst and iridium-catalyzed E-selective isomerization of the resulting vinyl boronic 
ester 111 giving rise to anti-configured homoallylic alcohol 112 (Scheme 39, top), and bioactive 
neolignane structures 114/115 (Scheme 39, bottom).72 
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Scheme 39: Tandem isomerization/cross-metathesis/allylboration reaction by Carboni (r.r. = regioisomeric 
ratio). 
1.2.3 Hydroboration/Isomerization/Allylboration Sequences 
The diverse chemistry of organoboron compounds can also be exploited in combination with 
an isomerization reaction. Chirik et al. described an aryl-substituted bis(imino)pyridine cobalt 
methyl complex (118 in Scheme 40) for alkene hydroboration. For internal olefins such as 116, 
an isomerization to the terminal position was observed first, providing a selective hydroboration 
of the remote C−H bond.73 
 
Scheme 40: Cobalt-catalyzed isomerization/hydroboration sequence by Chirik et al. 
Since vinylboronic acids are easily prepared from terminal alkynes through hydroboration, it is 
necessary to isomerize the double bond to the allylic position enabling an allylboration reaction 
with carbonyl moieties. A modification of Carboni’s iridium catalyst (cf. Scheme 39) was 
applied by Miyaura for the isomerization of the vinylic boronic ester 119 to enolether E-120 
and subsequent intramolecular allylboration to give trans-tetrahydropyranols 121 and 
tetrahydrooxepanols in good diastereoselectivity of up to 97% (Scheme 41, top). As reported 
earlier, nickel is known for the Z-selective isomerization of allyl ethers to their corresponding 
enolethers.13 Therefore, the cis-configured cyclic ethers 121 could be obtained by a Z-selective 
isomerization with a  catalyst system comprising Ni(PPh2Me)2Cl2/LiBHEt3 (cf. Scheme 41, 
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bottom) and subsequent allylboration. Either way, deprotection of the acetal group was 
achieved by addition of the Lewis acid Yb(OTf)3.
74  
 
Scheme 41: Tandem hydroboration/isomerization/allylboration sequence by Miyaura. 
For the E-selective isomerization of vinyl boronic esters another iridium catalyst was described 
by Murakami et al. in 2013. Starting from the desired terminal alkyne 122 they could get access 
to anti-configured homoallylic alcohol 112 in a hydroboration/isomerization/allylboration 
sequence. The final allylboration step could be achieved enantioselectively by utilization of the 
chiral phosphoric acid (R)-TRIP leading to excellent enantiomeric excesses of up to 96%.75 
 
Scheme 42: Enantioselective hydroboration/isomerization/allylboration sequence by Murakami et al. 
((R)-TRIP = (R)-3,3′-bis(2,4,6triisopropyl-phenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate). 
Further, the migration of the double bond could be accomplished in two different ways. Scheme 
42 illustrates the transposition away from the functional group whereas Murakami also 
described an isomerization towards the boronic ester functionality of 123.75 
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Scheme 43: Murakami’s iridium-catalyzed isomerization towards the functional group. 
Another three-component reaction was published by Horino and Abe in 2015. They used a 
palladium catalyst for the double bond transposition of allyl acetates 125 and subsequent 
Z-selective Suzuki cross-coupling of the resulting enol acetates (Scheme 44) and 
triethylborane.76 In 2017, they described a similar reaction using aryl tin organyls as 
transmetalating agent.77 
 
Scheme 44: Isomerization/cross-coupling sequence by Horino. 
Concerning the hydroboration of 1,3-dienes, a nice example was published by Morken et al. 
They used a Ni(cod)2/PCy3 catalyst for a 1,4-hydroboration of 1,3-diene 128 and the subsequent 
allylboration of the resulting allylboronic ester 129 giving rise to syn-configured alcohol 130 
with good diastereoselectivity syn/anti up to 20:1.78 
 
Scheme 45: Nickel-catalyzed 1,4-hydroboration of 1,3-dienes and subsequent allylboration. 
As shown above, the allylboration acts as a powerful follow-up reaction, not only for 
hydroboration, metathesis or isomerization. The Hilt group has investigated the allylboration 
as subsequent process for cobalt-catalyzed transformations. 
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1.2.4 Allylboration Sequences in the Hilt Group 
The Hilt group achieved various cobalt-catalyzed transformations, such as the hydrovinylation, 
Diels-Alder and Alder-ene reaction, in combination with an allylboration to get access to highly 
functionalized target molecules in good regioselectivity.77,78 The cobalt-catalyzed Alder-ene 
reaction of homoallylboronic ester 132 was combined with an allylboration to the 
corresponding syn-configured homoallylic alcohols of type 134. The first step of this 
multicomponent reaction is the formation of intermediate 135 with a Z-configured allylboronate 
moiety via Alder-ene reaction as shown in Scheme 46.79 
 
Scheme 46: Three-component Alder-ene/allylboration process by Sušnik and Hilt. 
In 2012, Erver and Hilt presented a four-component reaction of an allylboronic ester 136, 
1,4-enyne 137, dimethylbut-1,3-diene and an aldehyde R’CHO with a Diels-
Alder/hydrovinylation/allylboration sequence leading to syn-configured polyenol structures 
140.80 
 
Scheme 47: Four-component reaction by Erver and Hilt. 
The application of 1,3-dienes is not only limited to allylboration sequences. The following 
chapter will describe other applications of substrates with 1,3-diene subunit in the Hilt group 
and give a short overview of recent cobalt-catalyzed hydroacylation reactions. 
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1.3 Cobalt-Catalyzed Transformations of Terminal Alkenes and 1,3-
Dienes 
1.3.1 Cobalt-Catalyzed Isomerization and Hydrovinylation of 1,3-Dienes 
Cobalt-catalyzed transformations of 1,3-dienes are a central research area in the Hilt group. The 
formation of the active Co(I)-species follows the pathway presented in Scheme 15 and can be 
transferred to all of our cobalt-catalyzed reactions, such as the Diels-Alder reaction,81–85 the 
hydrovinylation,86–88 hydrobutadienylation,89,90 or the afore-mentioned isomerization of 
terminal alkenes32 as well as 1,3-dienes.91 Scheme 48 gives a brief overview. 
 
Scheme 48: Selected cobalt-catalyzed transformations of 1,3-dienes in the Hilt group. 
An isomerization step is not only limited to a single double bond. In case of 1,3-dienes, a formal 
1,5-hydride shift is also possible. In 2012, our group described a stereoconvergent isomerization 
of terminal 1,3-dienes leading to two different types of products depending on the ligand 
structure of the cobalt catalyst. The method could be successfully applied in the total synthesis 
of Urushiol.92 Co(dpppMe2)Br2 isomerizes the terminal 1,3-diene 141 to the corresponding 2Z-
4E-diene 142 as depicted in Scheme 49.91  
 
Scheme 49: Stereoconvergent cobalt-catalyzed isomerization of 1,3-dienes by Hilt. 
The generation of products of type 2Z-4E-142 is a formal 1,5-hydride shift, in which the E-
configured double bond is formed due to the syn-selectivity of the -hydride elimination step. 
The 2Z-double bond is intermediary predetermined by formation of the cobaltacyclopentene 
complex XXV with -hydride-elimination and reductive elimination of XXVI.91 
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Scheme 50: Proposed mechanistic pathway for the formal 1,5-hydride shift. 
Another popular application of 1,3-dienes is the hydrovinylation reaction. In the RajanBabu93 
and the Hilt group several approaches concerning cobalt and nickel-catalyzed variants with 
different regioselectivities were developed.87,94  
 
Scheme 51: Regioselectivity of the cobalt-catalyzed 1,4-hydrovinylation of 1,3-dienes with alkenes. 
The 1,4-hydrovinylation, shown in Scheme 51, provided linear or branched products depending 
on the steric and electronic nature of the alkene. Non-conjugate alkenes predominantly formed 
the branched 1,4-diene 144’ with an exo-double bond whereas acrylates formed the linear 
product 144. When styrene is used, only a moderate preference of the linear product with a 
144a/144a’ ratio of 63:37 was observed. Unsymmetrical 1,3-dienes can give up to four 
regioisomers.87,94  
The regioselectivity of the hydrovinylation could also be controlled by variation of the ligand. 
Utilization of the bulky SchmalzPhos ligand (see Scheme 52) allowed the formation of the 
linear product 146 with unactivated neutral alkenes 99 and 2,3-dimethylbuta-1,3-diene (DMB, 
145). In contrast, dppe as ligand would give the branched products of type 146’. Limitation of 
the SchmalzPhos ligand was that only 2-substituted 1,3-dienes could be used, otherwise the 
alkene was not completely consumed.95 
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Scheme 52: Control of the regioselectivity by ligand variation. 
Last year, our group developed a novel multi-component reaction comprising a regioselective 
cobalt-catalyzed hydrovinylation combined with a Wittig olefination of unsaturated 
phosphonium salts and 1,3-dienes for the synthesis on non-conjugated trienes with a well-
defined double bond location and configuration.96 
Instead of using an olefinic double bond in a hydrovinylation process, the application of a 
carbonyl moiety leads to a hydroacylation of 1,3-dienes.  
1.3.2 Hydroacylation of Terminal Alkenes and 1,3-Dienes 
A hydroacylation is a formal alkene insertion into a formyl C-H-bond. The Dong group has 
established a cobalt-catalyzed intermolecular 1,4-hydroacylation leading to a new 
regioselectivity in the product with a 148/148’ ratio greater than 20:1.97  
 
Scheme 53: Intermolecular hydroacylation by the Dong group. 
They propose the mechanism illustrated Scheme 54. When the hydroacylation was performed 
with deutero-benzaldehyde (51-d), the deuterium atom was incorporated at position 4 of the 
diene 149 without any detectable deuterium at other positions. This result suggests that the 
hydroacylation with aromatic aldehydes proceeds through a 1,4-addition pathway with seven-
membered cobaltacycle XXIX.97 
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Scheme 54: Deuterium labeling for a mechanistic proposal of the 1,4-hydroacylation with 1,3-dienes. 
An intramolecular hydroacylation of 1,3-dienes can be performed via rhodium catalysis and 
was described by Sato et al. in 2007. The reaction generated products with cyclohept-3-en-1-
one structure (152) whereas the cyclization of the inner double bond to the five-membered ring 
substructures (153 and 154) was observed as side-reaction. Their mechanistic proposal 
proceeds through a -allylrhodium intermediate, similar to Dong’s cobalt species XXIX in 
Scheme 54.98 
 
Scheme 55: Rh-catalyzed intramolecular hydroacylation of 1,3-dienes. 
Dong et al. further described an intramolecular enantioconvergent hydroacylation of terminal 
olefins leading preferably to cyclobutanone moieties 156 with excellent diastereo-, regio- and 
enantiocontrol in a diastereomeric ratio (d.r.) up to >20:1 and enantiomeric excesses (ee) greater 
than 90%. The formation of five-membered rings of type 157 was not observed.99 The reaction 
is illustrated in Scheme 56. 
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Scheme 56: Intramolecular hydroacylation for the formation of cyclobutanones (bdpp = pentane-2,4-diylbis-
(biphenyl-4-phosphane), r.r. = regioisomeric ratio). 
Another enantioselective variant of cobalt-catalyzed intramolecular hydroacylations was 
described by Yoshikai et al. and shown in Scheme 57.100,101  
 
Scheme 57: Enantioselective intramolecular hydroacylation of styrene derivatives. 
They used either mono- or disubstituted styrene derivatives 158 for the formation of up to two 
stereocenters in the products of type 159 or 160 with excellent enantiomeric excesses (ee) and 
diastereomeric ratios (d.r.) greater than 20:1 (Scheme 57).100,101 
To the best of my knowledge, there is no cobalt-catalyzed intramolecular hydroacylation of 1,3-
dienes described in literature, yet. The application of the Hilt catalyst system in a possible 
hydroacylation reaction would expand our research expertise concerning cobalt and nickel-
catalyzed reactions for C−C-bond formation and migration processes.
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2. Research Objective 
2.1 Scope, Application and Mechanism of the Nickel-Catalyzed 
Z-Selective Isomerization 
In 2014, Anastasia Schmidt identified a cobalt catalyst system for the Z-selective 
monoisomerization of -olefins 37 to 2-alkenes 38. The use of diphenylphosphine had a 
significant impact concerning selectivity and reactivity.32,33 During my Master thesis, the 
neighboring nickel catalyst showed even better Z-selectivity, an outstanding reactivity even at 
low temperatures, and a high functional group tolerance for the same transformation.102 
 
Scheme 58: Comparison of the cobalt and nickel-catalyzed Z-selective isomerization of terminal alkenes. 
In the course of this work, the substrate scope shall be investigated to get access to higher 
functionalized target molecules. The nickel-catalyzed isomerization should be applicable for 2-
point binding substrates, such as N-allyl amides or carbamates. Suitable follow-up reactions, 
such as an allylation of carbonyl compounds R’CHO, can be performed as one-pot sequence to 
illustrate scope and possible limitations of the nickel catalyst. 
 
Scheme 59: Proposed nickel-catalyzed isomerization/allylation sequence of homoallylic substrates. 
The structure motif of conjugated and non-conjugated diene substructures can be found in 
pheromones. To demonstrate the applicability of the method in natural product synthesis, a 
cobalt and nickel-catalyzed isomerization of the corresponding 1,4- and 1,5-dienes as starting 
material is worth to be examined as an atom-economic alternative to conventional cross-
coupling reactions or metathesis. The potential target structures are shown in Figure 2. 
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Figure 2: Pheromones with 2Z,4Z- and 2Z,5Z-diene substructure as target molecules. 
The pivotal isomerization step would contain a threefold challenge: generation of high Z-
selectivity in presence of another intern double bond without converting the diene substructure 
into a conjugate system (in case of the 1,5-diene).  
A mechanistic investigation of the isomerization process is desired. The investigations shall 
give insight into the elementary steps of the reaction on the one hand and the source of the 
stereochemical outcome of the reaction for both, cobalt and nickel catalyst, on the other. EPR 
and CV measurements should give information about the oxidation state and ligand sphere of 
the active catalyst species, since NMR spectroscopy is not suitable for the detection of 
paramagnetic species. Theoretical investigations are targeted to reveal the mode of action of 
the crucial co-ligand diphenylphosphine and to propose a defined mechanistic pathway. 
2.2 Cobalt-Catalyzed Hydroacylation of 1,3-Dienes 
On the path for the development of new nickel and cobalt-catalyzed transformations of alkenes 
and 1,3-dienes, the hydroacylation of 1,3-dienes is still missing in the Hilt group’s research 
expertise, which is mainly based on isomerization, cycloaddition, Alder-ene, Diels-Alder and 
hydrovinylation reactions (for an overview, see Scheme 48).81–92 The proposed reaction, an 
intramolecular hydroacylation of diene 166, is inspired by former work of the Dong group97 
and is shown in Scheme 60. 
 
Scheme 60: Planned conjugate intramolecular hydroacylation of 1,3-dienes. Up to 4 regioisomers are possible. 
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Once the reaction conditions towards the desired intramolecular hydroacylation or cyclization 
have been optimized, the substrate scope shall be further explored. For initial investigations, 
the aldehyde function and 1,3-diene subunit should both be present within the starting material. 
Further, the translocation of the formyl hydrogen atom shall be revealed by deuterium labeling 
experiments. 
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3. Results and Discussion 
3.1 Nickel-Catalyzed Z-Selective Isomerization of Terminal Alkenes 
The following chapters address the nickel-catalyzed Z-selective monoisomerization of terminal 
alkenes. The method was developed in the course of my Master thesis102 together with 
Anastasia Schmidt. Mechanistic studies, revealing the stereochemical outcome of the reaction, 
as well as experiments concerning the elucidation of the active catalyst species will be discussed 
first. After that, the application of the isomerization reaction in natural product synthesis and 
multicomponent reactions will be presented. 
3.1.1 Preliminar Studies 
During my Master thesis,102 the double bond isomerization with a catalytic system, consisting 
of the nickel precursor Ni(dppp)Br2, Zn powder as reductant, the Lewis acid ZnI2 and co-ligand 
diphenylphosphine (HPPh2) was investigated and showed even better Z-selectivity than the 
similar reaction with the neighboring cobalt-based catalyst. Furthermore, the nickel catalyst 
featured an outstanding reactivity even at low temperatures as well as a high functional group 
tolerance. 
 
Scheme 61: Formation of the proposed active Ni(I) species and Z-selective isomerization of terminal olefins. 
The postulated paramagnetic reactive Ni(I) species XXXI (Scheme 61) is formed upon in situ 
reduction of the Ni(II) precursor with Zn and HPPh2. The reduction process is apparently 
realized via electron transfer from Zn to the nickel center. During my Master thesis the substrate 
scope of the isomerization could already be explored. The reaction temperature and time had to 
be adjusted for each substrate to “find the right balance between reactivity and selectivity”.103 
Further, the reaction needed to be stopped at the point where further conversion of the -olefin 
lowered the amount of Z-isomer, because formation of the thermodynamically preferred E-
isomer increased over time.102 Figure 3 shows a selection of accessible Z-configured 2-alkenes. 
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Figure 3: Substrate scope of the nickel-catalyzed monoisomerization of terminal olefins. 
The main difference of the nickel catalyst compared with the cobalt catalyst is that chain 
walking can occur. When the nickel-catalyzed isomerization was performed at ambient 
temperature multiple double bond translocations took place at the expense of the reaction’s 
selectivity. Thus, the thermodynamically equilibrated E-configured isomeric product mixture 
E-170/E-40 was obtained (Scheme 62, top). By lowering the reaction temperature, the reactivity 
could be reduced in behalf of a good isomeric excess of the Z-configured 2-alkene 40 (Scheme 
62, bottom).102 
 
Scheme 62: Multiple 1,3-hydride shift (top) versus kinetic discrimination (bottom), (i.r. = isomeric ratio). 
The transposition of the terminal double bond in 169 at ambient temperature is limited to two 
positions. Likewise, up to four isomers can be obtained. When 1-hexadecene was isomerized 
with the nickel catalyst at ambient temperature, a vast mixture of internal isomers could be 
detected via GC/MS analysis. Lowering the temperature to −40 °C, Z-configured 2-hexadecene 
could be obtained in a good Z/E ratio of 94:6 with 88% conversion, which again demonstrated 
the temperature-dependence of the nickel-catalyst’s activity.33,102 Instead, the cobalt catalyst 
isomerized the double bond over exactly one position, even at elevated temperatures. At a lower 
temperature (0 °C), the amount of Z-isomer increased, with very low conversion of the starting 
material, though.33  
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As described in chapter 1.2, chain walking occurs when a metal hydride species is present in 
the catalytic cycle of the reaction. An alkyl mechanism (Scheme 2) can therefore be expected 
for the nickel-based catalyst system with the hypothesis that the active catalyst species is a Ni(I) 
species formed by in situ reduction with Zn. Cyclic voltammetry (CV) and electron spin 
resonance (EPR) studies were performed. The postulated mechanistic suggestions were 
underlined by density functional theory (DFT) calculations. 
3.1.2 Mechanistic Investigations 
3.1.2.1 Cyclic Voltammetry 
Cyclic voltammetry is of particular interest for the characterization of the active metal species 
in the double bond transposition. It is a reliable technique to acquire qualitative information 
about the transfer of electrons in organic molecules or transition metal complexes. The 
equipment required to perform CV consists of a conventional potentiostat connected to three 
electrodes (working, reference, and auxiliary electrode) immersed in a non-stirred solution. The 
potentiostat applies and maintains the potential between the working and reference electrode 
while at the same time measuring the current at the working electrode. Charge flows between 
the working electrode and the auxiliary electrode.104 Triangular potential excitation signal 
sweeps the potential of an electrode between two values Emin and Emax. The scan rateν is defined 
as potential change per time.105  
 
Figure 4: Triangular potential excitation for CV. 
A current I flows through the electrode that either oxidizes or reduces the analyte. In our case, 
the catalyst M(dppp)Br2 (with M = Co or Ni). The current density is plotted against the potential 
in the cyclic voltammogram and indicates the potential at which the redox process occurs. 
Dichloromethane is the solvent of choice for the studies, since the target reaction, the 
isomerization, is also performed in this solvent. Dichloromethane is stable up to +3.0 V. As 
supporting electrolyte tetrabutylammonium tetrafluoroborate (TBABF4) was chosen. 
For all isomerization reactions, the catalyst is prepared according to a general procedure (GP), 
in the following known as GP 1:  The catalyst precursor M(L)X2 (with M = first row transition 
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metal, usually Co or Ni), Zn powder and ZnI2 are dissolved in anhydrous dichloromethane. 
After 10 min, HPPh2 is added as stock-solution and after additional 10 min the substrate is 
added at the desired temperature. In the first 10 min of stirring Hilt et al. propose the formation 
of a M(I)-species (with M = Co).103 HPPh2 acts as ligand and hydrogen donor to the substrate.
32 
The preparation of the CV samples followed a similar procedure. Dr. Philipp Röse is thankfully 
acknowledged for his assistance. 
When preparing the cobalt and nickel-based catalyst systems for CV measurement, the metal 
precursor M(dppp)Br2 was suspended in a 0.1 M dichloromethane/TBABF4 solution (2.5 mM 
with respect to metal precatalyst). In case of M = Co, the solution is always blue-green, in case 
of M = Ni it is red-brown. When Zn powder (2.0 eq with respect to metal precatalyst) was 
added, the mixture changed to darker green/brownish (Co) but remained unchanged for Ni. In 
both cases the addition of ZnI2 (2.0 eq) had no more observable color change. The afore 
homogeneous solution showed schlieren when Zn and ZnI2 were added. The most remarkable 
color change occured when HPPh2 (0.5 eq in relation to the metal M) was added to the mixture. 
Either way, the color turned to dark red-brown as Figure 5 illustrates. 
    
Co(dppp)Br2 in 
CH2Cl2/TBABF4 
addition of Zn addition of ZnI2 addition of HPPh2 
    
  
  
  
Ni(dppp)Br2, Zn and ZnI2 in 
CH2Cl2/TBABF4 
NiBr2(dppp), Zn, ZnI2 
and HPPh2 
in CH2Cl2/TBABF4 
Figure 5: Pictures of the cobalt (top) and the nickel catalyst (bottom) solutions during CV measurements. CV was 
carried out on a BAS C3 Cell Strand and a BAS 100 series Electrochemical Analyzer using a platinum disk 
working electrode (2.0 mm diameter) and a platinum wire counter electrode (0.5 mm diameter) at ambient 
temperature in dichloromethane/TBABF4 (0.1 M). Potentials were referred to a saturated Ag/AgCl reference 
electrode (3.0 M NaCl). Before each experiment the surface of the working electrode was polished followed by 
thorough rinsing with distilled water and the solution was purged with nitrogen.  
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Figure 6 shows the cyclic voltammograms for the reduction of the Co(II) precursor with zinc. 
The reduction potential of Co(II)/Co(I) is located at −0.74 V. The corresponding oxidation peak 
at 47 mV. When zinc is added to the solution, the reduction peak is diminished. This observation 
is in good accordance to the assumption that Co(II) is reduced to the Co(I) species by zinc. The 
reduction potential of Co(II)/Co(I) is a little shifted to −0.82 V compared to the voltammogram 
of pure Co(II) precursor, since zinc is also able to abstract a halide atom and can therefore 
slightly change the electronic properties of the precursor. When ZnI2 and HPPh2 are added, the 
characteristic peaks from Figure 6 (left side) vanish. Real reversible electron transfers could not 
be detected any longer. The small potentials of the dotted CV in Figure 6 (right side) could be 
an effect of traces of oxygen in the experimental setup, since a complete exclusion of air could 
not be guaranteed. Because of the moderate quality of the voltammograms, only a qualitative 
analysis is possible.  
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Figure 6: Cyclic voltammograms of Co(dppp)Br2 (2.5 mM, 1.0 eq) in CH2Cl2/TBABF4 (0.1 M) at ambient 
temperature using a platinum disc working electrode (0.5 mm diameter) with a scan rate of 100 mV/s. Potentials 
are referred to an Ag/AgCl reference electrode. (a) Co(dppp)Br2; (b) in presence of Zn (2.0 eq); (c) in presence of 
Zn and ZnI2 (2.0 eq each); (d) in presence of Zn, ZnI2 (2.0 eq each) and HPPh2 solution in CH2Cl2 (0.125 mM, 
1.0  eq). 
A major difference between the cobalt and nickel systems can be observed when comparing the 
cyclic voltammogram in Figure 6 with the one of the nickel precursor in Figure 7. The reduction 
peak of Ni(II)/Ni(I) at −0.61 V is not affected when Zn is added to the solution. With the 
addition of ZnI2 the spectrum remains unchanged, too. Upon addition of HPPh2, a reduction 
takes place, letting the reduction peak of Ni(II)/Ni(I) vanish to form the postulated active Ni(I) 
catalyst species. Again, a complete exclusion of air could not be guaranteed, what could explain 
the pseudo-reversible peaks of the dashed CV. 
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Figure 7: Cyclic voltammograms of Ni(dppp)Br2 (2.5 mM, 1.0 eq) in CH2Cl2/Bu4NBF4 (0.1 M) at ambient 
temperature using a platinum disc working electrode (0.5 mm diameter) with a scan rate of 100 mV/s. Potentials 
are referred to an Ag/AgCl reference electrode. (a) Ni(dppp)Br2; (b) in presence of Zn, ZnI2 (4.0 eq); (c) a mixture 
of Ni(dppp)Br2 (1.0 eq), Zn, ZnI2 (4.0 eq) and HPPh2 solution in CH2Cl2 (0.125 mM, 1.0 eq) were prepared in a 
separated heatgun dried Schlenk flask under argon atmosphere and diluted to the stated concentration followed by 
immediate measurement under nitrogen atmosphere. 
As compared with literature data, the quasi-reversible wave reduction potential of Ni(II) to Ni(I) 
species is in the same range as the above measured values (E1/2 = −0.84 V vs. Fc/Fc+ for 
Ni(II)/Ni(I) in THF, respectively). Hillhouse et al. further describe the Ni(I)/Ni(0) transition to 
proceed with E1/2 = 2.41 V.
106 The presence of a possible Ni(0) species can be excluded. 
In summary, cyclic voltammograms of the Co(dppp)Br2 complex changed significantly after 
addition of zinc powder and zinc iodide, indicating that the cobalt(II) precursor is easily reduced 
by zinc powder in the presence of a Lewis acid to the corresponding cobalt(I) complex. This 
change in oxidation state is visible by a distinct color change of the dichloromethane solution 
from green-blue to darker brownish-green. In contrast, the corresponding cyclic 
voltammograms of the nickel complex Ni(dppp)Br2 exhibit no significant change after addition 
of Zn and ZnI2.
103 However, after addition of HPPh2 to this mixture, the reduction peak in the 
cyclic voltammograms vanishes, in combination with the observable characteristic color change 
from red to deep brown. 
3.1.2.2 Electron Paramagnetic Resonance 
From a mechanistic point of view, the reactive catalyst species is a nickel(I) complex with dppp 
and Ph2PH in the ligand sphere. To confirm the CV experiments, further EPR spectra were 
measured under the supervision of Dr. Olaf Burghaus. As external standard for calibration 
DPPH (2,2-diphenyl-1-picrylhydrazyl) was utilized. 
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Frozen solutions of Ni(dppp)Br2, Zn, ZnI2 and HPPh2 in dichloromethane were analyzed by 
EPR at either 130 K (nitrogen cooling) or 20 K (helium cooling). The left spectrum in Figure 8 
shows the signal of a paramagnetic d9-Ni(I) system for which a g-value of 2.181 could be 
calculated. The right spectrum has a rather broadened signal of the Ni(I) species. 
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Figure 8: Left: X-band EPR spectrum (9.1581 GHz) of the active NiI-species Ni(dppp)Br(PHPh2), resp. 
Ni(dppp)(PHPh2)+ solution in CH2Cl2 (0.002 M) at 130 K (g = 2.1818). Right: X-band EPR spectrum (9.2469 GHz) 
of the active species in CH2Cl2 (0.01 M) at 20 K. For EPR measurement a mixture of Ni(dppp)Br2 (1.0 eq), Zn, 
ZnI2 (2.0 eq each) and HPPh2 solution in CH2Cl2 (0.125 mM, 0.5 eq) were prepared in a separated heatgun dried 
Schlenk flask under argon atmosphere and diluted to the stated concentration followed by immediate measurement 
under argon atmosphere. 
EPR measurements are inconclusive as an equilibrium between a square planar 
[Ni(I)(dppp)Br(PHPh2)] complex (XXI) or a cationic [Ni(I)(dppp)(PHPh2)]
+ (XXII) species 
that could explain the hyperfine coupling pattern (Scheme 63).103 
 
Scheme 63: Postulated equilibrium between a square planar [Ni(I)Br(dppp)(PHPh2)] complex or a cationic 
[Ni(I)(dppp)(PHPh2)]+ species.  
A comparison with a simulated EPR spectrum (Figure 9) led to the conclusion that the presence 
of an additional bromide ligand is possible. It could be simulated with g tensor principal values 
of gx = 2.2251, gy =2.20706, and gz = 2.00317.  
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Figure 9: Top (black): X-band EPR spectrum (9.2469 GHz) of the active Ni(I)-species in CH2Cl2 (0.01 M) at 20 K. 
Bottom (red): Simulated EPR spectrum. Fits and simulations were carried out with the EPR data analysing program 
NSIMEPR using an orthorhombic spin Hamiltonian with hyperfine couplings calculated to second order. The 
fitting procedure is a simplex algorithm. Fits were started many times with different starting values and with 
different spin compositions. All parameters given here were allowed to relax free to the minimum. Best fit was 
obtained for three independent S = 1/2 hyperfine couplings. The simulation was carried out by Dr. Olaf Burghaus. 
The g values of d9 transition metal ion centers are very sensitive to the coordination 
environment. The broadened line-widths could arise from the hyperfine couplings to the non-
equivalent 31P (I = 1/2) nuclei (two for the dppp ligand and one for PHPh2)
102 and to the 79Br 
(I = 3/2) nucleus.
107 This would mean either a four or a three-coordinate nickel atom is present. 
As can be compared to data for similar complexes in the literature.108 Krossing et al. describe 
a four-coordinate d9-[Ni(dppp)2Al(OR
F)4] complex with similar three coordinate complexes.
109 
In conclusion, the postulated Ni(I) species could be identified via CV and EPR analysis which 
convinced us for determining a Ni(I) complex being the active catalyst species for the 
isomerization process. 
3.1.2.3 Computational Investigations 
A computational study of the mechanism for the cobalt and nickel-catalyzed isomerization 
reactions was performed by Prof. Dr. Robert Berger and Evgeny I. Grigoryev in order to reveal 
the origin of the hydrogen and to determine the source of the Z-stereoselectivity. This chapter 
serves as an overview of the cooperation with the Berger group describing the general pathway 
of our postulated mechanism with potential differences to conventional alkyl and allyl 
mechanisms. More detailed computational data can be found in the corresponding literature.110  
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As EPR analysis revealed, the reaction is mediated by a square-planar [Ni(I)Br(dppp)(PHPh2)] 
complex or a cationic [Ni(I)(dppp)(PHPh2)]
+ species. The reaction only proceeds in the 
presence of HPPh2 in catalytic amounts as inherent part of the active catalyst species.  
Alkyl Mechanism 
The isomerization reaction proceeds via a so-called alkyl mechanism for most terminal alkenes 
(for corresponding literature, see chapter 1.1.1). For the alkyl mechanism, usually a metal 
hydride species is necessary. As Hilt et al. described for the cobalt-catalyzed isomerization, 
they suggested the hydrogen being directly transferred from the HPPh2 co-ligand to the 
substrate without an intermediary formed cobalt hydride species.32,33 The same assumption was 
made for the nickel-based catalyst system.102 The initial mechanistic proposal was investigated 
to reveal the role of HPPh2, which is crucial for the reaction, because it acts as hydrogen source 
to initiate an isomerization via an alkyl pathway by transferring the hydrogen directly to the 
substrate.32  
The catalytic cycle is initiated by a low barrier reversible 1,2-hydrogen shift. As can be seen in 
Scheme 3, the equilibrium is on the left side, since the activation barrier of 56 kcal/mol for the 
1,2-hydride shift is too high to actually form a real nickel hydride.110 
 
Scheme 64: 1,2-Hydride shift with calculated activation energies.  
Depicted in Scheme 65, the -agostically activated species XXXV acts as an active form of the 
catalyst. Complex XXXI is the pre-catalyst. Moreover, the active catalyst XXXV is not a true 
metal-hydrogen species, because it is stabilized by an -agostic interaction with a bond order 
of 0.6 for P−H and 0.3 for H−Ni. The Ni−H−P arrangement is a three-center-two-electron bond.  
 
Scheme 65: Formation of the active catalyst species XXXV (TS = transition state). 
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The catalytic isomerization of the terminal alkene is conducted by the [(dppp)Ni···H···(PPh2)]
+ 
species XXXV which is activated for alkene insertion through an -agostic interaction between 
the P−H bond of the HPPh2 co-ligand and the nickel atom. The calculated mechanism is 
illustrated in Scheme 66.110 
 
Scheme 66: Selected steps of the calculated alkyl mechanism for the Z-selective nickel-catalyzed isomerization. 
Selectivity arises on the stage of diastereomeric complex XXXIX (TS = transition state). 
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Upon coordination of the 1-alkene, in other words the formal 1,2-H-insertion into the 
-agostically activated catalyst species XXXVII, the P−H bond breaks and a hydrogen transfer 
to the terminal olefinic CH2-group leads to formation of a CH3-group in XXXIX stabilized by 
-agostic interaction. Then, a bifurcation of the reaction pathway takes place. The subsequent 
stereoselective -H-elimination, running through the formal four-membered transition state 
TS-XL, provides the corresponding 2- or -complexes E-XLI and Z-XLI, respectively. XLI 
dissociates to release the E- and Z-configured 2-alkenes (shown for the Z-isomer 36 in Scheme 
66) and can undergo another catalytic cycle after reversible 1,2-H-transfer back to the co-ligand.   
Evgeny I. Grigoryev could show that the selectivity of the catalyst arises at the stage of the 
formation of the -agostic complexes E-XXXIX and Z-XXXIX, which are diastereomeric to 
each other. Consequently, the syn/anti-notation can be used for the relative conformation of the 
substrate in the complex. The substrate has anti-conformation in E-XXXIX complex and syn-
conformation in the Z-XXXIX conformer. 
The E-configured 2-alkene 36 in free form is always thermodynamically more stable than the 
Z-configured counterpart. When they are bonded to the catalyst, though, the steric congestions 
around the nickel atom have to be considered. Because of the interaction between the 
substituent of the olefin and the bulky ligands, the -hydride elimination becomes Z-
selective.110 
-Allyl Mechanism for Allylbenzene 
A major difference is given when allylbenzene (17) is isomerized. E-configured prop-1-en-1-
ylbenzene (18) is always formed, not depending on the metal used. In case of M = Co this 
reaction only proceeds in the presence of HPPh2. An interesting observation was made when 
isomerizing allylbenzene with the nickel catalyst without the use of HPPh2.  
 
Scheme 67: Nickel-catalyzed E-selective isomerization of allylbenzene without the use of HPPh2. 
As shown in Scheme 67, 17 was the only substrate which was isomerizable without HPPh2. 
This observation led to the hypothesis that a different reaction pathway via -allyl mechanism 
could be present when using the nickel-based pre-catalyst. To reveal this assumption, 
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Z-methylstyrene (Z-18) was isomerized to the corresponding E-isomer. Indeed, the reaction 
also succeeded without the use of the HPPh2 co-ligand. 
 
Scheme 68: Nickel-catalyzed isomerization of Z-methylstyrene to E-methylstyrene without the use of HPPh2. 
The Z-configured -methylstyrene is presumably converted into the thermodynamically more 
stable E-isomer presumably via an allyl mechanism, which does not need any external hydrogen 
source. It requires one more vacant site on the nickel atom. This phenomenon was also 
described by Ong et al. for a tandem isomerization/C−H activation sequence.111 Based on these 
results, Evgeny I. Grigoryev calculated activation barriers which fit to a formal 1,3-hydride 
shift running through 3-nickel hydride intermediates via -allyl mechanism (cf. Scheme 2 in 
chapter 1.1.1).  
To confirm the proposed 1,3-hydride shift, deuterated allylbenzene (17-d2) was isomerized 
(Scheme 69). As expected, the deuteride is incorporated to the terminal position of the substrate 
in 76%. 12% deuterium were further transferred to position 2.  
 
Scheme 69: Nickel-catalyzed E-selective isomerization of deuterated allylbenzene without the use of HPPh2. 
A crossover experiment using 17-d2 and non-deuterated 4-methoxyallylbenzene (171) revealed 
that a deuteride from the benzylic position is also incorporated in the second substrate after 
isomerization (Scheme 70). 
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Scheme 70: Crossover experiment with deuterated allylbenzene and 4-methoxyallylbenzene. 
46% deuterium were incorporated to the methyl group of 172, whereas 44% remained at the 
benzylic position of 18-d. Additionally, around 20% deuterium were transferred to position 2 
of each product.  
The nickel catalyst is able to abstract a deuteride to transfer it to the second starting material 
during the isomerization process. This observation led to the idea of an alkyl mechanism with 
allylic activation. The isomerization of allylbenzene derivatives could therefore proceed via 
both mechanisms. Further mechanistical calculations concerning the isomerization of 
allylbenzene are currently underway. 
In summary, the -hydride elimination determines the high Z-selectivity. For most terminal 
alkenes (except for allylbenzene) the reaction follows the pathway of a conventional alkyl 
mechanism. The co-ligand HPPh2 is required for the initial transfer of the hydrogen atom to the 
substrate without the formation of a real nickel hydride species. The steric congestion around 
the nickel atom stabilizes the substrate in a syn-conformation that provides a high Z-
stereoselectivity. The nickel-catalyzed isomerization of allylbenzene proceeded E-selectively 
in the absence of HPPh2 and could follow an alkyl mechanism with allylic activation. The 
cobalt-catalyzed isomerization does not give any conversion in the absence of HPPh2. 
The cooperation with the Berger group underlined the “substrate-dependent mechanistic 
diversity” of the nickel-catalyzed isomerization.110 
3.1.3 Isomerization with Diphenylphosphine Derivatives 
Diphenylphosphine acts as the crucial additive concerning reactivity and selectivity of the 
cobalt and nickel-based catalyst system providing the necessary hydrogen atom for the above 
verified alkyl mechanism. Corinna Kohlmeyer already addressed different hydrogen sources 
for the formation of the active nickel catalyst species, such as water, acids, silanes and amines 
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in her Master thesis.112 Therefore, these additives will not be features in this chapter. At this 
point, one last issue shall be clarified, whether the electronic and steric configuration of the 
phosphine additive have a measurable impact on the catalyst’s reactivity and the Z-selectivity 
of the isomerization. For this purpose, differently substituted HPPh2-derivatives were 
synthesized according to a procedure of Busacca together with Lukas Alig (Scheme 71).113 
 
Scheme 71: Synthesis of substituted HPPh2-derivatives with overall yield. 
The target molecules are addressable via Grignard reaction of diethyl phosphite (173) and the 
corresponding aryl bromide. The second step comprises the reduction of the aryl phosphite 174 
with diisobutyl aluminum hydride (DIBAL). The secondary phosphines of type 175 are very 
air-sensitive. During the preparation and storage, it has to be made sure, that the product is not 
exposed to air. All compounds could be synthesized in acceptable overall yields of up to 66% 
in two steps.  
The application of the secondary phosphines in the Z-selective isomerization reaction should 
reveal, if the reactivity and especially the Z-selectivity of the established nickel-based catalyst 
system can be correlated to the electronic nature of the phosphines. Hopefully, an even better 
selectivity can be reached by varying the substituent on the phenyl moiety. The preparation of 
the catalyst was carried out according to GP 1 described in chapter 1.2.1. All reactions were 
compared to those performed with commercially available HPPh2.  
1-Octene (15) was used as first test substrate for the Z-selective isomerization at −50 °C with 
either HPPh2, the electron-rich bis(4-methoxyphenyl)phosphine 175b, or the rather electron-
deficient bis(4-chlorophenyl)phosphine 175d. The reaction is shown in Scheme 72. 
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Scheme 72: Isomerization of 1-octene with three different phosphines. 
The phosphine was added as stock solution (0.125 mM in dichloromethane) at ambient 
temperature and the mixture was stirred for another 10 min, until being cooled to −50 °C. 
1-Octene was then added and reaction samples were taken after defined times. GC analysis was 
performed for a determination of the conversion of the starting material, the Z/E-ratio of 2-
octene as well as the amount of other internal isomers formed at this temperature. The use of 
an internal standard was not necessary, since only the conversion of the starting material should 
be determined. The time course of the reaction obtained with the three phosphines are plotted 
in Figure 10. 
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Figure 10: Normalized conversion of 1-octene in dependence of time for different phosphines. 
When HPPh2 was used as co-ligand, the conversion of 1-octene was not complete. It reached 
the plateau of around 80% conversion after 6 h reaction time (black line in Figure 10). An 
outlier was measured at t = 180 min. The reaction with 4-chlorophosphine 175d was already 
completed within an hour with a maximum conversion of 96% (red line). As can be seen above, 
4-methoxy-substituted phosphine 175b reacts very poorly with the substrate. Even after 6 h 
reaction time, the conversion of 1-octene has not even reached 50%. The experiment is an 
average of two runs. Compared to the other phosphines, 4-chlorophosphine 175d works best in 
terms of reactivity. Figure 7 illustrates the Z/E-ratio of 2-octene (16) and the number of other 
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isomers formed in the process. Because of its low reactivity, the 4-methoxy-substituted 
phosphine 175b was no more considered for this examination. 
As can be seen in Figure 11, in terms of Z-selectivity HPPh2 (left diagram) is superior to its 4-
chloro-substituted counterpart (right diagram). A Z/E ratio of around 3:1 could be obtained with 
HPPh2 as co-ligand at a reaction temperature of −50 °C after 6 h reaction time. The 4-
chlorophosphine 175d provided a Z/E ratio of 2.5:1 with a significant higher amount of other 
internal isomers (right side, blue curve). The high reactivity of phosphine 175d provides a lack 
in selectivity, though.  
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Figure 11: Amount of internal octene isomers for the isomerization with HPPh2 (left) and bis(4-chlorophenyl)-
phosphine (right). 
Since 1-octene gave too many internal isomers at −50 °C, the reaction was difficult to be plotted 
accurately. The target substrate was therefore changed to boronic ester 132, which is easier to 
handle in the isomerization reaction and the amount of other internal isomer is limited to one, 
the vinyl boronic ester 111 (cf. Scheme 73).  
 
Scheme 73: Isomerization of homoallyl boronic acid pinacol ester 132 with different phosphine additives. 
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Furthermore, the peaks in the gas chromatogram of the possible isomers are better baseline 
separated compared to those of the octene isomers, so a better integration is provided and 
monitoring of the reaction via GC analysis was way easier. 
The reaction shown in Scheme 73 was performed under the established conditions utilizing 
5 mol% phosphine. The appropriate plot is shown in Figure 12. 
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Figure 12: Comparison of the isomerization with HPPh2 (left) and bis(4-chlorophenyl)phosphine (right). 
Interestingly, the isomerization with 4-chloro phosphine 175d in Figure 8 (right diagram) shows 
an excellent reactivity and Z-selectivity at −35 °C reaction temperature. Nearly no E-isomer 
can be detected via GC analysis, albeit the amount of vinyl boronic ester 111 increases slightly 
in the course of time. The isomerization of the Z-configured crotyl boronic ester 41 to the vinylic 
species 111 proceeds faster than the competing Z to E isomerization of the double bond located 
in the allylic position. The isomerization of 132 with other phosphines is depicted in Figure 13. 
Only low and therefore not satisfying conversion of the starting material is observed, which is 
also  already illustrated above when 1-octene was used as terminal alkene. Electron-rich 
phosphines, such as the mesityl- (175a), the 4-methoxy- (175b), or the cyclohexyl-substituted 
one are not suited to catalyze the isomerization reaction effectively. Also, bis(4-fluorophenyl) 
phosphine 175c was completely unreactive. These phosphines do not seem to be the ones of 
choice for the isomerization process. 
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Figure 13: Isomerization of homoallyl boronic ester 132 with bis(cyclohexyl)phosphine (green line), bis(4-
fluorophenyl)phosphine (red line), bis(4-methoxyphenyl)phosphine (black line) and bis(mesityl)phosphine (blue 
line) with no satisfying conversion of the starting material (s.m.). 
In summary, a screening of different secondary phosphines came to the result that outstanding 
reactivity could only be accomplished with simple HPPh2 and bis(4-chlorophenyl) phosphine. 
The phosphine screening was performed for two substrates: 1-octene (15) and homoallyl 
boronic ester 132. A correlation between electronic structure or steric factors and the reactivity 
and Z-selectivity of the phosphines applied could not be detected. Electron-rich phosphine do 
not show any reactivity. Alone, bis(4-chlorophenyl) phosphine shows a higher reactivity and in 
case of boronic ester 132 a better Z-selectivity than commercially available HPPh2. In case of 
1-octene HPPh2 was still the additive of choice, because of its outstanding selectivity. Bis(4-
chlorophenyl) phosphine could act as possible surrogate for future transformations with 
selected substrates. Since simple HPPh2 is commercially available and easier to handle and 
store, it will still be the phosphine of choice for all the future transformations via nickel-
catalyzed isomerization. The chloro-substituted phosphine 175d can be kept in mind for special 
substrates whose reactivity and Z-selectivity is not satisfying enough when HPPh2 is applied.  
3.1.4 Application of the Z-Selective Isomerization in Natural Product 
Syntheses 
3.1.4.1 Isomerization of ,-Dienes 
Simple aliphatic, branched, and functionalized -olefins could already be addressed via nickel-
catalyzed diphenylphosphine-assisted Z-selective isomerization. Through targeted adjustment 
of the reaction temperature, a regioselective isomerization of substrates with a second internal 
or terminal double bond present in the molecule, was achieved. An additional trisubstituted 
internal double bond remained untouched by the catalyst (Scheme 74, top), even at ambient 
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temperature. When a second terminal double bond was present in the starting material, a kinetic 
discrimination of the sterically more shielded double bond was only achieved at a temperature 
low enough for the monoisomerization of the better accessible one (−40 °C, Scheme 74, 
bottom). At higher temperatures the competing double bond of 177 was also isomerized, which 
leads to a dramatic loss in regioselectivity.102 
 
Scheme 74: Kinetic discrimination of terminal and internal double bonds at low temperatures. 
Diene subunits are a common structure motif in several natural products and pharmaceutically 
active compounds, especially in insect attractants and pheromones.114,115 Figure 14 illustrates a 
selection of natural compounds with a conjugated or skipped diene structure motif, which are 
sexual hormons of the beet armyworm spodoptera exigua (9Z,12Z-165), and Indianmeal moth 
plodia interpunctella (9E,12Z-165). Furthermore, the natural product aucanthen (180) is an 
odorous substance of the marine brown alga cutleria multifida.116 The molecule contains two 
double bonds in close proximity to each other. The molecules, shown in Figure 14, are natural 
products potentially addressable by the nickel-catalyzed monoisomerization. All substances 
contain a double bond next to a methyl group. By targeted temperature adjustment, either an E- 
or a Z-configured double bond can be formed according to which stereoisomer of the 
pheromone is desired. 
 
Figure 14: Aucanthen (180) and selection of insect pheromones with 8,10- and 9,12-diene substructure. 
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3.1.4.2 Pheromone Syntheses 
For the synthesis of the desired diene structures, our synthetic approach contained a threefold 
challenge in the final isomerization step. The catalyst should generate the double bond in 
position 2 (highlighted in green in Figure 15) with high Z-selectivity without converting the 
skipped diene subunit into a conjugated system and the configuration of the internal double 
bond should not be altered by the catalyst.103 Figure 15 illustrates the challenges for a selective 
double bond migration using the example of the pheromone (9Z,12Z)-tetradeca-9,12-dien-1-yl 
acetate (165), one of the sexual hormone ingredients of the beet armyworm spodoptera exigua.  
 
Figure 15: Challenges for a selective double bond isomerization. 
In a 2013 report, Grubbs highlighted the cross-metathesis reaction as an alternative convenient 
method for the preparation of Z-configured internal double bonds applicable in pheromone 
syntheses.114 Ortiz and co-workers could get access to (9Z,12E)-tetradeca-9,12-dien-1-yl 
acetate, the sex pheromone of the olive pyralid moth euzophera pinguis and the corresponding 
E-isomer of target molecule 165. They formed the internal Z-configured double bond via Wittig 
olefination of linear aldehyde 182 and pent-3-enyltriphenylphosphonium bromide (183) 
starting from commercially available nitrile 86 (cf. DuPont Adiponitrile Process in Scheme 32) 
and bromide 181 as Scheme 75 reveals.117 
 
Scheme 75: Pheromone synthesis by Ortiz and co-workers. 
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The own synthetic approaches towards the total synthesis of the C14-pheromone (9Z,12Z)-
tetradeca-9,12-dien-1-yl acetate (165) shall start from commercially available starting materials 
186 or 189 (Scheme 76) with either a subsequent Wittig olefination or Lindlar hydrogenation 
for the stereoselective formation of the Z-configured internal double bond. The syntheses shall 
be completed with a final Z-selective isomerization of alkene 184 as key step. 
 
Scheme 76: Planned approaches towards the starting material for the pheromone synthesis through a final 
Z-selective isomerization step. 
The second target structure, the C12-pheromone pheromone (8Z,10Z)-dodeca-8,10-dien-1-yl 
acetate (164 in Figure 16) should be addressable according to the same pathway.  
 
Figure 16: Target structure of the pheromone (8Z,10Z)-dodeca-8,10-dien-1-yl acetate (164). 
The initial synthetic approaches towards all-Z-configured pheromones 164 and 165 started with 
an alkyne zipper reaction of internal alkyne 189, which Anastasia Schmidt also applied in her 
total synthesis of O-protected urushiol.92 The literature-known118 formation of terminal alkynes 
188 and 190 proceeded easily in good yield (93% in case of the C-9 alcohol and 91% in case 
of the C10-alcohol). Subsequent acetyl protection and copper-catalyzed C-C-bond coupling of 
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the terminal alkynes with the corresponding (homo)allylbromide could be realized according 
to a procedure of da Silva in good yields (Scheme 77).119 
 
Scheme 77: Zipper reaction and C-C-coupling for enyne synthesis. 
With the acetyl-protected enynes 187 and 191 in hand, the triple bond reduction in Z-selective 
fashion should be accomplishable through Lindlar hydrogenation according to a procedure of 
Ghasemi.118 Unfortunately, the hydrogenation with a Pd/C-catalyst presumably formed the 
completely hydrogenated product 192 or the catalyst hydrogenated both, the alkyne moiety to 
the alkene as well as the terminal double bond to saturation. The undesired products could be 
verified by GC/MS analysis and NMR spectroscopy. A higher loading of the catalyst poisons 
Pb(OAc)2 and quinoline or a shorter reaction time resulted in no conversion at all.  
 
Scheme 78: Unselective Lindlar hydrogenation of enyne 191. 
The Lindlar hydrogenation was also unsuccessful for the free alcohol of 191 and the TBS-
protected alcohols. No regiodifferenciation between a terminal double bond and the internal, 
more reactive internal triple bond occurred.  
The second approach (Scheme 76, right side) included the formation of the Z-configured 
internal double bond via Wittig olefination. The synthesis started with a TBS-protection and 
oxidation of commercially available diols 186 (n = 1 or 2, Scheme 79). The resulting aldehydes 
were olefinated by a Wittig reaction with homoallyl or and 1-pentenyl-triphenylphosphonium 
bromide, respectively. The acetal group had to be introduced after the Wittig reaction, since the 
ester moiety inhibited the desired carbonyl olefination. Subsequent desilylation with 
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tetrabutylammonium fluoride (TBAF) and ester formation yielded the desired 1,4-diene 194 
and 1,5-diene 184 in acceptable yields over five linear steps, which could then be introduced 
for the final regioselective isomerization key step. The precursor synthesis is summarized in 
Scheme 79. 
 
Scheme 79: Synthesis of the pheromone precursors via alcohol oxidation/Wittig olefination sequence. 
The final isomerization step was achieved by initial reaction condition screening, such as metal 
(Co or Ni), phosphine ligand, and temperature for both target molecules, C12-pheromone 164 
and C14-pheromone 165. 
 
Scheme 80: Desired Z-selective isomerization of the pheromone precursor 194. 
The modifications for the C12-pheromone with 2,4-diene substructure 164 will be presented 
first. Table 1 summarizes the optimization of the reaction conditions. 
Table 1: Screening for conditions for the isomerization of the 1,4-diene subunit of 194. 
entry M(L)X2 T,  t reaction progressa 
1 Ni(dppp)Br2 rt, 18 h 
E/Z 73:27 
incomplete conversion 
2 Ni(dpppBuEt)Br2 rt, 18 h low conversion 
3 Ni(dppe)Cl2 rt, 18 h 
E/Z 70:30 
incomplete conversion 
4 Ni(dppe)Cl2 rt, 4 d 77% yield, E/Z 50:50 
5 Ni(bdpp)Br2 rt, 2 d 
E/Z 37:63 
incomplete conversion 
6 Co(dppp)Br2 rt, 18 h 90% yield, E/Z 87:13 
7 Co(dppp)Br2 0 °C, 18 h no conversion 
a: General reaction conditions: M(L)X2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%) in CH2Cl2 (0.1 M), 
10 min stirring at rt, then addition of the 1,4-diene 194 (1.0 M) and stirring at rt for the desired time. 
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Most of the time, the isomerization with a nickel-based catalyst provided incomplete conversion 
and a Z/E mixture of the resulting 1,3-diene. Especially at lower temperatures (< 0 °C, or < rt) 
the reaction did not proceed. After increasing the temperature to ambient temperature and 
adding another portion of catalyst, the conversion could be completed, but the Z/E ratio was not 
further improved (entries 4+5). The isomerization with the cobalt-based catalyst Co(dppp)Br2 
gave full conversion with mainly E-selectivity (entry 6). Lowering the temperature resulted, 
again, in no conversion of the starting material 194 (entry 7). For the 1,3-diene structure, the E-
isomer was the thermodynamically favored product. Either way (use of Ni, and Co-catalyst), 
the configuration of the internal double bond was not altered. The synthesis of the Z,Z-
configured product 164 did not succeed, but the corresponding Z,E-configured isomer could be 
obtained in a good isomeric excess (ie) of 74% and an excellent yield of 90%.  
In case of the 1,5-diene precursor 184, the nickel-catalyzed isomerization was easier to handle, 
since it proceeded smoothly at lower temperatures. The conversion could be controlled by 
targeted adjustment of the reaction temperature. The reaction proceeded slower and was better 
monitorable. 
 
scheme 81: Final isomerization step in the total synthesis of C14-pheromone 165. 
Table 2 summarizes the optimization of the reaction conditions. 
Table 2: Reaction condition screening for the isomerization of the 1,5-diene subunit of 184. 
entry M(L)X2 T / t reaction progressa 
1 Ni(dppp)Br2 rt, 1 h unselective reaction 
2 Ni(dppp)Br2 −30 °C, 4 h, → rt, o/n Z/E 83:17 
3 Ni(dppp)Br2 −50 °C, 18 h low conversion 
4 Ni(dppp)Br2 −15 °C, 8 h 92% yield Z/E 83:17 
5 Ni(dppe)Cl2 −15 °C, 8 h 92% yield Z/E 88:12 
a: General reaction conditions: Ni(L)X2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), 10 min stirring at rt, then addition of the 1,5-diene 184 (1.0 M) and stirring at rt for the desired time. 
The isomerization with the usual nickel-catalyst Ni(dppp)Br2 at ambient temperature resulted 
in the formation of an undefined mixture of internal diene isomers, which could be detected via 
GC/MS analysis and were not further characterized (Table 2, entry 1). The isomerization gave 
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full conversion, though. The temperature was decreased to −30 °C to slow down the reaction 
and decrease the number of isomers to the desired 2,5-diene substructure (entry 2). Warming 
up the reaction overnight to ambient temperature resulted in a Z/E mixture of 83:17 with nearly 
quantitative consumption of the starting material 184. A further decrease in temperature 
(−50 °C, entry 3) resulted in incomplete conversion of the starting material. Best results were 
obtained at −15 °C and 8 h reaction time to prevent the 2-Z-double bond from further chain 
walking or isomerizing to the E-isomer. Switching the ligand from dppp to dppe gave an 
increase in selectivity to the best achievable Z/E-ratio of 88:12. Pure (9Z,12Z)-tetradeca-9,12-
dien-1-yl acetate (165) could be isolated via AgNO3-impregnated silica flash column with a 
stepwise solvent gradient. Further information can be found in the experimental section. 
In summary, the C12-pheromone with the conjugate diene structure motif (164) could be 
obtained in 90% yield and 74% isomeric excess of the E-configured double bond in position 2. 
An isomerization to the initially desired Z,Z-configured isomer was not possible, whereas the 
C14-pheromone from spodoptera exigua 165 could be easily obtained by nickel-catalyzed 
isomerization of the corresponding 1,5-diene 184 at −15 °C in excellent yield (92%) and high 
isomeric excess (76%) of the desired Z,Z-configuration.  
 
Figure 17: Accomplished total syntheses of C-12 pheromone 164 with 8Z,10E-diene substructure and C-14 
pheromone 165 with 9Z,12Z-diene moiety. 
Rolf Emmerich is thankfully acknowledged for his synthetic contribution. The synthesis of 
(9Z,12Z)-tetradeca-9,12-dien-1-yl acetate was published in 2015.103 
3.1.4.3 Attempted Synthesis of Aucanthen 
Besides the isomerization of the terminal double bond in presence of another internal double 
bond, the second challenge for the nickel-catalyzed isomerization would be an isomerization of 
a non-substituted terminal double bond, ideally to one single stereoisomer, in presence of 
another -double bond with sterically more demanding substituents. This structure motif can 
be found in the natural product aucanthen (180), one of the ingredients of an odorous substance 
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of the marine brown alga cutleria multifida.116 The hypernym “aucanthen” describes a whole 
family of stereoisomers and diastereomers with the skeletal backbone shown in Figure 14. 
Browne et al. addressed the trans-configured diastereomer of the molecule in a simple 
enantioselective three-step synthesis. The reaction is shown in Scheme 82.120 
 
Scheme 82: Aucanthen synthesis by Browne et al. 
The following approach started with a reduction of tetrahydroisobenzofuran-1,3-dione (198) 
and subsequent TBS-monoprotection and Swern oxidation to give aldehyde 199 in 57% over 
three linear steps. The associate test molecule with two terminal double bonds in close 
proximity, diene 200, could be synthesized in another three steps with an overall yield of 27%. 
Philip Horx is thankfully acknowledged for his synthetic contribution towards the synthesis of 
200.  
 
Scheme 83: Synthesis of the potential aucanthen precursor 200. 
The final isomerization key step was carried out under different conditions, which are 
summarized in Table 3. 
 
Scheme 84: Isomerization of diene 200 to the desired aucanthen diastereomer 180 and probable side-products. 
Unfortunately, a chemoselective isomerization of the allylic terminal double bond (highlighted 
in red in Scheme 84) next to the vinylic double bond (highlighted in purple) did not succeed. 
Only at ambient temperature, a reaction took place. A mixture of isomers was detected via 
GC/MS analysis, though. Probably, the vinylic double bond was also isomerized to the 
thermodynamically favored trisubstituted position as shown for compounds 180’ and 180’’. 
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Table 3: Attempts for the isomerization of diene 200. 
entry M(L)X2 T / t reaction progressa 
1 Ni(dppp)Cl2 rt, 1 h unselective reaction 
2 Ni(dppp)Cl2 −30 °C, 3 h low conversion 
3 Ni(dppp)Cl2 −20 °C, 3 h → rt, o/n 
low conversion, 
then unselective 
4 Ni(dppp)Cl2 0 °C, 18 h low conversion 
5 
Ni(dppp)Cl2 
HSiEt3
b 
−30 °C, 3 h unselective reaction 
6 Co(dppp)Br2 rt, 18 h no conversion 
a: General reaction conditions: M(L)X2 (10 mol%), Zn, ZnI2 (20 mol%), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), 10 min stirring at rt, then addition of diene 200 (1.0 M) and stirring at rt for the desired time;  
b: Triethylsilane (1.5 eq) was used instead of HPPh2. 
Nevertheless, the limitations of our catalyst system could be identified. Due to the close 
proximity of both terminal alkene moieties, a coordination of the catalyst to the two double 
bonds could be the reason that the reaction does not proceed at lower temperatures. The same 
result was observed, when trying to isomerize allylstyrylether 201, as shown in Scheme 85.  
 
Scheme 85: Attempted isomerization of allylether 201. 
  
3. Results and Discussion 
59 
 
3.1.5 Isomerization of N-Allyl Amides and N/O-Allyl Carbamates 
In constant search for higher functionalized substrates, Anastasia Schmidt already identified 
amines and amides as non-applicable susbtrates for the cobalt-catalyzed double bond 
transposition, since they led to a deactivation of the cobalt catalyst presumably due to 
coordination.33 Other alumni of the Hilt group described the same observation when they 
applied starting materials with a free NH-group for a cobalt-catalyzed hydrovinylation 
reaction.121 At that point, the nickel-based catalyst system could provide a remedy by enabling 
the isomerization of nitrogen-containing molecules. The substrate screening for the nickel-
based catalyst system revealed that amines are no suitable substrates, either, as they lead to 
inhibition of the catalyst without any conversion occurring. As already described above, similar 
nickel catalysts have been applied for the isomerization of N-allyl amides and carbamates by 
Liu, Manolikakes, and Moran.50–52 Liu and Manolikakes obtain a rather unselective Z/E mixture 
of the corresponding enamides and enecarbamates,50,51 so that there is still a strong need for a 
Z-selective isomerization of N-allylic compounds. Helpful discussions with the latter led to the 
idea of testing the same substrate class for a regioselective double bond transposition with our 
nickel-based catalyst system.  
The following chapters describe the results achieved towards the desired Z-selective 
isomerization of N-allyl amides and carbamates. The synthesis of the starting materials 
followed literature-known procedures122 and can be found in the experimental section. The 
results were published in 2016.123  
3.1.5.1 Z-Selective Isomerization of Secondary N-Allyl Amides and Carbamates 
For an initial screening of reaction conditions, the established nickel catalyst system was 
applied according to a modified GP 1 (GP 2 in experimental section). Complete conversion of 
the test substrate N-allyl benzamide 71e was achieved after 20 h stirring at –20 °C with an 
isolated yield of 70% and an acceptable Z/E ratio of 80:20. 
 
Scheme 86: Isomerization of the test substrate N-allyl benzamide (71e). 
The conversion of the starting material and the Z/E ratio were monitored by GC/MS analysis. 
The determination of the final Z/E ratio after purification was confirmed by NMR spectroscopy 
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and verified by GC/MS analysis. As already seen above for other substrates, the performance 
of the reaction at ambient temperature provided a diminished Z-selectivity. More precisely, the 
thermodynamic equilibration led to a Z/E ratio of 45:55 and an isolated yield of 83%. Since the 
yield of the resulting enamide 72e was not yet adequate, a modification of the initial reaction 
conditions regarding the nature and amount of the Lewis acid, which could be the reason for a 
loss of yield, was addressed. The reactions were performed at −20 °C with a reaction time of 
20 h (cf. Scheme 86) and 20 mol% Lewis acid, unless otherwise stated (Table 4, entry 6). 
Table 4: Modifications of the reaction conditions by varying the amount and nature of the Lewis acid. 
entry Lewis acid reaction purification Z/E yielda 
1 ZnI2 complete conversion FC (Silica) 80:20 70% 
2 ZnI2 complete conversion 
FC (Silica, 
1% NEt3) 
66:34 47% 
3 10 mol% ZnI2 85% conversion FC (Silica) 67:33 62% 
4 without ZnI2 7% conversion - - - 
5 ZnCl2 60 % conversion FC (Silica) 74:26 55% 
6 AgOTs 
no conversion 
(−20 °C and rt, 48 h) 
- - - 
7 AgOAc 
complete conversion 
(24 h) 
FC (Silica) 65:35 71% 
8 BF3 · OEt2 no conversion - - - 
9 TiCl4 
decomposition of the 
s.m. 
- - - 
a: General reaction conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol%), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), 10 min stirring at rt, then addition of N-allyl benzamide (1.0 M) and stirring at −20 °C for 20 h, unless 
otherwise stated (s.m. = starting material). 
The purification of enamide 72e was performed via flash column chromatography on silica, 
making sure that both isomers (which sometimes varied in their Rf values on the TLC plate) 
were completely flushed down. Since a decomposition of the product can also occur on an 
acidic stationary phase, the silica was impregnated with 1 vol% triethylamine to prevent the 
product from potential decomposition (Table 4, entry 2). This led to a decrease in yield, so that 
silica was the stationary phase of choice. The amount and nature of the Lewis acid was further 
addressed. When only 10 mol% ZnI2 under otherwise steady reaction conditions were used, 
incomplete conversion (85% after 20 h at –20 °C, entry 3) could be detected via GC/MS. In the 
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absence of ZnI2 only 7% conversion were observed (entry 4). The Lewis acid was crucial for 
the activation of the catalyst. A halide substitution of ZnI2 to ZnCl2 (20 mol%) was possible, 
but a longer reaction time was necessary, due to incomplete conversion of the starting material 
(80% after 20 h at –20 °C). The use of other Lewis acids such as AgOTos (entry 6, no 
conversion) was also unsuccessful. The use of strong Lewis acids, such as BF3 · Et2O, or TiCl4 
led to decomposition of the starting material. Alone, the application of AgOAc led to full 
conversion after 48 h. However, an inferior excess of the Z-isomer (Z/E = 65:35, entry 7) was 
formed. All Lewis acids led to comparable or lower isolated yields of the enamide than obtained 
with the use of 20 mol% ZnI2, so that in conclusion ZnI2 remained as the Lewis acid of 
choice.123 Variation of the ligand revealed that dppp acts superior to dppe and other substituted 
dppp derivatives. Too bulky ligands, such as dpppBuEt or bdpp, led to a significant decrease in 
conversion of the starting material or completely shut down the reaction.  
During her Master thesis, Corinna Kohlmeyer revealed that, similar to HPPh2, other hydrogen 
sources, such as silanes, water, and even amines, were able to transfer the hydrogen to the 
substrate initiating an isomerization process. Unfortunately, the addition of other hydrogen 
sources always decreased the Z-isomeric excess in the product mixture. Kohlmeyer observed 
that the Z-isomer is transferred to the E-isomer even though a full conversion of the terminal 
alkene was not obtained. The amount of other internal isomers was increased when an amine is 
added.112 On basis of these results, a potential involvement of the amidic hydrogen atom of 71 
(highlighted in blue in Scheme 87) could be possible. 
 
Scheme 87: Possible involvement of the secondary amide group in the catalytic cycle. 
To test, if the hydrogen located at the nitrogen atom was somehow involved in the catalytic 
cycle, the N-deuterated benzamide derivative 72e-d was synthesized. 
 
Scheme 88: Deuterium-labeling of N-allyl benzamide (71e). 
No isomerization of the secondary amides took place in the absence of HPPh2. Isomerizing the 
deuterated benzamide 72e-d in presence of HPPh2, the desired reaction occurred. In the product, 
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no deuterium could be detected via GC/MS analysis and 2H NMR spectroscopy. In conclusion, 
the free NH-group did not participate in the catalytic cycle, since deuterium was not 
incorporated in the alkenyl chain of the isomerized product. 
With the final reaction conditions in hand, the substrate screening was focused on temperature 
modifications to obtain the best possible Z-selectivity. Similar to the results in my Master thesis, 
a targeted adjustment of the reaction temperature is necessary for each substrate.102 
 
Scheme 89: Isomerization of secondary N-allyl amides. 
A study was then carried out to screen a number of  representative secondary N-allyl amides 
with different alkyl and aryl substituents and reaction temperatures. The reactions were 
performed in cooperation with Philipp Steinlandt in the course of his Bachelor thesis.124 The 
best reaction conditions for each substrate, giving the highest conversion, the lowest amount of 
side products, and the best Z-isomeric excess, are summarized in Table 5. 
Table 5: Substrate scope of the isomerization of secondary N-allyl amide of type 71.  
entry starting material main product T, t yield Z/E ratioa 
1 
  
−20 °C, 48 h 12% 80:20 
2 
  
RT, 90 min 42% 82:18 
3 
  
−30 °C, 64 h 60% 92:8 
4 
  
83 °C,b 144 h 54% 50:50 
5 
  
−30 °C, 64 h 74% 91:9 
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entry starting material main product T, t yield Z/E ratioa 
6 
  
rt, 168 hc 47% 86:14d 
7 
  
rt, 192 hc 70% 64:36 
8 
  
−20 °C, 39 h 66% 81:19 
9 
  
−25 °C, 69 h 62% 93:7 
10 
  
18 °C, 45 h 63% 78:22 
11 
  
5 °C, 72 h 33% 84:16 
a: General conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), stirring for 10 min at rt and then cooling to desired temperature. Addition of 1.0 eq N-allyl amide; b: The 
reaction was performed in acetonitrile (1.0 M) instead of dichloromethane; c: Additional catalyst was added, see 
experimental section; d: A rotameric mixture of the product was obtained, see experimental section (the Z/E/s.m. 
ratio is 79:10:11). 
The use of the simplest alkyl chain R = Me resulted in isolation issues of the product 72a. 
Because of the product’s high volatility, the solvent could not be removed completely, and the 
yield was extremely low (Table 5, entry 1). The isomerization of N-allylacetamide (71a) gave 
a good Z/E ratio of 80:20. The introduction of a longer aliphatic side chain 72b solved the 
isolation issue. The yield remained relatively low (42%) and the reaction temperature had to be 
raised to ambient temperature to guarantee a satisfying conversion of the starting material 71b 
with a comparable Z/E ratio of 82:18. In general, aromatic amides 71c,h,i were more reactive. 
The isomerization could be performed at lower temperatures with better Z/E ratios. The 
benzylic amide 71c could be isomerized at –30 °C to furnish the product 72c in acceptable yield 
(60%) and good stereoselectivity with an isomeric excess (ie) of 84% (Table 5, entry 3). Of 
similar high reactivity was the benzamide derivative 71e (Scheme 86), which led to the 
formation of enamide 72e in slightly better yield and Z/E ratio (74%, Z/E = 91:9, entry 5). On 
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the other hand, the substrates derived from cinnamamide (71d), the sterically hindered mesityl-
substituted amide 71f, and 4-methoxyphenyl-N-allylamide (71g) required prolonged reaction 
times and elevated temperatures (83 °C), so that the reaction had to be performed in acetonitrile 
instead of dichloromethane. In general, the latter gives the best isomeric excesses of Z/E 64:36 
(entry 7) for these electron-rich substrates. The addition of more catalyst was necessary to 
obtain full conversion of the N-allyl amides 71f and 71g. Electron-withdrawing substituents on 
the arene moiety, such as halide- and trifluoromethyl-substituted benzamides 71h,i and 71j 
were more reactive and resulted in isomeric excesses of up to 86% (entry, 9). The idea that a 
weak coordination site, such as the thiophene substituent, would be beneficial (71k), could not 
be established. The isomerization of 71k gave an acceptable Z/E ratio (84:16), but poor yield 
(33%, entry 11).123 
The suitability of N-allyl carbamate derivatives as an alternative functional group was further 
investigated, as Scheme 90 depicts. 
 
Scheme 90: Isomerization of secondary N-allyl carbamates. 
Initial screening started with the Boc-protected allylamine 203a leading to the same results as 
above. The best Z-isomeric excess of 62% (Z/E = 81:19) was obtained at −30 °C after 19 h 
reaction time (Table 6, entry 1). Performance of the isomerization at ambient temperature led, 
again, to a decrease of the ie (44% of Z-isomer). Although the reactivity of all substrates was 
sufficient and moderate to acceptable yields of up to 79% could be realized, the Z/E ratios of 
the products 204b and 204c were inferior to the previously reported benzamide derivatives 72. 
Furthermore, enecarbamate 204c was sensitive towards the reaction conditions and the Lewis 
acid was found to cause the formation of decomposition products, such as benzylic alcohol (in 
the case of enecarbamate 204b, as well as phenyl isocyanate and aniline for 204c (entry 3), 
which explains the moderate yield of 204c. 
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Table 6: Z-Selective isomerization of selected secondary N-allyl carbamates. 
entry starting material main product T, t yield Z/E ratioa 
1 
  
−30 °C, 19 h 79% 81:19 
2 
  
−30 °C, 17 h 69%b 81:19 
3 
  
−20 °C, 48 h 36%c 87:13 
a: General conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), stirring for 10 min at rt and then cooling to desired temperature. Addition of 1.0 eq allyl carbamate. b: 
Benzylic alcohol as side product was detected via GC/MS analysis; c: Phenylisocyanate and aniline were detected 
via GC/MS analysis. 
3.1.5.2 E-Selective Isomerization of Electron-Deficient N-Allyl Amides 
Interestingly, the use of secondary electron-deficient N-allyl amides resulted in the formation 
of the E-isomer 206 as the major product.123 The same results were observed, when electron-
deficient -keto N-allyl amides were used.  
 
Scheme 91: Isomerization of electron-deficient N-allyl amides (EWG = electron withdrawing group) 
Table 7 gives an overview. Unfortunately, allyl amide 205d with an attached trichloromethyl 
group could not be transferred to the corresponding enamide (entry 4), maybe due to steric 
hindrance. The isomerizations had to be performed at ambient temperature, otherwise the 
reactions did not proceed (entries 1-3).  
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Table 7: Isomerization of electron-deficient substrates. 
entry starting material main product T, t yield Z/E ratioa 
1 
  
rt, 64 h 64% 15:85 
2 
  
rt, 95 h 29% 8:92 
3 
  
rt, 48 h n.i.b E only 
4 
  
rt, 72 h 
no 
reaction 
- 
5 
  
rt, 24 h 
no 
reaction 
- 
a: General conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), stirring for 10 min at rt. Addition of 1.0 eq allyl amide and stirring at rt for the desired time; b: n.i. = not 
isolated. Z/E ratio was determined via GC/MS analysis. 
 
3.1.5.3 E-Selective Isomerization of Tertiary N-Allyl Amides 
Besides the isomerization of secondary allylic amides, the question arised, if it is also possible 
to isomerize sterically more hindered N-alkylated derivatives. Unfortunately, even at elevated 
reaction temperatures N-methylated amide 207 gave no conversion at all, maybe due to steric 
hindrance. 
 
Scheme 92: Isomerization of N-allyl amide 207. 
Changing the methyl group to a rotationally more flexible n-butyl rest, the reaction did not 
proceed, either. Consequently, the question arised, if a free NH-group is beneficial for the 
nickel-catalyzed translocation of double bonds.123 Therefore, other cyclic tertiary N-allyl 
derivatives (Scheme 93) were investigated in cooperation with Monika Ballmann.  
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Scheme 93: Isomerization of tertiary N-allyl lactams and oxazolidinones. 
The results of the nickel-catalyzed reactions are summarized in Table 8. 
Table 8: Scope of the isomerization of tertiary N-allyl lactams and oxazolidinone of type 209. 
entry 
starting 
material 
main product T, t yield Z/E ratio 
1 
  
rt, 24 h 98% E only 
2 
  
rt, 16 h 93% 6:94 
3 
  
rt, 18 h 77% E only 
4 
  
rt, 18 hb 85% E only 
5 
  
0 °C, 72 h 70% 33:67 
a: General conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%) in dichloromethane 
(0.1 M), stirring for 10 min at rt and then cooling to desired temperature. Addition of 1.0 eq N-allyl lactam; b: 
Ni(dppp)Br2 was used instead of Ni(dppp)Cl2. 
N-allyl lactam systems were also isomerizable giving selectively the E-configured enamides in 
good yields. Simple lactams (209a/209c) or N-allyl phthalimide (209d) gave exclusively the E-
isomer at ambient temperatures . The E-selectivity of oxazolidinone 209b (Z/E = 6:94, Table 8, 
entry 2) was somewhat lower compared to the lactams. In case of the isomerization of branched 
systems, the racemic substrate 209e was applied. The desired product 210e was obtained as a 
33:67 mixture of Z- and E-isomer with a prolonged reaction time of 72 h (entry 5). 
Nevertheless, cyclic amides gave the E-configured products in outstanding yield and selectivity. 
A possible steric hindrance of the cyclic structure furnished the observed E-configuration of the 
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product. In contrast, the isomerization of the corresponding N-methyl derivative 207 failed. An 
interesting finding might be rationalized by the conformation the substrate adopts when 
coordinating to the nickel-catalyst during the overall 1,3-hydrogen shift process. According to 
the work of Hesse49 concerning his iron catalyst this conformation could be explained and 
adopted for the nickel catalyst. A cis-elimination of the nickel hydride is only possible from the 
sterically not hindered intermediate XLII, where the carbonyl group coordinates to the nickel 
catalyst (cf. Scheme 94). A Z/E ratio of 0:100 is unlikely a thermodynamically equilibrated 
process.123 
 
Scheme 94: Possible explanation for the stereochemical outcome. 
Besides the tertiary N-methylated amide 207 other substrates were found, which were not 
applicable, since potential coordination to the catalyst could inhibit the reaction. Non-cyclic 
tertiary amides as well as sulfonamide 214, Weinreb amide 215, and urea derivative 216, shown 
in Figure 18, did not undergo the desired isomerization process. 
 
Figure 18: Substrates, which gave no conversion. 
Finally, the double bond transposition was realized along a longer alkyl chain by a targeted 
adjustment of the reaction temperature to differentiate between a single and a twofold 
translocation process. N-Homoallyl oxazolidinone 217 was applied to the nickel catalyst system 
at different temperatures. The best results with respect to selectivity and yield are shown in 
Scheme 95.123 
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Scheme 95: Temperature-dependent isomerization of N-homoallyl oxazolidinone 217. 
As already observed during the isomerization of more simple functionalized substrates,103 the 
adjustment of the reaction temperature can conveniently direct the nickel-catalyzed 
transposition of the terminal double bond towards the Z-selective migration over one single 
position obtaining allyl carbamate 219 in 83% yield and a Z/E ratio of 84:16. At −10 °C the 
maximum achievable conversion of the starting material was 88%. When the reaction 
temperature was raised to ambient temperature two 1,3-hydrogen shifts occurred and the 
transposition proceeded towards the thermodynamically favored product, enamide 218, in an 
E-selective reaction and a good yield of 82%.123  
In summary, the nickel-based catalyst system bearing HPPh2 as co-ligand was able to isomerize 
the terminal double bond in secondary N-allylic amides and carbamates towards Z-configured 
enamides and enecarbamates. The NH-group does not participate in the reaction. In N-allyl 
lactams and oxazolidinones, the nickel catalyst led to the translocation of the double bond with 
outstanding E-selectivity. Furthermore, a temperature-controlled single or double migration 
process could be realized to either generate the Z-configured allyl amide 219 or the E-
configured enamide 218 (scheme 25). 
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3.2 Nickel-Catalyzed Diastereoselective Isomerization/Allylboration 
Sequence 
Homoallylic boronic esters and silanes could successfully be isomerized to their corresponding 
Z-configured crotyl derivatives with the established nickel catalyst according to GP 1. Scheme 
96 shows the substrates, which were accessible during the substrate screening.102  
 
Scheme 96: Z-selective isomerization of homoallyl boronic esters and silanes. 
Crotyl pinacol boronates 41 and 220 gave excellent Z-selectivities of up to 97:3 without the 
formation of the corresponding vinylboron product at low temperatures (−20 °C or −40 °C). 
The same phenomenon was observed when homoallyl silicon derivative 22 was used (Z/E 94:6 
at −50 °C).102  
The resulting crotyl boron and silicon species should be perfectly qualified for a combination 
of the nickel-catalyzed isomerization step with a subsequent carbonyl allylation reaction. With 
regards to a synthetically useful one-pot transformation, the catalyst should generate a high Z-
selectivity in presence of an aldehyde. The isomerization should not proceed faster than the 
allylboration step to decrease the number of other isomers formed in the process. The 
allylboration must proceed diastereoselectively to transfer the stereochemical information of 
the crotyl species into the product, anticipating the allylboration to proceed through a six-
membered Zimmerman-Traxler transition state. 
The isomerization itself can take place in two different directions. As Murakami has shown in 
2013, the double bond could either isomerize away from the boronic ester function to form E-
selectively a crotyl boronic acid pinacol ester from vinyl boronate 111 via iridium-catalysis 
(Scheme 97).75 
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Scheme 97: Diastereo- and enantioselective isomerization/allylboration sequence by Murakami et al. 
In this chapter, the complementary isomerization to the Z-configured crotyl boronic ester 
starting from homoallylic boronic esters of type 123 is described. Following the original 
protocol for the Z-selective olefin isomerization, the double bond migrates towards the 
functional group as Scheme 98 depicts.103 In presence of an aldehyde R’CHO, the isomerization 
is automatically stopped by the allylboration at the point where the double bond is located in 
the allylic position (compound XLIII) resulting in the diastereoselective formation of 
homoallylic alcohols 163 with two adjacent stereocenters. 
 
Scheme 98: Desired transformation of homoallylboron species 123 to syn-configured homoallyl alcohols 163. 
The results described below were published in 2016.125 Monika Ballmann, Corinna Kohlmeyer, 
Sebastian Brunen and Luca Schmermund are thankfully acknowledged for their synthetic 
contribution. 
3.2.1 Synthesis of the Boronic Esters  
In order to achieve the desired one-pot sequence, a series of boronic esters was prepared first. 
Unsubstituted alkenyl boronic esters could be synthesized according to a procedure by Hilt79 
by Grignard reaction from bromide 221 providing unsaturated products 132 and 222a-c with 
different alkenyl chain lengths in up to 99% yield. 
 
scheme 99: Grignard reaction to the desired alkenyl pinacol boronates. 
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For a future variation of the allylation product’s substitution pattern (cf. compound 123 in 
Scheme 98), differently substituted homoallyl boronic acid pinacol esters were further 
synthesized. An overview is shown in Figure 19. 
 
Figure 19: Substituted homoallyl boronates for the desired one-pot isomerization/allylboration sequence. 
Usually, the boronic esters were synthesized according to literature-known procedures. Further 
information and references can be found in the experimental section. 
3.2.2 syn-Selective Isomerization/Allylboration Sequence of Unsubsti-
tuted Homoallyl Boronic Esters  
Initial results concerning the functional group tolerance of the catalyst exposed that when 
benzaldehyde is added to the isomerization of homoallyl boronic acid pinacol ester (132) in the 
presence of the nickel catalyst system, the corresponding syn-configured allylboration product 
112 could be obtained in a diastereomeric ratio (d.r.) syn/anti of 80:20 at −30 °C. Lowering the 
temperature to −50 °C, the desired homoallyl alcohol 112 could be isolated in 81% yield and 
excellent d.r. syn/anti of 98:2 (Scheme 100). The reaction could also be accomplished in the 
absence of zinc iodide, but in this case the conversion of the starting material was way lower. 
Again, HPPh2 is inevitable for the reaction. 
 
Scheme 100: Isomerization of homoallyl pinacol boronic ester 132 and subsequent allylboration of 
benzaldehyde. 
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When the reaction sequence was performed at ambient temperature, an additional transposition 
toward vinyl pinacol boronic ester can be observed (∼14%) indicating that a fast isomerization 
outruns the allylboration reaction at elevated temperatures.126 The product 112 was obtained in 
moderate yield (27%), but lower diastereoselectivity (syn/anti = 80:20). The fact, that the syn-
configured diastereomer 112 was formed as main diastereomer even at elevated temperature, 
led to the assumption that the Z-configured crotyl boronic ester is formed first, even though in 
somewhat inferior amount compared with the reaction at −50 °C. The subsequent allylboration 
was faster than the Z to E-isomerization of the double bond. With increasing reaction time, the 
reaction equilibrated forming a mixture of syn/anti-configured alcohol 112 as well as the vinyl 
boron species as minor products. However, transposition of 112 toward a corresponding allylic 
alcohol was not observed.112 In general, an allylboration proceeds through a six-membered 
Zimmerman-Traxler transition state XLIV (Scheme 101). Since a predictable 
stereodifferentiation is required in the transition state, it can be assumed, that the syn-configured 
diastereomer was formed due to the Z-selectivity of the previous isomerization step. The anti-
diastereomer was formed vice versa.127 As Hoffmann et al. already explained in the 1980’s, the 
formation of the Zimmerman-Traxler transition state is the rate-determining step of an 
allylboration reaction. In case of the Z-configured crotyl boronic ester, the methyl group in the 
transition state XLIV is located in an axial position. The E-isomer, with the methyl group being 
located equatorially, is the thermodynamic favored conformation. Besides steric demand, the 
thermodynamic stability of the transition state is driven by polar effects.128 The pathway 
depicted in Scheme 101 can be assumed as the origin of the diastereoselectivity.  
 
Scheme 101: Z/E-Selectivity of the isomerization as origin of diastereoselectivity (equat. = equatorial). 
As mentioned above, the syn-configured diastereomer 112 was generated predominantly in the 
reaction sequence, thus the double bond transposition proceeded in a highly Z-selective fashion 
at low temperatures under kinetic control in the presence of benzaldehyde, which obviously did 
not inhibit the isomerization reaction. As Szabo described for a similar reaction, the regio- and 
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stereochemical integrity of allylboronate species can even be maintained at elevated 
temperatures.127 The double bond should be configurationally stable in the subsequent 
allylboration. At ambient temperature, more anti-diastereomer is observed, leading to the 
conclusion that, after isomerization, the E-configured crotyl boronic ester is formed in a higher 
amount. Figure 20 illustrates the temperature-dependence of the one-pot 
isomerization/allylboration sequence using the example 2-methyl-1-phenylbut-3-en-1-ol (112). 
 
Figure 20: Temperature-dependence of the isomerization/allylboration sequence. 
At −30 °C a syn/anti-ratio of 80:20 was obtained, which could be improved of up to 98:2 by 
lowering the temperature to −50 °C. The low temperature also prohibited the homoallylic 
alcohol 112 from isomerizing to the corresponding allyl alcohol. Further, compounds with a 
free hydroxyl group were no suitable substrates for the nickel-catalyst isomerization.102 Only 
the cobalt catalyst tolerated unprotected hydroxyl groups.32,33 For the diastereoselective 
allylboration sequence, the cobalt catalyst system was too unreactive, though. 
3. Results and Discussion 
75 
 
Based on these results, a number of functionalized aldehydes together with homoallylic boronic 
ester 132 were investigated in order to identify the scope and limitations of the nickel-catalyzed 
double bond transposition/allylation process. The reaction temperature and time have to be 
adjusted for each substrate combination.  
 
scheme 102: Isomerization of homoallyl pinacol boronic ester 132 and subsequent allylboration of different 
aldehydes. 
The results are summarized in Table 9. 
Table 9: Isomerization/allylboration of homoallyl boronic ester 132 with different aldehydes. 
entry main diastereomer T, t yield syn/anti a 
1 
 
−50 °C, 7 h 81% 98:2 
2 
 
−50 °C, 5 h 81% 96:4 
3 
 
−40 °C, 1 h 98% 97:3 
4 
 
−50 °C, 5.5 h 77% 97:3 
5 
 
−40 °C, 7 h 76% 95:5 
6 
 
−40 °C, 7 h 61% 98:2 
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entry main diastereomer T, t yield syn/anti a 
7 
 
−40 °C, 6 h 96% 92:8 
8 
 
−50 °C, 2 h 56% 86:14 
9 
 
−50 °C, 5 h 78% 95:5 
a: General conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%), 1.0 eq homoallyl 
boronic ester 132, 1.0 eq aldehyde in dichloromethane (1.0 M). different reaction temperatures and times are listed 
above. The reaction temperature was adjusted with an acetone or isopropanol/dry ice bath. 
In the GC/MS spectra, the peaks of the two diastereomers are merely baseline separated. 
Because of that, the syn/anti diastereomeric ratio was determined by 1H NMR spectroscopy and 
compared to literature-known data. Functional groups, such as a methoxy group (233a, Table 9, 
entry 2), halides (233b, 233c, entries 3-4), a trifluoromethyl group (233d, entry 5), and a nitro 
substituent on the phenyl ring (233e, entry 6) were well accepted and did not interfere with the 
catalytic system. Heterocycles, such as thiophene (233g) and α,β-unsaturated aldehydes (233f), 
were tolerated, as well. All products were obtained in good isolated yields and high 
diastereoselectivity (up to 98:2). Only the product derived from thiophene-2-carbaldehyde 
(233f) led to a lower yield of 56% and somewhat inferior diastereoselectivity of 86:14 (entry 
8). Aliphatic aldehyde octanal led to the desired product 233h, which was isolated in a good 
yield of 78% (entry 9). However, the determination of the diastereoselectivity of the overall 
process was problematic, since diagnostic 1H NMR signals overlapped significantly. 
Nevertheless, the diastereoselectivity for the formation of 233h could be estimated to be ~95:5 
(GC/MS analysis). No other side products generated by follow-up transposition reactions were 
detected when the reaction sequence ran at low temperatures.125  
3.2.2.1 Attempted Isomerization/Allylboration Sequence of Unsubstituted 
Homoallyl Esters with Activated Ketones 
The isomerization/allyboration sequence with a broad scope of functionalized aliphatic and 
aromatic aldehydes gives the desired homoallylic alcohols 233 in high yield and excellent 
diastereomeric excess (de) of up to 96% syn-diastereomer. These results beg the question 
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whether the method is also applicable for ketones, which would have higher steric demand and 
would therefore react slower compared to aldehydes. For a deeper investigation, a variation of 
activated ketones was selected, with the intention that they would be sufficiently reactive in the 
desired allylboration even in the absence of higher amount of an external Lewis acid. The 
reaction and the selection of ketones is illustrated in Scheme 103. 
 
Scheme 103: Isomerization/allylboration sequence with activated ketones. 
First, the isomerization reaction was performed at −50 °C ensuring a high Z-selectivity of the 
outcoming double bond in allylic position (compound 41). Then, 1.0 equivalent (eq) of the 
ketone 235 was added and the mixture was stirred at ambient temperature overnight.  
Unfortunately, the method did not work for the simple ketone acetophenone (235a) and neither 
for other electron-deficient ketones, such as alkynylketone 235b, bromoacetophenone 235d, or 
-ketoester 235e at different reaction temperatures. Alone, benzoyl cyanide (235c) was 
surprisingly able to undergo the desired transformation at ambient temperature leading to 
cyanhydrine 234c in a syn/anti-ratio of 14:86 and 70% isolated yield. The product did not 
decompose to the corresponding ketone and was even stable on the acidic stationary silica gel 
phase during FC. The anti-diastereomer was the main product and was compared to appropriate 
literature.127 At lower temperatures the ketone was not reactive enough. 
 
Scheme 104: anti-Selective isomerization/allylboration of homoallyl boronic acid pinacol ester 132 and benzoyl 
cyanide. 
At this point, the allylboration of ketones can be assumed as a limitation. Probably due to steric 
hindrance, ketones are not reactive enough under the established reaction conditions. 
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Consequently, aldehydes were considered as the carbonyl moiety of choice for the rest of the 
reactions. 
3.2.3 syn-Selective Isomerization/Allylboration Sequence of Long-Chain 
Alkenyl Boronic Esters  
If chain walking of the metal hydride occurs, the double bond transposition could be realized 
along a longer carbon chain. This would allow the introduction of alkyl substituents other than 
a simple methyl group adjacent to the hydroxyl group in the product. As prototype substrate, 1-
pentenyl pinacol boronic ester 222a was reacted with the nickel catalyst system in the absence 
of benzaldehyde at low temperature (−20 °C), and a mixture of homoallyl and allyl pinacol 
boronates were detected. In the presence of benzaldehyde, even at temperatures as low as 
−20 °C, the double bond transposition proceeded twice, and the desired product 237 could be 
obtained in quite good yield of 72% and diastereoselectivity (syn/anti = 91:9).125 
 
Scheme 105: Twofold double bond isomerization and subsequent allylboration of 1-pentenyl boronic acid 
pinacol ester and benzaldehyde. 
When 1-hexenyl or 1-octenyl boronic esters 222b and 222c were applied, the isomerization 
yielded in an unselective mixture of internal isomers at different reaction temperatures, which 
did not undergo the desired allylboration (Scheme 106).  
 
Scheme 106: Unsuccessful isomerization/allylboration of hexenyl- and octenyl boronic esters. 
A controllable Z-selective isomerization via chain walking was therefore limited to two 
positions, otherwise a product mixture of internal isomers of the corresponding boronic ester 
was obtained. Since the double bond did not migrate right up to the necessary allylic position, 
a subsequent allylboration did not take place. 
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3.2.4 Isomerization/Allylboration Sequence of - & -Substituted Homo-
allyl Boronic Esters  
When the one-pot sequence was transferred to differently substituted boronic esters 238, several 
substitution patterns in the desired homoallylic alcohol were addressable. The choice for the 
phenyl substituent at the α-carbon (238 with R’ = H, R’’ = Ph in Figure 19) was rationalized by 
the expectation that the phenyl substituent would preferentially adopt an E-configuration in the 
corresponding product 240 in order to minimize the number of stereoisomers formed in the 
reaction sequence.125  
 
Scheme 107: Isomerization/allylboration of either - or -substituted homoallyl boronic esters. 
A phenyl substituent in  -position (R’ = Ph, R’’ = H, entries 3 and 4) gave alcohol 240c and 
240d in >99:1 anti-configuration (Table 10, entries 3 and 4). The phenyl substituent in this 
position hindered an isomerization at low temperatures. Full conversion of the starting material 
could be obtained at ambient temperature only, independent on the aldehyde used (entries 3 and 
4 in Table 10).Vinyl boronate 240b (R’ = H, R’’ = Bpin, entry 2) could be a potential 
nucleophile for a subsequent Suzuki cross-coupling reaction, since the second Bpin-moiety 
remains intact after the first allylboration. The product is formed in 71% with a diastereomeric 
excess (de) of the syn-configured product of 52%. Unfortunately, a one-pot cross coupling final 
step could not be accomplished.  
Table 10: Substrate scope for the - or -substituted boronic esters. 
entry main diastereomera T, t yield syn/anti 
1 
 
−20 °C, 2 h 97% 95:5 
2 
 
rt, 18 h 71% 76:24 
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entry main diastereomera T, t yield syn/anti 
3 
 
rt, 18 h 71% <1:99 
4 
 
rt, 18 h 41% <1:99 
a: General conditions: Ni(dppp)Cl2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%), 1.0 eq homoallyl 
boronic ester 238, 1.0 eq aldehyde in dichloromethane (1.0 M). different reaction temperatures and times are listed 
above. The reaction temperature was adjusted with an acetone or isopropanol/dry ice bath. 
When an -bromo substituted boronic ester (223 in Scheme 108) was used, the intended 
isomerization did not proceed. Interestingly, a homocoupling, similar to a Kumada coupling, 
took place, instead. Diester 241 was exclusively obtained, which could be verified by GC/MS 
analysis and NMR spectroscopy. This phenomenon was also observed, when simple homoallyl 
bromide or homoallyl acetates were used for the isomerization process. 
 
Scheme 108: Undesired homocoupling of -bromo substituted homoallyl boronic ester 223. 
In conclusion, bromo-substituted homoallyl boronic esters as well as alkenyl bromide 242 and 
acetate, such as 225 (Figure 21), were not suited for an isomerization step as they underwent a 
nickel-catalyzed homocoupling instead.  
 
Figure 21: Substrates, not suitable for the nickel-catalyzed isomerization. A homocoupling took place instead. 
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3.2.5 Isomerization/Allylboration of 1,1-Substituted Homoallylic Boronic 
Esters 
In the last set of experiments, the question should be addressed, whether the double bond 
transposition could also be performed with homoallyl boronic acid pinacol esters with higher 
steric demand, such as 1,1-disubstituted substrates with an exo-double bond. Before turning 
attention to boron-containing starting materials, simple aliphatic alkenes were tested, first. 
3.2.5.1 Isomerization of 1,1-Substituted Alkenes  
As illustrated in the before-mentioned chapter, the nickel-catalyzed double bond transposition 
is applicable to higher functionalized target molecules as N-allyl amides and carbamates. Now, 
that several functional groups have been successfully addressed, the final question is whether 
the reaction is also possible for substrates with higher steric demand, such as for those with a 
1,1-disubstituted double bond as Shenvi, Liu or RajanBabu already described for their cobalt- 
and palladium-based catalysts (cf. Scheme 109).22,29,30 
 
Scheme 109: Overview of the isomerization of substrates with an exo-double bond. 
For this purpose, the established nickel catalyst system was first utilized for the isomerization 
of aliphatic substrates with an exo-double bond. The reaction is illustrated in Scheme 110. 
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Scheme 110: Desired nickel-catalyzed double bond transposition in 1,1-disubstituted alkenes. 
For the isomerization with R = Me, the number of internal isomers of the outcoming 
trisubstituted alkene was determined via GC/MS analysis. The reactions were not purified. 
Other isomers were formed in inferior amounts, even at ambient temperature, because the 
trisubstituted double bond is the thermodynamically favored one.  
As listed in Table 11, the nickel-catalyst was reactive enough to isomerize sterically more 
hindered exo-double bonds. The above shown isomerization approaches were applied as test 
reactions for the desired one-pot sequence, combining the isomerization of homoallylic boronic 
ester with a subsequent allylboration reaction. These experiments should pave the way for 
further isomerization of boron functionalized 1,1-disubstituted olefins in this reaction sequence. 
Table 11: Test reactions for the isomerization of 1,1-disubstituted olefins. 
entry starting material main isomera 
2-
alkeneb 
sum of other 
isomersb 
1 
  
65% 35% 
2 
  
66% 34% 
3 
  
54% 
E only  
46% 
a: General conditions: Ni(dppp)Br2 (10 mol%), Zn, ZnI2 (20 mol% each), HPPh2 (5 mol%), 1.0 eq olefin in 
dichloromethane (1.0 M). Stirring at rt for 18 h; b: Isomeric mixture of the product was analyzed via GC/MS only. 
3.2.5.2 Isomerization/Allylboration of 1,1-Substituted Homoallylic Boronic Esters 
Initially, the possibility of realizing an isomerization of an exo-chain double bond of a 1,1-
disubstituted homoallyl boronic ester was investigated. The isomerization should occur towards 
the boron functionality and thereby generate a geminal-dimethyl (230, R = H) subunit. If the 
substituent R in Scheme 111 is no hydrogen, but a methyl group (compound 231), an interesting 
scenario would occur. The double bond can either isomerized toward the functional group to 
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ensure the generation of the proposed intermediate Z/E-245 which would react with the desired 
aldehyde to generate the allylboration product 247. Intermediate 246 would probably resemble 
a dead-end and lead to a loss in efficiency. Both intermediates possess a trisubstituted double 
bond that likely does not exhibit a significant reactivity for the nickel catalyst or a driving force 
toward one or the other transposition to convert Z/E-245 into 246, or vice versa.125 
 
Scheme 111: Isomerization/allylboration of homoallylic boronic esters with an exo-double bond. 
By using 1,1-disubstituted starting materials, the sequence would allow the formation of a 
quaternary chiral carbon center in the proposed product 247. Due to the fact, that exo-double 
bonds are more difficult to isomerize, the reaction was carried out at ambient temperature 
instead of temperatures below 0 °C. A screening with different ligands and reaction 
temperatures was necessary to find the right conditions forcing the double bond to isomerize to 
the desired allylic position. In terms of reactivity and selectivity Ni(dppm)Br2 acted superior to 
the usually used Ni(dppe)Cl2 or Ni(dppp)Br2 pre-catalysts, which themselves resulted in 
unsatisfying conversion of the starting material (231, R = Me). Table 12 summarizes the results. 
Table 12: Isomerization/allylboration of homoallylic substrates with exo-double bond. 
entry main producta M(L)X2 T, t yield syn/anti 
1 
 
Ni(dppp)Br2 rt, 16 h 75% - 
2 
 
Ni(dppp)Cl2 rt, 16 h 81% - 
3 
 
Ni(dppp)Br2 rt, 16 h 80% - 
4 
 
Ni(dppm)Br2 rt, 48 h
b 43% 19:81 
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entry main producta M(L)X2 T, t yield syn/anti 
5 
 
Ni(dppm)Br2 rt, 48 h
b 73% 33:67 
6 
 
Ni(dppm)Br2 rt, 48 h
b 67%c 23:77 
7 
 
Ni(dppm)Br2 rt, 16 h
b 52% 31:69 
8 
 
Ni(dppp)Cl2 80 °C, 18 h 63% <1:99 
a: General conditions: Ni(L)X2 (10 mol%), Zn, ZnI2 (20 mol%  each), HPPh2 (5 mol%), 1.0 eq homoallyl boronic 
ester 230 or 231 and aldehyde. Stirring at rt. Different reaction times are listed above; b: The isomerization was 
performed first in absence of the aldehyde. The aldehyde was added after stirring at rt o/n; c: The product mixture 
contained 11 mg (20%) of unreacted cinnamaldehyde which could not be removed by multiple column 
chromatography. 
The exo-chain double bond derivative 230 (R = H) reacted very slowly. However, at room 
temperature after longer reaction times and catalyst addition, the desired homoallylic alcohols 
with a quarternary carbon-atom (247a+b) were obtained in acceptable yields of 75% and 81% 
(Table 12, entries 1 and 2). Noteworthy, the natural product artemisia alcohol 247c could be 
isolated as racemate in 80% yield in one single step (entry 3). Moreover, the transpositions of 
starting material 231 (R = Me) gave the anti-configured products predominantly. This means, 
with respect to the methyl group, the isomerization proceeded in a Z-selective fashion. The 
rationale for the formation of the anti-configured products was that the transposition proceeded 
predominantly through intermediate E-245. The diastereomeric ratios were only moderate up 
to 81:19 anti/syn ratio and 73% yield. The reason can be found in the undesired, but possible 
formation of by-product 246 (Scheme 111), in which a trisubstituted double bond was also 
formed, located in the homoallylic position, though, not undergoing the desired allyboration.125 
3.2.5.3 One-Pot Isomerization/Allylboration/Oxy-Cope Rearrangement Sequence 
Homoallylic alcohols 233f and 247b, derived from cinnamaldehyde, were qualified for a third 
reaction in a row, since they contained a 1,5-dien-3-ol structure motif for a possible anionic 
Oxy-Cope rearrangement. Through this process, -unsaturated aldehydes could be generated. 
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The rearrangement was realized by adding potassium hydride and [18]-crown-6 to the raw 
isomerization/allylboration mixtures. Scheme 112 shows the threefold reaction sequence.129 
 
Scheme 112: Isomerization/allylboration/Oxy-Cope rearrangement sequence. 
The anionic Oxy-Cope rearrangement proceeded very fast. The reaction passed again a six-
membered Zimmerman-Traxler transition state (XLV). Both aldehydes 248a and 248b could 
be obtained in moderate yields of 47% and 23%, respectively, in this three-step sequence. In 
product 248a the E-isomer predominated (E/Z = 90:10), since the formation of the enolate form 
was energetically favored. The sterically demanding groups (Me, Ph) were located in the 
equatorial position. 
3.2.6 Intramolecular Isomerization/Allylboration Sequence  
The applicability of the reaction sequence shall finally be verified for an intramolecular variant. 
Inspired by the work of Miyaura,74 who realized an intramolecular isomerization/allylboration 
process via isomerization away from the boron functionality towards the formation of the 
thermodynamically stable enolether 120 as driving force of the isomerization (Scheme 113). 
This enables a convenient practicability of this type of substrates.74 
 
Scheme 113: Intramolecular Isomerization/Allylboration Sequence by Miyaura. 
Aldehydes 249 and 251 in Scheme 114 were selected as potential substrates to realize such a 
process towards a diastereoselective formation of unsaturated cyclic alcohols 250 and 252. The 
double bond transposition shall, again, proceed towards the boronic ester moiety. 
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Scheme 114: Idea for the intramolecular isomerization/allylboration sequence. 
The acetal protected starting materials 255 and 259 were synthesized in simple five-step 
sequences in moderate overall yields starting from commercially available starting materials. 
They are shown in Scheme 115.  Bromide 253 was converted into the corresponding nitrile, 
first, before being reduced with diisobutyl aluminum hydride (DIBAL) to aldehyde 254. The 
subsequent Grignard and Appel reactions are followed by a final Grignard-type reaction 
introducing pinacol boronic ester 255 in an acceptable overall yield of 18% over five linear 
steps. Homoallyl boronic ester 259, containing an exo-double bond, was synthesized by 
DIBAL-reduction of commercially available ethyl 4-bromobutanoate (256), followed by acetal-
protection and enone-formation with methoxyallen to ,-unsaturated ketone 258 in 30% yield 
over three steps. The final copper-catalyzed hydroboration and Wittig reactions give target 
molecule 259 in 9% overall yield. 
 
Scheme 115: Syntheses of acetal-protected homoallyl boronic esters 255 and 259. 
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As usual, the intramolecular isomerization/allylboration process should be realized by reacting 
the starting materials with the nickel catalyst system. The first idea was to use stoichiometric 
amounts of the Lewis acid zinc iodide to activate the nickel catalyst on the one hand and 
deprotect the acetal on the other, enabling a direct intramolecular cyclization via allylboration 
to occur. The reaction is illustrated in Scheme 116 with boronic ester 255 in an exemplary way. 
 
Scheme 116: Proposed nickel-catalyzed isomerization/in situ intramolecular allylboration via ZnI2-mediated 
acetal-deprotection. 
For acetal deprotection, 1.2 eq ZnI2 were used instead of 20 mol%. Unfortunately, a 
deprotection was not detected via GC/MS-analysis, just an unselective isomerization of 255 
with a Z/E-ratio of 67:33. Since the deprotection did not take place, the intramolecular 
allylboration was pending. The same phenomenon was observed when the 1,1-disustituted 
homoallyl boronic ester 259 was used. Either way, the isomerization had to be done at ambient 
temperature. At lower temperatures, the reaction did not proceed at all.  
Since it was possible to at least isomerize the starting material, (Lewis or Brönstedt) acidic 
conditions, potentially enabling a subsequent intramolecular allylboration, were further 
investigated. The isomerization was performed first. The acid was added afterwards to the 
reaction mixture in order not to bother the preceding isomerization step.  
 
Scheme 117: Isomerization, first. Then desired deprotection and cyclization. 
Table 13 summarizes the reactions. 
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Table 13: Approaches concerning the acetal deprotection after isomerization. 
entry reagents solvent T,  t reaction progress 
1 10 mol% InCl3 MeOH/H2O (1:1) 90 °C, 18 h decomposition 
2 2.5 eq CAN MeCN/H2O (1:1) 65 °C, 18 h decomposition 
3 10 mol% I2 acetone rt, 18 h decomposition 
4 50 mol% AcOH MeOH/H2O (1:1) rt, 18 h no conversion 
5 1.0 eq p-TsOH MeOH/H2O (1:1) rt, 18 h decomposition 
6 10 mol% FeCl3 - rt, 24 h partial conversion 
7 SiO2 acetone rt, 5 d no conversion 
8 BF3 · OEt2 CH2Cl2 rt, 18 h decomposition 
9 20 mol% TiCl4 CH2Cl2 rt, 18 h 
product detectable in GC/MS; 
no isolation possible 
10 Yb(OTf)3 MeCN or THF rt, 18 h decomposition 
Nearly all attempts to deprotect the acetal, except for entries 6 and 9 in Table 13, failed. They 
led to decomposition of the starting material 261. With catalytic amounts of FeCl3 or TiCl4, the 
aldehyde form of alkene 261 could be detected via GC/MS analysis, but a subsequent 
allylboration did not take place.  
An isomerization of acetal-protected homoallyl boronic esters 255 and 259 was successful, 
albeit with lower isomeric excess of Z/E ~2:1. Unfortunately, an in situ cyclization by 
intramolecular allylboration could not be realized due to deprotection issues of the acetal group. 
A dimethyl acetal would be probably better suited, since the stability against acidic conditions 
is lower than with the ethylene glycol acetal.  
In conclusion, the established nickel-catalyzed isomerization of terminal alkenes is possible in 
the presence of an aldehyde. The carbonyl moiety did not interfere with the catalyst system, 
enabling a subsequent highly diastereoselective allylboration when homoallylic boronic esters 
were transferred to their Z-configured crotyl species. Nevertheless, this multistep sequence was 
limited to an intermolecular variant.  
The method is leaving the question, if the versatile carbonyl moiety could also be applied in 
other nickel- or cobalt-catalyzed transformations, which were not yet addressable by the Hilt 
group. A hydroacylation would be an attractive target reaction.  
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3.3 Cobalt-Catalyzed Reductive Cyclization of 1,3-Dienes 
In 2014, the Dong group presented an intermolecular hydroacylation of 1,3-dienes in the 
presence of a cobalt catalyst and appropriate reductants to form the active cobalt(I) species.97 
Further, they described an intramolecular hydroacylation of alkenes for the formation of four-
membered target structures (see Schemes 53 and 56).99 Since their reaction conditions were 
quite similar to the Hilt group’s, the question arose, if a hydroacylation of 1,3-dienes would 
also be possible with Hilt’s established cobalt catalyst system (Co(L)X2, Zn, ZnI2) which was 
already successfully applied for other formal cycloaddition reactions (for selected examples, 
see chapter 1.3.1). 
In order to reduce the number of possible regioisomers, an intramolecular variant of the 
hydroacylation was targeted, using 2-(buta-1,3-dien-1-yl)benzaldehyde (262) as test substrate. 
Diene 262 can either undergo the desired cyclization with the terminal double bond providing 
a seven-membered ring 263 or with the internal double bond leading to product structures of 
type 264. 
 
Scheme 118: Proposed conjugate intramolecular hydroacylation of 1,3-diene 262 with possible regioisomers. 
3.3.1 Optimization of Reaction Parameters 
1,3-Diene 262 (with R, R’ = H) could be easily prepared in a two-step synthesis comprising a 
Wittig olefination of 2-bromo benzaldehyde (265) followed by a subsequent Grignard reaction 
in 42% overall yield and a Z/E-ratio of 76:24. 
 
Scheme 119: Synthesis of (Z/E)-2-(buta-1,3-dien-1-yl)benzaldehyde. 
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Diene 262 was then reacted with the cobalt catalyst according to a general procedure (in the 
following referred to as GP 9) using Co(L)Br2, Zn, and ZnI2 under different reaction conditions 
to initiate the desired transformation and to find out which regioisomers could be addressed. 
The reaction conditions are summarized in Table 14. 
 
Scheme 120: Potential cobalt-catalyzed intramolecular hydroacylation. 
Table 14: Screening of reaction conditions for the cobalt-catalyzed intramolecular cyclization of 1,3-diene 262. 
entry [Co]a solvent T,  t reaction progressb 
1 
10 mol% Co(dppe)Br2 
20 mol% Zn, ZnI2 
CH2Cl2 rt, o/n no conversion 
2 
10 mol% Co(dppe)Br2 
50 mol% Zn 
CH2Cl2 rt, o/n no conversion 
3 
10 mol% Co(dppe)Br2 
50 mol% Zn 
MeCN rt, o/n no conversion 
4 
10 mol% Co(dppe)Br2 
50 mol% Zn 
MeCN 80 °C, o/n 
no conversion, 
partial reduction of s.m. 
5 
10 mol% Co(dppe)Br2 
50 mol% Zn 
toluene rt, o/n no conversion 
6 
10 mol% Co(dppe)Br2 
50 mol% Zn 
toluene 80 °C, o/n 
no conversion, 
partial reduction of s.m. 
7 
10 mol% Co(dppe)Br2 
50 mol% Zn 
DMF rt, o/n 
44% conversion, 
3 new peaks in GC/MS 
8 
10 mol% Co(dppe)Br2 
50 mol% Zn 
DMF 80 °C, o/n 
full conversion, 
3 new peaks in GC/MS 
9 
10 mol% Co(dppe)Br2 
50 mol% Zn 
DMF 80 °C, o/n 
35%c 
(3 products in NMR) 
10 
10 mol% Co(dppe)Br2 
150 mol% Zn 
DMF 80 °C, o/n 
32%c 
(3 products in NMR) 
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entry [Co]a solvent T,  t reaction progressb 
11 
10 mol% Co(dppe)Br2 
150 mol% Zn 
DMF rt, o/n 
48%c 
(3 products in NMR) 
12 
10 mol% Co(dppe)Br2 
150 mol% Zn, 40 mol% ZnI2 
DMF rt, o/n impurities in GC/MS 
13 
no cobalt catalyst, 
150 mol% Zn 
DMF rt or 80 °C, o/n no reactiond 
14 
10 mol% Co(dppe)Br2 
no Zn 
DMF rt or 80 °C, o/n no conversion 
15 
20 mol% ZnI2, 
50 mol% Zn 
DMF 80 °C, o/n decomposition 
16 aldehyde 262 only DMF 80 °C partial decomposition 
a: General conditions: Co(L)X2 (10 mol%), Zn (20 - 150 mol%), solvent. First, the cobalt catalyst and Zn were 
suspended in the solvent and stirred for 10 min at rt until substrate 262 (0.5 M) was added and the reaction was 
stirred overnight at the desired temperature; b: Monitoring of the reaction was performed without internal standard 
to reveal conversion of the s.m.; c: Isolated yield after purification by FC (n-pentane/Et2O 4:1); d: Partial reduction 
of the aldehyde was detected via GC/MS analysis. 
As can be seen in Table 14 (entry 1), the initial cobalt catalyst system in dichloromethane did 
not provide any product. The reaction in dichloromethane also failed when using different 
amounts of the catalyst components (entry 2). When changing the solvent to MeCN or toluene 
(entries 3-6) the reaction did not proceed, either. In toluene, the catalyst was barely soluble. 
When N,N-dimethyl formamide (DMF) was applied as solvent and 50 mol% Zn were used 
(entry 7), the corresponding gas chromatogram (GC/MS analysis) showed three new peaks with 
a mass-to-charge ratio (m/z) of 160 u indicating that a reduction process, similar to a Prins 
reaction, instead of a hydroacylation took place. When raising the temperature to 80 °C and the 
amount of Zn powder to 150 mol% (entry 9), the amount of the new products could be increased 
with full conversion of the starting material 262. NMR characterization of the product 
underlined the result that no hydroacylation, but a reductive cyclization occurred. The hydroxyl 
group of the product mixture (266, 266’, and 267 in Scheme 121) could further be detected via 
infrared (IR) spectroscopy. A carbonyl band was no longer visible. 
The terminal double bond of 1,3-diene 262 potentially acts as nucleophile letting the other 
double bond remain in place. As by-product, the seven-membered ring with the isomerized 
double bond (266’) could be detected and characterized by NMR spectroscopy. 
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Scheme 121: Product spectrum of the cobalt-catalyzed conjugate reductive cyclization. 
The second by-product was the reduced starting material with an E-configured double bond, 
leading to the assumption that only the Z-configured isomer of the starting material 262 
underwent the cyclization, whereas the E-configured part of the starting material was solely 
reduced by Zn. 
To underline this hypothesis, E-configured 2-(buta-1,3-dien-1-yl)benzaldehyde was 
synthesized in a three-step sequence and then reacted with the initial cyclization conditions, 
shown in Scheme 122. Benzyl alcohol 267 was a result of the reduction of E-configured starting 
material and was isolated in 65% yield. At 80 °C reaction temperature, a polymerization of the 
starting material cannot be excluded. 
 
Scheme 122: Reduction of the E-configured 1,3-diene to benzylic alcohol 267. 
To exclude a background reaction, the cyclization was also performed without Co(dppe)Br2 
(entries 13+15 in Table 14), without Zn powder (entry 14) and completely without any reagent 
(entry 16). In all cases, no reaction occurred. At 80 °C, it was assumed that partial 
polymerization of the starting material could occur. Therefore, the reaction temperature was 
reduced to ambient temperature, thus the isolated yield of the product mixture could be 
increased from initial 35% to 48%. 
In the literature, other reductants than Zn powder were used for hydroacylation reactions.100,101 
Consequently, other reductants were screened for the newly developed intramolecular 
cyclization (Table 15). 
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Table 15: Reductant screening. 
entry [Co]a solvent T,  t reaction progress 
1 
10 mol% Co(dppe)Br2 
150 mol% Zn 
DMF rt, o/n 48% 
2 
10 mol% Co(dppe)Br2 
150 mol% In 
DMF rt, o/n no reaction 
3 
10 mol% Co(dppe)Br2 
150 mol% Mn 
DMF rt, o/n no reaction 
4 
10 mol% Co(dppe)Br2 
150 mol% Mgb 
DMF 
rt, o/n → 
80 °C, o/n 
no reaction, then 
decomposition 
a: General conditions: Co(L)X2 (10 mol%), Zn (20 - 150 mol%), solvent. First, the cobalt catalyst and Zn were 
suspended in the solvent and stirred for 10 min at rt until substrate 262 (0.5 M) was added and the reaction was 
stirred overnight at the desired temperature; b: Another portion of catalyst and reductant was added and the reaction 
was stirred overnight at 80 °C. 
No reaction occurred when Mn or In powder was used instead of Zn (entries 2 and 3). Only Mg 
(150 mol%, entry 4) showed enhanced reactivity at 80 °C. Unfortunately, the reaction with Mg 
lead to decomposition of the starting material and the formation of undefined product species 
(detectable via GC/MS analysis).  
Finally, different ligands were tested, anticipating that dppe already was the ligand of choice. 
Bidentate ligand dppp acted similar to dppe (entry 2), whereas all other substituted dppp 
derivatives resulted in no conversion at all (entries 3-6). The reaction temperature of 80 °C was 
applied to ensure full conversion of the starting material. Imine-based ligand py-imin (entry 7) 
gave a change in regioselectivity, since the double bond isomerizes within the ring to a new 
266:266’ ratio of 44:56. Nitrogen-containing ligands could be a good alternative to phosphine 
ligands to address isomer 266’ more regioselectively. 
Table 16: Ligand screening. 
entry [Co]a solvent T,  t reaction progressb 
1 
10 mol% Co(dppe)Br2 
150 mol% Zn 
DMF 80 °C, o/n 266:266’ = 81:19 
2 
10 mol% Co(dppp)Br2 
150 mol% Zn 
DMF 80 °C, o/n 266:266’ = 78:22 
3 
10 mol% Co(dpppMe2)Br2 
150 mol% Zn 
DMF 80 °C, o/n no conversion 
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entry [Co]a solvent T,  t reaction progressb 
4 
10 mol% Co(bdpp)Br2 
150 mol% Zn 
DMF 80 °C, o/n no conversion 
5 
10 mol% Co(dpppBuEt)Br2 
150 mol% Zn 
DMF 80 °C, o/n no conversion 
6 
10 mol% Co(PPh3)2Br2 
150 mol% Zn 
DMF 80 °C, o/n no conversion 
7 
10 mol% Co(py-iminc)Br2 
150 mol% Zn 
DMF 80 °C, o/n 266:266’ = 44:56 
a: General conditions: Co(L)X2 (10 mol%), Zn (150 mol%) in DMF. First, the cobalt catalyst and Zn were 
suspended in the solvent and stirred for 10 min at rt, until aldehyde 262 (0.5 M) was added and the reaction was 
stirred overnight at the desired temperature; b: The reaction progress and the isomeric ration were monitored by 
GC/MS analysis; c: py-imin = (E)-2-((pyridin-2-ylmethylene)-amino)ethan-1-amine. 
After this examination, it was clear that under reductive conditions, the cyclization was only 
successful with the Z-configured starting material Z-262. A stoichiometric amount of Zn 
powder (150 mol%) is necessary for the formation of the active Co(I) species on the one hand 
and the reduction of the product on the other.  
3.3.2 Reductive Cyclization with the Z-Configured Diene 
After initial studies and optimization of the parameters towards a reductive cyclization, the 
optimization of the yield of the dihydrobenzoannulenol target structures 263 was addressed. 
The synthesis of pure Z-configured 1,3-diene was necessary to prevent the corresponding E-
configured isomer from solely being reduced to benzyl alcohol 267. In the literature, there are 
some approaches towards the synthesis of Z-configured double bonds in styrene position.130,131 
First, it was planned to address the product by a Peterson-like olefination/elimination sequence 
according to a procedure of Stupp.131 Unfortunately, an isomeric mixture of 1,3-diene 270 with 
a high E-isomeric excess (E/Z = 85:15, monitored via GC/MS, Scheme 123) was obtained.  
 
Scheme 123: Allylboration/elimination sequence according to a procedure of Stupp.131 
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Changing the conditions to a Z-selective Takai-type olefination with CrCl2 and basic work-up 
(6 M KOH), the Z-configured bromide 273 could be obtained in acceptable yield of 54% and 
good Z/E ratio. Subsequent debromocarbonylation at low temperatures provided the desired Z-
configured aldehyde 262 in moderate yield (49%) with a Z/E ratio of 95:5 (Scheme 124). 
 
Scheme 124: Three-step synthesis of Z-configured 1,3-diene 262. 
Since the yield was not satisfactory when the isomeric mixture of 1,3-diene 262 was used, the 
cyclization in DMF with 10 mol% Co(dppe)Br2 and 150 mol% Zn powder was performed again 
with the pure Z-configured isomer in hand. 
 
Scheme 125: Cobalt-catalyzed reductive cyclization of (Z)-2-(buta-1,3-dien-1-yl)benzaldehyde. 
As expected, the reaction proceeded smoothly at ambient temperature leading to a dramatic 
increase in yield (91%) and improved regioisomeric ratio (r.r.) 266:266’ of 86:14. The 
uncyclized by-product 267 was not observed any longer. But even with isomerically enriched 
1,3-diene, the formation of isomer 266’ could not be completely suppressed. The formation of 
266’ could be a result of the ring isomerization of preformed isomer 266 during the Prins-like 
cyclization running through a carbocation species. Katja Feismann is thankfully acknowledged 
for the optimization of reaction parameters.132  
Cyclization of the methyl-substituted 1,3-diene derivative 274 gave 275 in moderate yield as 
Scheme 126 depicts. The substrate scope of the reaction is under ongoing investigation in our 
group. 
 
Scheme 126: Intramolecular conjugate cyclization of 2-((1Z/E,3E)-penta-1,3-dien-1-yl)benzaldehyde (274). 
3. Results and Discussion 
96 
 
3.3.3 Initial Mechanistic Investigations 
For the reduction process, the electrons are presumably provided by stoichiometric amounts of 
Zn powder. To reveal the origin of the necessary protons, initial mechanistic investigations 
were performed using the formyl-deuterated starting material 262-d, which was synthesized in 
a two-step synthesis with 46% overall yield (Scheme 127). 
 
Scheme 127: Synthesis of deuterated 2-(buta-1,3-dien-1-yl)benzaldehyde.  
The substrate was cyclized according to GP 9. The deuterium atom remained at its place and 
266-d could be obtained in an isomeric mixture of 85:15.  
 
Scheme 128: Cobalt-catalyzed reductive cyclization of 262-d. The deuterium atom remains at the benzylic 
position. 
As distinguished from Dong’s proposed mechanism (see Scheme 54),97 the deuterium atom 
stays at its position. The cyclization can be seen as formal intramolecular nucleophilic attack 
of the terminal double bond of the 1,3-diene subunit to the formyl group in the manner of a 
Prins reaction. The cobalt catalyst could serve as Lewis acid. In conclusion, no Co−D species 
is formed via -hydride elimination during the process. The electrons are provided by Zn. A 
possibility as origin for protons is the solvent. When the reaction was performed in anhydrous 
DMF-d7, no incorporation of deuterium was detected via GC/MS and NMR analysis, though. 
When 2.0 equivalents (eq) deuterium oxide were added to the reaction mixture, the isotope 
incorporation could not reliably be detected. Additional mechanistic investigations are currently 
underway.  
In the course of this work, a reliable basis was provided to broaden the Hilt group’s expertise 
concerning new cobalt-catalyzed transformations of 1,3-dienes and carbonyl compounds. The 
cobalt-catalyzed intramolecular reductive cyclization of 1,3-dienes is now at a stage where 
conversion of the starting material as well as yield were already improved. Only the Z-
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configured 1,3-diene can undergo the transformation. Therefore, the reaction could also be used 
as an elegant separation of isomeric mixtures of 1,3-dienes, which are often obtained when a 
Wittig olefination with an allylphosphonium salt is performed. The method is still a research 
topic in our group and will be further examined by Sebastian M. Weber.  
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4. Summary and Outlook 
4.1 Nickel-catalyzed Z-Selective Isomerization of Terminal Alkenes 
In this dissertation, the mechanism of the nickel-catalyzed Z-selective isomerization of terminal 
alkenes with the additive diphenylphosphine could be successfully clarified. 
 
Scheme 129: Nickel-catalyzed Z-selective isomerization of terminal alkenes. 
A verification of the postulated nickel(I) as well as cobalt(I) species was achieved by cyclic 
voltammetry. Further, the existence of a paramagnetic nickel(I) species could be verified via 
qualitative EPR.103 
In cooperation with Prof. Dr. Robert Berger and Evgeny I. Grigoryev, the mode of action of the 
additive HPPh2 could be clarified through DFT-calculations. They led to the result that the co-
ligand transfers the hydrogen directly to the substrate to initiate the isomerization process. A 
three-membered transition state TS-XXXIV is passed for the activation of the pre-catalyst 
XXXI. The active catalyst species XXXV is stabilized by an -agostic interaction with a Ni−H-
bond order of 0.3 and a P−H bond order of 0.6 (Scheme 130). The Ni−H−P arrangement is a 
3-center-2-electron bond according to Wiberg bond indices.110 
 
Scheme 130: Formation of the active nickel catalyst species XXXV. 
The Z-Selectivity of the isomerization process arises at the final step, the -hydride elimination, 
which occurs from -agostic complex XXXIX, in which the methyl group and the rest R are 
predominantly arranged in syn-conformation. The active catalyst species XXXV is reformed 
after the release of the 2-alkene 36 (shown for the Z-configured alkene in Scheme 131). 
Calculated and experimental Z/E ratios of selected isomerization products are in good 
agreement to each other.110 
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Scheme 131: -Hydride elimination as selectivity-determining step in the calculated alkyl mechanism. 
The isomerization of allylbenzene derivatives always proceeded E-selectively. In this case, it 
was assumed that the isomerization runs through a -allyl mechanism, as could be verified by 
DFT calculations and deuteration experiments. 
The nickel-catalyzed Z-selective isomerization of terminal alkenes was successfully applied as 
key step in natural product synthesis. The pheromone of the beet armyworm spodoptera exigua, 
(9Z,12Z)-tetradeca-9,12-dien-1-yl acetate (165), was chosen as target molecule. For the final 
isomerization step, Ni(dppe)Cl2 emerged as the pre-catalyst of choice. Scheme 132 summarizes 
the pheromone synthesis. 
 
Scheme 132: Nickel-catalyzed Z-selective isomerization as key step in the total synthesis of (9Z,12Z)-tetradeca-
9,12-dien-1-yl acetate (165). 
Regarding the diversification of the substrate scope, secondary and tertiary N-allyl amides and 
carbamates were well-tolerated by the catalyst.123 Further, the nickel catalyst acted superior to 
the similar cobalt catalyst, which barely tolerated starting materials with a free NH-group.33  
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Scheme 133: Substrate-dependence of the nickel-catalyzed isomerization of the terminal double bond in 
secondary and tertiary N-allyl amides (X = CH2) and carbamates (X = O). 
The feature of the method was a substrate-specific isomerization. Secondary amides (and 
carbamates) predominantly formed the Z-configured enamide (and enecarbamate, respectively) 
with Z-isomeric excesses of up to 86%, whereas tertiary amides and oxazolidinones gave the 
E-configured product.123 
The final challenge of the catalyst system was the tolerance towards functional groups, which 
were not located in the substrate itself, but additional reactants. This would allow an application 
in a one-pot multicomponent reaction sequence.  
 
Scheme 134: Nickel-catalyzed diastereoselective isomerization/allylboration sequence. 
In the course of this work, an isomerization/allylboration sequence was realized. Homoallyl 
pinacol boronic esters of type 243 could be isomerized to their crotyl species in the presence of 
an aldehyde R’CHO, which then underwent an in situ allylboration at adjusted reaction 
temperature. In the sequence with unfunctionalized homoallyl boronic esters 132 (R = H) syn-
diastereomeric excesses of up to 96% were obtained. Through utilization of substituted boronic 
esters with an exo-double bond (R = Alkyl, Ph, ≠ H), the corresponding anti-configured product 
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could be obtained in anti/syn ratios of up to 81:19.125 Scheme 51 gives an overview of selected 
substrate combinations.  
On the basis of mechanistic investigations, the isomerization of a broad substrate scope and the 
application in natural product synthesis as well as a one-pot sequence, the cobalt and nickel-
catalyzed Z-selective isomerization of terminal alkenes could be successfully elaborated and 
finalized. 
4.2 Cobalt-catalyzed Intramolecular Reductive Cyclization of 1,3-
Dienes 
A cobalt-catalyzed reductive cyclization of 1,3-dienes could be realized by using the established 
cobalt catalyst Co(dppe)Br2 and stoichiometric amounts of Zn for the synthesis of 
phenylazepanol derivatives 266. 
 
Scheme 135: Cobalt-catalyzed reductive cyclization of (Z)-2-(buta-1,3-dien-1-yl)benzaldehyde (262). 
It is important to use pure Z-configured starting material, since the E-isomer solely undergoes 
a Zn-mediated reduction to the corresponding benzyl alcohol without the desired cyclization. 
The terminal double bond of the 1,3-diene moiety reacted as nucleophile, probably in the 
manner of a Prins reaction. Deuteration experiments conclude that the formyl hydrogen atom 
did not undergo a -hydride elimination. In the product, the deuterium atom remained at its 
original position (see Scheme 136). The protons must be donated from traces of water in the 
solvent, since deuterons from DMF-d7 were not incorporated in the product, as well.  
 
Scheme 136: Reductive cyclization of 262-d. The deuterium atom remains in benzylic position. 
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In future studies, the origin of the protons as well as a potential existence of a Co−H species 
shall be clarified. Furthermore, the substrate scope of the method shall be extended to get 
diastereoselective access to different seven-membered ring structures through variation of the  
alk(en)yl substituents as shown in Figure 22. 
 
Figure 22: Possible substrates for the cobalt-catalyzed reductive cyclization. 
In addition to the synthesis of benzylic alcohols, a cyclization of 1,3-dienes with an imine 
moiety could be an attractive approach for a potential application in natural product synthesis. 
The structure motif of cycloheptanamines can be found in the natural product class of the 
allocolchicinoids (279 in Scheme 137), which show potential as anti-cancer drugs.133 
 
Scheme 137: Allocolchicine and potential retrosynthetic approach. 
In this dissertation, first investigations concerning the cobalt-catalyzed reductive cyclization of 
1,3-dienes were performed. The reaction is still a part of ongoing research in the Hilt group. 
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4. Zusammenfassung und Ausblick 
4.1 Nickel-katalysierte Z-selektive Isomerisierung terminaler Alkene 
Im Rahmen der vorliegenden Dissertation konnte der Mechanismus der Nickel-katalysierten Z-
selektiven Isomerisierung terminaler Alkene mit dem Additiv Diphenylphosphin aufgeklärt 
werden.  
 
Schema 138: Nickel-katalysierte Isomerisierung terminaler Alkene. 
Ein Nachweis der postulierten aktiven Nickel(I)- und Cobalt(I)-Spezies erfolgte durch 
cyclovoltammetrische Messungen. Des Weiteren konnte qualitativ die Existenz einer Nickel(I)-
Spezies durch EPR-Experimente bestätigt werden.103  
Die Rolle des Additivs HPPh2 konnte in Kooperation mit Evgeny I. Grigoryev und Prof. Dr. 
Robert Berger durch DFT-Rechnungen enthüllt werden. Die Berechnungen kommen zu dem 
Ergebnis, dass das Wasserstoff-Atom direkt vom Co-Liganden auf das Substrat übertragen 
wird, um den Isomerisierungsprozess einzuleiten. Im Alkylmechanismus konnte die 
Aktivierung des Präkatalysators XXXI über einen dreigliedrigen Überganszustand TS-XXXIV 
beschrieben werden. Die aktive Katalysatorspezies XXXV ist über eine -agostische 
Wechselwirkung stabilisiert, bei der die Ni−H Bindungsordnung bei 0.3 liegt und jene für P−H 
bei 0.6 (Schema 139).110  
 
Schema 139: Bildung der aktiven Nickelkatalysator-Spezies XXXV. 
Die Z-Selektivität der Isomerisierung ließ sich auf den finalen Schritt, die -Hydrid-
Eliminierung, zurückführen, die aus dem -agostischen Komplex XXXIX erfolgt, in dem die 
Methylgruppe und Rest R syn-artig zueinanderstehen. Daraus entsteht die Z-Konfiguration der 
resultierenden internen Doppelbindung. Die aktive Katalysatorspezies XXXV wird nach 
4. Zusammenfassung und Ausblick 
104 
 
Freisetzung des 2-Alkens 36 zurückgebildet. Berechnete und experimentelle Werte der Z/E-
Verhältnisse ausgewählter Isomerisierungsprodukte waren hierbei in guter Übereinstimmung 
miteinander.110 
 
Schema 140: -Hydrid-Eliminierung als selektivitätsbestimmender Schritt im berechneten Alkyl-Mechanismus. 
Da die Isomerisierung von Allylbenzol-Derivaten stets E-selektiv ablief, wurde der 
Reaktionsablauf über einen -Allylmechanismus (siehe Kapitel 1.1.1) durch DFT-Rechnungen 
vorhergesagt und konnte durch Deuterierungsexperimente untermauert werden. 
Die Nickel-katalysierte Z-selektive Isomerisierung terminaler Alkene konnte erfolgreich als 
Schlüsselschritt in der Naturstoffsynthese eingesetzt werden. Als Zielmolekül diente das 
Pheromon des Eulenfalters spodoptera exigua, (9Z,12Z)-Tetradeca-9,12-dien-1-ylacetat (165). 
Der finale Isomerisierungsschritt gelang bei einer substratspezifisch angepassten 
Reaktionstemperatur von −15 °C und 8 h Reaktionszeit. Ni(dppe)Cl2 stellte sich als effektivster 
Katalysatorvorläufer heraus. Schema 141 fasst die gesamte Pheromon-Synthese zusammen.103 
 
Schema 141: Nickel-katalysierte Z-selektive Isomerisierung als Schlüsselschritt in der Totalsynthese von 
(9Z,12Z)-Tetradeca-9,12-dien-1-ylacetat (165). 
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Bezüglich der Erweiterung der Substratbreite, wurden sekundäre sowie tertiäre N-Allylamide 
und -carbamate als vom Katalysator tolerierte stickstoffhaltige Substrate ausfindig gemacht.123 
Die Nickel-katalysierte Variante der Isomerisierung war hier dem üblichen Hilt’schen Cobalt-
Katalysator deutlich überlegen, da dieser Substrate mit freier NH-Funktion unzureichend bis 
gar nicht umsetzte.33 
 
Schema 142: Substratabhängigkeit der Nickel-katalysierten Isomerisierung der terminalen Doppelbindung in 
sekundären und tertiären N-Allylamiden (X = CH2) und -carbamaten (X = O). 
Die Besonderheit der Methode bestand darin, dass die Regioselektivität der Isomerisierung 
substratspezifisch gesteuert wurde. Bei sekundären Vertretern der Substratklasse wurde meist 
bevorzugt das Z-konfigurierte Produkt mit einem Isomerenüberschuss von bis zu 86% gebildet, 
während bei cyclischen N-Allyllactamen und -carbamaten hauptsächlich das E-konfigurierte 
Enlactam bzw. Encarbamat gebildet wurde.123 
Die finale Herausforderung der Methode war die Toleranz gegenüber funktionellen Gruppen, 
die nicht im zu isomerisierenden Substrat, sondern weiteren Reaktanden, enthalten sind. Dies 
ließe eine Anwendung in Mehrkomponentenreaktionen im Eintopfverfahren zu.   
Im Rahmen dieser Arbeit konnte eine Isomerisierungs/Allylborierungs-Sequenz realisiert 
werden, bei der Homoallylboronsäurepinacolester vom Typ 243 in Gegenwart 
funktionalisierter Aldehyde R’CHO bei angepasster Reaktionstemperatur zunächst zur 
Crotylbor-Spezies isomerisiert werden, um in situ eine Allylborierung zu unterlaufen. 
Schema 143 gibt einen Überblick.125  
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Schema 143: Nickel-katalysierte diastereoselektive Isomerisierungs/Allylborierungs-Sequenz. 
Bei der Sequenz mit linearen Alkenyl-Homoallylboronsäureestern (132, R = H) konnten syn-
Diastereomerenüberschüsse von bis zu 96% erhalten werden. Wurden Substrate, die eine exo-
Doppelbindung aufwiesen (R = Alkyl, Ph; ≠ H), eingesetzt, konnte das entsprechende anti-
konfigurierte Produkt in einem anti/syn-Verhältnis von bis zu 81:19 erhalten werden.125 
Auf Grundlage mechanistischer Untersuchungen, der Erweiterung der Substratbreite sowie der 
Anwendung der Methode in der Naturstoffsynthese und im Eintopfverfahren konnte das 
Themenfeld der Cobalt- und Nickel-katalysierten Z-selektiven Monoisomerisierung terminaler 
Olefine in dieser Arbeit erfolgreich ausgearbeitet werden. 
4.2 Cobalt-katalysierte intramolekulare reduktive Zyklisierung von 
1,3-Dienen 
Weiterhin konnte im Rahmen dieser Arbeit eine Cobalt-katalysierte intramolekulare reduktive 
Zyklisierung von 1,3-Dienen realisiert werden. Unter Verwendung des in der eigenen Gruppe 
etablierten Cobalt-Katalysators Co(dppe)Br2 und stöchiometrischen Mengen Zink gelang die 
Synthese von Dihydrobenzoannulenol-Derivaten (266). 
 
Schema 144: Cobalt-katalysierte reduktive Zyklisierung von (Z)-2-(Buta-1,3-dien-1-yl)benzaldehyd (262). 
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Bei der Reaktionsführung war wichtig, dass rein Z-konfiguriertes 1,3-Dien 262 eingesetzt 
wurde, da das entsprechende E-Isomer durch Zink lediglich reduziert wurde, ohne eine 
Zyklisierung zu unterlaufen. 
Die terminale Doppelbindung der 1,3-Dien Einheit reagierte formal als Nucleophil, womöglich 
nach Art einer Prins Reaktion. Deuterierungsexperimente legten den Schluss nahe, dass das 
formylische Wasserstoff-Atom keine -Hydrid-Eliminierung durchlief, da es im Produkt an 
seiner ursprünglichen Stelle wiederzufinden (siehe Schema 145) war. Die Protonen stammen 
womöglich aus Spuren von Wasser im Lösungsmittel DMF, da sie auch nicht aus DMF selbst 
eingebaut wurden. 
 
Schema 145: Reduktive Zyklisierung von 262-d mit Verbleib des Deuterium-Atoms an benzylischer Position im 
Produkt. 
In fortlaufenden Studien soll der Ursprung der Protonen sowie die Existenz einer Co−H-Spezies 
noch weiter aufgeklärt werden. Zudem soll die Substratbreite dieser Methode ausgedehnt 
werden, um den diastereoselektiven Zugang zu verschieden substituierten Siebenringen zu 
ermöglichen. Zudem kann das Rückgrat durch die Verwendung anderer Alk(en)yl-Ringe 
variiert werden, wie Abbildung 23 verdeutlicht. 
 
Abbildung 23: Mögliche Substrate für die Cobalt-katalysierte reduktive Zyklisierung. 
Neben dem bisherigen Zugang zu benzylischen Alkoholen wäre auch die Zyklisierung von 1,3-
Dienen an eine Imin-Funktion für eine potentielle Anwendung in der Naturstoffsynthese 
erstrebenswert. Das Strukturmotiv des Cycloheptanamids findet sich in der Naturstoffklasse 
der Allocolchizinoide wider (279 in Schema 146), welche als potentielle Wirkstoffe 
Anwendung finden könnten.133 
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Schema 146: Allocolchizin und möglicher retrosynthetischer Zugang. 
Im Rahmen dieser Dissertation wurden erste Untersuchungen zur Cobalt-katalysierten 
reduktiven Zyklisierung von 1,3-Dienen angestellt. Die Reaktion gehört zu den aktuellen 
Forschungsthemen in der eigenen Gruppe. 
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5. Experimental Section  
5.1 Materials and Analytical Methods  
Nuclear Magnetic Resonance (NMR) 
1H, 2H and 13C spectra were either recorded on a Bruker AV III HD 300 (300 MHz for 1H, 
46 MHz for 2H, and 75 MHz for 13C), a Bruker DRX-500 or a Bruker AV III HD 500 (500 MHz 
for 1H, 77 MHz for 2H, and 125 MHz for 13C). Chemical shifts are reported in parts per million 
(ppm) and are referenced to the solvent peak as internal standard (CHCl3:  = 7.26 ppm for 1H 
NMR, CDCl3:  = 7.26 ppm for 2H NMR, and 77.16 ppm for 13C NMR, C6H6: 7.16 ppm for 1H 
NMR and 128.06 ppm for 13C, DMSO: 2.50 ppm for 1H NMR and 39.52 ppm for 13C, THF: 
1.72, 3.58 ppm for 1H NMR and 25.31, 67.21 ppm for 13C NMR). 19F and 11B NMR 
spectroscopic data were recorded on a Bruker AV III HD 300 (121 MHz for 31P, 283 MHz for 
19F and 96 MHz for 11B) and are referenced to the external standards CCl3F ( = 0.00 ppm for 
19F) and BF3·OEt2 ( = 0.00 ppm for 11B). 31P NMR spectroscopic data were either recorded on 
a Bruker DRX-250 (101 MHz) or a Bruker AV III HD 300 (121 MHz) and are referenced to 
the external standard H3PO4 (85%,  = 0.00 ppm). All NMR spectroscopic data were recorded 
at ambient temperature. 
The multiplicity of the signals is described by the following abbreviations: s (singlet), 
d (dublet), t (triplet), q (quartett), quin (quintett), sept (septet), m (multiplet) and p (pseudo 
signal, e.g. pd = pseudo-dublet). 
Infrared Spectroscopy (IR) 
IR spectra were recorded on a Bruker IFS 88 fourier transform infrared spectrometer (FTIR). 
Absorption bands ν are given in wavenumbers (cm−1). 
Gaschromatography (GC and GC/MS) 
GC analysis was performed on a Shimadzu GC-2010 Plus series gas chromatograph with a 
flame ionization detector (FID). GC/MS spectra were either recorded on an Agilent 6890 gas 
chromatograph coupled with a Hewlett Packard 5973 mass selective detector or a Shimadzu 
GC-2010 Plus gas chromatograph coupled with a Shimadzu GCMS-QP2020 mass selective 
detector. Helium was used as carrier gas on a Macherey Nagel Optima 5 HT column (30 m, 
0.25 mm ID, 0.25 mm film). 
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High Resolution Mass Spectrometry (HRMS) 
EI-HRMS spectra were recorded on a Finnigan MAT 95S mass spectrometer at an energy of 
70 eV. ESI-HRMS spectra were recorded on a Thermo Fisher Scientific LTQ-FT mass 
spectrometer.  
Thin Layer Chromatography and Flash Chromatography (TLC and FC) 
Flash chromatography was carried out on Macherey-Nagel Silica 60 (40-63 mm, 230-400 mesh 
ASTM). Thin layer chromatography was carried out on Merck TLC plates (Silica 60, F254 with 
fluorescence indicator). 
Cyclic Voltammetry 
Cyclic voltammetry was carried out on a BAS C3 Cell Strand and a BAS 100 series 
electrochemical analyzer using a platinum disk working electrode (2.0 mm diameter) and a 
platinum wire counter electrode (0.5 mm diameter) at ambient temperature in CH2Cl2 
containing Bu4NBF4 (0.1 M). Potentials were referred to a saturated Ag/AgCl (3.0 M NaCl) 
reference electrode. Before each experiment, the surface of the working electrode was polished 
followed by thorough rinsing with distilled water and the solution was purged with nitrogen. 
EPR Spectroscopy 
EPR spectra were recorded on a Bruker ESP 300 EPR spectrometer operating in the X-band 
with a microwave frequency of 9.1 – 9.3 GHz and a microwave power of 0.32 mW. The 
spectrometer is equipped with a standard variable temperature set up, a suitable data station for 
the storage and manipulation of the EPR spectra, an NMR gaussmeter for calibration of the 
magnetic field and a microwave frequency counter for the determination of the g-factors that 
were corrected with respect to that of the external standard DPPH (2,2-diphenyl-1-
picrylhydrazyl, g = 2.0037).  
Solvents and Chemicals 
Dichloromethane was dried over calcium hydride and diethyl ether (Et2O) and tetrahydrofuran 
(THF) over sodium under nitrogen atmosphere. All solvents were distilled under nitrogen 
atmosphere and stored over molecular sieves (4 Å). HPLC grade acetonitrile, toluene and DMF 
were further dried over molecular sieves (4 Å) and stored under nitrogen atmosphere. All 
reagents were used as purchased from commercial suppliers (Sigma Aldrich, Alfa Aesar, TCI, 
Chempur, abcr, Acros) without further purification or were prepared according to literature-
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known procedures. Zinc iodide was purchased from Acros and dried in vacuo at 180 °C for 
24 h. 
Nickel(II) and Cobalt(II) complexes were synthesized by treatment of the corresponding metal 
halide (1.0 eq) and ligand (1.0 eq) in anhydrous THF (0.1 M) at ambient temperature overnight. 
By addition of n-pentane, the catalyst was precipitated, filtered, dried, and used without further 
purification or characterization. 
General Operational Methods 
All experiments with water or air-sensitive reagents were carried out utilizing standard Schlenk 
techniques under argon atmosphere. The determination of yields was carried out 
gravimetrically. The stated values are in weight-% relative to the quantities of the starting 
material. In case of volatile products, the content of solvent residues was evaluated by 1H NMR-
analysis and considered when determining the yield.  
5.2 General Procedures 
GP 1: General Procedure for the Nickel-Catalyzed Isomerization of 1-Alkenes to 
2-Alkenes 
 
 
Under argon atmosphere, 10 mol% of the nickel catalyst (50.0 mmol), 20 mol% zinc powder 
and anhydrous zinc iodide (100 mmol) are suspended in 0.3 mL anhydrous dichloromethane in 
a heat gun dried Schlenk tube fitted with a Teflon® screwcap. The mixture is stirred for 10 min. 
Then, 0.2 mL of a HPPh2 solution (25.0 mmol, 5.0 mol%, 0.125 M in dichloromethane) are 
added. After stirring for additional 10 min the mixture is cooled to the stated temperature and 
0.50 mmol of the 1-alkene (1.0 eq) are added. 
The reaction progress is monitored by GC and/or GC/MS analysis. By addition of n-pentane 
the reaction is stopped at the point where a further conversion lowers the excess of the Z-
configured isomer. The general workup contains filtering through a short pad of silica gel with 
n-pentane or n-pentane/Et2O as eluent, removal of the solvent and purification of the crude 
product by FC on silica gel. The conversion, as well as the E/Z ratio is determined by integration 
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of suitable baseline separated 1H NMR signals. The content of other isomers is determined by 
integration of baseline separated gas chromatogram peaks. 
GP 2: General Procedure for the Preparation of N-Allyl Amides 
 
According to a procedure of Staubitz122 under argon atmosphere, allylamine (1.0 eq) and 
triethylamine (1.0 eq) are dissolved in anhydrous dichloromethane (1.0 M) and a solution of the 
corresponding acid chloride (1.0 eq) in anhydrous dichloromethane (2.5 M) is added at 0 °C. 
After stirring overnight at ambient temperature, the reaction mixture is quenched with H2O, 
followed by extraction with dichloromethane. The crude product is purified by FC 
(n-pentane/EtOAc or n-pentane/Et2O) or recrystallization.  
GP 3: General Procedure for the Isomerization of N-Allylamides and N/O-
Allylcarbamates 
 
Under argon atmosphere, 10 mol% of the nickel catalyst (50.0 mmol), 20 mol% zinc powder 
and anhydrous zinc iodide (100 mmol each) are suspended in either 0.3 mL anhydrous 
dichloromethane or 0.3 mL anhydrous acetonitrile in a heat gun dried Schlenk tube fitted with 
a Teflon® screwcap. The mixture is stirred for 10 min and 0.2 mL of a HPPh2 solution 
(25.0 mmol, 5.0 mol%, 0.125 m in dichloromethane or acetonitrile) are added. After stirring for 
additional 10 min the mixture is cooled to the stated temperature. Then, 0.50 mmol of the 
corresponding N-allylamide or N/O-allylcarbamate (1.0 eq) are added and the reaction is stirred 
at the desired temperature. 
The reaction progress is monitored by GC/MS analysis. In case of incomplete conversion of the 
starting material another portion of catalyst is added. The reaction is stopped by addition of 
Et2O, when no further conversion could be detected. The solution is directly purified by FC on 
silica gel (n-pentane/Et2O or n-pentane/EtOAc). The E/Z ratio of the product is determined by 
integration of suitable baseline separated 1H NMR signals and comparison with the 
corresponding peaks in the GC/MS spectrum. 
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GP 4: General Procedure for the Grignard Reaction with B(OR)3 
 
According to a procedure of Hilt(Peters Paper) under argon atmosphere, magnesium turnings 
(1.2 eq) are suspended in either anhydrous Et2O or THF (1.0 M based on the bromide) and the 
corresponding bromide (1.0 eq) is added at ambient temperature. The reaction mixture is stirred 
at 40 °C for 1 h and then cooled to −78 °C. B(OMe)3 or B(OiPr)3 (1.2 eq) is added at −78 °C 
and the reaction mixture is stirred for 15 min at this temperature. 1 M aqueous HCl is used to 
quench the reaction, followed by extraction of the aqueous layer with Et2O. After removal of 
the solvent the residue is taken up in the solvent mixture n-pentane/Et2O (4:1) and pinacol 
(1.2 eq) is added. After stirring for 3 d at ambient temperature, the solvent is evaporated, and 
the crude product is purified by FC (n-pentane/Et2O). 
GP 5: General Procedure for the Grignard Reaction with Pinacolborane 
 
According to a procedure of Duñach1 under argon atmosphere, the corresponding bromide 
(1.0 eq) is added to a suspension of magnesium turnings (1.2 eq), pinacolborane (1.0 eq) and 
triethylamine (1.0 eq) in anhydrous THF (0.3 M) at ambient temperature. The mixture is stirred 
to reflux overnight. 0.1 M HCl is used to quench the reaction, followed by extraction with Et2O. 
The crude product is purified by FC (n-pentane/Et2O). 
GP 6: General Procedure for the Wittig Reaction for the Preparation of Terminal 
Alkenes 
 
The corresponding alkenyltriphenylphosphonium salt (1.1 – 1.5 eq) and potassium 
tert-butoxide (1.1 – 1.5 eq) are suspended in either ahydrous Et2O or THF (0.5 M) at 0 °C under 
argon atmosphere. The mixture is stirred at ambient temperature for 20 – 30 min before the 
corresponding aldehyde or ketone (1.0 eq) is added at 0 °C. The reaction mixture is stirred 
overnight at ambient temperature before being quenched with saturated aqueous NH4Cl 
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solution and extraction with n-pentane or Et2O. The crude product is adsorbed on silica and 
purified by FC (pure n-pentane or n-pentane/Et2O). 
GP 7: General Procedure for the Nickel-Catalyzed Isomerization/Allylboration 
Sequence of Homoallylic Boronic Esters 
 
Under argon atmosphere, 10 mol% of the nickel catalyst (either 25 or 50 mmol), 20 mol% zinc 
powder and anhydrous zinc iodide (either 50 or 100 mmol each) are suspended in either 0.15 or 
0.3 mL anhydrous dichloromethane in a heat gun dried Schlenk tube fitted with a Teflon® 
screwcap. The mixture is stirred for 10 min and either 0.1 or 0.2 mL of a HPPh2 solution (12.5 or 
25.0 mmol, 5.0 mol%, 0.125 M in dichloromethane) are added. After stirring for additional 
10 min the mixture is cooled to the stated temperature. Then, either 0.25 or 0.50 mmol of the 
aldehyde and the corresponding homoallylic boronic ester (1.0 eq each) are added and the 
reaction is stirred at the desired temperature. 
The reaction progress is monitored by GC and/or GC/MS analysis. By addition of Et2O the 
reaction is stopped at the point where no further conversion is detected. The general workup 
contains filtering through a short pad of silica gel with n-pentane or n-pentane/ Et2O as eluent, 
removal of the solvent and purification of the crude product by FC on silica gel. The conversion, 
as well as the diastereomeric syn/anti ratio (d.r.) of the product are determined by integration 
of suitable baseline separated 1H NMR signals. 
GP 8: General Procedure for the Nickel-Catalyzed Isomerization/Allylboration 
Sequence of Branched Homoallylic Boronic Esters 
 
Under argon atmosphere, 10 mol% of the nickel catalyst (25 mmol), 20 mol% zinc powder and 
anhydrous zinc iodide (50 mmol each) are suspended in 0.15 mL anhydrous dichloromethane 
in a heat gun dried Schlenk tube fitted with a Teflon® screwcap. The mixture is stirred for 
10 min and 0.1 mL of a HPPh2 solution (12.5 mmol, 5.0 mol%, 0.125 M in dichloromethane) 
are added. After stirring for additional 10 min at ambient temperature 0.25 mmol of the 
corresponding homoallylic boronic ester (1.0 eq) are added and the reaction is stirred overnight. 
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After complete conversion 0.25 mmol of the aldehyde (1.0 eq) are added and the mixture was 
stirred for another 24 h at ambient temperature. 
The reaction progress is monitored by GC and/or GC/MS analysis. By addition of Et2O the 
reaction is stopped at the point where no further conversion is detected. The general workup 
contains filtering through a short pad of silica gel with n-pentane or n-pentane/ Et2O as eluent, 
removal of the solvent and purification of the crude product by FC on silica gel. The conversion, 
as well as the diastereomeric syn/anti ratio (d.r.) of the product are determined by integration 
of suitable baseline separated 1H NMR signals. 
GP 9: General Procedure for the Cobalt-Catalyzed Reductive Cylization 
 
Under argon atmosphere, 10 mol% of Co(dppp)Br2 (50.0 mmol) and 150 mol% zinc powder 
(0.75 mmol) were suspended in 1.0 mL anhydrous DMF in a heat gun dried Schlenk tube fitted 
with a Teflon® screwcap. The mixture was stirred for 10 min and 0.50 mmol of the 
corresponding 1,3-diene (1.0 eq) were added and the reaction was stirred overnight  at ambient 
temperature, unless otherwise stated. 
The reaction progress was monitored by GC/MS analysis. In case of incomplete conversion of 
the starting material, another portion of catalyst was added. By addition of Et2O, the reaction 
was stopped when no further conversion could be detected. The solution was directly purified 
by FC on silica gel (n-pentane/Et2O).  
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5.3 Isomerization of Terminal Alkenes to Z-2-Alkenes 
5.3.1 Synthesis of Diphenylphosphine Analogues 
Dimesitylphosphine oxide (174a) 
According to a procedure of Busacca,113 0.67 g (27.5 mmol, 7.6 eq) magnesium 
turnings were suspended in ahydrous THF and 2.38 g (12.0 mmol, 3.3 eq) 
bromomesitylen and a small amount of I2 were added. After exothermic reaction 
of the Grignard reagent and stirring for another hour at 75 °C 0.50 g diethyl phosphite 
(3.62 mmol, 1.0 eq)  were added within 15 min at 0 °C and the reaction was stirred overnight 
at ambient temperature. Aqueous HCl (5 mL) was added at 0 °C followed by addition of MTBE. 
The aqueous layer was extracted three times with CH2Cl2 and the combined organic layers were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The crude 
product was recrystallized from hot EtOAc to give dimesitylphosphine oxide (174a) in 82% 
yield (0.85 g, 2.97 mmol) as white solid. 
1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 476 Hz, 1H, PH), 6.85 (d, J = 3.9 Hz, 4H, CHar), 
2.39 (s, 12H, o-CH3), 2.28 (s, 6H, p-CH3). 
13C NMR (75 MHz, CDCl3) δ 142.0 (d, J = 2.5 Hz, p-Cq, ar), 141.9 (d, J = 10.7 Hz, o-Cq, ar), 
130.6 (d, J = 10.6 Hz, m-CHar), 126.5 (d, J = 100.1 Hz, PCq, ar), 21.3 (s, p-CH3), 20.9 (d, J = 7.8 
Hz, o-CH3). 
31P NMR (121 MHz, THF-d8) δ 10.3 (d, J = 475 Hz, PH). 
The NMR spectroscopic data are in accordance with the literature.113 
Dimesitylphosphine (175a) 
According to a procedure of Busacca,113 500 mg dimesitylphosphine oxide 
(1.75 mmol, 1.0 eq) were dissolved in 8.0 mL anhydrous toluene and 12.7 mL 
DIBAL (1.1 M in toluene, 14.0 mmol, 8.0 eq) were added at ambient temperature. The reaction 
mixture was stirred at 70 °C for 24 h and then cooled to −78 °C. Degassed aqueous 2 M NaOH 
(10 mL) was added and the resulting suspension was warmed to ambient temperature. The 
lower aqueous layer was separated via syringe and the remaining organic layer was filtered over 
MgSO4 and celite. The solvent was carefully removed in vacuo making sure that the product 
was not exposed to air. Dimesitylphosphine (175a) was obtained in 69% yield (330 mg, 
1.20 mmol) as white crystalline powder and stored under argon atmosphere. 
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1H NMR (300 MHz, C6D6) δ 6.69 (s, 4H, CHar), 5.32 (d, J = 230 Hz, 1H, PH), 2.27 (s, 12H, o-
CH3), 2.08 (s, 6H, p-CH3).  
13C NMR (75 MHz, C6D6) δ 142.5 (d, J = 12.6 Hz, PCq, ar), 137.8 (s, p-Cq, ar), 130.0 (d, J = 
16.7 Hz, o-Cq, ar) 129.5 (d, J = 2.8 Hz, CHar), 23.0 (d, J = 11.6 Hz, o-CH3), 21.0 (s, p-CH3). 
31P NMR (121 MHz, C6D6) δ −92.8 (d, J = 230 Hz, PH). 
The NMR spectroscopic data are in accordance with the literature.113 
Bis(4-methoxyphenyl)phosphine oxide (174b) 
According to a procedure of Busacca,113 0.92 g (38.0 mmol, 
5.8 eq) magnesium turnings were suspended in THF and 3.09 g 
(16.5 mmol, 3.3 eq) 1-bromo-4-methoxybenzene and a small 
amount of I2 were added. After exothermic reaction of the Grignard reagent 0.90 g diethyl 
phosphite (6.50 mmol, 1.0 eq) were added within 15 min at 0 °C and the reaction was stirred 
overnight at ambient temperature. Aqueous HCl (5 mL) was added at 0 °C followed by addition 
of MTBE. The aqueous layer was extracted three times with CH2Cl2 and the combined organic 
layers were dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The crude product was recrystallized from hot EtOAc to give bis(4-methoxyphenyl)phosphine 
oxide (174b) in 88% yield (1.51 g, 5.75 mmol) as white solid. 
1H NMR (300 MHz, CDCl3) δ 8.05 (d, J = 459 Hz, 1H, PH), 7.60 (dd, J = 13.2, 8.7 Hz, 4H, 
CHar), 6.99 (dd, J = 8.7, 2.1 Hz, 4H, CHar), 3.84 (s, 6H, OCH3). 
13C NMR (75 MHz, CDCl3) δ 163.1 (COCH3), 132.9 (CHar), 132.7 (CHar), 114.7 (d, J = 
10.0 Hz, PCq, ar), 114.5 (PCq, ar), 55.5 (OCH3). 
31P NMR (121 MHz, THF-d8) δ 20.9 ((quin)d, J = 477.2, 13.2 Hz, PH).  
The NMR spectroscopic data are in accordance with the literature.113 
Bis(4-methoxyphenyl)phosphine (175b) 
According to a procedure of Busacca,113 1.51 g 
bis(4-methoxyphenyl)phosphine oxide (5.75 mmol, 1.0 eq) were 
dissolved in 30 mL anhydrous THF and 28.8 mL DIBAL (1.0 M 
in cyclohexane, 28.8 mmol, 5.0 eq) were added at ambient temperature. The reaction mixture 
was stirred at ambient temperature for 15 min and then cooled to  °C. Degassed MTBE 
5. Experimental Section 
118 
 
(20 mL) and degassed aqueous 2 M NaOH (10 mL) were added very carefully. After the 
addition of 10 mL of degassed brine solution the lower aqueous layer was separated via syringe 
and the remaining organic layer was filtered over MgSO4. The solvent was carefully removed 
in vacuo making sure that the product was not exposed to air. Bis(4-methoxyphenyl)phosphine 
(175b) was obtained in 75% yield (1.06 g, 4.29 mmol) as white solid and stored under argon 
atmosphere. 
1H NMR (300 MHz, C6D6) δ 7.39 (dd, J = 8.7, 6.9 Hz, 4H, CHar), 6.70 (dd, J = 8.7, 0.9 Hz, 
4H, CHar), 5.29 (d, J = 214 Hz, 1H, PH), 3.23 (s, 6H, OCH3).  
13C NMR (75 MHz, C6D6) δ 160.7 (s, COCH3), 136.0 (d, J = 18.3 Hz, CHar), 132.8 (d, J = 
12.2 Hz, CHar), 126.5 (d, J = 8.8 Hz, Cq, ar), 114.7 (d, J = 6.8 Hz, CHar), 54.7 (OCH3). 
31P NMR (121 MHz, C6D6) δ −44.5 ((quin)d, J = 215.0, 6.9 Hz, PH). 
The NMR spectroscopic data are in accordance with the literature.113 
Bis(4-fluorophenyl)phosphine oxide (174c)  
According to a procedure of Busacca,113 1.38 g (56.9 mmol, 7.6 eq) 
magnesium turnings were suspended in anhydrous THF and 4.33 g 
(24.8 mmol, 3.3 eq) 1-bromo-4-fluorobenzene were added. After 
exothermic reaction of the Grignard reagent 1.04 g (7.50 mmol, 1.0 eq) diethyl phosphite were 
added within 15 min at 0 °C and the reaction was stirred overnight at ambient temperature. 
Aqueous HCl (5 mL) was added at 0 °C followed by addition of MTBE. The aqueous layer was 
extracted three times with CH2Cl2 and the combined organic layers were dried over MgSO4, 
filtered and the solvent was removed under reduced pressure. The crude product was purified 
by FC (EtOAc/n-pentane 7:3→1:0) to give bis(4-fluorophenyl)phosphine oxide (174c) in 90% 
yield (1.60 g, 6.72 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 8.09 (d, J = 485 Hz, 1H, PH), 7.75 – 7.66 (m, 4H, CHar), 7.25 – 
7.18 (m, 4H, CHar).  
13C NMR (75 MHz, CDCl3) δ 133.4 (dd, J = 13.1, 8.9 Hz, FCq, ar), 116.5 (dd, J = 21.5, 14.0 Hz, 
CHar). Cq, ar not detectable. 
19F NMR (282 MHz, CDCl3) δ −104.8.  
31P NMR (121 MHz, CDCl3) δ 19.0 ((quin)d, J = 486 Hz, PH).  
The NMR spectroscopic data are in accordance with the literature.113 
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Bis(4-fluorophenyl)phosphine (175c) 
According to a procedure of Busacca,113 990 mg bis(4-
fluorophenyl)phosphine oxide (4.14 mmol, 1.0 eq) were dissolved in 
10 mL anhydrous THF and 12.4 mL DIBAL (1.0 M in cyclohexane, 
12.4 mmol, 3.0 eq) were added at ambient temperature. The reaction mixture was stirred at 
ambient temperature for 14 h and then cooled to  °C. Degassed aqueous 2 M NaOH (10 mL) 
was added very carefully. After the addition of 10 mL of degassed brine solution and further 
stirring for 1 h the lower aqueous layer was separated via syringe and the remaining organic 
layer was filtered over MgSO4. The solvent was carefully removed in vacuo making sure that 
the product was not exposed to air. Bis(4-fluorophenyl)phosphine (175c) was obtained in 49% 
yield (380 mg, 2.01 mmol) as white solid and stored under argon atmosphere. 
1H NMR (300 MHz, C6D6) δ 7.10 – 7.03 (m, 4H, CHar), 6.71 – 6.65 (m, 4H, CHar), 4.98 (d, J = 
216 Hz, 1H, PH).  
13C NMR (75 MHz, C6D6) δ 163.8 (d, J = 248 Hz, FCq, ar), 136.2 (dd, J = 18.5, 8.0 Hz, CHar), 
130.5 (dd, J = 10.2, 3.2 Hz, PCq, ar), 116.0 (dd, J = 20.8, 6.9 Hz, CHar). 
19F NMR (282 MHz, C6D6) δ −112.6. 
31P NMR (121 MHz, C6D6) δ −44.4 (d, J = 217 Hz, PH).  
The NMR spectroscopic data are in accordance with the literature.113 
Bis(4-chlorophenyl)phosphine oxide (174d) 
According to a procedure of Busacca,113 1.14 g (46.9 mmol, 6.3 eq) 
magnesium turnings were suspended in anhydrous THF and 3.59 g 
(18.8 mmol, 2.5 eq) 1-bromo-4-chlorobenzene were added. After 
exothermic reaction of the Grignard reagent 1.04 g (7.50 mmol, 1.0 eq) diethyl phosphite were 
added within 15 min at 0 °C and the reaction was stirred overnight at ambient temperature. 
Aqueous HCl (5.0 mL) was added at 0 °C followed by addition of MTBE. The aqueous layer 
was extracted three times with CH2Cl2 and the combined organic layers were dried over 
MgSO4, filtered and the solvent was removed under reduced pressure. Pure bis(4-
chlorophenyl)phosphine oxide (174d) was obtained in 50% yield (1.02 g, 3.76 mmol) as 
colorless oil without further purification. 
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1H NMR (300 MHz, CDCl3) δ 8.06 (d, J = 486 Hz, 1H, PH), 7.67 – 7.58 (m, 4H, CHar), 7.52 – 
7.48 (m, 4H, CHar).  
13C NMR (75 MHz, CDCl3) δ 132.0 (d, J = 12.6 Hz, CHar), 129.5 (d, J = 13.8 Hz, CHar). Cq, ar 
not detectable. 
31P NMR (121 MHz, CDCl3) δ 19.0 (dt, J = 486, 13.4 Hz, PH).  
The NMR spectroscopic data are in accordance with the literature.113 
Bis(4-chlorophenyl)phosphine (175d) 
According to a procedure of Busacca,113 1.02 g bis(4-
chlorophenyl)phosphine oxide (3.76 mmol, 1.0 eq) were dissolved 
in 15 mL anhydrous THF and 11.3 mL DIBAL (1.0 M in 
cyclohexane, 11.3 mmol, 3.0 eq) were added at ambient temperature. The reaction mixture was 
stirred at ambient temperature for 15 min and then cooled to  °C. Degassed aqueous 2 M NaOH 
(10 mL) was added very carefully. After the addition of 10 mL of degassed brine solution and 
further stirring for 1 h the lower aqueous layer was separated via syringe and the remaining 
organic layer was filtered over MgSO4. The solvent was carefully removed in vacuo making 
sure that the product was not exposed to air. Bis(4-chlorophenyl)phosphine (175d) was 
obtained in 35% yield (480 mg, 1.31 mmol) as white solid and stored under argon atmosphere. 
1H NMR (300 MHz, C6D6) δ 6.99 – 6.92 (m, 8H, CHar), 4.87 (d, J = 217 Hz, 1H, PH).  
13C NMR (75 MHz, C6D6) δ 135.5 (d, J = 17.7 Hz, CHar), 134.3 (d, J = 17.3 Hz, PCq, ar), 133.2 
(d, J = 11.7 Hz, Cq, ar), 129.0 (d, J = 6.6 Hz, CHar).  
31P NMR (121 MHz, C6D6) δ −43.4 (d, J = 218 Hz, 1P, PH).  
The NMR spectroscopic data are in accordance with the literature.113 
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5.3.2 Synthesis of the Pheromone (9Z,12Z)-Tetradeca-9,12-dien-1-yl 
Acetate 
9-((tert-Butyldimethylsilyl)oxy)nonan-1-ol (282) 
According to a procedure of Blair,134 1.50 g sodium hydride 
(60% dispersion in mineral oil, 37.5 mmol, 1.1 eq) were 
suspended in 250 mL anhydrous THF under argon atmosphere and 5.47 g 1,9-nonanediol 
(34.2 mmol, 1.0 eq) were added at ambient temperature in one portion. The mixture was stirred 
overnight. Then, 5.15 g TBSCl (34.2 mmol, 1.0 eq) were added in one portion at 0 °C. Stirring 
was continued for another 2 h. After addition of water the mixture was extracted with EtOAc. 
The combined organic layers were washed with brine, dried over MgSO4, filtered and the 
solvent was removed under reduced pressure. The crude product was purified by FC 
(n-pentane/EtOAc 2:1) to give 9-((tert-butyldimethylsilyl)oxy)nonan-1-ol (282) in 73% yield 
(6.82 g, 24.8 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 3.64 (t, J = 6.6 Hz, 2H, CH2), 3.60 (t, J = 6.7 Hz, 2H, CH2), 
1.62 – 1.48 (m, 4H, CH2), 1.30 (m, 11H, CH2, OH), 0.89 (s, 9H, C(CH3)3), 0.04 (s, 6H, SiCH3). 
13C NMR (75 MHz, CDCl3) δ 63.4 (CH2), 63.2 (CH2), 33.0 (CH2), 32.9 (CH2), 29.7 (CH2), 
29.5 (CH2), 26.1 (C(CH3)3), 25.9 (CH2), 25.8 (CH2), 25.7 (CH2), 18.5 (SiC(CH3)3), −5.1 
(SiCH3). 
The NMR spectroscopic data are in accordance with the literature.135 
9-((tert-Butyldimethylsilyl)oxy)nonanal (283) 
According to a procedure of Sammis,136 under argon 
atmosphere, 6.2 mL dimethyl sulfoxide (86.4 mmol, 4.0 eq) 
were added to a solution of 3.69 mL oxalyl chloride (43.2 mmol, 2.0 eq) in anhydrous CH2Cl2 
(20 mL) at −78 °C dropwise over a period of 30 min. Then a solution of 5.93 g 9-((tert-
butyldimethylsilyl)oxy)nonan-1-ol (21.6 mmol, 1.0 eq) in 20 mL anhydrous CH2Cl2 was added 
over the same period of time and the mixture was stirred for another 90 min. Then, 24 mL 
triethylamine (173 mmol, 8.0 eq) were added dropwise and the resulting slurry was stirred 
overnight at ambient temperature. The mixture was poured into water and extracted with 
CH2Cl2, the organic layer was washed with water and brine, dried over MgSO4, filtered and the 
solvent was removed by rotary evaporation. The crude product was purified by FC 
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(n-pentane/Et2O 5:1) to give 9-((tert-butyldimethylsilyl)oxy)nonanal (283) in 88% yield 
(5.19 g, 19.1 mmol) as yellow oil. 
1H NMR (300 MHz, CDCl3) δ 9.76 (t, J = 1.8 Hz, 1H, CHO), 3.59 (t, J = 6.6 Hz, 2H), 2.42 (dt, 
J = 7.4, 1.9 Hz, 2H, CH2), 1.68 – 1.58 (m, 2H, CH2), 1.55 – 1.46 (m, 2H, CH2) 1.30 (br s, 8H, 
CH2), 0.89 (s, 9H, C(CH3)3), 0.05 (s, 6H, SiCH3). 
13C NMR (75 MHz, CDCl3) δ 203.1 (CHO), 63.4 (CH2), 33.8 (CH2), 33.0 (CH2), 29.5 (CH2), 
29.4 (CH2), 29.3 (CH2), 26.2 (C(CH3)3), 26.0 (CH2), 22.2 (CH2), 18.5 (SiC(CH3)3), −5.1 
(SiCH3). 
The NMR spectroscopic data are in accordance with the literature.137 
(Z)-tert-Butyldimethyl(tetradeca-9,13-dien-1-yloxy)silane (185) 
According to a procedure of Hansson,138 1.75 g pent-
4-enyltriphenylphosphonium bromide (4.26 mmol, 
1.1 eq) in 10 mL anhydrous THF were cooled to 0 °C and 1.7 mL n-butyllithium (2.5 M in 
n-hexane, 4.26 mmol, 1.1 eq) were added via syringe. The resulting red suspension was stirred 
for 90 min at ambient temperature. It was then cooled to −78 °C and 1.3 mL anhydrous DMPU 
(10.4 mmol, 2.7 eq) were added. After 15 min 1.00 g 9-((tert-butyldimethylsilyl)oxy)nonanal 
(3.87 mmol, 1.0 eq) was added and the mixture was stirred overnight slowly warming up to 
ambient temperature. NH4Cl solution was added and the solution was extracted with Et2O, dried 
over MgSO4, filtered and concentrated by rotary evaporation. The crude product was purified 
by FC (n-pentane/Et2O 200:1) to give (Z)-tert-butyldimethyl(tetradeca-9,13-dien-1-
yloxy)silane (185) in 75% (993 mg, 2.89 mmol) as colorless oil.  
1H NMR (500 MHz, CDCl3) δ 5.87 – 5.79 (m, 1H, CHolef), 5.41 – 5.33 (m, 2H, CHolef), 5.04 –
4.95 (m, 2H, CH2, olef), 3.60 (t, J = 6.6 Hz, 2H, CH2), 2.15 – 2.08 (m, 4H, CH2), 2.02 (dd, J = 
6.9, 6.3 Hz, 2H, CH2), 1.52 – 1.48 (m, 2H, CH2), 1.27 (br s, 10H, CH2), 0.89 (s, 9H, C(CH3)3), 
0.05 (s, 6H, SiCH3). 
13C NMR (75 MHz, CDCl3) δ 138.7 (CHolef), 130.6 (CHolef), 129.0 (CHolef), 114.7 (CH2, olef), 
63.5 (CH2), 34.0(CH2), 33.0 (CH2), 29.9 (CH2), 29.7 (CH2), 29.6 (CH2), 29.4 (CH2), 27.4 (CH2), 
26.9 (CH2), 26.2 (C(CH3)3), 26.0 (CH2), −5.1 (SiCH3). C(CH3)3 not detectable.  
IR (neat) 3078, 3006, 2927, 2855, 1641, 1463, 1388, 1361, 1254, 1097, 1005, 993, 939, 910, 
834, 812, 773, 713, 679, 661, 571, 397. 
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HRMS (ESI) calculated for C20H41OSi
+: m/z = 325.2921; found m/z = 325.2930. 
(Z)-Tetradeca-9,13-dien-1-ol (284) 
According to a procedure of Kalesse,139 5.34 mL of a 
TBAF solution (1.0 M in THF, 5.34 mmol, 1.2 eq) were 
added to a solution of 1.52 g (Z)-tert-butyldimethyl(tetradeca-9,13-dien-1-yloxy)silane 
(4.45 mmol, 1.0 eq) in anhydrous THF (30 mL) at 0 °C. After 1 h the reaction was quenched 
with water and extracted with Et2O. The combined organic layers were washed with brine, dried 
over MgSO4, filtered and concentrated by rotary evaporation. The crude product was purified 
by FC (n-pentane/Et2O 5:1) to give alcohol (Z)-tetradeca-9,13-dien-1-ol (284) in 96% yield 
(897 mg, 4.26 mmol) as colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.89 – 5.76 (m, 1H, CHolef), 5.43 – 5.31 (m, 2H, CHolef), 5.05 – 
4.94 (m, 2H, CH2,olef), 3.64 (dd, J = 10.8, 6.4 Hz, 2H, CH2), 2.16 – 2.09 (m, 4H, CH2), 2.07 – 
1.99 (m, 2H, CH2), 1.60 – 1.52 (m, 2H, CH2), 1.30 (br s, 10H, CH2), 1.21 (br s, 1H, OH). 
13C NMR (75 MHz, CDCl3) δ 138.7 (CHolef), 130.6 (CHolef), 129.0 (CHolef), 114.7 (CH2, olef), 
63.2 (CH2), 34.0 (CH2), 33.0 (CH2), 29.8 (CH2), 29.6 (CH2), 29.5 (CH2), 29.4 (CH2), 27.4 
(CH2), 26.8 (CH2), 25.9 (CH2). 
IR (neat) 3327, 3078, 3006, 2924, 2854, 1641, 1456, 1371, 1055, 993, 910, 721, 640, 460, 382. 
HRMS (EI) calculated for C14H26O: m/z = 210.1984; found m/z = 210.1999. 
(Z)-Tetradeca-9,13-dien-1-yl Acetate (184) 
According to a procedure of Jamison,140 1.43 mL 
triethylamine (10.29 mmol, 3.0 eq), 0.49 mL acetic 
anhydride (5.15 mmol, 1.5 eq) and 41.7 mg DMAP (0.34 mmol, 10 mol%) were added to a 
solution of 722 mg (Z)-tetradeca-9,13-dien-1-ol (3.43 mmol, 1.0 eq) in 7.0 mL anhydrous 
CH2Cl2 at 0 °C. The mixture was stirred for 2 h at ambient temperature, then quenched with 
NH4Cl solution and extracted with Et2O. The combined organic layers were washed with 
NaHCO3 and NH4Cl solution, water and brine, dried over MgSO4, filtered and the solvent was 
evaporated. The crude product was purified by FC (n-pentane/Et2O 15:1) to give (Z)-tetradeca-
9,13-dien-1-yl acetate (184) in 95% yield (819 mg, 3.24 mmol) as colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.89 – 5.76 (m, 1H, CHolef), 5.43 – 5.31 (m, 2H, CHolef), 5.05 – 
4.93 (m, 2H, CH2, olef), 4.05 (t, J = 6.8 Hz, 2H, CH2), 2.16 – 2.09 (m, 4H, CH2), 2.07 – 1.99 (m, 
2H, CH2), 2.04 (s, 3H, CH3), 1.66 – 1.57 (m, 2H, CH2), 1.30 (br s, 10 H, CH2). 
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13C NMR (125 MHz, CDCl3) δ 171.3 (C=O), 138.7 (CHolef), 130.6 (CHolef), 129.0 (CHolef), 
114.7 (CH2, olef), 64.8 (CH2), 34.0 (CH2), 29.8 (CH2), 29.5 (CH2), 29.4 (CH2), 29.3 (CH2), 28.8 
(CH2), 27.4 (CH2), 26.9 (CH2), 26.1 (CH2), 21.1 (CH3). 
IR (neat) 3078, 3006, 2926, 2855, 1740, 1640, 1456, 1387, 1365, 1233, 1036, 994, 910, 723, 
635, 606, 428. 
HRMS (EI) calculated for C16H28O2: m/z = 252.2089; found m/z = 252.2092. 
(9Z,12Z)-Tetradeca-9,12-dien-1-yl Acetate (165) 
The title compound was prepared according to GP 1 
utilizing 13.2 mg Ni(dppe)Cl2 (25.0 mmol, 10 mol%), 
3.3 mg zinc powder (50.0 mmol, 20 mol%), 16.0 mg zinc iodide (50.0 mmol, 20 mol%), 0.1 mL 
of the 0.125 mM HPPh2 solution (12.5 mmol, 5.0 mol%) and 64 mg (Z)-tetradeca-9,13-dien-1-
yl acetate (0.25 mmol, 1.0 eq). The reaction mixture was stirred for 8 h at −15 °C. After general 
workup (9Z,12Z)-Tetradeca-9,12-dien-1-yl acetate was obtained as an E/Z mixture (12:88) in 
92% yield (59 mg, 0.23 mmol) as colorless oil. The product mixture contained 4% of unreacted 
starting material. Pure 2-(Z)-configured product (165) was obtained after flash chromatography 
on silica gel impregnated with 10 weight-% AgNO3 eluting with a stepwise gradient of 
n-pentane/EtOAc (40:1→10:1) as colorless oil. 
1H NMR (500 MHz, CDCl3) δ 5.52 – 5.30 (m, 4H, CHolef), 4.05 (t, J = 6.7 Hz, 2H, CH2), 2.78 
(t, J = 6.2 Hz, 2H, CH2), 2.09 – 1.98 (m, 2H, CH2), 2.04 (s, 3H, CH3, Ac), 1.64 (ddd, J = 6.5, 
2.5, 1.0 Hz, 3H, CH3), 1.63 – 1.57 (m, 2H, CH2), 1.31 (br s, 10H, CH2). 
13C NMR (125 MHz, CDCl3) δ 171.3 (C=O), 130.3 (CHolef), 129.1 (CHolef), 128.0 (CHolef), 
124.1 (CHolef), 64.8 (CH2), 29.8 (CH2), 29.5 (CH2), 29.4 (CH2), 29.3 (CH2), 28.8 (CH2), 27.4 
(CH2), 26.1 (CH2), 25.5 (CH2), 21.1 (CH3, Ac), 12.9 (CH3). 
IR (neat) 3014, 2926, 2855, 1741, 1656, 1458, 1387, 1365, 1234, 1125, 1100, 1039, 967, 893, 
847, 722, 695, 634, 606, 421. 
HRMS (EI) calculated for C16H28O2: m/z = 252.2089; found m/z = 252.2097. 
Resolved signals of the minor product (9Z,12E)-tetradeca-9,12-dien-1-yl acetate: 
1H NMR (300 MHz, CDCl3) δ 5.48 – 5.31 (m, 4H, CHolef), 4.05 (t, J = 6.8 Hz, 2H, CH2), 2.72 
(t, J = 5.0 Hz, 2H, CH2), 2.06 – 1.95 (m, 2H, CH2), 2.04 (s, 3H, CH3, Ac), 1.66 – 1.56 (m, 5H, 
CH2 + CH3), 1.30 (br s, 10H, CH2).  
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13C NMR (75 MHz, CDCl3) δ 171.3 (C=O), 130.5 (CHolef), 129.8 (CHolef), 127.9 (CHolef), 125.2 
(CHolef), 64.8 (CH2), 30.6 (CH2), 29.8 (CH2), 29.5 (CH2), 29.4 (CH2), 29.3 (CH2), 28.8 (CH2), 
27.2 (CH2), 26.1 (CH2), 21.1 (CH3, Ac), 18.0 (CH3). 
The NMR spectroscopic data for the minor product are in accordance with the literature.117 
5.3.3 Synthesis of the Pheromone (8Z,10E)-Dodeca-8,10-dien-1-yl Acetate 
8-((tert-Butyldimethylsilyl)oxy)octan-1-ol (285) 
According to a procedure of Blair,134 1.50 g sodium hydride 
(60% dispersion in mineral oil, 37.5 mmol, 1.1 eq) were suspended in 250 mL anhydrous THF 
under argon atmosphere and 5.00 g 1,8-octanediol (34.2 mmol, 1.0 eq) were added at ambient 
temperature in one portion. The mixture was stirred overnight. Then, 5.20 g TBSCl (34.5 mmol, 
1.0 eq) were added in one portion at 0 °C. Stirring was continued for another 4 h. After addition 
of water the mixture was extracted with EtOAc. The combined organic layers were washed 
with brine, dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The crude product was purified by FC (n-pentane/EtOAc 6:1) to give 8-((tert-
butyldimethylsilyl)oxy)octan-1-ol (285) in 68% yield (6.04 g, 22.2 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 3.66 – 3.57 (m, 4H, CH2), 1.59 – 1.46 (m, 4H, CH2), 1.31 (br s, 
8H, CH2), 0.89 (s, 9H, C(CH3)3), 0.04 (s, 6H, SiCH3). 
13C NMR (75 MHz, CDCl3) δ 63.4 (CH2), 63.2 (CH2), 33.02 (CH2), 32.97 (CH2), 29.6 (CH2), 
26.1 (C(CH3)3), 25.9 (CH2), 25.8 (CH2), 18.5 (C(CH3)3), −5.1 (SiCH3). 
The NMR spectroscopic data are in accordance with the literature.136 
8-((tert-Butyldimethylsilyl)oxy)octanal (286) 
According to a procedure of Sammis,136 under argon 
atmosphere, 6.6 mL dimethyl sulfoxide (92.7 mmol, 4.0 eq) were added to a solution of 3.97 mL 
oxalyl chloride (46.4 mmol, 2.0 eq) in anhydrous CH2Cl2 (50 mL) at −78 °C dropwise over a 
period of 30 min. Then a solution of 6.038 g 8-((tert-butyldimethylsilyl)oxy)octan-1-ol 
(22.2 mmol, 1.0 eq) in 50 mL anhydrous CH2Cl2 was added over the same period of time and 
the mixture was stirred for another 90 min. Then, 25.7 mL triethylamine (185 mmol, 8.0 eq) 
were added dropwise and the resulting slurry was stirred overnight at ambient temperature. The 
mixture was poured into water and extracted with CH2Cl2, washed with water and brine, dried 
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over MgSO4, filtered and the solvent was removed by rotary evaporation. The crude product 
was purified by FC (n-pentane/Et2O 5:1) to give 8-((tert-butyldimethylsilyl)oxy)octanal (286) 
in 87% yield (5.20 g, 20.1 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 9.76 (t, J = 1.9 Hz, 1H, CHO), 3.59 (t, J = 6.5 Hz, 2H, CH2), 
2.41 (dt, J = 7.4, 1.9 Hz, 2H, CH2), 1.32 (br s, 6H, CH2), 0.89 (s, 9H, C(CH3)3), 0.04 (s, 6H, 
SiCH3). 
13C NMR (75 MHz, CDCl3) δ 202.9 (C=O), 63.3 (CH2), 32.9 (CH2), 29.3 (CH2), 26.1 
(C(CH3)3), 25.8 (CH2), 22.2 (CH2), 18.5 (C(CH3)3), −5.1 (SiCH3).  
The NMR spectroscopic data are in accordance with the literature.136 
(Z)-tert-Butyl(dodeca-8,11-dien-1-yloxy)dimethylsilane (287) 
According to a procedure of Hansson,138 5.95 g but-3-
enyltriphenylphosphonium bromide (8.83 mmol, 1.0 eq) in 
16 mL anhydrous THF were cooled to 0 °C and 3.5 mL n-BuLi (2.5 M in n-hexane, 8.83 mmol, 
1.0 eq) were added via syringe. The suspension was stirred for 90 min at ambient temperature. 
It was then cooled to −60 °C and 3.06 mL anhydrous DMPU (23.8 mmol, 2.7 eq) were added. 
After 15 min 2.28 g 8-((tert-butyldimethylsilyl)oxy)octanal (8.83 mmol, 1.0 eq) were added 
and the mixture was stirred overnight at ambient temperature. NH4Cl solution was added and 
the solution was extracted with Et2O, dried over MgSO4, filtered and the solvent was 
evaporated. The crude product was purified by FC (n-pentane/Et2O 100:1) to give (Z)-tert-
butyl(dodeca-8,11-dien-1-yloxy)dimethylsilane (287) in 62% (1.63 g, 5.48 mmol) as colorless 
oil. 
1H NMR (500 MHz, CDCl3) δ 5.85 – 5.77 (m, 1H, CHolef), 5.48 – 5.35 (m, 2H, CHolef), 5.03 
(dq, J = 17.1, 1.8 Hz, 1H, CHolef), 4.97 (dq, J = 10.1, 1.9 Hz, 1H, CHolef), 3.60 (t, J = 6.5 Hz, 
2H, CH2), 2.79 (dt, J = 7.1, 1.6 Hz, 2H, CH2), 2.03 (q, J = 7.0 Hz, 2H, CH2), 1.52 – 1.48 (m, 
2H, CH2), 1.36 – 1.30 (m, 8H, CH2), 0.90 (s, 9H, C(CH3)3), 0.05 (s, 6H, SiCH3). 
13C NMR (125 MHz, CDCl3) δ 137.3 (CHolef), 131.3 (CHolef), 126.8 (CHolef), 114.6 (CH2, olef), 
63.5 (CH2), 33.1 (CH2), 31.7 (CH2), 29.7 (CH2), 29.5 (CH2), 29.4 (CH2), 27.3 (CH2), 26.2 
(C(CH3)3), 25.9 (CH2), 18.5 (C(CH3)3), −5.1 (SiCH3). 
IR (neat) 3011, 2928, 2856, 1638, 1471, 1462, 1387, 1361, 1254, 1097, 1005, 992, 938, 910, 
832, 813, 773, 712, 679, 661, 572, 541, 503. 
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HRMS (ESI) calculated for C20H40OSi+H
+: m/z = 325.2921; found m/z = 325.2930. 
(Z)-Dodeca-8,11-dien-1-ol (288) 
According to a procedure of Kalesse,139 under argon 
atmosphere, 1.4 mL of a TBAF solution (1.0 M in THF, 
5.47 mmol, 1.2 eq) were added to a solution of 1.35 g (Z)-tert-butyl(dodeca-8,11-dien-1-
yloxy)dimethylsilane (4.56 mmol, 1.0 eq) in 40 mL anhydrous THF at 0 °C. After 1 h the 
reaction was quenched with water and extracted with Et2O. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and concentrated by rotary evaporation. The 
crude product was purified by FC (n-pentane/MTBE 5:1) to give alcohol (Z)-dodeca-8,11-dien-
1-ol (288) in 86% yield (717 mg, 3.93 mmol) as yellow oil. 
1H NMR (300 MHz, CDCl3) δ 5.88 – 5.74 (m, 1H, CHolef), 5.49 – 5.34 (m, 2H, CHolef), 5.03 
(dq, J = 17.2, 1.8 Hz, 1H, CHolef), 4.96 (dq, J = 10.1, 1.9 Hz, 1H, CHolef), 3.64 (t, J = 6.6 Hz, 
2H, CH2), 2.79 (t, J = 6.3 Hz, 2H, CH2), 2.03 (q, J = 7.0 Hz, 2H, CH2), 1.61 – 1.52 (m, 2H, 
CH2), 1.32 (br s, 8H, CH2). 
13C NMR (75 MHz, CDCl3) δ 137.3 (CHolef), 131.2 (CHolef), 126.8 (CHolef), 114.7 (CH2, olef), 
63.2 (CH2), 32.9 (CH2), 31.7 (CH2), 29.7 (CH2), 29.4 (CH2), 29.3 (CH2), 27.3 (CH2), 25.9 
(CH2). 
IR (neat) 3323, 3079, 3009, 2926, 2854, 1637, 1462, 1432, 1376, 1272, 1056, 992, 909, 836, 
775, 723, 635, 530. 
HRMS (ESI) calculated for C12H22O: m/z = 182.1671; found m/z = 182.1655. 
(Z)-Dodeca-8,11-dien-1-yl Acetate (194) 
According to a procedure of Jamison,140 1.37 mL 
triethylamine (9.87 mmol, 3.0 eq), 504 mg acetic anhydride 
(4.94 mmol, 1.5 eq) and 40 mg DMAP (0.33 mmol, 10 mol%) were added to a solution of 
600 mg (Z)-dodeca-8,11-dien-1-ol (3.29 mmol, 1.0 eq) in 7.0 mL anhydrous CH2Cl2 at 0 °C. 
The mixture was stirred for 5 h at ambient temperature, then quenched with NH4Cl solution and 
extracted with Et2O. The combined organic layers were washed with aqueous NaHCO3, NH4Cl, 
water and brine, dried over MgSO4, filtered and the solvent was evaporated. The crude product 
was purified by FC (n-pentane/Et2O 15:1) to give (Z)-dodeca-8,11-dien-1-yl acetate (194) in 
90% yield (666 mg, 2.97 mmol) as colorless oil. 
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1H NMR (500 MHz, CDCl3) δ 5.88 – 5.80 (m, 1H, CHolef), 5.51 – 5.39 (m, 2H, CHolef), 5.06 
(dq, J = 17.5, 2.0 Hz, 1H, CHolef), 5.00 (dq, J = 10.1, 1.9 Hz, 1H, CHolef), 4.08 (t, J = 6.6 Hz, 
2H, CH2), 2.83 – 2.81 (m, 2H, CH2), 2.07 (s, 3H, CH3, Ac), 2.03 (t, J = 7.1 Hz, 2H, CH2), 1.67 
– 1.62 (m, 2H, CH2), 1.35 (br s, 8H, CH2). 
13C NMR (125 MHz, CDCl3) δ  171.3 (C=O), 137.3 (CHolef), 131.2 (CHolef), 126.9 (CHolef), 
114.7 (CH2, olef), 64.7 (CH2), 31.7 (CH2), 29.6 (CH2), 29.3 (CH3, Ac), 28.8 (CH2), 27.2 (CH2), 
26.1 (CH2), 21.0 (CH2). 
IR (neat) 3080, 3009, 2928, 2856, 1739, 1638, 1464, 1435, 1388, 1365, 1232, 1036, 993, 910, 
838, 723, 634, 605, 526. 
HRMS (EI) calculated for C14H24O2: m/z = 224.1776; found m/z = 224.1779. 
(8Z,10E)-Dodeca-8,10-dien-1-yl Acetate (164) 
The title compound was prepared according to GP 1 utilizing 
32 mg Co(dppp)Br2 (50.0 mmol, 10 mol%), 6.6 mg zinc 
powder (100 mmol, 20 mol%), 32.0 mg zinc iodide 
(100 mmol, 20 mol%), 0.2 mL of the 0.125 mM HPPh2 solution (25.0 mmol, 5.0 mol%) and 
112 mg  (Z)-dodeca-8,11-dien-1-yl acetate (0.25 mmol, 1.0 eq). The reaction mixture was 
stirred for 16 h at ambient temperature. After general workup (8Z,10E)-dodeca-8,10-dien-1-yl 
acetate (164) was obtained as an E/Z mixture (87:13) in 90% yield (100 mg, 0.45 mmol) as 
colorless oil.  
1H NMR (300 MHz, CDCl3) δ 6.06 – 5.90 (m, 2H, CHolef), 5.62 – 5.48 (m, 2H, CHolef), 4.04 
(dt, J = 6.7, 1.2 Hz, 2H, CH2), 2.04 (s, 3H, CH3, Ac), 1.72 (d, J = 6.8 Hz, 3H, CH3), 1.63 – 1.58 
(m, 2H, CH2), 1.30 (br s, 10H, CH2). 
13C NMR (75 MHz, CDCl3) δ 171.3 (C=O), 132.1 (CHolef), 131.9 (CHolef), 130.5 (CHolef), 126.9 
(CHolef), 64.8 (CH2), 32.6 (CH2), 29.5 (CH2), 29.3 (CH2), 29.2 (CH2), 28.8 (CH2), 26.0 (CH2), 
21.1 (CH3, Ac), 18.1 (CH3). 
Resolved signals of the minor product (8Z,10Z)-dodeca-8,10-dien-1-yl acetate: 
1H NMR (300 MHz, CDCl3) δ 6.36 – 6.24 (m, 2H, CHolef), 5.70 – 5.65 (m, 2H, CHolef), 1.76 
(d, J = 6.8 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 134.5 (CHolef), 128.7 (CHolef), 125.6 (CHolef), 33.0 (CH2), 29.8 
(CH2), 27.8 (CH2), 18.4 (CH3, Ac), 13.4 (CH3). 
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The NMR spectroscopic data for the minor product are in accordance with the literature.141 
5.3.4 Attempted Synthesis of Aucanthen 
(cis)-6-(((tert-Butyldimethylsilyl)oxy)methyl)cyclohex-3-ene-1-carbaldehyde (199)   
Under argon atmosphere, 2.8 mL oxalyl chloride (32.8 mmol, 2.0 eq) were 
dissolved in 50 mL anhydrous dichloromethane and cooled to −78 °C. 4.7 mL 
DMSO (65.6 mmol, 4.0 eq)  in 50 mL anhydrous dichloromethane were added over a period of 
30 min. After stirring for another 30 min at −78 °C 4.21 g ((cis)-6-(((tert-
butyldimethylsilyl)oxy)methyl)cyclohex-3-en-1-yl)methanol (16.4 mmol, 1.0 eq)  were added 
within 30 min at −78 °C. After 90 min 17.5 mL triethylamin (131 mmol, 8.0 eq) were added at 
−78 °C within 30 min and the reaction mixture was allowed to warm up to ambient temperature 
overnight. H2O was added, and the aqueous layer was extracted three times with 
dichloromethane. The combined organic layers were washed with brine, dried over MgSO4, 
filtered and the solvent was evaporated. The crude product was purified by FC (n-pentane/Et2O 
11:1) to give (cis)-6-(((tert-butyldimethylsilyl)oxy)methyl)cyclohex-3-ene-1-carbaldehyde 
(199) in 84% yield (3.49 g, 13.7 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 9.74 (s, 1H, HCO), 5.73 – 5.60 (m, 2H, CHolef), 3.63 – 3.52 (m, 
2H, CH2), 2.60 – 1.92 (m, 6H, CH + CH2), 0.86 (s, 9H, C(CH3)3), 0.01 (d, J = 2.9 Hz, 6H,  
SiCH3). 
13C NMR (75 MHz, CDCl3) δ 203.9 (C=O), 125.9 (CHolef), 125.1 (CHolef), 63.6 (CH2), 47.7 
(CH), 36.6 (CH), 27.0 (CH2), 26.0 (C(CH3)3) 22.1 (CH2), 18.4 (SiC(CH3)3), −5.45 (SiCH3). 
IR (neat) 3027, 2953, 2928, 2898, 2856, 1721, 1471, 1389, 1251, 1093, 1077, 1006, 832, 774, 
663, 401. 
HRMS (EI) calculated for C14H26O2Si: m/z = 254.1702; found m/z = 254.1700.  
tert-Butyldimethyl(((cis)-6-vinylcyclohex-3-en-1-yl)methoxy)silane (289)  
Under argon atmosphere, 7.90 g methyltriphenylphosphonium bromide 
(22.1 mmol, 1.2 eq) and 2.80 g potassium tert-butoxide (25.0 mmol, 1.4 eq) 
were suspended in 60 mL anhydrous Et2O and stirred for 20 min at ambient temperature. 4.86 g 
(cis)-6-(((tert-butyldimethylsilyl)oxy)methyl)cyclohex-3-ene-1-carbaldehyde (19.3 mmol, 
1.0 eq) were added and the reaction mixture was stirred overnight at ambient temperature. 
NH4Cl solution was added and the aqueous layer was extracted three times with Et2O. The 
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combined organic layers were washed with brine, dried over MgSO4, filtered and the solvent 
was evaporated. The crude product was purified by FC (n-pentane/Et2O 50:1) to give tert-
butyldimethyl(((cis)-6-vinylcyclohex-3-en-1-yl)methoxy)silane (289) in 72% yield (4.04 g, 
16.0 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.67 – 5.59 (m, 3H, CHolef), 5.05 – 4.95 (m, 2H, CH2, olef), 3.61 – 
3.40 (m, 2H, CH2), 2.43 – 1.72 (m, 6H, CH + CH2), 0.87 (s, 9H, C(CH3)3), 0.05 (s, 6H, SiCH3). 
13C NMR (75 MHz, CDCl3) δ 139.3 (CHolef), 126.1 (CHolef), 125.6 (CHolef), 115.1 (CH2, olef), 
64.5 (CH2), 37.9 (CH), 30.4 (CH2), 26.1 (C(CH3)3), 25.8 (CH), 18.5 (SiC(CH3)3), −5.45 
(SiCH3). 
IR (neat) 3075, 3024, 2954, 2927, 2896, 2856, 1637, 1471, 1253, 1079, 1000, 938, 833, 773, 
655, 403. 
HRMS (EI) calculated for C14H25OSi: m/z = 237.1675; found m/z = 237.1684.  
(cis)-2-(6-Vinylcyclohex-3-en-1-yl)acetonitrile (290) 
The title compound was prepared after quantitative deprotection of of tert-
butyldimethyl(((cis)-6-vinylcyclohex-3-en-1-yl)methoxy)silane and mesyla-
tion of the corresponding alcohol. Then, 3.10 g ((cis)-6-vinylcyclohex-3-en-1-yl)methyl 
methanesulfonate (14.3 mmol, 1.0 eq) and 2.04 g 18-crown-6 (7.72 mmol, 54 mol%) were 
dissolved in 60 mL anhydrous acetonitrile followed by the addition of 1.86 g potassium cyanide 
(28.6 mmol, 2.0 eq) and 150 mg sodium iodide (1.00 mmol, 7.0 mol%). The reaction mixture 
was stirred for 60 h at 80 °C. H2O was then added and the aqueous layer was extracted three 
times with MTBE. The combined organic layers were dried over MgSO4, filtered and the 
solvent was evaporated. The crude product was purified by FC (n-pentane/Et2O 8:1) to give 
(cis)-2-(6-vinylcyclohex-3-en-1-yl)acetonitrile (290) in 78% yield (1.64 g, 11.2 mmol) as 
colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.83 – 5.52 (m, 3H, CHolef), 5.22 – 5.08 (m, 2H, CH2, olef), 2.81 
– 1.82 (m, 8H, CH + CH2). 
13C NMR (75 MHz, CDCl3) δ 137.5 (CHolef), 125.5 (CHolef), 124.7 (CHolef), 117.0 (CH2, olef), 
116.8 (CN), 39.8 (CH2CN), 34.2 (CH), 30.3 (CH2), 28.5 (CH2) 25.8 (CH).  
The NMR spectroscopic data are in accordance with the literature.142 
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(cis)-4-Allyl-5-vinylcyclohex-1-ene (200) 
 Under argon atmosphere, 1.64 g (cis)-2-(6-vinylcyclohex-3-en-1-
yl)acetonitrile (11.2 mmol, 1.0 eq) were dissolved in 40 mL anhydrous THF 
and 23.5 mL DIBAL (1.0 M in THF, 23.5 mmol, 2.1 eq) were added at −78 °C. The reaction 
was stirred for 30 min at −78 °C and another 3 h at ambient temperature. Aqueous NaHCO3 
solution was added carefully and the aqueous layer was extracted three times with Et2O. The 
combined organic layers were washed with brine, dried over MgSO4, filtered and the solvent 
was evaporated. A preformed mixture of 5.59 g methyltriphenylphosphonium bromide 
(15.7 mmol, 1.4 eq) and 6.3 mL n-BuLi (2.5 M in n-hexane, 15.7 mmol, 1.4 eq) in 60 mL 
anhydrous THF was stirred for 2 h before crude (cis)-2-(6-vinylcyclohex-3-en-1-
yl)acetaldehyde was added at 0 °C. The reaction mixture was stirred overnight at ambient 
temperature. The mixture was adsorbed on silica, the solvent was evaporated followed by 
purification by FC (n-pentane) to give (cis)-4-allyl-5-vinylcyclohex-1-ene (200) in 35% yield 
(583 mg, 3.93 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 5.71-5.92 (m, 2H, CHolef), 5.64 (s, 2H, CHolef), 4.96-5.18 (m, 
4H, CH2, olef), 2.49 – 2.42 (m, 1H, CH), 2.34 – 1.74 (m, 7H, CH + CH2). 
13C NMR (75 MHz, CDCl3) δ 139.5 (CHolef), 137.9 (CHolef), 126.3 (CHolef), 125.5 (CHolef), 
115.7 (CH2, olef), 115.2 (CH2, olef), 40.4 (CH), 36.6 (CH2), 36.5 (CH2), 30.3 (CH), 28.7 (CH2). 
The NMR spectroscopic data are in accordance with the literature.142 
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5.4 Isomerization of N-Allyl Amides 
5.4.1 Synthesis of N-Allyl Amides and Carbamates 
N-Allylacetamide (71a) 
The title compound was prepared according to GP 2. First, 1.50 mL 
allylamine (20.0 mmol, 1.0 eq) and 4.16 mL triethylamine (30.0 mmol, 
1.5 eq) were dissolved in 50 mL dichloromethane and 1.56 mL acetyl chloride (22.0 mmol, 
1.1 eq) were added at 0 °C. After stirring overnight at ambient temperature, the reaction mixture 
was quenched with 0.1 M aqueous HCl and the aqueous layer was extracted three times with 
Et2O. The combined organic layers were washed with brine, dried over Na2SO4, filtered and 
the solvent was evaporated. N-Allylacetamide (71a) was obtained in 43% yield (843 mg, 
8.50 mmol) as colorless volatile liquid without further purification. 
1H NMR (300 MHz, CDCl3) δ 5.83 (tdd, J = 16.6 Hz, 11.6 Hz, 5.9 Hz, 1H, CHolef), 5.58 (s, 
1H, NH), 5.21 – 5.11 (m, 2H, CH2, olef), 3.87 (t, J = 5.4 Hz, 2H, CH2), 2.00 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 170.0 (C=O), 134.4 (CHolef), 116.6 (CH2, olef), 42.2 (CH2), 23.4 
(CH3). 
The NMR spectroscopic data are in accordance with the literature.143 
N-Allyloctanamide (71b) 
 The title compound was prepared according to GP 2. First, 
2.25 mL allylamine (30.0 mmol, 1.0 eq) and 4.16 mL 
triethylamine (30.0 mmol, 1.0 eq) were dissolved in 30 mL dichloromethane and 5.13 mL 
octanoyl chloride (30.0 mmol, 1.0 eq) were added at 0 °C. After stirring overnight at ambient 
temperature, the reaction mixture was quenched with H2O and the aqueous layer was extracted 
three times with dichloromethane. The combined organic layers were washed with brine, dried 
over MgSO4, filtered and the solvent was evaporated. The crude product was purified by FC 
(n-pentane/Et2O 9:1) to give N-allyloctanamide (71b) in 87% yield (4.77 g, 26.0 mmol) as white 
solid. 
1H NMR (300 MHz, CDCl3) δ 5.99 – 5.77 (m, 1H, CHolef), 5.52 (s, 1H, NH), 5.20 – 5.10 (m, 
2H, CH2, olef) 3.88 (tt, J = 5.7, 1.5 Hz, 2H, CH2), 2.19 (t, J = 7.3 Hz, 2H, CH2), 1.63 (m, J = 7.3 
Hz, 2H, CH2), 1.28 (m, J = 3.6 Hz, 8H, CH2), 0.87 (t, J = 6.9 Hz, 3H, CH3). 
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13C NMR (75 MHz, CDCl3) δ 173.2 (C=O), 134.6 (CHolef), 116.3 (CH2, olef), 42.0 (CH2), 36.9 
(CH2), 31.8 (CH2), 29.4 (CH2), 29.1 (CH2), 25.9 (CH2), 22.7 (CH2), 14.1 (CH3). 
The NMR spectroscopic data are in accordance with the literature.122 
N-Allyl-2-phenylacetamide (71c)  
 The title compound was prepared according to GP 2. First, 1.13 mL 
allylamine (15.0 mmol, 1.0 eq) and 2.06 mL triethylamine (15.0 mmol, 
1.0 eq) were dissolved in 30 mL dichloromethane and 2.00 mL 
phenylacetyl chloride (15.0 mmol, 1.0 eq) were added at 0 °C. After stirring overnight at 
ambient temperature, the reaction mixture was quenched with H2O and the aqueous layer was 
extracted three times with dichloromethane. The combined organic layers were washed with 
brine, dried over MgSO4, filtered and the solvent was evaporated. Pure N-allyl-2-
phenylacetamide (71c) was obtained in 94% yield (2.47 g, 14.1 mmol) as white solid without 
further purification. 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7. 26 (m, 5H, CHar), 5.83 – 5.70 (m, 1H, CHolef), 5.42 (s, 
1H, NH), 5.08 (d, J = 1.5 Hz, 1H, CHolef), 5.03 (dd, J = 7.8, 1.5 Hz, 1H, CHolef), 3.85 (tt, J = 
5.6,1.5 Hz, 2H, CH2), 3.61 (s, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 170.9 (C=O), 135.0 (Cq, ar), 134.2 (CHolef), 129.6 (CHar), 129.2 
(CHar), 127.5 (CHar), 116.2 (CH2, olef), 44.0 (CH2), 42.0 (CH2). 
The NMR spectroscopic data are in accordance with the literature.122 
N-Allylcinnamamide (71d)  
 The title compound was prepared according to GP 2. First, 2.25 mL 
allylamine (30.0 mmol, 1.0 eq) and 4.16 mL triethylamine 
(30.0 mmol, 1.0 eq) were dissolved in 30 mL dichloromethane and 
5.00 g cinnamoyl chloride (30.0 mmol, 1.0 eq) were added at 0 °C. After stirring overnight at 
ambient temperature, the reaction mixture was quenched with H2O and the aqueous layer was 
extracted three times with dichloromethane. The combined organic layers were washed with 
brine, dried over MgSO4, filtered and the solvent was evaporated. The crude product was 
purified by FC (n-pentane/Et2O 3:1) to give N-allylcinnamamide (71d) in 59% yield (3.32 g, 
17.8 mmol) as white solid. 
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1H NMR (300 MHz, CDCl3) δ 7.66 (d, J = 15.7 Hz, 1H, CHolef), 7.52 – 7.49 (m, 2H, CHar), 
7.39 – 7.35 (m, 3H, CHar), 6.41 (d, J = 15.5 Hz, 1H, CHolef), 5.97 – 5.84 (m, 1H, CHolef), 5.66 
(s, 1H, NH), 5.24 (dd, J = 17.1, 1.4 Hz, 1H, CHolef), 5.19 (dd, J = 10.2, 1.2 Hz, 1H, CHolef), 4.03 
(tt, J = 5.7, 1.5 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 165.8 (C=O), 141,5 (CHolef), 135.0 (Cq, ar), 134.3 (CHolef), 129.9 
(CHar), 129.0 (CHar), 128.0 (CHar), 120.6 (CHolef), 116.8 (CH2, olef), 42.3 (CH2). 
The NMR spectroscopic data are in accordance with the literature.144 
N-Allylbenzamide (71e) 
 The title compound was prepared according to GP 2. First, 2.25 mL 
allylamine (30.0 mmol, 1.0 eq) and 4.16 mL triethylamine (30.0 mmol, 
1.0 eq) were dissolved in 30 mL dichloromethane and 4.36 mL benzoyl 
chloride (37.5 mmol, 1.3 eq) were added at 0 °C. After stirring overnight at ambient 
temperature, the reaction mixture was quenched with H2O and the aqueous layer was extracted 
three times with dichloromethane. The combined organic layers were washed with brine, dried 
over MgSO4, filtered and the solvent was evaporated. The crude product was purified by FC 
(n-pentane/Et2O 4:1) to give N-allylbenzamide (71e) in 89% yield (4.28 g, 26.6 mmol) as 
colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.78 (dd, J = 8.6, 1.4 Hz, 2H, CHar), 7.52 – 7.40 (m, 3H, CHar), 
6.27 (s, 1H, NH), 6.00 – 5.88 (m, 1H, CHolef), 5.25 (dd, J = 17.1, 1.4 Hz, 1H, CHolef), 5.18 (dd, 
J = 10.2, 1.3 Hz, 1H, CHolef), 4.09 (t, J = 5.7 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 167.5 (C=O), 134.7 (Cq, ar), 134.3 (CHolef), 131.6 (CHar), 128.7 
(CHar), 127.1 (CHar), 116.8 (CH2, olef), 42.6 (CH2). 
The NMR spectroscopic data are in accordance with the literature.122 
N-(But-3-en-1-yl)benzamide (290) 
 The title compound was prepared according to GP 2. First, 1.14 g but-
3-enylamine (16.0 mmol, 1.0 eq) and 2.22 mL triethylamine 
(16.0 mmol, 1.0 eq) were dissolved in 16 mL dichloromethane and 
1.84 mL benzoyl chloride (16.0 mmol, 1.0 eq) were added at 0 °C. After stirring overnight at 
ambient temperature, the reaction mixture was quenched with H2O and the aqueous layer was 
extracted three times with dichloromethane. The combined organic layers were washed with 
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brine, dried over Na2SO4, filtered and the solvent was evaporated. The crude product was 
purified by FC (n-pentane/Et2O 4:1) to give N-(but-3-en-1-yl)benzamide (290) in 25% yield 
(711 mg, 4.06 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.74 (t, J = 8.4, 1.5 Hz, 2H, CHar), 7.50 – 7.388 (m, 3H, CHar), 
6.28 (s, 1H, NH), 5.83 (tdd, J = 17.2 Hz, 10.3 Hz, 7.0 Hz, 1H, CHolef), 5.18 – 5.10 (m, 2H, CH2, 
olef), 3.68 (q, J = 6.3 Hz, 2H, CH2), 2.38 (q, J = 6.8 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 167.6 (C=O), 135.5 (CHolef), 134.9 (Cq, ar), 131.5 (CHar), 128.7 
(CHar), 127.0 (CHar), 117.5 (CH2, olef), 39.0 (CH2), 33.9 (CH2). 
IR (neat) 3312, 3076, 2978, 2932, 1636, 1537, 1219, 1182, 915, 692. 
HRMS (ESI) calculated for C11H13NONa
+: m/z = 198.0889; found m/z = 198.0891.  
N-Allyl-2,4,6-trimethylbenzamide (71f) 
 The title compound was prepared according to GP 2. First, 2.25 mL 
allylamine (30.0 mmol, 1.0 eq) and 4.16 mL triethylamine 
(30.0 mmol, 1.0 eq) were dissolved in 30 mL dichloromethane and 
5.00 mL trimethylbenzoyl chloride (30.0 mmol, 1.0 eq) were added at 0 °C. After stirring 
overnight at ambient temperature, the reaction mixture was quenched with H2O and the aqueous 
layer was extracted three times with dichloromethane. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent was evaporated. Pure N-allyl-
2,4,6-trimethylbenzamide (71f) was obtained in 91% yield (5.53 g, 27.2 mmol) as white solid. 
1H NMR (300 MHz, CDCl3) δ 6.84 (s, 2H, CHar), 6.00 – 5.87 (m, 1H, CHolef), 5.67 (s, 1H, 
NH), 5.25 (dq, J = 17.2, 1.4 Hz, 1H, CHolef), 5.20 (dd, J = 10.1, 1.5 Hz, 1H, CHolef), 4.09 (tt, 
J = 5.8, 1.4 Hz, 2H, CH2), 2.29 (s, 6H, CH3, ortho), 2.27 (s, 3H, CH3, para). 
13C NMR (75 MHz, CDCl3) δ 170.5 (C=O), 138.6 (Cq, ar), 135.0 (Cq, ar), 134.3 (Cq, ar), 134.2 
(CHolef), 128.4 (CHar), 117.0 (CH2, olef), 42.1 (CH2), 21.2 (CH3, para), 19.3 (CH3, ortho). 
The NMR spectroscopic data are in accordance with the literature.122 
N-Allyl-4-methoxybenzamide (71g) 
 The title compound was prepared according to GP 2. First, 2.25 mL 
allylamine (30.0 mmol, 1.0 eq) and 4.16 mL triethylamine 
(30.0 mmol, 1.0 eq) were dissolved in 30 mL dichloromethane and 
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5.12 g 4-methoxybenzoyl chloride (30.0 mmol, 1.0 eq) were added at 0 °C. After stirring 
overnight at ambient temperature, the reaction mixture was quenched with H2O and the aqueous 
layer was extracted three times with dichloromethane. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent was evaporated. The crude 
product was purified by FC (n-pentane/Et2O 4:1) to give N-allyl-4-methoxybenzamide (71g) in 
87% yield (4.97 g, 26.0 mmol) as pale redish solid (m.p. 45–52 °C). 
1H NMR (300 MHz, CDCl3) δ 7.76 (d, J = 8.6 Hz, 2H, CHar), 6.92 (d, J = 8.8 Hz, 2H, CHar), 
6.20 (s, 1H, NH), 6.00 – 5.87 (m, 1H, CHolef), 5.23 (d, J = 17.2 Hz, 1H, CHolef), 5.19 (dd, J = 
10.2, 1.0 Hz, 1H, CHolef), 4.07 (dt, J = 5.8, 0.9 Hz, 2H, CH2), 3.84 (s, 3H, O-CH3). 
13C NMR (75 MHz, CDCl3) δ 167.0 (C=O), 162.3 (Cq, ar), 134.5 (CHolef), 128.9 (CHar), 126.9 
(Cq, ar), 116.6 (CH2, olef), 113.9 (CHar), 55.5 (O-CH3), 42.5 (CH2). 
IR (neat) 3328, 1606, 1542, 1504, 1297, 1250, 1178, 1026, 995, 920, 841, 765, 595. 
HRMS (ESI)  calculated for C11H13NO2Na
+: m/z = 214.0838; found m/z = 214.0839.  
N-Allyl-4-chlorobenzamide (71h)  
 The title compound was prepared according to GP 2. First, 1.50 mL 
allylamine (20.0 mmol, 1.0 eq) and 2.77 mL triethylamine 
(20.0 mmol, 1.0 eq) were dissolved in 20 mL dichloromethane and 
2.56 mL 4-chlorobenzoyl chloride (20.0 mmol, 1.0 eq) were added at 0 °C. After stirring 
overnight at ambient temperature, the reaction mixture was quenched with H2O and the aqueous 
layer was extracted three times with dichloromethane. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent was evaporated. Pure N-allyl-4-
chlorobenzamide (71h) was obtained in 81% yield (3.18 g, 16.3 mmol) as white solid (m.p. 
65−69 °C). 
1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.6 Hz, 2H, CHar), 7.41 (d, J = 8.6 Hz, 2H, CHar), 
6.18 (s, 1H, NH), 6.00 – 5.87 (m, 1H, CHolef), 5.24 – 5.18 (m, 2H, CH2, olef), 4.08 (tt, J = 5.8, 
1.5 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 166.4 (C=O), 137.9 (Cq, ar), 134.1 (CHolef), 133.0 (Cq, ar), 129.0 
(CHar), 128.5 (CHar), 117.1 (CH2, olef), 42.7 (CH2). 
IR (neat) 3280, 1631, 1592, 1533, 1483, 1273, 1153, 1088, 1013, 993, 930, 841, 758, 720, 648. 
HRMS (ESI) calculated for C10H10ClNONa
+: m/z = 218.0343; found m/z = 218.0344.  
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N-Allyl-4-bromobenzamide (71i) 
 The title compound was prepared according to GP 2. First, 0.75 mL 
allylamine (10.0 mmol, 1.0 eq) and 1.78 mL triethylamine 
(10.0 mmol, 1.0 eq) were dissolved in 10 mL dichloromethane and 
2.20 g 4-bromobenzoyl chloride (10.0 mmol, 1.0 eq) were added at 0 °C. After stirring 
overnight at ambient temperature, the reaction mixture was quenched with H2O and the aqueous 
layer was extracted three times with dichloromethane. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent was evaporated. Pure N-allyl-4-
bromobenzamide (71i) was obtained in 92% yield (2.12 g, 9.21 mmol) as white solid (m.p. 
89−94 °C). 
1H NMR (300 MHz, CDCl3) δ 7.66 (d, J = 8.6 Hz, 2H, CHar), 7.57 (d, J = 8.6 Hz, 2H, CHar), 
6.22 (s, 1H, NH), 5.99 – 5.86 (m, 1H, CHolef), 5.25 (dd, J = 17.2, 1.4 Hz, 1H, CHolef), 5.20 (dd, 
J = 15.9, 1.4 Hz, 1H, CHolef), 4.07 (tt, J = 5.8, 1.4 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 166.5 (C=O), 134.1 (CHolef), 133.5 (Cq, ar), 132.0 (CHar), 128.7 
(CHar), 126.3 (Cq, ar), 117.1 (CH2, olef), 42.7 (CH2). 
IR (neat) 3289, 1628, 1587, 1530, 1457, 1347, 1274, 1148, 1066, 1008, 929, 842, 756, 702, 
646, 620, 525, 449. 
HRMS (ESI) calculated for C10H10BrNONa
+: m/z = 263.9818; found m/z = 263.9819.  
N-Allyl-4-trifluoromethylbenzamide (71j) 
 The title compound was prepared according to GP 2. First, 0.60 mL 
allylamine (8.00 mmol, 1.0 eq) and 1.10 mL triethylamine 
(8.00 mmol, 1.0 eq) were dissolved in 8.0 mL dichloromethane and 
1.67 g 4-trifluoromethylbenzoyl chloride (8.00 mmol, 1.0 eq) were added at 0 °C. After stirring 
overnight at ambient temperature, the reaction mixture was quenched with H2O and the aqueous 
layer was extracted three times with dichloromethane. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent was evaporated. The crude 
product was purified by FC (n-pentane/EtOAc 8:1 → 3:1) to give N-allyl-4-
trifluoromethylbenzamide (71j) in 95% yield (1.732 g, 7.56 mmol) as white solid (m.p. 
102−105 °C). 
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1H NMR (300 MHz, CDCl3) δ 7.88 (d, J = 8.2 Hz, 2H, CHar), 7.67 (d, J = 8.2 Hz, 2H, CHar), 
6.43 (s, 1H, NH), 5.99 – 5.86 (m, 1H, CHolef), 5.25 (dd, J = 17.2, 1.2 Hz, 1H, CHolef), 5.19 (dd, 
J = 10.2, 1.0 Hz, 1H, CHolef), 4.09 (t, J = 5.7 Hz, 2H, CH2). 
19F NMR (283 MHz, CDCl3) δ  = −63.09 (s, CF3). 
13C NMR (75 MHz, CDCl3) δ 166.3 (C=O), 137.9 (Cq, ar), 133.9 (CHolef), 133.4 (q, J = 32.7 Hz, 
CF3Cq, ar), 127.6 (CHar), 125.7 (q, J = 3.8 Hz, CHar), 123.9 (q, J = 272.1 Hz, CF3), 117.2 (CH2, 
olef), 42.7 (CH2). 
IR (neat) 3294, 1651, 1638, 1577, 1542, 1508, 1423, 1407, 1362, 1326, 1308, 1266, 1152, 
1121, 1081, 1066, 1031, 1017, 998, 982, 963, 919, 857, 843, 771, 697, 674, 626, 593, 558, 509, 
474, 434. 
HRMS (ESI)  calculated for C11H10F3NONa
+: m/z = 252.0607; found m/z = 252.0609.  
N-Allyl-4-nitrobenzamide (205e) 
 The title compound was prepared according to GP 2. First, 2.25 mL 
allylamine (30.0 mmol, 1.0 eq) and 4.16 mL triethylamine 
(30.0 mmol, 1.0 eq) were dissolved in 30 mL dichloromethane and 
5.57 g 4-nitrobenzoyl chloride (30.0 mmol, 1.0 eq) were added at 0 °C. After stirring overnight 
at ambient temperature, the reaction mixture was quenched with H2O and the aqueous layer 
was extracted three times with dichloromethane. The combined organic layers were washed 
with brine, dried over MgSO4, filtered and the solvent was evaporated. The crude product was 
purified by FC (n-pentane/Et2O 4:1) to give N-allyl-4-nitrobenzamide (205e) in 97% yield 
(5.99 g, 29.1 mmol) as white solid (m.p. 110−115°C). 
1H NMR (300 MHz, CDCl3) δ 8.26 (dd, J = 6.9, 1.9 Hz, 2H, CHar), 7.94 (dd, J = 6.9, 1.9 Hz, 
2H, CHar), 6.49 (s, 1H, NH), 5.99 – 5.86 (m, 1H, CHolef), 5.26 (dd, J = 17.2, 1.3 Hz, 1H, CHolef), 
5.20 (dd, J = 10.2, 1.2 Hz, 1H, CHolef), 4.09 (ddt, J = 5.8, 1.3, 1.2 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 165.5 (C=O), 149.8 (Cq, ar), 140.2 (Cq, ar), 133.6 (CHolef), 128.3 
(CHar), 123.9 (CHar), 117.5 (CH2, olef), 42.9 (CH2). 
IR (neat) 3316, 3107, 2926, 1652, 1637, 1597, 1543, 1514, 1488, 1344, 1301, 1256, 930, 724, 
706, 687. 
HRMS (ESI) calculated for C10H10N2O3Na
+: m/z = 229.0584; found m/z = 229.0584.  
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N-Allylthiophene-2-carboxamide (71k)  
 The title compound was prepared according to GP 2. First, 1.50 mL 
allylamine (20.0 mmol, 1.0 eq) and 2.77 mL triethylamine (20.0 mmol, 
1.0 eq) were dissolved in 20 mL dichloromethane and 2.17 mL 
thiophencarbonyl chloride (20.0 mmol, 1.0 eq) in 8 mL dichloromethane were added at 0 °C. 
After stirring overnight at ambient temperature, the reaction mixture was quenched with H2O 
and the aqueous layer was extracted three times with dichloromethane. The combined organic 
layers were washed with brine, dried over Na2SO4, filtered and the solvent was evaporated. The 
crude product was adsorbed on silica and purified by FC (n-pentane/EtOAc 6:1) to give N-
allylthiophene-2-carboxamide (71k) in 94% yield (3.19 g, 18.7 mmol) as white solid (m.p. 
62−65°C). 
1H NMR (300 MHz, CDCl3) δ 7.52 (d, J = 3.7 Hz, 1H, CHar), 7.47 (d, J = 4.9 Hz, 1H, CHar), 
7.07 (t, J = 4.3 Hz, 1H, CHar), 6.09 (s, 1H, NH), 5.93 (tdd, J = 16.8 Hz, 11.5 Hz, 6.5 Hz, 1H, 
CHolef), 5.26 (d, J = 17.6 Hz, 1H, CHolef), 5.19 (d, J = 10.2 Hz, 1H, CHolef), 4.06 (t, J = 5.6 Hz, 
2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 161.8 (C=O), 139.0 (Cq, ar), 134.2 (CHolef), 130.0 (CHar), 128.2 
(CHar), 127.7 (CHar), 117.0 (CH2, olef), 42.5 (CH2). 
IR (neat) 3297, 3074, 1619, 1546, 1514, 1418, 1354, 1302, 1246, 1209, 1144, 1021, 960, 911, 
856, 791, 751, 708, 664, 545. 
HRMS (ESI) calculated for C8H10NOS: m/z = 168.0478; found m/z = 168.0478.  
Benzyl-N-allylcarbamate (203b)  
First, 2.25 mL allylamine (30.0 mmol, 1.0 eq) and 5.04 g NaHCO3 
(60.0 mmol, 2.0 eq) were suspended in 60 mL of a 1:1 EtOH/H2O 
solvent mixture. 4.71 mL CbzCl (33.0 mmol, 1.1 eq) were added at 
0 °C within 1 h and the reaction mixture was stirred overnight at ambient temperature. H2O was 
then added, and the aqueous layer was extracted three times with MTBE. The combined organic 
layers were dried over MgSO4, filtered and the solvent was evaporated. The crude product was 
purified by FC (n-pentane/MTBE 1:1) to give benzyl-N-allylcarbamate (203b) in 30% yield 
(1.73 g, 9.06 mmol) as colorless oil after additional evaporation of CbzCl in vacuo at 120 °C. 
1H NMR (300 MHz, CDCl3) δ 7.37 – 7.28 (m, 5H, CHar), 5.91 – 5.79 (m, 1H, CHolef), 5.19 (dq, 
J = 17.3, 1.4 Hz, 1H, CHolef), 5.14 – 5.12 (m, 3H, CHolef + CH2), 3.82 (t, J = 5.4 Hz, 2H, CH2). 
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13C NMR (75 MHz, CDCl3) δ 156.4 (C=O), 136.7 (Cq, ar), 134.6 (CHolef), 128.6 (CHar), 128.2 
(CHar), 116.2 (CHolef), 68.9 (CH2), 43.7 (CH2).  
The NMR spectroscopic data are in accordance with the literature.145 
Allyl-N-phenylcarbamate (203c) 
According to a procedure of Knowles,146 1.63 mL phenylisocyanate 
(15.0 mmol, 1.0 eq) and 1.02 mL allylalcohol (15.0 mmol, 1.0 eq) were 
dissolved in 30 mL anhydrous THF and 2.08 mL triethylamine 
(15.0 mmol, 1.0 eq) were added at 0 °C. After stirring for 90 min at ambient temperature the 
reaction mixture was quenched with H2O and the aqueous layer was extracted three times with 
dichloromethane. The combined organic layers were washed with brine, dried over MgSO4, 
filtered and the solvent was evaporated. The crude product was purified by recrystallization 
from n-hexane to give allyl-N-phenylcarbamate (203c) in 78% yield (2.07 g, 11.7 mmol) as 
yellowish solid. 
1H NMR (300 MHz, CDCl3) δ 7.38 – 7.24 (m, 4H, CHar), 7.05 (t, J = 7.14 Hz, 1H, CHar), 6.66 
(s, 1H, NH), 6.02 – 5.89 (m, 1H, CHolef), 5.32 (d, J = 17.4 Hz, 1H, CHolef), 5.28 (d, J = 10.5 Hz, 
1H, CHolef), 4.65 (d, J = 5.6 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 153.4 (C=O), 137.9 (Cq, ar), 132.6 (CHolef), 129.2 (CHar), 123.7 
(CHar), 118.9 (CHar), 118.4 (CH2, olef), 66.0 (CH2). 
The analytic data are in accordance with the literature.146 
N-Allyl-2,2,2-trifluoroacetamide (205a) 
According to a procedure of Harned,147 0.77 mL trifluoroacetic acid 
(10.0 mmol, 1.0 eq) and 2.77 mL triethylamine (20.0 mmol, 2.0 eq) were 
dissolved in 33 mL anhydrous dichloromethane and 0.95 mL ethylchloroformiate (10.0 mmol, 
1.0 eq) were added at 0 °C. After 30 min 0.90 mL allylamine (12.0 mmol, 1.2 eq) were added 
and the reaction mixture was stirred overnight. Aqueous NaHCO3 solution was then added and 
the aqueous layer was extracted three times with dichloromethane. The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and the solvent was evaporated. The crude 
product was adsorbed on silica and purified by FC (n-pentane/EtOAc 4:1) to give N-allyl-2,2,2-
trifluoroacetamide (205a) in 35% yield (531 mg, 3.47 mmol) as colorless oil. 
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1H NMR (300 MHz, CDCl3) δ 6.36 (s, 1H, NH), 5.85 (tdd, J = 17.0 Hz, 11.3 Hz, 6.7 Hz, 1H, 
CHolef), 5.30 – 5.24 (m, 2H, CH2, olef), 3.99 (t, J = 6.0 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 157.0 (C=O), 132.0 (CHolef), 118.5 (CF3, CH2, olef), 42.3 (CH2). 
The NMR spectroscopic data are in accordance with the literature.147 
Ethyl 2-(allylamino)-2-oxoacetate (205b)  
Under argon atmosphere, 1.72 mL oxalyl chloride (20.0 mmol, 2.0 eq) 
was stirred at ambient temperature and 0.6 mL anhydrous EtOH 
(10.0 mmol, 1.0 eq) were added within 30 min. The reaction mixture was 
cooled to 0 °C and a mixture of 3.32 mL triethylamine (24.0 mmol, 2.4 eq) and 1.8 mL 
allylamine (24.0 mmol, 2.4 eq) were added. After stirring for 2 h at ambient temperature the 
reaction was quenched with H2O and extracted three times with dichloromethane. The 
combined organic layers were dried over MgSO4, filtered and the solvent was evaporated. The 
crude product was purified by FC (n-pentane/Et2O 3:1) to give ethyl 2-(allylamino)-2-
oxoacetate (205b) in 27% yield (837 mg, 5.33 mmol) as yellowish oil. 
1H NMR (300 MHz, CDCl3) δ 5.91 – 5.78 (m, 1H, CHolef), 5.27 – 5.18 (m, 2H, CH2, olef), 4.34 
(q, J = 7.1 Hz, 2H, CH2), 3.96 (tt, J = 6.0, 1.4 Hz, 2H, CH2), 1.38 (t, J = 7.2 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 160.8 (C=O), 156.5 (C=O), 132.8 (CHolef), 117.7 (CH2, olef), 63.4 
(CH2), 42.3 (CH2), 14.1 (CH3). 
IR (neat) 3297, 3082, 2986, 2939, 1734, 1683, 1646, 1524, 1467, 1421, 1393, 1370, 1339, 
1302, 1258, 1201, 1097, 1016, 921, 860, 822, 806, 760, 733, 699, 955, 545. 
HRMS (EI)  calculated for C7H11NO3: m/z = 157.0739; found m/z = 157.0734.  
3-Allyloxazolidin-2-one (209b) 
According to a procedure of Cushman,148 9.78 g cesium carbonate (30.0 mmol, 
3.0 eq) were dissolved in 36 mL acetone. Then, 873 mg 2-oxazolidinone 
(10.0 mmol, 1.0 eq) and 1.1 mL allylbromide (13.0 mmol, 1.3 eq) were added. 
After stirring for 48 h at 60 °C the reaction mixture was filtered, and the solvent was evaporated. 
The crude product was adsorbed on silica and purified by FC (n-pentane/EtOAc 3:1) to give 3-
allyloxazolidin-2-one (209b) in 97% yield (1.23 g, 9.67 mmol) as colorless oil. 
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1H NMR (300 MHz, CDCl3) δ 5.78 (tdd, J = 16.9 Hz, 10.8 Hz, 6.8 Hz, 1H, CHolef), 5.27 – 5.22 
(m, 2H, CH2, olef), 4.33 (t, J = 7.9 Hz, 2H, CH2), 3.87 (d, J = 6.2 Hz, 2H, CH2), 3.52 (t, J = 8.5 
Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 158.4 (C=O), 132.2 (CHolef), 118.8 (CH2, olef), 61.9 (CH2), 47.2 
(CH2), 44.3 (CH2). 
The NMR spectroscopic data are in accordance with the literature.149 
3-(But-3-en-1-yl)oxazolidin-2-one (217)  
According to a procedure of Cushman,148 9.78 g cesium carbonate 
(30.0 mmol, 3.0 eq) were dissolved in 36 mL acetone. 873 mg 
2-oxazolidinone (10.0 mmol, 1.0 eq) and 1.32 mL 4-bromobut-1-ene 
(13.0 mmol, 1.3 eq) were added. After stirring for 48 h at 60 °C the reaction mixture was 
filtered, and the solvent was evaporated. The crude product was adsorbed on silica and purified 
by FC (n-pentane/EtOAc 3:1) to give 3-(but-3-en-1-yl)oxazolidin-2-one (217) in 52% yield 
(732 mg, 5.18 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.79 (tdd, J = 17.2 Hz, 10.3 Hz, 6.9 Hz, 1H, CHolef), 5.16 – 5.06 
(m, 2H, CH2, olef), 4.31 (t, J = 7.9 Hz, 2H, CH2), 3.57 (t, J = 8.0 Hz, 2H, CH2), 3.35 (t, J = 7.1 
Hz, 2H, CH2), 2.33 (q, J = 7.0 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 134.8 (CHolef), 117.4 (CH2, olef), 61.8 (CH2), 44.8 (CH2), 43.7 
(CH2), 32.1 (CH2). 
The NMR spectroscopic data are in accordance with the literature.148 
1-Allylazepan-2-one (209c)  
According to a procedure of Tokunaga,149 1.20 g NaH (60%, dispersion in 
mineral oil, 30.0 mmol, 1.5 eq) were suspended in 20 mL anhydrous THF. 
Then, 2.49 g caprolactame (20.0 mmol, 1.0 eq) were added at 0 °C. The 
reaction mixture was stirred overnight at 60 °C. 2.23 mL allylbromide (22.0 mmol, 1.1 eq) were 
added followed by further stirring at ambient temperature overnight. The reaction mixture was 
quenched with H2O and the aqueous layer was extracted three times with Et2O. The combined 
organic layers were dried over Na2SO4, filtered and the solvent was evaporated. The crude 
product was adsorbed on silica and purified by FC (n-pentane/EtOAc 4:1) to give 1-allylazepan-
2-one (209c) in 85% yield (2.61 g, 17.0 mmol) as white solid. 
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1H NMR (300 MHz, CDCl3) δ 5.76 (tdd, J = 16.8 Hz, 10.7 Hz, 6.0 Hz, 1H, CHolef), 5.18 – 5.12 
(m, 2H, CH2, olef), 4.00 (d, J = 6.1 Hz, 2H, CH2), 3.29 (t, J = 4.9 Hz, 2H, CH2), 2.54 (t, J = 
5.4 Hz, 2H, CH2), 1.75 – 1.57 (m, 6H, CH2). 
13C NMR (75 MHz, CDCl3) δ 175.7 (C=O), 134.0 (CHolef), 117.3 (CH2, olef), 50.6 (CH2), 48.8 
(CH2), 37.3 (CH2), 30.1 (CH2), 28.6 (CH2), 23.6 (CH2). 
The NMR spectroscopic data are in accordance with the literature.149 
5.4.2 Isomerization of N-Allyl Amides and Carbamates 
(Z)-N-(Prop-1-en-1-yl)acetamide (72a) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc iodide 
(100 mmol, 20 mol% each). These materials were suspended in 0.3 mL 
dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to −20 °C, 50 mg N-
allylacetamide (0.505 mmol, 1.0 eq) were added. The reaction mixture was stirred for 2 d at 
−20 °C. After general workup and purification by FC (n-pentane/EtOAc 1:1) N-(prop-1-en-1-
yl)acetamide (72a) was obtained as Z/E-mixture (80:20) in 12% yield (6 mg, 0.061 mmol) as 
colorless, highly volatile liquid. 
1H NMR (300 MHz, CDCl3) δ = 6.91 (s, 1H, NH), 6.74 – 6.68 (m, 1H, NCHolef), 4.79 (dq, J = 
8.3, 7.1 Hz, 1H, CHolef), 2.08 (s, 3H, CH3), 1.61 (dd, J = 7.0, 1.7 Hz, 3H, CHolefCH3).  
13C NMR (125 MHz, CDCl3)  = 200.9 (C=O), 122.1 (NCHolef), 104.9 (CHolef), 23.5 (CH3), 
10.9 (CHolefCH3). 
Resolved signals of the minor isomer (E)-N-(prop-1-en-1-yl)acetamide:  
1H NMR (300 MHz, CDCl3) δ = 5.15 – 5.08 (m, 1H, CHolef), 2.01 (s, 3H, CH3), 1.66 (dd, J = 
6.5, 1.5 Hz, 3H, CHolefCH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.43 
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(Z)-N-(Prop-1-en-1-yl)octanamide (72b) 
The title compound was prepared according to GP 3 utilizing 
28 mg Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc 
powder and 32 mg zinc iodide (100 mmol, 20 mol% each). 
These materials were suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 
0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. 
92 mg N-allyloctanamide (0.502 mmol, 1.0 eq) were added at ambient temperature and the 
reaction mixture was stirred for 90 min. After general workup and purification by FC 
(n-pentane/Et2O 7:1) N-(prop-1-en-1-yl)octanamide (72b) was obtained as Z/E-mixture (82:18) 
in 42% yield (39 mg, 0.213 mmol) as white solid (m.p. 32−35 °C). 
1H NMR (300 MHz, CDCl3) δ = 6.86 (br s, 1H, NH), 6.74 (qq, J = 8.8, 1.6 Hz, 1H, NCHolef), 
4.78 (dq, J = 15.6, 7.7 Hz, 1H, CHolef), 2.26 (t, J = 7.8 Hz, 2H, CH2), 1.69 – 1.59 (m, 5H, CH2 
+ CHolefCH3), 1.29 (dd, J = 7.1, 1.4 Hz, 8H, CH2), 0.88 (t, J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3)  = 170.3 (C=O), 122.2 (NCHolef), 104.7 (CHolef), 37.0 (CH2), 31.8 
(CH2), 29.4 (CH2), 29.1 (CH2), 25.7 (CH2), 22.7 (CH2), 14.2 (CH3), 10.9 (CHolefCH3). 
IR (neat) 3190, 2957, 2944, 2917, 2854, 1678, 1650, 1513, 1465, 1456, 1410, 1383, 1324, 
1274, 1260, 1232, 1213, 1195, 1149, 1028, 952, 925, 740, 708, 599, 577. 
HRMS (ESI) m/z [M+H]+ calculated for C11H22NO: 183.1696; found: 183.1696.  
Resolved signals of the minor isomer (E)-N-(prop-1-en-1-yl)octanamide:  
1H NMR (300 MHz, CDCl3) δ = 5.12 (dq, J = 14.0, 6.8 Hz, 1H, CHolef), 2.18 (t, J = 7.9 Hz, 
2H, CH2), 1.68 – 1.64 (m, 3H, CHolefCH3). 
13C NMR (75 MHz, CDCl3)  = 123.5 (NCHolef), 107.4 (CHolef), 36.8 (CH2), 14.9 (CH3). 
(Z)-2-Phenyl-N-(prop-1-en-1-yl)acetamide (72c)  
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to −30 °C, 88 mg N-allyl-
2-phenylacetamide (0.502 mmol, 1.0 eq) were added. The reaction mixture was stirred for 64 h 
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at − °C. After general workup and purification by FC (n-pentane/Et2O 2:1) 2-phenyl-N-(prop-
1-en-1-yl)acetamide (72c) was obtained as Z/E-mixture (92:8) in 60% yield (53 mg, 
0.303 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = 7.42 – 7.28 (m, 5H, CHar), 6.86 (s, 1H, NH), 6.69 (tt, J = 9.7, 
1.8 Hz, 1H, NCHolef), 4.76 (dq, J = 15.6, 7.6 Hz, 1H, CHolef), 3.66 (s, 2H, CH2), 1.36 (dd, J = 
7.0, 1.6 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3)  = 168.0 (C=O), 134.5 (Cq, ar), 129.6 (CHar), 129.4 (CHar), 127.8 
(CHar), 121.9 (NCHolef), 105.8 (CHolef), 43.9 (CH2), 10.6 (CH3). 
Resolved signals of the minor isomer (E)-2-phenyl-N-(prop-1-en-1-yl)acetamide: 
1H NMR (300 MHz, CDCl3) δ = 5.01 (dq, J = 14.0, 6.8 Hz, 1H, CHolef), 3.60 (s, 2H, CH2), 1.61 
(dd, J = 6.8, 1.5 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3)  = 14.8 (CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.50 
(Z)/(E)-N-(Prop-1-en-1-yl)cinnamamide (72d) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL acetonitrile and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution 
(0.125 M in acetonitrile, 25.0 mmol, 5.0 mol%) were added. 94 mg N-allylcinnamamide 
(0.502 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 6 d at 83 °C. After general workup and purification by FC (n-pentane/Et2O 4:1) N-(prop-1-
en-1-yl)cinnamamide (72d) was obtained as Z/E-mixture (50:50) in 54% yield (51 mg, 
0.272 mmol) as white solid. 
1H NMR (300 MHz, CDCl3) δ = 7.73 (d, J = 15.5 Hz, 1H, PhCHolef), 7.54 – 7.48 (m, 2H, CHar), 
7.38 – 7.35 (m, 3H, CHar), 6.96 – 6.86 (m, 1H, NCHolef), 6.47 (d, J = 15.5 Hz, 1H, CHolef), 4.90 
(dq, J = 15.8, 8.0 Hz, 1H, CHolef), 1.70 (dt, J = 7.5, 1.5 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3)  = 163.0 (C=O), 142.2 (CHolef), 134.8 (Cq, ar), 130.0 (CHar), 
128.99 (CHar), 128.1 (CHar), 122.3 (CHolef), 120.0 (NCHolef), 106.1 (CHolef), 11.2 (CH3).  
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Resolved signals of (E)-N-(prop-1-en-1-yl)cinnamamide: 
1H NMR (300 MHz, CDCl3) δ = 7.70 (d, J = 15.5 Hz, 1H, PhCHolef), 6.41 (d, J = 15.6 Hz, 1H, 
CHolef), 5.26 (dq, J = 14.1, 6.9 Hz, 1H, CHolef). 
13C NMR (75 MHz, CDCl3) δ = 162.8 (C=O), 142.7 (CHolef), 134.9 (Cq, ar), 130.1 (CHar), 128.96 
(CHar), 128.0 (CHar), 123.7 (CHolef), 120.2 (NCHolef), 108.7 (CHolef), 15.1 (CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.50 
(Z)-N-(Prop-1-en-1-yl)benzamide (72e) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to −30 °C, 83 mg N-
allylbenzamide (0.514 mmol, 1.0 eq) were added. The reaction mixture was stirred for 64 h at 
−30 °C. After general workup and purification by FC (n-pentane/Et2O 4:1) N-(prop-1-en-1-
yl)benzamide (72e) was obtained as Z/E-mixture (91:9) in 74% yield (61 mg, 0.379 mmol) as 
white solid. 
1H NMR (300 MHz, CDCl3) δ = 7.80 (dd, J = 7.0, 1.5 Hz, 2H, CHar), 7.60 (s, 1H, NH), 7.56 – 
7.43 (m, 3H, CHar), 6.94 (ddq, J = 10.7, 7.2, 1.7 Hz, 1H, NCHolef), 4.94 (dq, J = 14.4, 7.3 Hz, 
1H, CHolef), 1.70 (dd, J = 7.1, 1.8 Hz, 3H, CH3). 
 13C NMR (75 MHz, CDCl3)  = 164.4 (C=O), 134.2 (Cq, ar), 132.0 (CHar), 128.9 (CHar), 127.2 
(CHar), 122.4 (NCHolef), 106.2 (CHolef), 11.1 (CH3).  
Resolved signals of the minor isomer (E)-N-(prop-1-en-1-yl)benzamide: 
1H NMR (300 MHz, CDCl3) δ = 5.32 (dq, J = 13.6, 6.9 Hz, 1H, CHolef), 1.73 (dd, J = 6.7, 1.7 
Hz, 3H, CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.50 
(Z)-2,4,6-Trimethyl-N-(prop-1-en-1-yl)benzamide (72f) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
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suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. 102 mg N-allyl-2,4,6-
trimethylbenzamide (0.502 mmol, 1.0 eq) were added at ambient temperature and the reaction 
mixture was stirred for 7 d at ambient temperature. Additional 14 mg Ni(dppp)Cl2 (25.0 mmol, 
5.0 mol%), 3.3 mg zinc powder and 16 mg zinc iodide (50 mmol, 10 mol% each) and 0.1 mL 
of the HPPh2 solution (0.125 M in dichloromethane, 12.5 mmol, 2.5.0 mol%) were added to the 
reaction mixture after 48 h as well as 4 d of stirring at ambient temperature to complete the 
conversion of the starting material. After general workup and purification by FC (n-
pentane/Et2O 4:1) 2,4,6-trimethyl-N-(prop-1-en-1-yl)benzamide (72f) was obtained as Z/E-
mixture (86:14) in 47% yield (48 mg, 0.236 mmol) as white solid (m.p.123-128 °C). The Z-
isomer appears as rotameric mixture. 
1H NMR (500 MHz, CDCl3) δ (main rotamer) = 7.05 (d, J = 9.6 Hz, 1H, NH), 6.96 – 6.90 (m, 
1H, NCHolef), 6.88 (s, 2H, CHar), 4.91 (dq, J = 13.7, 7.4 Hz, 1H, CHolef), 2.30 (s, 9H, CHarCH3), 
1.59 (dd, J = 7.3, 1.0 Hz, 3H, CH3). δ (resolved signals minor rotamer) = 6.86 (s, 2H, CHar), 
5.77 – 5.72 (m, 1H, CHolef), 4.54 (dq, J = 14.8, 7.9 Hz, 1H, CHolef), 2.22 (s, 9H, CarCH3), 1.63 
(dd, J = 7.4, 1.7 Hz, 3H, CH3).   
13C NMR (125 MHz, CDCl3) δ (main rotamer) = 167.7 (C=O), 139.1 (Cq, ar), 134.7 (Cq, ar), 
128.5 (Cq, ar), 128.4 (CHar), 121.9 (NCHolef), 106.1 (CHolef), 21.2 (CarCH3), 19.4 (CHarCH3), 
11.1 (CH3). δ (resolved signals minor rotamer) = 167.6 (C=O), 138.95 (Cq, ar), 128.40 (Cq, ar), 
123.6 (NCHolef), 104.8 (CHolef), 19.1 (CarCH3), 10.6 (CH3).  
IR (neat) 3257, 3177, 2917, 2858, 1730, 1677, 1641, 1503, 1438, 1319, 1286, 1177, 1142, 
1114, 1015, 965, 882, 749, 726, 622, 485, 449. 
HRMS (ESI) m/z [M+Na]+ calculated for C13H17NONa: 226.1202; found: 226.1204.  
Resolved signals of the minor isomer (E)-2,4,6-trimethyl-N-(prop-1-en-1-yl)benzamide: 
1H NMR (300 MHz, CDCl3) δ = 6.84 (s, 2H, CHar), 5.22 – 5.15 (m, 1H, CHolef), 2.27 (s, 9H, 
CarCH3), 1.72 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ = 171.4 (C=O), 138.92 (Cq, ar), 128.38 (Cq, ar), 123.4 (NCHolef), 
108.6 (CHolef), 21.3 (CarCH3), 19.3 (CarCH3), 15.0 (CH3). 
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(Z)-4-Methoxy-N-(Prop-1-en-1-yl)benzamide (72g) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. 96 mg N-allyl-4-
methoxybenzamid (0.502 mmol, 1.0 eq) were added at ambient temperature and the reaction 
mixture was stirred for 8 d at ambient temperature. After general workup and purification by 
FC (n-pentane/Et2O 4:1→2:1) 4-methoxy-N-(Prop-1-en-1-yl)benzamide (72g) was obtained as 
Z/E-mixture (64:36) in 70% yield (67 mg, 0.350 mmol) as colorless oil which solidifies upon 
storage. 
1H NMR (300 MHz, CDCl3) δ = 7.77 (t, J = 7.4 Hz, 2H, CHar), 7.52 (s, 1H, NH), 6.94 (t, J = 
8.4 Hz, 3H, CHar + NCHolef), 4.90 (dq, J = 14.2, 7.1 Hz, 1H, CHolef), 3.86 (s, 3H, OCH3), 1.72 
(t, J = 7.1 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3)  = 163.9 (CH3OCq, ar), 162.7 (C=O), 129.0 (CHar), 126.4 
(NCHolef), 122.6 (Cq, ar), 114.1 (CHar), 105.5 (CHolef), 55.59 (OCH3), 11.0 (CH3).  
The NMR spectroscopic data are in accordance with the literature.150 
Resolved signals of the minor isomer (E)-4-methoxy-N-(prop-1-en-1-yl)benzamide: 
1H NMR (300 MHz, CDCl3) δ = 5.27 (dq, J = 14.2, 6.8 Hz, 1H, CHolef), 3.85 (s, 3H, OCH3), 
1.71 (t, J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3)  = 162.6 (C=O), 128.9 (CHar), 126.3 (NCHolef), 124.0 (Cq, ar), 
114.0 (CHar), 108.2 (CHolef), 55.56 (OCH3), 15.1 (CH3). 
(Z)-4-Chloro-N-(prop-1-en-1-yl)benzamide (72h) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to 
−20 °C, 98 mg N-allyl-4-chlorobenzamide (0.501 mmol, 1.0 eq) were added. The reaction 
mixture was stirred for 39 h at − °C. After general workup and purification by FC 
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(n-pentane/Et2O 4:1) 4-chloro-N-(prop-1-en-1-yl)benzamide (72h) was obtained as Z/E-
mixture (81:19) in 66% yield (65 mg, 0.332 mmol) as white solid (m.p. 87-89 °C). 
1H NMR (300 MHz, CDCl3) δ = 7.74 (d, J = 8.5 Hz, 2H, CHar), 7.54 (s, 1H, NH), 7.44 (d, J = 
8.7 Hz, 2H, CHar), 6.95 – 6.88 (m, 1H, NCHolef), 4.97 (dq, J = 14.4, 7.1 Hz, 1H, CHolef), 1.71 
(dd, J = 7.1, 1.7 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3)  = 163.4 (C=O), 138.4 (Cq, ar), 132.5 (Cq, ar), 129.2 (CHar), 128.6 
(CHar), 122.3 (NCHolef), 106.7 (CHolef), 11.1 (CH3).  
IR (neat) 3290, 1637, 1593, 1516, 1479, 1276, 1149, 1091, 1013, 953, 868, 843, 731, 666, 524, 
489, 442. 
HRMS (ESI) m/z [M+Na]+ calculated for C10H10ClNONa: 218.0343; found: 218.0344.  
Resolved signals of the minor isomer (E)-4-chloro-N-(prop-1-en-1-yl)benzamide: 
1H NMR (300 MHz, CDCl3) δ = 5.32 (dq, J = 14.1, 6.7 Hz, 1H, CHolef). 
13C NMR (75 MHz, CDCl3) δ = 129.1 (CHar), 123.6 (NCHolef), 109.4 (CHolef), 15.1 (CH3). 
(Z)-4-Bromo-N-(prop-1-en-1-yl)benzamide (72i) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to 
−25 °C, 120 mg N-allyl-4-bromobenzamide (0.502 mmol, 1.0 eq) were added. The reaction 
mixture was stirred for 69 h at − °C. After general workup and purification by FC 
(n-pentane/Et2O 4:1) 4-bromo-N-(prop-1-en-1-yl)benzamide (72i) was obtained as Z/E-mixture 
(93:7) in 62% yield (74 mg, 0.310 mmol) as white solid. The isomers are separable through FC 
(m.p. 94-98 °C for the Z-isomer, 160 °C for the E-isomer). 
1H NMR (300 MHz, CDCl3) δ = δ 7.67 (d, J = 8.6 Hz, 2H, CHar), 7.58 (d, J = 8.6 Hz, 2H, 
CHar), 6.89 (dt, J = 9.8, 1.6 Hz, 1H, NCHolef), 4.96 (dq, J = 15.9, 7.8 Hz, 1H, CHolef), 1.70 (dd, 
J = 7.1, 1.6 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3)  = 163.5 (C=O), 133.0 (Cq, ar), 132.2 (CHar), 128.8 (CHar), 126.8 
(NCHolef), 122.3 (Cq, ar), 106.8 (CHolef), 11.1 (CH3). 
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IR (neat) 3295, 1636, 1589, 1509, 1477, 1366, 1273, 1178, 1147, 1068, 1008, 866, 837, 728, 
673, 611, 512, 446. 
HRMS (ESI) m/z [M+Na]+ calculated for C10H10BrNONa: 263.9818; found: 263.9821.  
Resolved signals of the minor isomer (E)-4-bromo-N-(prop-1-en-1-yl)benzamide: 
1H NMR (300 MHz, CDCl3) δ = 5.26 (dq, J = 14.0, 6.9 Hz, 1H, CHolef).  
(Z)-N-(Prop-1-en-1-yl)-4-(trifluoromethyl)benzamide (72j) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to 
18 °C, 113 mg N-allyl-4-trifluoromethylbenzamide (0.493 mmol, 1.0 eq) were added. The 
reaction mixture was stirred for 45 h at  °C. After general workup and purification by FC 
(n-pentane/Et2O 4:1) N-(prop-1-en-1-yl)-4-(trifluoromethyl)benzamide (72j) was obtained as 
Z/E-mixture (78:22) in 63% yield (71 mg, 0.310 mmol) as white solid (m.p. 172 °C). 
1H NMR (300 MHz, CDCl3) δ = 7.92 (d, J = 8.0 Hz, 2H, CHar), 7.73 (d, J = 8.4 Hz, 2H, CHar), 
7.59 (br s, 1H, NH), 6.99 – 6.89 (m, 1H, NCHolef), 5.00 (dq, J = 14.5, 7.1 Hz, 1H, CHolef), 1.72 
(dd, J = 7.0, 1.8 Hz, 3H, CH3).  
13C NMR (125 MHz, CDCl3) δ = 163.3 (C=O), 133.7 (q, J = 32.9 Hz, CF3Cq, ar), 127.7 (CHar), 
125.9 (q, J = 3.7 Hz, CHar), 123.7 (q, J = 272.6 Hz, CF3), 122.1 (NCHolef), 107.4 (CHolef), 11.2 
(CH3).  
19F NMR (283 MHz, CDCl3) δ  = −63.13 (s, CF3). 
IR (neat) 3294, 1678, 1635, 1580, 1529, 1505, 1438, 1409, 1320, 1258, 1162, 1119, 1076, 
1062, 1016, 954, 859, 847, 795, 726, 693, 680, 600, 469. 
HRMS (ESI) m/z [M+H]+ calculated for C11H11F3NO: 230.0787; found: 230.0789.  
Resolved signals of the minor isomer (E)-N-(prop-1-en-1-yl)-4-(trifluoromethyl)benzamide: 
1H NMR (300 MHz, CDCl3) δ = 5.36 (dq, J = 14.8, 7.3 Hz, 1H, CHolef), 1.75 (dd, J = 7.0, 1.6 
Hz, 3H, CH3). 
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13C NMR (125 MHz, CDCl3) δ = 163.0 (C=O), 137.3 (Cq, ar), 125.8 (q, J = 3.9 Hz, CHar), 123.4 
(NCHolef), 110.1 (CHolef), 15.1 (CH3). 
19F NMR (283 MHz, CDCl3) δ = −63.12 (s, 3F, CF3). 
(Z)-N-(Prop-1-en-1-yl)thiophene-2-carboxamide (72k) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to 5 °C, 84 mg 
N-allylthiophene-2-carboxamide (0.502 mmol, 1.0 eq) were added. The reaction mixture was 
stirred for 3 d at  °C. After general workup and purification by FC (n-pentane/Et2O 4:1) 
N-(prop-1-en-1-yl)thiophene-2-carboxamide (72k) was obtained as Z/E-mixture (84:16) in 
33% yield (28 mg, 0.167 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = δ 7.57 (dd, J = 3.6, 0.9 Hz, 1H, CHar), 7.52 (dd, J = 5.1, 0.9 Hz, 
1H, CHar), 7.43 (s, 1H, NH), 7.11 (dd, J = 4.9, 1.1 Hz, 1H, CHar), 6.91 – 6.84 (m, 1H, NCHolef), 
4.92 (dq, J = 8.5, 7.3 Hz, 1H, CHolef), 1.70 (dd, J = 7.1, 1.7 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 158.9 (C=O), 138.4 (Cq, ar), 130.8 (CHar), 128.7 (CHar), 127.9 
(CHar), 122.0 (NCHolef), 106.1 (CHolef), 11.1 (CH3).  
Resolved signals of the minor isomer (E)-N-(prop-1-en-1-yl)thiophene-2-carboxamide: 
1H NMR (300 MHz, CDCl3) δ  = 7.08 (dd, J = 5.0, 1.0 Hz, 1H, CHar), 5.29 (m, 1H, CHolef). 
13C NMR (75 MHz, CDCl3) δ = 130.6 (CHar), 128.5 (CHar), 127.9 (CHar), 123.3 (NCHolef), 
108.9 (CHolef), 15.0 (CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.43 
tert-Butyl (Z)-prop-1-en-1-ylcarbamate (204a) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to −30 °C, 79 mg tert-
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butyl allylcarbamate (0.503 mmol, 1.0 eq) were added and the reaction mixture was stirred for 
19 h at −30 °C. After general workup and purification by FC (n-pentane/Et2O 3:1) tert-butyl-
prop-1-en-1-ylcarbamate (204a) was obtained as Z/E-mixture (81:19) in 79% yield (62 mg, 
0.395 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = δ 6.42 (pt, J = 10.4 Hz, 1H, NCHolef), 6.09 (s, 1H, NH), 4.67 
– 4.59 (m, 1H, CHolef), 1.55 (dd, J = 6.9, 1.6 Hz, 3H, CH3), 1.48 (s, 9H, C(CH3)3).  
13C NMR (75 MHz, CDCl3) δ = 153.0 (C=O), 123.3 (NCHolef), 102.0 (CHolef), 80.5 (C(CH3)3), 
28.4 (C(CH3)3), 10.6 (CH3).  
Resolved signals of the minor isomer tert-butyl (E)-prop-1-en-1-ylcarbamate: 
1H NMR (300 MHz, CDCl3) δ = 4.96 – 4.87 (m, 1H, CHolef), 1.63 (dd, J = 6.6, 1.5 Hz, 3H, 
CH3), 1.46 (s, 9H, C(CH3)3). 
13C NMR (75 MHz, CDCl3) δ = 124.5 (CHolef), 104.5 (CHolef), 15.4 (CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.50 
Benzyl (Z)-prop-1-en-1-ylcarbamate (204b)  
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling to 
−30 °C, 96 mg benzyl allylcarbamate (0.502 mmol, 1.0 eq) were added and the reaction mixture 
was stirred for 17 h at −30 °C. After general workup and purification by FC (n-pentane/Et2O 
4:1) benzyl prop-1-en-1-ylcarbamate (204b) was obtained as Z/E-mixture (81:19) in 69% yield 
(66 mg, 0.345 mmol) as colorless oil. 
1H NMR (500 MHz, CDCl3) δ = 7.38 – 7.32 (m, 5H, CHar), 6.50 – 6.45 (m, 1H, NCHolef), 6.37 
(br s, 1H, NH), 5.16 (s, 2H, CH2), 4.70 (dq, J = 14.3, 7.2 Hz, 1H, CHolef), 1.55 (dd, J = 7.0, 1.6 
Hz, 3H, CH3).  
13C NMR (125 MHz, CDCl3) δ = 153.7 (C=O), 136.1 (Cq, ar), 128.72 (CHar), 128.48 (CHar), 
128.4 (CHar), 123.1 (NCHolef), 103.3 (CHolef), 67.3 (CH2), 10.6 (CH3).  
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Resolved signals of the minor isomer benzyl (E)-prop-1-en-1-ylcarbamate: 
1H NMR (500 MHz, CDCl3) δ = 5.03 – 4.97 (m, 1H, CHolef), 1.65 (d, J = 6.4 Hz, 3H, CH3).  
13C NMR (125 MHz, CDCl3) δ = 153.6 (C=O), 128.66 (CHar), 128.51 (CHar), 128.3 (CHar), 
124.1 (NCHolef), 105.9 (CHolef), 67.1 (CH2), 14.8 (CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.50 
(Z)-Prop-1-en-1-yl phenylcarbamate (204c) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were 
suspended in 0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 
solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) were added. After cooling 
to −20 °C, 89 mg allyl phenylcarbamate (0.502 mmol, 1.0 eq) were added and the reaction 
mixture was stirred for 48 h at −20 °C. After general workup and purification by FC (n-
pentane/Et2O 8:1) (Z)-prop-1-en-1-yl phenylcarbamate (204c) was obtained as Z/E-mixture 
(87:13) in 36% yield (32 mg, 0.181 mmol) as white solid. 
1H NMR (300 MHz, CDCl3) δ = δ 7.41 (t, J = 7.8 Hz, 2H, CHar), 7.33 (t, J = 7.7 Hz, 2H, CHar), 
7.10 (t, J = 7.3 Hz, 1H, CHar), 7.03 – 7.00 (m, 1H, NCHolef), 6.79 (s, 1H, NH), 4.90 (dq, J = 
13.6, 6.7 Hz, 1H, CHolef), 1.69 (dd, J = 6.9, 1.7 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 151.0 (C=O), 137.4 (Cq, ar), 135.4 (NCHolef), 129.3 (CHar), 
124.1 (CHar), 119.1 (CHar), 107.3 (CHolef), 9.8 (CH3). 
Resolved signals of the minor isomer (E)-prop-1-en-1-yl phenylcarbamate: 
1H NMR (300 MHz, CDCl3) δ = 5.38 (dq, J = 12.4, 6.9 Hz, 1H, CHolef). 
13C NMR (75 MHz, CDCl3) δ = 136.4 (NCHolef), 12.4 (CH3). 
The NMR spectroscopic data for both isomers are in accordance with the literature.151 
(E)-2,2,2-Trifluoro-N-(prop-1-en-1-yl)acetamide (206a) 
The title compound was prepared according to GP 3 utilizing 14 mg 
Ni(dppp)Cl2 (25.0 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
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0.15 mL dichloromethane and stirred for 10 min. Then, 0.1 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 12.5 mmol, 5.0 mol%) and 33 mg N-allyl-2,2,2-trifluoroacetamide 
(0.215 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 2 d. Additionally, 7 mg Ni(dppp)Cl2 (12.5 mmol, 5.0 mol%), 1.7 mg zinc powder and 8 mg 
zinc iodide (25 mmol, 10 mol% each) and 0.05 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 6.0 mmol, 2.5.0 mol%) were added to the reaction mixture after 16 h at 
ambient temperature to complete the conversion of the starting material.  After general workup 
and purification by FC (n-pentane/Et2O 2:1) 2,2,2-trifluoro-N-(prop-1-en-1-yl)acetamide 
(206a) was obtained as Z/E-mixture (15:85) in 64% yield (21 mg, 0.137 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = δ 7.77 (s, 1H, NH), 6.65 (t, J = 11.6 Hz, 1H, NCHolef), 5.50 
(qd, J = 14.1 Hz, 7.1 Hz, 1H, CHolef), 1.73 (dd, J = 6.9, 1.4 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 121.0 (NCHolef), 114.2 (CHolef), 15.0 (CH3). C=O and CF3 not 
detectable. 
19F NMR (283 MHz, CDCl3) δ = −75.77 (s, 3F, CF3).  
IR (neat) 3289, 3214, 3078, 1698, 1542, 1439, 1300, 1273, 1215, 1157, 947, 871, 774, 520. 
HRMS (ESI) m/z [M+Na]+ calculated for C5H6F3NONa: 176.0299; found: 176.0299. 
Resolved signals of the minor isomer (Z)-2,2,2-trifluoro-N-(prop-1-en-1-yl)acetamide: 
1H NMR (300 MHz, CDCl3) δ = 5.16 (dq, J = 8.2, 5.7 Hz, 1H, CHolef), 1.69 (dd, J = 7.1, 1.5 Hz, 
3H, CH3). 
13C NMR (75 MHz, CDCl3) δ = 117.8 (NCHolef), 111.5 (CHolef), 11.1 (CH3). 
19F NMR (283 MHz, CDCl3) δ = −75.70 (s, 3F, CF3). 
Ethyl (E)-2-oxo-2-(prop-1-en-1-ylamino)acetate (206b)  
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) and 79 mg ethyl-2-(allylamino)-2-oxoacetate 
(0.503 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 95 h. After general workup and purification by FC (n-pentane/Et2O 2:1) ethyl-2-oxo-2-
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(prop-1-en-1-ylamino)acetate (206b) was obtained as Z/E-mixture (8:92) in 29% yield (23 mg, 
0.150 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 8.52 (br s, 1H, NH), 6.73 – 6.64 (m, 1H, NCHolef), 5.50 – 5.38 
(m, 1H, CHolef), 4.35 (q, J = 7.1 Hz, 2H, CH2), 1.71 (dd, J = 6.8, 1.7 Hz, 3H, CH3), 1.37 (t, J = 
7.1 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CDCl3) δ 160.7 (C=O), 153.2 (C=O), 122.2 (NCHolef), 112.7 (CHolef), 63.5 
(CH2), 15.0 (CH3), 14.1 (CH2CH3). 
IR (neat) 3245, 3185, 2991, 2964, 2921, 2856, 1734, 1667, 1578, 1516, 1475, 1444, 1393, 
1367, 1317, 1258, 1219, 1205, 1154, 1112, 1092, 1017, 958, 921, 861, 808, 782, 742, 697, 603, 
533, 482, 455, 402. 
HRMS (ESI)  calculated for C7H12NO3: m/z = 158.0812; found m/z = 158.0812.  
Resolved signals of the minor isomer ethyl (Z)-2-oxo-2-(prop-1-en-1-ylamino)acetate: 
1H NMR (300 MHz, CDCl3) δ 5.09 – 4.99 (m, 1H, CHolef). 
13C NMR (75 MHz, CDCl3) δ 11.1 (CH3). 
(E)-1-(Prop-1-en-1-yl)pyrrolidin-2-one (210a) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc iodide 
(100 mmol, 20 mol% each). These materials were suspended in 0.3 mL 
dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 25.0 mmol, 5.0 mol%) were added. 62 mg 1-allylpyrrolidin-2-one 
(0.495 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 24 h. After general workup and purification by FC (n-pentane/Et2O 2:1) 1-(prop-1-en-1-
yl)pyrrolidin-2-one (210a) was obtained as single E-isomer in 98% yield (61 mg, 0.487 mmol) 
as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ = 6.88 (d, J = 14.1 Hz, 1H, NCHolef), 4.94 (qd, J = 14.1, 7.4 Hz, 
1H, CHolef), 3.48 (t, J = 7.2 Hz, 2H, CH2), 2.46 (t, J = 8.1 Hz, 2H, CH2), 2.12 – 2.02 (m, 2H, 
CH2), 1.72 (dd, J = 6.7 1.3 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ = 172.7 (C=O), 124.6 (NCHolef), 106.9 (CHolef), 45.4 (CH2), 31.4 
(CH2), 17.6 (CH2), 15.3 (CH3). 
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The NMR spectroscopic data are in accordance with the literature.50 
(E)-3-(Prop-1-en-1-yl)oxazolidin-2-one (210b)  
The title compound was prepared according to GP 3 utilizing 14 mg 
Ni(dppp)Cl2 (25.0 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 0.15 mL 
dichloromethane and stirred for 10 min. Then, 0.1 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 12.5 mmol, 5.0 mol%) were added. 32 mg 3-allyloxazolidin-2-one 
(0.250 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 16 h at ambient temperature. After general workup and purification by FC (n-
pentane/EtOAc 2:1) 3-(prop-1-en-1-yl)oxazolidin-2-one (210b) was obtained as Z/E-mixture 
(6:94) in 94% yield (30 mg, 0.236 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = δ 6.65 (d, J = 14.5 Hz, 1H, NCHolef), 4.81 (dt, J = 14.1, 7.2 Hz, 
1H, CHolef), 4.42 (t, J = 8.0 Hz, 2H, CH2), 3.67 (t, J = 8.1 Hz, 2H, CH2), 1.72 (dd, J = 7.0, 1.0 
Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 155.5 (C=O), 124.8 (NCHolef), 105.8 (CHolef), 62.2 (CH2), 42.8 
(CH2), 15.0 (CH3). 
Resolved signals of the minor isomer (Z)-3-(prop-1-en-1-yl)oxazolidin-2-one: 
1H NMR (300 MHz, CDCl3) δ = 6.23 (d, J = 7.6 Hz, 1H, NCHolef), 5.02 – 4.91 (m, 1H, CHolef), 
3.98 (t, J = 7.9 Hz, 2H, CH2). 
The NMR spectroscopic data are in accordance with the literature.44 
(E)-1-(Prop-1-en-1-yl)azepan-2-one (210c)  
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) were added. 77 mg 1-allylazepan-2-one 
(0.502 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 16 h. After general workup and purification by FC (n-pentane/EtOAc 2:1) 1-(prop-1-en-1-
yl)azepan-2-one (210c) was obtained as single E-isomer in 77% yield (59 mg, 0.385 mmol) as 
white solid. 
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1H NMR (300 MHz, CDCl3) δ = 7.11 (dd, J = 14.6, 1.3 Hz, 1H, NCHolef), 5.10 – 4.98 (m, 1H, 
CHolef), 3.55 (t, J = 4.7 Hz, 2H, CH2), 2.59 (t, J = 5.4 Hz, 2H, CH2), 1.73 – 1.70 (m, 6H, CH2), 
1.68 – 1.63 (m, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ = 174.0 (C=O), 127.8 (NCHolef), 106.0 (CHolef), 45.8 (CH2), 37.4 
(CH2), 29.7 (CH2), 27.6 (CH2), 23.6 (CH2), 15.4 (CH3). 
The NMR spectroscopic data are in accordance with the literature.46 
(E)-2-(Prop-1-en-1-yl)isoindoline-1,3-dione (210d)  
The title compound was prepared according to GP 3 utilizing 32 mg 
Ni(dppp)Br2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the 
HPPh2 solution (0.125 M in dichloromethane, 25.0 mmol, 5.0 mol%) and 94 mg 2-
allylisoindoline-1,3-dione (0.502 mmol, 1.0 eq) were added at ambient temperature and the 
reaction mixture was stirred for 18 h. After general workup and purification by FC 
(n-pentane/MTBE 20:1) 2-(prop-1-en-1-yl)isoindoline-1,3-dione (210d) was obtained as single 
E-isomer in 85% yield (80 mg, 0.426 mmol) as yellow solid. 
1H NMR (300 MHz, CDCl3) δ = 7.87 – 7.83 (m, 2H, CHar), 7.75 – 7.70 (m, 2H, CHar), 6.64 – 
6.53 (m, 2H, CHolef), 1.84 (d, J = 5.0 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ = 168.8 (C=O), 134.4 (CHar), 131.9 (Cq, ar), 123.6 (CHar), 118.5 
(CHolef), 118.3 (CHolef), 16.4 (CH3). 
The NMR spectroscopic data are in accordance with the literature.44 
(E)-2-(But-2-en-2-yl)isoindoline-1,3-dione (210e) 
The title compound was prepared according to GP 3 utilizing 14 mg 
Ni(dppp)Cl2 (25.0 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and stirred for 10 min. Then, 0.1 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 12.5 mmol, 5.0 mol%) were added. After cooling to 0 °C, 50 mg 2-(but-3-
en-2-yl)isoindoline-1,3-dione  (0.250 mmol, 1.0 eq) were added and the reaction mixture was 
stirred for 3 d at 0 °C. After general workup and purification by FC (n-pentane/EtOAc 9:1) 2-
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(but-2-en-2-yl)isoindoline-1,3-dione (210e) was obtained as Z/E-mixture (33:67) in 70% yield 
(35 mg, 0.170 mmol) as colorless oily solid.  
1H NMR (300 MHz, CDCl3) δ = δ 7.90 – 7.83 (m, 2H, CHar), 7.77 – 7.71 (m, 2H, CHar), 5.58 
(q, J = 7.0 Hz, 1H, CHolef), 1.97 (s, 3H, CH3), 1.83 (d, J = 7.0 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 167.7 (C=O), 134.2 (CHar), 132.2 (Cq, olef), 127.2 (Cq, ar), 127.0 
(CHolef), 123.6 (CHar), 15.7 (CH3), 13.4 (CH3). 
IR (neat) 3464, 2977, 2924, 2861, 1715, 1699, 1308, 1286, 1121, 1078, 885, 713, 530. 
HRMS (ESI) m/z [M+Na]+ calculated for C12H11NO2Na: 224.0682; found: 224.0682.  
Resolved signals of the minor isomer (Z)-2-(but-2-en-2-yl)isoindoline-1,3-dione: 
1H NMR (300 MHz, CDCl3) δ = 5.81 (q, J = 6.9 Hz, 1H, CHolef), 2.00 (s, 3H, CH3), 1.53 (d, 
J = 6.8 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ = 167.1 (C=O), 134.1 (CHar), 132.4 (Cq, olef), 127.2 (CHolef), 
126.0 (CHar), 123.5 (CHar), 21.1 (CH3), 13.5 (CH3). 
(E)-3-(But-1-en-1-yl)oxazolidin-2-one (218) 
The title compound was prepared according to GP 3 utilizing 28 mg 
Ni(dppp)Cl2 (50.0 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 25.0 mmol, 5.0 mol%) and 71 mg 3-(but-3-en-1-yl)oxazolidin-2-one 
(0.503 mmol, 1.0 eq) were added at ambient temperature and the reaction mixture was stirred 
for 16 h. After general workup and purification by FC (n-pentane/EtOAc 1:1) 3-(but-1-en-1-
yl)oxazolidin-2-one (218) was obtained as single E-isomer in 82% yield (58 mg, 0.411 mmol) 
as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = 6.65 (d, J = 14.2 Hz, 1H, NCHolef), 4.86 (dt, J = 14.4, 7.2 Hz, 
1H, CHolef), 4.42 (t, J = 8.1 Hz, 2H, CH2), 3.68 (t, J = 8.0 Hz, 2H, CH2), 2.09 (dq, J = 7.1, 1.2 
Hz, 2H, CH2), 1.02 (t, J = 7.4 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ = 155.6 (C=O), 123.5 (NCHolef), 113.5 (CHolef), 62.2 (CH2), 42.8 
(CH2), 23.1 (CH2), 14.6 (CH3). 
The NMR spectroscopic data are in accordance with the literature.152 
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(Z)-3-(But-2-en-1-yl)oxazolidin-2-one (219) 
The title compound was prepared according to GP 3 utilizing 14 mg 
Ni(dppp)Cl2 (25.0 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and stirred for 10 min. Then, 0.1 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 12.5 mmol, 5.0 mol%) were added. After cooling to −10 °C 36 mg 3-(but-
3-en-1-yl)oxazolidin-2-one (0.251 mmol, 1.0 eq) were added at ambient temperature and the 
reaction mixture was stirred for 16 h at – 10 °C. After general workup and purification by FC 
(n-pentane/EtOAc 1:1) (Z)-3-(but-2-en-1-yl)oxazolidin-2-one (219) was obtained as Z/E-
mixture (84:16) in 83% yield (30 mg, 0.208 mmol) as colorless oil. The product contained 11% 
of remaining starting material. 
1H NMR (300 MHz, CDCl3) δ = 5.79 – 5.64 (m, 1H, CHolef), 5.45 – 5.34 (m, 1H, CHolef), 4.31 
(t, J = 8.0 Hz, 2H, CH2), 3.92 (d, J = 7.2 Hz, 2H, CH2), 3.51 (t, J = 8.0 Hz, 2H, CH2), 1.70 (dd, 
J = 7.0, 0.7 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 158.5 (C=O), 129.6 (CHolef), 123.9 (CHolef), 61.8 (CH2), 44.2 
(CH2), 40.7 (CH2), 13.0 (CH3).  
IR (neat) 2919, 1737, 1484, 1424, 1255, 1192, 1066, 1034, 762, 726. 
HRMS (ESI) m/z [M+Na]+ calculated for C7H11NO2Na: 164.0682; found: 164.0682. 
Resolved signals of the minor isomer (E)-3-(but-2-en-1-yl)oxazolidin-2-one: 
1H NMR (300 MHz, CDCl3) δ  = 3.80 (d, J = 7.0 Hz, 2H, CH2), 1.26 (d, J = 7.9 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ = 60.5 (CH2), 44.6 (CH2), 17.9 (CH3). 
Resolved signals of the starting material 3-(but-3-en-1-yl)oxazolidin-2-one: 
1H NMR (300 MHz, CDCl3) δ = 5.15 – 5.06 (m, 2H, CH2, olef), 3.34 (t, J = 7.1 Hz, 2H, CH2), 
2.33 (pq, J = 7.2 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ = 43.6 (CH2), 32.1 (CH2). 
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5.5 Isomerization/Allylboration Sequence 
5.5.1 Synthesis of Homoallyl Boronic Esters 
2-(But-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (132)  
The title compound was prepared according to GP 4. First, 875 mg magnesium 
turnings (36.0 mmol, 1.2 eq) were suspended in 30 mL Et2O and 4.05 g 4-bromobut-
1-ene (30.0 mmol, 1.0 eq) were added at ambient temperature. The reaction mixture was stirred 
at 50 °C for 1 h and then cooled to −78 °C. At this temperature, 8.31 mL B(OiPr)3 (36.0 mmol, 
1.2 eq) were added and the reaction mixture was stirred for 30 min. The reaction was quenched 
with 1 M aqueous HCl, the aqueous layer was extracted with Et2O, dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure, the residue was taken up in 100 mL 
of the solvent mixture n-pentane/ Et2O (4:1) and 3.55 g pinacol (30 mmol, 1.0 eq) were added. 
The reaction was stirred for 3 d at ambient temperature, the solvent was evaporated, and the 
residue was purified by FC (n-pentane/Et2O 25:1) to give 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (132) in 99% yield (5.38 g, 29.6 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 5.95 – 5.82 (m, 1H, CHolef), 4.99 (dd, J = 17.1, 1.8 Hz, 1H, 
CHolef), 4.90 (dd, J = 10.5, 1.6 Hz, 1H, CHolef), 2.23 – 2.13 (m, 2H, CH2), 1.24 (s, 12H, CH3, pin), 
0.89 (t, J = 7.8 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 140.9 (CHolef), 113.3 (CHolef), 83.2 (Cq, pin), 28.1 (CH2), 25.0 
(CH3, pin). pinB−CH2 not detectable. 
The NMR spectroscopic data are in accordance with the literature.79 
4,4,5,5-Tetramethyl-2-(pent-4-en-1-yl)-1,3,2-dioxaborolane (222a) 
 The title compound was prepared according to GP 4. First, 583 mg magnesium 
turnings (24.0 mmol, 1.2 eq) were suspended in 30 mL Et2O and 2.89 g 
5-bromopent-1-ene (20.0 mmol, 1.0 eq) were added at ambient temperature. The reaction 
mixture was stirred at 50 °C for 1 h and then cooled to −78 °C. At this temperature, 4.62 mL 
B(OiPr)3 (20.0 mmol, 1.0 eq) were added and the reaction mixture was stirred for 30 min. The 
reaction was quenched with 1 M aqueous HCl, the aqueous layer was extracted with Et2O, dried 
over MgSO4 and filtered. The solvent was removed under reduced pressure, the residue was 
taken up in 80 mL of the solvent mixture n-pentane/Et2O (4:1) and 2.36 g pinacol (20.0 mmol, 
1.0 eq) were added. The reaction was stirred for 3 d at ambient temperature, the solvent was 
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evaporated and the residue was purified by FC (n-pentane/Et2O 25:1) to give 4,4,5,5-
tetramethyl-2-(pent-4-en-1-yl)-1,3,2-dioxaborolane (222a) in 67% yield (2.62 g, 13.3 mmol) as 
colorless liquid. 
1H NMR (300 MHz, CDCl3) δ = 5.79 (ddd, J = 16.9, 10.3, 6.6 Hz, 1H, CHolef), 4.97 (dd, J = 
17.2, 1.6 Hz, 1H, CHolef), 4.92 (d, J = 17.2 Hz, 1H, CHolef), 2.04 (dd, J = 7.5, 7.2 Hz, 2H, CH2), 
1.50 (p, J = 7.6 Hz, 2H, CH2), 1.24 (s, 12H, CH3, pin), 0.78 (t, J = 7.8 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ = 139.1 (CHolef), 114.6 (CH2, olef), 83.0 (Cq, pin), 36.5 (CH2), 24.9 
(CH3, pin), 23.5 (CH2), 10.4 (br s, B-CH2). 
The NMR spectroscopic data are in accordance with the literature.153 
2-(Hex-5-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (222b)  
The title compound was prepared according to GP 4. First, 583 mg magnesium 
turnings (24.0 mmol, 1.2 eq) were suspended in 20 mL THF and 2.76 mL 
6-bromohex-1-ene (20.0 mmol, 1.0 eq) were added at ambient temperature. The reaction 
mixture was stirred at 40 °C for 1 h and then cooled to −78 °C. At this temperature, 5.54 mL 
B(OiPr)3 (24.0 mmol, 1.2 eq) were added and the reaction mixture was stirred for 15 min. The 
reaction was quenched with 1 M aqueous HCl, the aqueous layer was extracted with Et2O, dried 
over MgSO4 and filtered. The solvent was removed under reduced pressure, the residue was 
taken up in 100 mL of the solvent mixture n-pentane/ Et2O (4:1) and 2.84 g pinacol (24.0 mmol, 
1.2 eq) were added. The reaction was stirred for 3 d at ambient temperature, the solvent was 
evaporated, and the residue was purified by FC (n-pentane/Et2O 70:1) to give 2-(hex-5-en-1-
yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (222b) in 55% yield (2.29 g, 11.0 mmol) as 
colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.88 – 5.74 (m, 1H, CHolef), 5.02 – 4.89 (m, 2H, CH2, olef), 2.08 
– 2.01 (m, 2H, CH2), 1.45 – 1.37 (m, 4H, CH2), 1.24 (s, 12H, Hpin), 0.78 (t, J = 7.35 Hz, 2H, 
CH2). 
13C NMR (75 MHz, CDCl3) δ 139.4 (CHolef), 114.2 (CH2, olef), 83.1 (Cq, pin), 33.8 (CH2), 31.9 
(CH2), 25.0 (Cpin), 23.8 (B-CH2). 
11B NMR (96 MHz, CDCl3) δ 34.0 (Bpin). 
IR (neat) 3076, 2978, 2927, 2860, 1640, 1462, 1407, 1371, 1317, 1272, 1224, 1144, 1111, 990, 
967, 908, 880, 846, 805, 724, 672, 633, 577, 543, 439, 397. 
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HRMS (EI) calculated for C12H23BO2: m/z = 210.1791; found m/z = 210.1792.  
4,4,5,5-Tetramethyl-2-(oct-7-en-1-yl)-1,3,2-dioxaborolane (222c)  
The title compound was prepared according to GP 4. First, 583 mg 
magnesium turnings (24.0 mmol, 1.2 eq) were suspended in 20 mL THF 
and 3.35 mL 8-bromooct-1-ene (20.0 mmol, 1.0 eq) were added at ambient temperature. The 
reaction mixture was stirred at 50 °C for 2 h and 15 min and then cooled to −78 °C. At this 
temperature, 5.54 mL B(OiPr)3 (24.0 mmol, 1.2 eq) were added and the reaction mixture was 
stirred for 15 min. The reaction was quenched with 1 M aqueous HCl, the aqueous layer was 
extracted with Et2O, dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure, the residue was taken up in 100 mL of the solvent mixture n-pentane/ Et2O (4:1) and 
2.84 g pinacol (24.0 mmol, 1.2 eq) were added. The reaction was stirred for 3 d at ambient 
temperature, the solvent was evaporated, and the residue was purified by FC (n-pentane/Et2O 
70:1) to give 4,4,5,5-tetramethyl-2-(oct-7-en-1-yl)-1,3,2-dioxaborolane (222c) in 71% yield 
(3.40 g, 14.3 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ = 5.88 – 5.74 (m, 1H, CHolef), 5.02 – 4.90 (m, 2H, CH2, olef), 
2.06 – 2.00 (m, 2H, CH2), 1.42 – 1.26 (m, 8H, CH2), 1.24 (s, 12H, CH3, pin), 0.77 (t, J = 7.5 Hz, 
2H, CH2). 
13C NMR (75 MHz, CDCl3) δ = 139.5 (CHolef), 114.2 (CH2, olef), 83.0 (Cq, pin), 34.0 (CH2), 32.4 
(CH2), 29.1 (CH2), 29.1 (CH2), 25.0 (CH3, pin), 24.1 (BCH2). 
11B NMR (96 MHz, CDCl3) δ 34.0 (Bpin). 
IR (neat) 3076, 2978, 2925, 2855, 2028, 1640, 1464, 1407, 1371, 1316, 1271, 1214, 1144, 
1111, 992, 968, 908, 877, 846, 804, 721, 672, 634, 577, 545, 519, 440, 406. 
EI-HRMS  calculated for C14H27BO2: m/z = 238.2105; found m/z = 238.2109.  
4,4,5,5-Tetramethyl-2-(2-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane (227)  
The title compound was prepared according to GP 5. First, 160 mg magnesium 
turnings (6.58 mmol, 1.2 eq), 740 mg pinacolborane (5.80 mmol, 1.0 eq) and 0.8 mL 
triethylamine (5.80 mmol, 1.0 eq) were suspended in 15 mL THF. At ambient 
temperature 2.10 g (1-bromobut-3-en-2-yl)benzene (5.71 mmol, 1.0 eq) were added 
and the reaction mixture was stirred overnight at 66 °C. The reaction was quenched with 0.2 M 
aqueous HCl, the aqueous layer was extracted with Et2O, dried over MgSO4 and filtered. The 
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solvent was removed under reduced pressure and the crude product was purified by FC (n-
pentane/Et2O 20:1) to give 4,4,5,5-tetramethyl-2-(2-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane 
(227) in 50% yield (743 mg, 2.88 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.29 – 7.21 (m, 5H, CHar), 6.07 – 5.95 (m, 1H, CHolef), 5.07 – 
4.91 (m, 2H, CH2, olef), 3.61 (q, J = 8.46 Hz, 1H, CH), 1.19 (d, J = 6.36 Hz, 2H, CH2), 1.14 (s, 
12H, CH3, pin). 
13C NMR (75 MHz, CDCl3) δ 145.9 (Cq, ar), 143.9 (CHolef), 128.5 (CHar), 127.6 (CHar), 126.2 
(CHar), 112.9 (CH2, olef), 83.3 (Cq, pin), 45.2 (CH), 24.8 (CH3, pin), 24.9 (BCH2). 
11B NMR (96 MHz, CDCl3) δ 33.7 (Bpin). 
IR (neat) 3062, 3027, 2977, 2930, 1637, 1601, 1492, 1480, 1467, 1452, 1388, 1362, 1323, 
1270, 1213, 1164, 1142, 1112, 1071, 1030, 994, 967, 911, 885, 846, 825, 779, 749, 698, 671, 
578, 554, 510, 420. 
HRMS (EI) calculated for C16H23BO2: m/z = 258.1791; found m/z = 258.1786.  
2-(1-Bromobut-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (223)  
According to a procedure of Hoffmann,128 6.57 g 2-(dibromomethyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (21.9 mmol, 1.0 eq)  were dissolved in 50 mL 
anhydrous THF. At −100 °C, 21.9 mL allylmagnesiumbromide solution (1.0 m in Et2O, 
21.9 mmol, 1.0 eq) were added and the reaction was warmed very slowly to ambient 
temperature (overnight) with the Schlenk flask remaining inside the cooling bath. The reaction 
mixture was quenched with H2O and the aqueous layer was extracted three times with Et2O, 
the organic layer was dried over MgSO4, filtered and the solvent was evaporated. The crude 
product was purified by FC (n-pentane/Et2O 25:1) to give 2-(1-bromobut-3-en-1-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (223) in 62% yield (3.55g, 13.6 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 5.88 – 5.72 (m, 1H, CHolef), 5.15 – 5.07 (m, 2H, CH2, olef), 3.31 
(t, J = 7.9 Hz, 1H, CH), 2.74 – 2.56 (m, 2H, CH2), 1.28 (s, 12H, CH3, pin).  
13C NMR (75 MHz, CDCl3) δ 135.8 (CHolef), 117.6 (CH2, olef), 84.5 (Cq, pin), 38.4 (CH2), 24.6 
(CH3, pin). BCH2 not detectable.  
11B NMR (96 MHz, CDCl3) δ 33.8 (Bpin). 
IR (neat) 2979, 2931, 1641, 1379, 1372, 1347, 1272, 1250, 1167, 1141, 994, 966, 920, 844, 
673, 606, 577.  
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HRMS (EI) calculated for C10H18BBrO2: m/z = 260.0583; found m/z = 260.0597.  
2,2'-(But-3-en-1,1-diyl)-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (224) 
According to a procedure of Meek,154 1.72 mL diisopropylamine (12.3 mmol, 
1.03 eq) were dissolved in 41 mL anhydrous THF and 4.9 mL n-BuLi solution 
(2.5 M in n-hexane, 12.3 mmol, 1.03 eq) were added at 0 °C. After stirring for 30 min at 0 °C 
3.19 g bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (11.9 mmol, 1.0 eq) were 
added and the reaction mixture was stirred for another 10 min. Then, 2.5 mL allylbromide (29.3 
mmol, 2.46 eq) were added. The reaction was warmed to ambient temperature and stirred 
overnight. The reaction was quenched with sat. aqueous NH4Cl solution and the aqueous layer 
was extracted three times with Et2O, dried over MgSO4, filtered and the solvent was evaporated. 
The crude product was purified by FC (n-pentane/Et2O 30:1) to give 2,2'-(but-3-en-1,1-diyl)-
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (224) in 27% yield (980 mg, 3.18 mmol) as pale 
yellow sticky oil.   
1H NMR (300 MHz, CDCl3) δ 5.95 – 5.80 (m, 1H, CHolef), 5.04 – 4.83 (m, 2H, CH2, olef), 2.29 
(ddt, J = 8.3, 6.5, 1.5 Hz, 2H, CH2), 1.22 (s, 24H, CH3, pin), 0.84 (t, J = 8.1 Hz, 1H, CH).  
13C NMR (75 MHz, CDCl3) δ 140.9 (CHolef), 113.3 (CH2, olef), 83.1 (Cq, pin), 27.7 (CH2), 25.0 
(CH3, pin), 24.7 (CH3, pin). B2CH not detectable. 
The NMR spectroscopic data are in accordance with the literature.154 
1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl acetate (225)  
According to a procedure of Nefedov,155 7.48 g potassium acetate (76.2 mmol, 
5.6 eq), 3.55 g 2-(1-bromobut-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxa-
borolane (13.6 mmol, 1.0 eq) and 324 mg dibenzo-18-crown-6 (0.90 mmol, 0.06 eq) were 
dissolved in 45 mL acetonitrile and stirred overnight at 90 °C. When full conversion of the 
starting material was detected by GC/MS analysis the reaction mixture was quenched with H2O 
and the aqueous layer was extracted three times with Et2O, the organic layer was washed with 
brine, dried over MgSO4, filtered and the solvent was evaporated. The crude product was 
purified by FC (EtOAc n-pentane/triethylamine 1:3:0.5) to give 1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)but-3-en-1-yl acetate (225) in 40% yield (1.37 g, 5.48 mmol) as colorless 
oil. 
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1H NMR (300 MHz, CDCl3) δ 5.92 – 5.77 (m, 1H, CHolef), 5.15 – 5.02 (m, 2H, CH2, olef), 4.02 
(t, J = 6.8 Hz, 1H, CH), 2.49 – 2.41 (m, 2H, CH2), 2.07 (s, 3H, CH3, Ac), 1.25 (d, J = 5.8 Hz, 
12H, CH3, pin).  
13C NMR (75 MHz, CDCl3) δ 173.1 (C=O), 135.0 (CHolef), 117.1 (CH2, olef), 83.9 (Cq, pin), 75.2 
(CH), 34.9 (CH2), 24.8 (CH3, pin), 20.5 (CH3, Ac).  
11B NMR (96 MHz, CDCl3) δ 30.1 (Bpin). 
IR (neat) 2978, 2932, 1724, 1642, 1371, 1343.6, 1232, 1143, 1112, 1026, 976, 966, 915, 851, 
670, 619.  
HRMS (EI) calculated for C11H18BO4: m/z = 225.1298; found m/z = 225.1282.  
4,4,5,5-Tetramethyl-2-(1-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane (226)  
The title compound was prepared according to GP 5. First, 1.89 g (1-
bromobut-3-en-1-yl)benzene (9.00 mmol, 1.0 eq) were added to a 
suspension of 263 mg magnesium turnings (10.8 mmol, 1.2 eq), 1.15 g 
pinacolborane (9.00 mmol, 1.0 eq) and 1.25 mL triethylamine (9.0 mmol, 1.0 eq) in 27 mL THF 
at ambient temperature. The mixture was stirred overnight at 65 °C. Then, 0.1 M HCl was added 
and the solution was extracted three times with diethylether, washed with brine, dried over 
MgSO4, filtered and concentrated by rotary evaporation. The crude product was purified by FC 
(n-pentane/Et2O 20:1) to give 4,4,5,5-tetramethyl-2-(1-phenylbut-3-en-1-yl)-1,3,2-
dioxaborolane (226) in 52% yield (1.197 g, 4.64 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 7.28 – 7.20 (m, 4H, CHar), 7.16 – 7.10 (m, 1H, CHar), 5.89 – 
5.76 (dddd, J = 17.0, 10.8, 6.8, 6.3 Hz, 1H, CHolef), 5.06 – 4.91 (m, 2H, CH2, olef), 2.66 – 2.55 
(m, 1H, CH), 2.45 – 2.36 (m, 2H, CH2), 1.20 (s, 6H, CH3, pin), 1.18 (s, 6 H, CH3, pin). 
13C NMR (75 MHz, CDCl3) δ 142.8 (Cq, ar), 138.3 (CHolef), 128.5 (CHar), 128.4 (CHar), 125.4 
(CHar), 115.2 (CH2, olef), 83.5 (Cq, pin), 36.8 (CH2), 24.8 (CH3, pin), 24.7 (CH3, pin). BCH not 
detectable. 
11B NMR (96 MHz, CDCl3) δ 33.8 (Bpin). 
IR (neat) 2978, 2928, 1359, 1323, 1245, 1141, 967, 910, 847, 763, 699, 513.  
HRMS (EI) calculated for C16H23BO2: m/z = 258.1791; found m/z = 258.1804. 
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2-(1-(1,3-Dioxolan-2-yl)hex-5-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (255)  
The title compound was prepared according to GP 5. First, 1.80 g 2-(3-
bromohex-5-en-1-yl)-1,3-dioxolane (7.67 mmol, 0.86 eq) were added 
to a suspension of 217 mg magnesium turnings (8.92 mmol, 1.0 eq), 
1.14 g pinacolborane (8.92 mmol, 1.0 eq) and 1.24 mL triethylamine (8.92 mmol, 1.0 eq) in 30 
mL anhydrous THF at ambient temperature. The mixture was stirred overnight at 80 °C. 0.1 M 
HCl was added and the aqueous layer was extracted three times with Et2O. The combined 
organic layers were washed with brine, dried over MgSO4, filtered and concentrated by rotary 
evaporation. The crude product was purified by FC (n-pentane/Et2O 10:1) to give 2-(1-(1,3-
dioxolan-2-yl)hex-5-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (255) in 24% yield (613 
mg, 2.17 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.80 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H, CHolef), 5.05 – 4.90 (m, 
2H, CH2, olef), 4.83 (t, J = 4.8 Hz, 1H, CH), 3.99 – 3.79 (m, 4H, CH2, oxolane), 2.26 – 2.07 (m, 2H, 
CH2), 1.72–1.46 (m, 4H, CH2), 1.22 (s, 12H, CH3, pin), 1.16 – 1.05 (m, 1H, CH). 
13C NMR (75 MHz, CDCl3) δ 138.5 (CHolef), 115.1 (CH2, olef), 105.0 (CH), 83.2 (Cq, pin), 65.0 
(CH2, oxolane), 64.9 (CH2, oxolane), 35.6 (CH2), 33.5 (CH2), 25.3 (CH2), 25.0 (CH3, pin), 24.97 (CH3, 
pin). BCH not detectable. 
11B NMR (96 MHz, CDCl3) δ 33.8 (Bpin). 
IR (neat) 2923, 2854, 1640, 1457, 1380, 1358, 1318, 1242, 1214, 1143, 1033, 992, 968, 942, 
939, 853, 836, 734, 694, 671, 647, 579, 529, 443, 395. 
HRMS (ESI) calculated for C15H27BO4Li
+: m/z = 289.1270; found m/z = 289.1281.  
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one (291)  
According to a procedure of Molander,156 12 mg CuCl (0.12 mmol, 
3.0 mol%), 49 mg 1,3-bis(diphenylphosphino)propane (0.120 mmol, 
3.0 mol%) and 29 mg  lithium tert-butoxide (0.39 mmol, 10 mol%) were suspended in 4 mL 
anhydrous THF and stirred for 30 min at ambient temperature. 1.07 g bis(pinacolato)diboron 
(4.10 mmol, 1.1 eq) were dissolved in 7 mL anhydrous THF and added to the reaction mixture. 
After 15 min 0.34 mL methylvinylketone (4.00 mmol, 1.0 eq) as well as 0.32 mL methanol 
(8.00 mmol, 2.0 eq) were added and the reaction mixture was stirred overnight. H2O was then 
added and the aqueous layer was extracted three times with Et2O, the combined organic layers 
were dried over MgSO4, filtered and the solvent was evaporated. The crude product was 
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purified by FC (n-pentane/Et2O 10:1) to give 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butan-2-one (291) in 65% yield (516 mg, 2.60 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 2.58 (t, J = 7.1 Hz, 2H, CH2), 2.12 (s, 3H, CH3), 1.23 (s, 12H, 
CH3, pin), 0.90 (t, J = 7.1 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 209.3 (C=O), 83.3 (Cq, pin), 38.6 (CH2), 29.5 (CH3), 25.2 (CH2), 
24.9 (CH3, pin). 
The NMR spectroscopic data are in accordance with the literature.157 
4,4,5,5-Tetramethyl-2-(3-methylbut-3-en-1-yl)-1,3,2-dioxaborolane (292)  
The title compound was prepared according to GP 6. First, 2.17 g 
methyltriphenylphosphonium bromide (6.06 mmol, 1.1 eq) and 680 mg 
potassium tert-butoxide (6.06 mmol, 1.1 eq) were suspended in 30 mL Et2O at 0 °C. After 
stirring for 1 h at ambient temperature, 1.14 g 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)butan-2-one (5.77 mmol, 1.0 eq) were added dropwise and the mixture was stirred overnight. 
Sat. aqueous NH4Cl solution was added and the aqueous layer was extracted three times with 
Et2O. The combined organic layers were dried over MgSO4, filtered, adsorbed on silica gel and 
the solvent was evaporated. The adsorbed crude product was purified by FC (n-pentane/Et2O 
8:1) to give 4,4,5,5-tetramethyl-2-(3-methylbut-3-en-1-yl)-1,3,2-dioxaborolane (292) in 61% 
yield (693 mg, 3.53 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 4.66 – 4.67 (m, 2H, CH2, olef), 2.12 (t, J = 8.0 Hz, 2H, CH2), 1.72 
(s, 3H, CH3), 1.24 (s, 12H, CH3, pin), 0.93 (t, J = 8.1 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 148.0 (Cq, olef), 108.6 (CH2, olef), 83.1 (Cq, pin), 31.9 (CH2), 25.0 
(CH3, pin), 22.6 (CH3). BCH2 not detectable. 
The NMR spectroscopic data are in accordance with the literature.158 
1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-one (230)  
According to a procedure of Molander,156 24 mg CuCl (0.24 mmol, 
3.0 mol%), 99 mg 1,3-bis(diphenylphosphino)propane (0.37 mmol, 
3.0 mol%) and 57 mg lithium tert-butoxide (720 mmol, 10 mol%) were suspended in 7 mL 
anhydrous THF and stirred for 30 min at ambient temperature. 2.13 g bis(pinacolato)diboron 
(8.19 mmol, 1.1 eq) were dissolved in 14 mL anhydrous THF and added to the reaction mixture. 
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After 15 min 0.80 mL ethylvinylketone (8.00 mmol, 1.0 eq) as well as 0.64 mL methanol 
(16.0 mmol, 2.0 eq) were added and the reaction mixture was stirred overnight. H2O was then 
added, and the aqueous layer was extracted three times with Et2O, the combined organic layer 
was dried over MgSO4, filtered and the solvent was evaporated. The crude product was purified 
by FC (n-pentane/Et2O 8:1) to give 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-3-
one (230) in 90% yield (1.52 g, 7.17 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 2.55 (t, J = 7.1 Hz, 2H, CH2), 2.40 (q, J = 7.5 Hz, 2H, CH2), 
1.23 (s, 12H, CH3, pin), 1.05 (t, J = 7.4 Hz, 3H, CH3), 0.91 (t, J = 7.1 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 212.0 (C=O), 83.2 (Cq, pin), 37.1 (CH2), 35.5 (CH2), 24.9 (CH3, 
pin), 8.2 (CH3). BCH2 not detectable. 
The NMR spectroscopic data are in accordance with the literature.159 
4,4,5,5-Tetramethyl-2-(3-methylenepentyl)-1,3,2-dioxaborolane (231)  
The title compound was prepared according to GP 6. First, 4.59 g 
methyltriphenylphosphonium bromide (12.9 mmol, 1.1 eq) and 1.45 g 
potassium tert-butoxide (12.9 mmol, 1.1 eq) were suspended in 65 mL THF at 0 °C. After 
stirring for 1 h at ambient temperature, 2.61 g 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentan-3-one (12.3 mmol, 1.0 eq) were added dropwise and the mixture was stirred 
overnight. Sat. aqueous NH4Cl solution was added and the aqueous layer was extracted three 
times with Et2O. The combined organic layers were dried over MgSO4, filtered, adsorbed on 
silica gel and the solvent was evaporated. The adsorbed crude product was purified by FC (n-
pentane/Et2O 8:1) to give 4,4,5,5-tetramethyl-2-(3-methylenepentyl)-1,3,2-dioxaborolane 
(231) in 67% yield (1.73 g, 8.23 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 4.69 (d, J = 9.1 Hz, 2H, CH2, olef), 2.14 (t, J = 8.0 Hz, 2H, CH2), 
2.03 (q, J = 7.4 Hz, 2H, CH2), 1.24 (s, 12H, CH3, pin), 1.02 (t, J = 7.5 Hz, 3H, CH3), 0.93 (t, J = 
8.0 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 106.5 (CH2, olef), 83.1 (Cq, pin), 30.3 (CH2), 29.0 (CH2), 25.0 (CH3, 
pin), 12.6 (CH3). B−CH2 not visible. 
11B NMR (96 MHz, CDCl3) δ 33.8 (Bpin). 
IR (neat) 2978, 2933, 1646, 1370, 1316, 1144, 968, 884, 869, 796. 
HRMS (EI) calculated for C12H23BO2: m/z = 210.1791; found m/z = 210.1786. 
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4,4,5,5-Tetramethyl-2-(3-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane (232)  
The title compound was prepared according to GP 6. First, 740 mg 
methyltriphenylphosphonium bromide (2.10 mmol, 1.1 eq) and 230 mg 
potassium tert-butoxide (2.10 mmol, 1.1 eq) were suspended in 12 mL 
Et2O at 0 °C. After stirring for 50 min at ambient temperature, 500 mg 1-phenyl-3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-one (1.90 mmol, 1.0 eq) were added dropwise and 
the mixture was stirred overnight. NH4Cl solution was added and the aqueous layer was 
extracted three times with Et2O, dried over MgSO4, filtered, adsorbed on silica gel and the 
solvent was evaporated. The adsorbed crude product was purified by FC (n-pentane/Et2O 10:1) 
to give 4,4,5,5-tetramethyl-2-(3-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane (232) in 31% yield 
(150 mg, 0.580 mmol) as pale yellow oil. 
1H NMR (300 MHz, CDCl3) δ 7.42 – 7.24 (m, 5H, CHar), 5.23 (s, 1H, CHolef), 5.07 (s, 1H, H 
CHolef), 2.61 (t, J = 7.80 Hz, 2H, CH2), 1.24 (s, 12H, CH3, pin), 0.99 (t, J = 8.10 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 150.6 (Cq, olef), 142.0 (Cq, ar), 128.3 (CHar), 127.3 (CHar), 126.4 
(CHar), 111.2 (CH2, olef), 83.2 (Cq, pin), 29.6 (CH2), 25.0 (CH3, pin). BCH2 not detectable. 
11B NMR (96 MHz, CDCl3) δ 34.2 (Bpin). 
IR (neat) 3081, 3056, 2977, 2292, 1627, 1600, 1574, 1494, 1443, 1403, 1369, 1318, 1244, 
1213, 1164, 1142, 1109, 1072, 1004, 967, 888, 869, 846, 776, 700, 673, 577, 541, 513, 388. 
HRMS (EI)  calculated for C16H23BO2: m/z = 258.1791; found m/z = 258.1782.  
6-(1,3-Dioxolan-2-yl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-one (293)  
According to a procedure of Molander,156 37 mg CuCl 
(0.37 mmol, 3.0 mol%), 154 mg 1,3-
bis(diphenylphosphino)propane (0.37 mmol, 3.0 mol%) and lithium tert-butoxide (99.6 mg, 
1.2 mmol, 10 mol%) were suspended in 12 mL anhydrous Et2O and stirred for 30 min at 
ambient temperature. Then, 3.32 g bis(pinacolato)diboron (13.1 mmol, 1.1 eq) were dissolved 
in 12 mL anhydrous Et2O and added to the reaction mixture. After 15 min 2.12 g 6-(1,3-
dioxolan-2-yl)hex-1-en-3-one (12.4 mmol, 1.0 eq) as well as 1.0 mL methanol (24.7 mmol, 
2.0 eq) were added and the reaction mixture was stirred overnight. H2O was then added  and 
the aqueous layer was extracted three times with Et2O, the combined organic layer was dried 
over MgSO4, filtered and the solvent was evaporated. The crude product was purified by FC 
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(n-pentane/Et2O 1:1) to give 6-(1,3-dioxolan-2-yl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)hexan-3-one (293) in 92% yield (3.41 g, 11.5 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 4.84 (t, J = 4.3 Hz, 1H, CH), 3.98 – 3.82 (m, 4H, CH2, oxolane), 
2.55 (t, J = 7.1 Hz, 2H, CH2), 2.45 (t, J = 7.0 Hz, 2H, CH2), 1.77 – 1.59 (m, 4H, CH2), 1.29 –
1.21 (m, 12H, CH3, pin), 0.90 (t, J = 7.1 Hz, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 211.1 (C=O), 104.5 (CH), 83.2 (Cq, pin), 65.0 (CH2, oxolane), 42.0 
(CH2), 37.6 (CH2), 33.3 (CH2), 24.9 (CH3, pin), 18.6 (CH2). BCH2 not detectable. 
11B NMR (96 MHz, CDCl3) δ 33.1 (Bpin). 
IR (neat) 2977, 2887, 1711, 1473, 1453, 1418, 1371, 1313, 1142, 1036, 1009, 983, 967, 949, 
875, 850, 699, 673. 
HRMS (EI) calculated for C15H27BO5: m/z = 298.1952; found m/z = 298.1943.  
2-(6-(1,3-Dioxolan-2-yl)-3-methylenehexyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (259)  
The title compound was prepared according to GP 6. 6.67 g 
methyltriphenylphosphonium bromide (18.7 mmol, 1.5 eq) and 
2.23 g potassium tert-butoxide (19.9 mmol, 1.6 eq) were suspended in 60 mL Et2O at 0 °C. 
After stirring for 45 min at ambient temperature, 3.71 g 6-(1,3-dioxolan-2-yl)-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-3-one (12.4 mmol, 1.0 eq) were added dropwise 
and the mixture was stirred overnight. Sat. aqueous NH4Cl solution was added and the aqueous 
layer was extracted three times with Et2O, dried over MgSO4, filtered, adsorbed on silica gel 
and the solvent was evaporated. The adsorbed crude product was purified by FC 
(n-pentane/Et2O 3:1) to give 2-(6-(1,3-dioxolan-2-yl)-3-methylenehexyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (259) in 30% yield (1.11 g, 3.75 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 4.86 (t, J = 4.6 Hz, 1H, CH), 4.73 (d, J = 1.4 Hz, 1H, CHolef), 
4.69 (d, J = 0.8 Hz, 1H, CHolef), 3.99 – 3.81 (m, 4H, CH2, oxolane), 2.17 – 2.02 (m, 4H, CH2), 1.70 
– 1.49 (m, 4H, CH2), 1.23 (s, 12H, CH3, pin), 0.96 – 0.88 (m, 2H, CH2). 
13C NMR (75 MHz, CDCl3) δ 151.3 (Cq, olef), 108.1 (CH2, olef), 104.8 (CH2), 83.1 (Cq, pin), 65.0 
(CH2, oxolane), 36.2 (CH2), 33.8 (CH2), 30.0 (CH2), 25.0 (CH2, pin), 22.4 (CH2). BCH2 not 
detectable. 
11B NMR (96 MHz, CDCl3) δ 33.9 (Bpin). 
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IR (neat) 2935, 2882, 1645, 1434, 1405, 1370, 1317, 1273, 1238, 1214, 1143, 1034, 968, 943, 
885, 847, 753, 708, 673, 578, 541, 440, 380. 
HRMS (EI)  calculated for C15H26BO4: m/z = 281.1924; found m/z = 281.1934.  
2,2'-(But-3-ene-1,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (229) 
The title compound was prepared according to GP 5. 175 mg magnesium 
turnings (7.20 mmol, 1.2 eq), 768 mg pinacolborane (6.00 mmol, 1.0 eq) 
and 0.83 mL NEt3 (6.00 mmol, 1.0 eq) were suspended in 20 mL THF. 1.57 g 2-(3-bromobut-
3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (6.00 mmol, 1.0 eq) were added at ambient 
temperature and the reaction mixture was stirred overnight at 75 °C. The reaction was quenched 
with 0.1 M aqueous HCl, the aqueous layer was extracted three times with Et2O, the aqueous 
layer was washed with brine, dried over MgSO4 and filtered. The solvent was removed under 
reduced pressure and the crude product was purified by FC (n-pentane) to give 2,2'-(but-3-ene-
1,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (229) in 41% yield (760 mg, 2.47 mmol) 
as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.72 (d, J = 2.3 Hz, 1H, CHolef), 5.61 (s, 1H, CHolef), 2.26 (t, J = 
8.1 Hz, 2H, CH2), 1.25 (s, 12H, CH3, pin), 1.23 (s, 12H, CH3, pin), 0.92 (t, J = 8.1 Hz, 2H, CH2).  
13C NMR (75 MHz, CDCl3) δ 127.7 (CH2, olef), 83.4 (Cq, pin), 83.0 (Cq, pin), 29.3 (CH2), 25.0 
(CH3, pin), 24.9 (CH3, pin). BCH2 not detectable.  
11B NMR (96 MHz, CDCl3) δ 33.7 (Bpin), 30.0 (Bpin). 
IR (neat) 2977, 2930, 1447, 1369, 1309, 1214, 1190, 967, 864, 848, 672, 578.  
HRMS (EI)  calculated for C16H30B2O4: m/z = 308.2330; found m/z = 308.2340.  
5.5.2 Isomerization/Allylboration Sequence 
syn-2-Methyl-1-phenylbut-3-en-1-ol (112)  
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc iodide 
(100 mmol, 20 mol% each). These materials were suspended in 0.3 mL 
dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 25 mmol, 
5.0 mol%) were added. After cooling to −50 °C, 53 mg benzaldehyde and 91 mg 2-(but-3-en-
1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq each) were added. The 
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reaction mixture was stirred for 7 h at − °C. After general workup and purification by FC (n-
pentane/Et2O 10:1) 2-methyl-1-phenylbut-3-en-1-ol (112) was obtained as syn/anti mixture 
(98:2) in 81% yield (66 mg, 0.407 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.37 – 7.24 (m, 5H, CHar), 5.82 – 5.71 (m, 1H, CHolef), 5.09 – 
5.03 (m, 2H, CH2, olef), 4.62 (dd, J = 5.2 Hz, 3.1 Hz, 1H, CH), 2.65 – 2.54 (m, 1H, CH), 1.95 
(d, J = 2.9 Hz, OH), 1.02 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 142.8 (Cq, ar), 140.5 (CHolef), 128.2 (CHar), 127.5 (CHar), 126.7 
(CHar), 115.7 (CH2, olef), 77.5 (CH), 44.8 (CH), 14.2 (CH3). 
Resolved signals of the minor diastereomer anti-2-methyl-1-phenylbut-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 4.37 (dd, J = 7.9 Hz, 2.2 Hz, 1H, CH), 2.15 (d, J = 1.9 Hz, 1H, 
OH), 0.88 (d, J = 7.0 Hz, 3H, CH3). 
The NMR spectroscopic data for both diastereomers are in accordance with the literature.160,161 
syn-(4-Methoxyphenyl)-2-methylbut-3-en-1-ol (233a) 
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −50 °C, 68 mg 4-methoxybenzaldehyde and 
89 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq each) 
were added. The reaction mixture was stirred for 5 h at − °C. After general workup and 
purification by FC (n-pentane/Et2O 12:1→8:1) (4-methoxyphenyl)-2-methylbut-3-en-1-ol 
(233a) was obtained as syn/anti mixture (96:4) in 81% yield (78 mg, 0.406 mmol) as colorless 
oil.  
1H NMR (300 MHz, CDCl3) δ 7.22 (ddd, J = 8.6, 2.7, 1.9 Hz, 2H, CHar), 6.87 (ddd, J = 8.7, 
2.8, 2.0 Hz, 2H, CHar), 5.79 – 5.68 (m, 1H, CHolef), 5.07 – 5.00 (m, 2H, CH2, olef), 4.55 (dd, J = 
5.8, 2.6 Hz, 1H, CH), 3.80 (s, 3H, OCH3), 2.61 – 2.51 (m, 1H, CH), 1.86 (d, J = 3.0 Hz, 1H, 
OH), 1.02 (d, J = 6.8 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 159.1 (Cq, ar), 140.5 (CHolef), 135.0 (Cq, ar), 127.8 (CHar), 115.5 
(CH2, olef), 113.7 (CHar), 77.2 (CH), 55.4 (OCH3), 44.8 (CH), 14.5 (CH3). 
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Resolved signals of the minor diastereomer anti-(4-methoxyphenyl)-2-methylbut-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.85 (dd, J = 17.4, 10.2 Hz, 1H, CHolef), 5.23 – 5.16 (m, 2H, 
CH2, olef), 4.30 (d, J = 7.4 Hz, 1H, CH), 2.49 – 2.42 (m, 1H, CH), 2.09 (s, 1H, OH), 0.85 (d, J = 
6.9 Hz, 3H, CH3). 
The NMR spectroscopic data for both diastereomers are in accordance with the literature.160–162 
syn-1-(4-Chlorophenyl)-2-methylbut-3-en-1-ol (233b)  
The title compound was prepared according to GP 7 utilizing 14 mg 
Ni(dppp)Cl2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and stirred for 10 min. Then, 0.1 mL of the HPPh2 solution (0.125 M 
in dichloromethane, 12.5 mmol, 5.0 mol%) were added. After cooling to − °C, 35 mg 4-
chlorobenzaldehyde and 45 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(0.25 mmol, 1.0 eq each) were added. The reaction mixture was stirred for 1 h at − °C. After 
general workup and purification by FC (n-pentane/Et2O 10:1) 1-(4-chlorophenyl)-2-methylbut-
3-en-1-ol (233b) was obtained as syn/anti mixture (97:3) in 98% yield (48 mg, 0.244 mmol) as 
colorless oil.  
1H NMR (300 MHz, CDCl3) δ 7.33 – 7.21 (m, 4H, CHar), 5.80 – 5.68 (m, 1H, CHolef), 5.10 – 
5.02 (m, 2H, CH2, olef), 4.61 (d, J = 5.3 Hz, 1H, CH), 2.60 – 2.49 (m, 1H, CH), 1.93 (s, 1H, OH), 
0.98 (d, J = 6.7 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 141.1 (Cq, ar), 140.1 (CHolef), 133.2 (Cq, ar), 128.4 (CHar), 128.0 
(CHar), 116.1 (CH2, olef), 76.7 (CH), 44.8 (CH), 14.0 (CH3). 
Resolved signals of the minor diastereomer anti-1-(4-chlorophenyl)-2-methylbut-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 4.85 – 4.79 (m, 2H, CH2, olef), 4.35 (d, J = 7.7 Hz, 1H, CH), 2.42 
– 1.93 (m, 1H, CH), 0.88 (d, J = 6.9 Hz, 3H, CH3).  
The NMR spectroscopic data for both diastereomers are in accordance with the literature.163 
syn-1-(4-Bromophenyl)-2-methylbut-3-en-1-ol (233c)  
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
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0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −50 °C, 92 mg 4-bromobenzaldehyde and 
91 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.5 mmol, 1.0 eq each) were 
added. The reaction mixture was stirred for 5 h and 30 min at − °C. After general workup 
and purification by FC (n-pentane/Et2O 12:1) 1-(4-bromophenyl)-2-methylbut-3-en-1-ol 
(233c) was obtained as syn/anti mixture (97:3) in 77% yield (93 mg, 0.386 mmol) as colorless 
oil.  
1H NMR (300 MHz, CDCl3) δ 7.46 (ddd, J = 8.4, 2.4, 1.9 Hz, 2H, CHar), 7.18 (ddd, J = 8.3, 
2.2, 1.6 Hz, 2H, CHar), 5.80 – 5.69 (m, 1H, CHolef), 5.10 – 5.02 (m, 2H, CH2, olef), 4.59 (d, J = 
5.3 Hz, 1H, CH), 2.61 – 2.49 (m, 1H, CH), 1.92 (s, 1H, OH), 0.98 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 140.0 (CHolef), 131.3 (CHar), 128.4 (CHar), 121.3 (Cq, ar), 116.1 
(CH2, olef), 76.7 (CH), 44.7 (CH), 13.9 (CH3). BrCq, ar not detectable. 
Resolved signals of the minor diastereomer anti-1-(4-bromophenyl)-2-methylbut-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.22 – 5.16 (m, 2H, CH2, olef), 4.34 (d, J = 7.7 Hz, 1H, CH), 2.47 
– 2.39 (m, 1H, CH), 0.88 (d, J = 6.9 Hz, 3H, CH3).  
The NMR spectroscopic data for both diastereomers are in accordance with the literature.164 
syn-2-Methyl-1-(4-(trifluoromethyl)phenyl)but-3-en-1-ol (233d)  
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −40 °C, 87 mg 4-
trifluoromethylbenzaldehyde and 91 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (0.50 mmol, 1.0 eq each) were added. The reaction mixture was stirred for 7 h 
at − °C and overnight at ambient temperature. After general workup and purification by FC 
(n-pentane/Et2O 10:1) 2-methyl-1-(4-(trifluoromethyl)phenyl)but-3-en-1-ol (233d) was 
obtained as syn/anti mixture (95:5) in 76% yield (88 mg, 0.382 mmol) as colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 8.1 Hz, 2H, CHar), 7.43 (d, J = 8.1 Hz, 2H, CHar), 
5.83 – 5.72 (m, 1H, CHolef), 5.13 – 5.05 (m, 2H, CH2, olef), 4.71 (d, J = 5.1 Hz, 1H, CH), 2.65 – 
2.54 (m, 1H, CH), 1.98 (s, 1H, OH), 0.99 (d, J = 6.9 Hz, 3H, CH3). 
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13C NMR (125 MHz, CDCl3) δ 146.6 (Cq, ar), 139.8 (CHolef), 129.6 (q, J = 32.3 Hz, CF3Cq, ar), 
126.9 (CHar), 125.1 (q, J = 3.8 Hz, CHar), 116.4 (CH2, olef), 76.6 (CH), 44.7 (CH), 13.6 (CH3). 
CF3 not detectable. 
19F NMR (282 MHz, CDCl3) δ −62.55 (s, CF3). 
Resolved signals of the minor diastereomer anti-2-methyl-1-(4-(trifluoromethyl)phenyl)but-3-
en-1-ol: 
1H NMR (500 MHz, CDCl3) δ 5.23 – 5.17 (m, 2H, CH2, olef), 4.45 (d, J = 7.6 Hz, 1H. CH), 2.51 
– 2.44 (m, 1H, CH), 0.91 (d, J = 7.0 Hz, 3H, CH3).  
13C NMR (125 MHz, CDCl3) δ 139.9 (CHolef), 125.3 (q, J = 3.7 Hz, CHar), 117.8 (CH2, olef), 
77.3 (CH), 46.5 (CH), 16.5 (CH3). 
19F NMR (282 MHz, CDCl3) δ −62.59 (s, CF3). 
The NMR spectroscopic data for the syn-configured diastereomer are in accordance with the 
literature.165 
syn-2-Methyl-1-(3-nitrophenyl)but-3-en-1-ol (233e)  
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −40 °C, 71 mg 3-nitrobenzaldehyde and 
91 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq each) 
were added. The reaction mixture was stirred for 7 h at − °C and overnight at ambient 
temperature. After general workup and purification by FC (n-pentane/Et2O 10:1 → 8:1) 2-
methyl-1-(3-nitrophenyl)but-3-en-1-ol (233e) was obtained as syn/anti mixture (98:2) in 61% 
yield (62 mg, 0.304 mmol) as colorless oil.  
1H NMR (500 MHz, CDCl3) δ 8.19 (d, 1H, CHar), 8.13 – 8.11 (m, 1H, CHar), 7.65 (dd, J = 7.7, 
0.5 Hz, 1H, CHar), 7.50 (t, J = 7.9 Hz, 1H, CHar), 5.82 – 5.75 (m, 1H, CHolef), 5.14 – 5.07 (m, 
2H, CH2, olef), 4.77 (d, J = 5.0 Hz, 1H, CH), 2.65 – 2.58 (m, 1H, CH), 2.10 (s, 1H, OH), 0.99 (d, 
J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 144.9 (Cq, ar), 139.5 (CHolef), 132.7 (CHar), 129.1 (CHar), 122.5 
(CHar), 121.6 (CHar), 116.8 (CH2, olef), 76.2 (CH), 44.8 (CH), 13.6 (CH3). 
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IR (neat) 3430, 3081, 2971, 2876, 1524, 1347, 1200, 1095, 1029, 999, 917, 807, 739, 690. 
HRMS (EI) calculated for C11H13NO3: m/z = 207.0895; found m/z = 207.0885. 
Resolved signals of the minor diastereomer anti-2-methyl-1-(3-nitrophenyl)but-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.24 – 5.19 (m, 2H, CH2, olef), 4.50 (d, J = 7.6 Hz, 1H, CH), 
2.51 – 2.46 (m, 1H, CH), 0.94 (d, J = 6.9 Hz, 3H, CH3). 
syn-4-Methyl-1-phenylhexa-1,5-dien-3-ol (233f) 
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −40 °C, 66 mg cinnamaldehyde and 91 mg 
2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq each) were 
added. The reaction mixture was stirred for 6 h at − °C. After general workup and purification 
by FC (n-pentane/Et2O 10:1) 4-methyl-1-phenylhexa-1,5-dien-3-ol (233f) was obtained as 
syn/anti mixture (92:8) in 96% yield (90 mg, 0.478 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.22 (m, 5H, CHar), 6.60 (d, J = 16.0 Hz, 1H, CHolef), 
6.24 (dd, J = 15.6 Hz, 6.3 Hz, 1H, CHolef), 5.91 – 5.79 (m, 1H, CHolef), 5.18 – 5.12 (m, 2H, CH2, 
olef), 4.22 (dd, J = 10.3 Hz, 5.0 Hz, 1H, CH), 2.54 – 2.43 (m, 1H, CH), 1.70 (d, J = 4.9 Hz, 1H, 
OH), 1.09 (d, J = 7.0 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 140.1 (CHolef), 137.0 (Cq, ar), 131.4 (CHolef), 130.2 (CHolef), 128.7 
(CHar), 127.8 (CHar), 126.6 (CHar), 116.2 (CH2, olef), 75.9 (CH), 44.1 (CH), 15.0 (CH3). 
Resolved signals of the minor diastereomer anti-4-methyl-1-phenylhexa-1,5-dien-3-ol: 
1H NMR (300 MHz, CDCl3) δ 4.06 (m, 1H, CH), 2.41 – 2.34 (m, 1H, CH), 1.83 (d, J = 3.4 Hz, 
1H, OH), 1.02 (d, J = 6.8 Hz, 3H, CH3). 
The NMR spectroscopic data for the anti-configured diastereomer are in accordance with the 
literature.164,166 
 
 
 
5. Experimental Section 
177 
 
syn-2-Methyl-1-(thiophen-2-yl)but-3-en-1-ol (233g)  
The title compound was prepared according to GP 7 utilizing 28 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc iodide 
(100 mmol, 20 mol% each). These materials were suspended in 0.3 mL 
dichloromethane and stirred for 10 min. Then, 0.2 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 25 mmol, 5.0 mol%) were added. After cooling to −50 °C, 56 mg thiophene-
2-carbaldehyde and 91 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(0.50 mmol, 1.0 eq each) were added. The reaction mixture was stirred for 2 h at − °C and 
overnight at ambient temperature. After general workup and purification by FC (n-
pentane/Et2O 10:1) 2-methyl-1-(thiophen-2-yl)but-3-en-1-ol (233g) was obtained as syn/anti 
mixture (86:14) in 56% yield (47 mg, 0.279 mmol) as pale-yellow oil. 
1H NMR (300 MHz, CDCl3) δ 7.24 (dd, J = 4.8, 1.4 Hz, 1H, CHar), 6.98 – 6.94 (m, 2H, CHar), 
5.89 – 5.74 (m, 1H, CHolef), 5.14 – 5.10 (m, 1H, CHolef), 5.07 (d, J = 1.1 Hz, 1H, CHolef), 4.85 
(d, J = 5.8 Hz, 1H, CH), 2.70 – 2.58 (m, 1H, CH), 2.07 (s, 1H, OH), 1.09 (d, J = 6.8 Hz, 3H, 
CH3). 
13C NMR (75 MHz, CDCl3) δ 146.7 (CHar), 139.8 (CHolef), 126.6 (CHar), 124.6 (CHar), 124.4 
(CHar), 116.2 (CH2, olef), 74.0 (CH), 45.2 (CH), 14.9 (CH3). 
IR (neat) 3409, 3076, 2969, 2930, 2872, 1659, 1439, 1417, 1261, 1005, 914, 854, 829, 695. 
HRMS (EI) calculated for C9H12OS: m/z = 168.0609; found m/z = 168.0605. 
Resolved signals of the minor diastereomer anti-2-methyl-1-(thiophen-2-yl)but-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.27 – 5.18 (m, 2H, CH2, olef), 4.66 (d, J = 7.7 Hz, 1H, CH), 2.58 
– 2.51 (m, 1H, CH), 2.26 (s, 1H, OH), 0.96 (d, J = 6.8 Hz, 3H, CH3). 
syn-3-Methylundec-1-en-4-ol (233h)  
The title compound was prepared according to GP 7 utilizing 
27 mg Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder 
and 32 mg zinc iodide (100 mmol, 20 mol% each). These 
materials were suspended in 0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution 
(0.125 M in dichloromethane, 25 mmol, 5.0 mol%) were added. After cooling to −45 °C, 65 mg 
octanal and 91 mg 2-(but-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.50 mmol, 
1.0 eq each) were added. The reaction mixture was stirred for 5 h at − °C and overnight at 
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ambient temperature. After general workup and purification by FC (n-pentane/Et2O 20:1) 3-
methylundec-1-en-4-ol (233h) was obtained as syn/anti mixture (93:7) in 78% yield (72 mg, 
0.391 mmol) as colorless liquid.  
1H NMR (300 MHz, CDCl3) δ 5.86 – 5.74 (m, 1H, CHolef), 5.13 – 5.05 (m, 2H, CH2, olef), 3.49 
(m, 1H, CH), 2.33 – 2.19 (m, 1H, CH), 1.48 (br s, 1H, OH), 1.28 (br s, 12H, CH2), 1.03 (d, J = 
6.9 Hz, 3H, CH3), 0.88 (t, J = 7.0 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 141.2 (CHolef), 115.1 (CH2, olef), 74.8 (CH), 43.4 (CH), 34.1 
(CH2), 31.8 (CH2), 29.6 (CH2), 29.3 (CH2), 26.1 (CH2), 22.6 (CH2), 14.02 (CH3), 13.99 (CH3). 
Resolved signals of the minor diastereomer anti-3-methylundec-1-en-4-ol: 
1H NMR (300 MHz, CDCl3) δ 3.38 (m, 1H, CH), 1.04 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 140.4 (CHolef), 116.1 (CH2, olef), 34.3 (CH2), 29.7 (CH2), 25.7 
(CH2), 15.2 (CH3). 
The NMR spectroscopic data for the syn-configured diastereomer are in accordance with the 
literature.167 
anti-2-Hydroxy-3-methyl-2-phenylpent-4-enenitrile (234)  
 The title compound was prepared according to a modified GP 7 utilizing 
26 mg Ni(dppe)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −50 °C, 91.0 mg 2-(but-3-en-1-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq) were added. The reaction mixture was 
stirred for 5 h. Then, 66.0 mg benzoyl cyanide (0.5 mmol, 1.0 eq) were added. The reaction 
was warmed up to ambient temperature overnight. After general workup and purification by 
FC (n-pentane/Et2O 3:1) 2-methyl-1,3-diphenylbut-3-en-1-ol (234) was obtained as syn/anti 
mixture (14:86) in 70% yield (65.0 mg, 0.347 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 7.57 – 7.52 (m, 2H, CHar), 7.45 – 7.38 (m, 3H, CHar), 5.78 (ddd, 
J = 17.4, 10.7, 7.2 Hz, 1H, CHolef), 5.19 (d, J = 10.4 Hz, 1H, CH2, olef), 5.10 (d, J = 17.2 Hz, 1H, 
CH2, olef), 4.86 – 4.77 (m, 1H, CH), 1.15 (d, J = 6.9 Hz, 3H, CH3). 
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13C NMR (75 MHz, CDCl3) δ 150.6 (CH, olef), 141.9 (Cq, ar), 128.3 (CHar), 128.1 (CHar), 127.3 
(CHar), 127.2 (CHar), 126.4 (CHar), 126.2 (CN), 111.2 (CH2, olef), 83.2 (CH), 29.6 (CH), 25.0 
(CH3). 
Resolved signals of the minor diastereomer syn-2-hydroxy-3-methyl-2-phenylpent-4-
enenitrile: 
1H NMR (300 MHz, CDCl3) δ 6.00 – 5.89 (m, 1H, CHolef), 5.41 – 5.34 (m, 2H, CH2, olef), 1.00 
(d, J = 6.9 Hz, 3H, CH3). 
The NMR spectroscopic data for both diastereomers are in accordance with the literature.127 
syn-2-Ethyl-1-phenylbut-3-en-1-ol (237)  
The title compound was prepared according to a modified GP 7 utilizing 
27 mg Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg 
zinc iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. After cooling to −20 °C, 53 mg benzaldehyde and 98 mg 
4,4,5,5-tetramethyl-2-(pent-4-en-1-yl)-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq each) were 
added. The reaction mixture was stirred for 4 h at − °C and overnight at ambient temperature. 
After general workup and purification by FC (n-pentane/Et2O 10:1) 2-ethyl-1-phenylbut-3-en-
1-ol (237) was obtained as syn/anti mixture (91:9) in 72% yield (64 mg, 0.363 mmol) as 
colorless oil.  
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.19 (m, 5H, CHar), 5.52 – 5.40 (m, 1H, CHolef), 5.06 – 
4.94 (m, 2H, CH2, olef), 4.59 (d, J = 5.9 Hz, 1H, CH), 2.33 – 2.23 (m, 1H, CH), 2.04 – 1.85 (br 
s, 1H, OH), 1.66 – 1.53 (m, 1H, CH2CH3), 1.26 – 1.11 (m, 1H, CH2CH3), 0.82 (t, J = 7.4 Hz, 
CH3). 
13C NMR (125 MHz, CDCl3) δ 142.8 (Cq, ar), 138.4 (CHolef), 128.2 (CHar), 127.5 (CHar), 126.9 
(CHar), 117.6 (CH2, olef), 76.9 (Cq), 53.4 (CH), 22.7 (CH2), 11.9 (CH3). 
Resolved signals of the minor diastereomer anti-2-ethyl-1-phenylbut-3-en-1-ol: 
1H NMR (500 MHz, CDCl3) δ 5.68 – 5.56 (m, 1H, CHolef), 5.25 – 5.13 (m, 2H, CH2, olef), 4.36 
(d, J = 8.0 Hz, 1H, CH), 2.21 – 2.11 (m, 1H, CH), 0.75 (t, J = 7.4 Hz, 3H, OH). 
13C NMR (125 MHz, CDCl3) δ 128.4 (CHar), 127.1 (CHar), 119.2 (CH2, olef), 54.8 (CH), 23.6 
(CH2), 13.8 (CH3). 
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The NMR spectroscopic data for both diastereomers are in accordance with the literature.168 
syn-(E)-2-Methyl-1,4-diphenylbut-3-en-1-ol (240a)  
The title compound was prepared according to GP 7 utilizing 14 mg 
Ni(dppp)Cl2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg 
zinc iodide (50 mmol, 20 mol% each). These materials were 
suspended in 0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 12.5 mmol, 5.0 mol%) were added. After cooling to −20 °C, 27 mg 
benzaldehyde and 68 mg 4,4,5,5-tetramethyl-2-(1-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane 
(0.25 mmol, 1.0 eq each) were added. The reaction mixture was stirred for 2 h at − °C and 
overnight at ambient temperature. After general workup and purification by FC 
(n-pentane/Et2O 8:1) (E)-2-methyl-1,4-diphenylbut-3-en-1-ol (240a) was obtained as syn/anti 
mixture (95:5) in 97% yield (58 mg, 0.243 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.38 – 7.20 (m, 10 H, CHar), 6.40 (d, J = 16.0 Hz, 1H, CHolef), 
6.13 (dd, J = 16.0 Hz, 8.3 Hz, 1H, CHolef), 4.71 (d, J = 5.7 Hz, 1H, CH), 2.79 – 2.72 (m, 1H, 
CH), 1.93 (s, 1 H, OH), 1.11 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 142.7 (Cq, ar), 132.2 (CHolef), 130.9 (CHolef), 128.7 (CHar), 128.3 
(CHar), 127.6 (CHar), 127.3 (CHar), 126.7 (CHar), 126.3 (CHar), 77.9 (CH), 44.3 (CH), 15.0 
(CH3). 
Resolved signals of the minor diastereomer anti-(E)-2-methyl-1,4-diphenylbut-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 6.55 (d, J = 15.9 Hz, 1H, CHolef), 6.19 (dd, J = 16.0 Hz, 8.3 Hz, 
1H, CHolef), 4.47 (d, J = 7.9 Hz, 1H, CH), 0.98 (d, J = 6.9 Hz, 3H, CH3). 
The NMR spectroscopic data for both diastereomers are in accordance with the literature.169 
syn-2-Methyl-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-ol 
(240b)  
The title compound was prepared according to GP 7 utilizing 27 mg 
Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc 
iodide (100 mmol, 20 mol% each). These materials were suspended in 
0.3 mL dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 
25 mmol, 5.0 mol%) were added. 53 mg benzaldehyde and 154 mg 2,2'-(but-3-en-1,1-diyl)-
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (0.50 mmol, 1.0 eq each) were added. The 
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reaction mixture was stirred overnight at ambient temperature. After general workup and 
purification by FC (n-pentane/Et2O 20:1) 2-methyl-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)but-3-en-1-ol (240b) was obtained as syn/anti mixture (76:24) in 71% yield 
(102 mg, 0.354 mmol) as colorless liquid. 
1H NMR (300 MHz, CDCl3) δ 7.37 – 7.29 (m, 5H, CHar), 6.66 (dd, J = 18.0, 6.6 Hz, 1H, 
CHolef), 5.50 (dd, J = 18.0, 1.4 Hz, 1H, CHolef), 4.76 (t, J = 4.0 Hz, 1H, CH), 2.64 (tq, J = 6.6, 
1.9 Hz, 1H, CH), 1.82 (d, J = 3.4 Hz, 1H, OH), 1.26 (s, 12H, CH3, pin), 0.96 (d, J = 6.8 Hz, 3H, 
CH3).  
13C NMR (75 MHz, CDCl3) δ 155.7 (CHolef), 142.8 (Cq, ar), 128.2 (CHar), 127.4 (CHar), 126.4 
(CHar), 83.3 (Cq, pin), 76.7 (CH), 46.5 (CH), 24.9 (CH3, pin), 12.9 (CH3). BCH not detectable.  
11B NMR (96 MHz, CDCl3) δ 30.01 (Bpin). 
IR (neat) 3477, 3028, 2976, 2930, 2874, 1726, 1635, 1493, 1452, 1390, 1356, 1318, 1271, 
1212, 1165, 1142, 1108, 1073, 1042, 1001, 968, 933, 913, 898, 849, 751, 700, 673, 578, 531. 
HRMS (EI) calculated for C16H22BO3 (M
+ − CH3): m/z = 273.1665; found m/z = 273.1644.  
Resolved signals of the minor diastereomer anti-2-methyl-1-phenyl-4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)but-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.62 (dd, 1 H, J = 18.1, 0.8 Hz, CHolef).  
13C NMR (75 MHz, CDCl3) δ 131.0 (CHolef), 48.2 (CH), 15.4 (CH3).  
anti-2-Methyl-1,3-diphenylbut-3-en-1-ol (240c)  
 The title compound was prepared according to GP 7 utilizing 26 mg 
Ni(dppe)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder and 32 mg zinc iodide 
(100 mmol, 20 mol% each). These materials were suspended in 0.3 mL 
dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in 
dichloromethane, 25 mmol, 5.0 mol%) were added. 53 mg benzaldehyde and 129 mg 4,4,5,5-
tetramethyl-2-(2-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane (0.50 mmol, 1.0 eq each) were 
added. The reaction mixture was stirred overnight at ambient temperature. After general workup 
and purification by FC (n-pentane/Et2O 3:1) anti-2-methyl-1,3-diphenylbut-3-en-1-ol (240c) 
was obtained in 71% yield (84 mg, 0.352 mmol) as colorless oil.  
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1H NMR (300 MHz, CDCl3) δ 7.35 – 7.16 (m, 10H, CHar), 5.37 (s, 1H, CHolef), 5.18 (s, 1H, 
CHolef), 4.67 – 4.66 (m, 1H, CH), 3.15 – 3.07 (m, 1H, CH), 1.76 (d, 1H, OH), 1.05 (d, J = 6.9 
Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 152.0 (Cq, olef), 143.1 (Cq, ar), 142.5 (Cq, ar), 128.6 (CHar), 128.2 
(CHar), 127.8 (CHar), 127.2 (CHar), 126.9 (CHar), 126.1 (CHar), 114.3 (CH2, olef), 74.2 (CH), 45.6 
(CH), 12.4 (CH3). 
The NMR spectroscopic data are in accordance with the literature.170 
anti-3-Methyl-2-phenylundec-1-en-4-ol (240d)  
 The title compound was prepared according to GP 7 utilizing 
26 mg Ni(dppe)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder 
and 32 mg zinc iodide (100 mmol, 20 mol% each). These 
materials were suspended in 0.3 mL dichloromethane and 
0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 25 mmol, 5.0 mol%) were added. 
52 mg octanal and 129 mg 4,4,5,5-tetramethyl-2-(2-phenylbut-3-en-1-yl)-1,3,2-dioxaborolane 
(0.50 mmol, 1.0 eq each) were added. The reaction mixture was stirred overnight at ambient 
temperature. After general workup and purification by FC (n-pentane/Et2O 10:1) anti-3-methyl-
2-phenylundec-1-en-4-ol (240d) was obtained in 41% yield (53 mg, 0.210 mmol) as colorless 
oil.  
1H NMR (300 MHz, CDCl3) δ 7.27 – 7.17 (m, 5H, CHar), 5.29 – 5.28 (m, 1H, CHolef), 5.05 – 
5.04 (s, 1H, CHolef), 3.45 – 3.39 (m, 1H, CH), 2.81 – 2.74 (m, 1H, CH), 1.39 – 1.09 (m, 15H, 
OH), 0.78 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 152.7 (Cq, olef), 142.6 (Cq, ar), 142.5 (Cq, ar), 128.7 (CHar), 128.6 
(CHar), 127.7 (CHar), 126.9 (CHar), 126.8 (CHar), 126.1 (CHar), 113.6 (CH2, olef), 74.2 (CH), 43.1 
(CH), 34.8 (CH2), 32.0 (CH2), 29.8 (CH2), 29.4 (CH2), 26.5 (CH2), 22.8 (CH2), 14.2 (CH3), 
12.4 (CH3). 
The NMR spectroscopic data are in accordance with the literature.170 
2,2-Dimethyl-1-phenylbut-3-en-1-ol (247a)  
The title compound was prepared according to GP 8 utilizing 16 mg 
Ni(dppp)Br2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc iodide 
(50 mmol, 20 mol% each). These materials were suspended in 0.15 mL 
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dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in dichloromethane, 12.5 mmol, 
5.0 mol%) were added. After stirring for additional 10 min at ambient temperature, 49 mg 
4,4,5,5-tetramethyl-2-(3-methylbut-3-en-1-yl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq) were 
added. The reaction mixture was stirred overnight at ambient temperature. Then, 27 mg 
benzaldehyde (0.25 mmol, 1.0 eq) were added. After further stirring overnight, general workup 
and purification by FC (n-pentane/Et2O 10:1) 2,2-dimethyl-1-phenylbut-3-en-1-ol (247a) was 
obtained in 75% yield (33 mg, 0.187 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 7.31 – 7.27 (m, 5H, CHar), 5.92 (dd, J = 17.5, 10.8 Hz, 1H, 
CHolef), 5.15 (dd, J = 10.7, 1.2 Hz, 1H, CHolef), 5.09 (dd, J = 17.5, 1.4 Hz, 1H, CHolef), 4.44 (s, 
1H, CH), 2.00 (s, 1 H, OH), 1.02 (s, 3H, CH3), 0.97 (s, 3 H, CH3). 
13C NMR (75 MHz, CDCl3) δ 145.3 (CHolef), 141.0 (Cq, ar), 128.0 (CHar), 127.7 (CHar), 127.6 
(CHar), 114.0 (CH2, olef), 80.9 (CH), 42.5 (C(CH3)2), 24.7 (CH3), 21.3 (CH3). 
The NMR spectroscopic data are in accordance with the literature.171 
4,4-Dimethyl-1-phenylhexa-1,5-dien-3-ol (247b) 
The title compound was prepared according to GP 8 utilizing 14 mg 
Ni(dppp)Cl2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in dichloromethane, 
12.5 mmol, 5.0 mol%) were added. After stirring for additional 10 min at ambient temperature, 
49 mg 4,4,5,5-tetramethyl-2-(3-methylbut-3-en-1-yl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq) 
were added. The reaction mixture was stirred overnight at ambient temperature. Then, 33 mg 
cinnamaldehyde (0.25 mmol, 1.0 eq) were added. After further stirring overnight, general 
workup and purification by FC (n-pentane/Et2O 8:1) 4,4-dimethyl-1-phenylhexa-1,5-dien-3-ol 
(247b) was obtained in 81% yield (41 mg, 0.203 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.46 – 7.29 (m, 5 H, CHar), 6.60 (d, J = 15.9 Hz, 1H, CHolef), 
6.25 (dd, J = 15.9 Hz, 7.0 Hz, 1H, CHolef), 5.93 (dd, J = 17.4 Hz, 10.8 Hz, 1H, CHolef), 5.15 (dd, 
J = 8.4, 1.3 Hz, 1H, CHolef), 5.11 (dd, J = 15.1, 1.3 Hz, 1H, CHolef), 3.99 (d, J = 6.6 Hz, 1H, 
CH), 1.69 (s, 1H, OH), 1.09 (s, 3 H, CH3), 1.07 (s, 3 H, CH3). 
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13C NMR (75 MHz, CDCl3) δ 145.1 (CHolef), 137.0 (Cq, ar), 132.3 (CHolef), 128.9 (CHar), 128.6 
(CHar), 127.8 (CHar), 126.7 (CHolef), 114.0 (CH2, olef), 79.5 (Cq), 42.1 (CH), 24.0 (CH3), 22.0 
(CH3). 
The NMR spectroscopic data are in accordance with the literature.165,172 
Artemisia Alcohol (247c) 
The title compound was prepared according to GP 8 utilizing 16 mg 
Ni(dppp)Br2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in dichloromethane, 
12.5 mmol, 5.0 mol%) were added. After stirring for additional 10 min at ambient temperature, 
49 mg 4,4,5,5-tetramethyl-2-(3-methylbut-3-en-1-yl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq) 
were added. The reaction mixture was stirred overnight at ambient temperature. Then, 21 mg 
3-methylcrotonaldehyde (0.25 mmol, 1.0 eq) were added. After further stirring overnight, 
general workup and purification by FC (n-pentane/Et2O 20:1) artemisia alcohol (247c) was 
obtained in 80% yield (31 mg, 0.200 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.89 (dd, J = 17.5 Hz, 10.9 Hz, 1H, CHolef), 5.21 – 5.16 (m, 1H, 
CHolef), 5.10 (dd, J = 7.4, 1.5 Hz, 1H, CHolef), 5.06 (dd, J = 14.1, 1.5 Hz, 1H, CHolef), 4.05 (d, J 
= 9.3 Hz, 1H, CH), 1.75 (s, 3H, CH3), 1.70 (s, 3H, CH3), 1.01 (s, 3H, CH3), 0.99 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 145.4 (CHolef), 136.7 (Cq, olef), 124.3 (CHolef), 113.5 (CH2, olef), 
74.8 (CH), 42.1 (C(CH3)2), 26.2 (CH3), 24.1 (CH3), 21.4 (CH3), 18.6 (CH3). 
The NMR spectroscopic data are in accordance with the literature.173 
anti-2-Ethyl-2-methyl-1-phenylbut-3-en-1-ol (130)  
The title compound was prepared according to GP 8 utilizing 15 mg 
Ni(dppm)Br2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in dichloromethane, 
12.5 mmol, 5.0 mol%) were added. After stirring for additional 10 min at ambient temperature, 
53 mg 4,4,5,5-tetramethyl-2-(3-methylenepentyl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq) 
were added. The reaction mixture was stirred 2 d at ambient temperature. Then, 27 mg 
benzaldehyde (0.25 mmol, 1.0 eq) were added. After further stirring overnight, general workup 
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and purification by FC (n-pentane/Et2O 10:1) 2-ethyl-2-methyl-1-phenylbut-3-en-1-ol (130) 
was obtained as syn/anti mixture (19:81) in 43% yield (21 mg, 0.108 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 7.32 – 7.26 (m, 5H, CHar), 5.83 (dd, J = 17.7 Hz, 10.8 Hz, 1H, 
CHolef), 5.29 (dd, J = 10.9, 1.4 Hz, 1H, CHolef), 5.08 (dd, J = 16.3, 1.4 Hz, 1H, CHolef), 4.44 (s, 
1H, CH), 2.02 (d, J = 2.0 Hz, 1H, OH), 1.54 – 1.22 (m, 2H, CH2), 0.88 (s, 3H, CH3), 0.78 (t, 
J = 7.5 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 144.0 (CHolef), 128.2 (CHar), 127.6 (CHar), 116.1 (CH2, olef), 
80.2 (CH), 46.3 (Cq), 30.1 (CH2), 15.9 (CH3), 8.5 (CH3). 
Resolved signals of the minor diastereomer syn-2-ethyl-2-methyl-1-phenylbut-3-en-1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.75 (dd, J = 17.5, 10.2 Hz, 1H, CHolef), 5.20 (dd, J = 10.8, 1.5 
Hz, 1H, CHolef), 5.01 (dd, J = 17.7, 1.5 Hz, 1H, CHolef), 4.46 (s, 1H, CH), 1.05 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 142.6 (CHolef), 128.0 (CHar), 127.6 (CHar), 115.5 (CH2, olef), 
80.9 (CH), 29.0 (CH2), 18.7 (CH3). 
The NMR spectroscopic data for the syn-configured diastereomer are in accordance with the 
literature.78 
anti-1-(4-Chlorophenyl)-2-ethyl-2-methylbut-3-en-1-ol (247d)  
The title compound was prepared according to GP 8 utilizing 15 mg 
Ni(dppm)Br2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in dichloromethane, 
12.5 mmol, 5.0 mol%) were added. After stirring for additional 10 min at ambient temperature, 
53 mg 4,4,5,5-tetramethyl-2-(3-methylenepentyl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq) 
were added. The reaction mixture was stirred 2 d at ambient temperature. Then, 35 mg 4-
chlorobenzaldehyde (0.25 mmol, 1.0 eq) were added. After further stirring overnight, general 
workup and purification by FC (n-pentane/Et2O 10:1) 1-(4-chlorophenyl)-2-ethyl-2-methylbut-
3-en-1-ol (247d) was obtained as syn/anti mixture (33:67) in 73% yield (41 mg, 0.182 mmol) 
as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.34 – 7.23 (m, 4H, CHar), 5.83 (dd, J = 17.6 Hz, 11.0 Hz, 1H, 
CHolef), 5.34 (d, J = 10.8 Hz, 1H, CHolef), 5.14 (d, J = 17.6 Hz, 1H, CHolef), 4.46 (s, 1H, CH), 
2.05 (s, 1H, OH), 1.56 – 1.24 (m, 2H, CH2), 0.90 (s, 3H, CH3), 0.83 (t, 3H, J = 7.4 Hz, CH3). 
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13C NMR (75 MHz, CDCl3) δ 143.6 (CHolef), 139.2 (Cq, ar), 133.3 (Cq, ar), 129.5 (CHar), 127.8 
(CHar), 116.5 (CH2, olef), 79.5 (CH), 46.3 (Cq), 30.1 (CH2), 15.8 (CH3), 8.4 (CH3). 
IR (neat) 3453, 2969, 2937, 2878, 1637, 1489, 1459, 1412, 1379, 1185, 1090, 1068, 1031, 910, 
831, 788, 751, 733, 677, 544, 467. 
HRMS (EI)  calculated for C7H6ClO (fragment): m/z = 141.0095; found m/z = 141.0107. 
Resolved signals of the minor diastereomer syn-1-(4-chlorophenyl)-2-ethyl-2-methylbut-3-en-
1-ol: 
1H NMR (300 MHz, CDCl3) δ 5.75 (dd, J = 17.5, 10.9 Hz, 1H, CHolef), 5.25 (d, J = 11.0 Hz, 
1H, CHolef), 5.04 (d, J = 17.6 Hz, 1H, CHolef), 4.48 (s, 1H, CH), 1.06 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 142.3 (CHolef), 140.0 (Cq, ar), 133.2 (Cq, ar), 129.3 (CHar), 127.7 
(CHar), 115.8 (CH2, olef), 80.2 (CH), 45.7 (Cq), 28.9 (CH2), 18.5 (CH3). 
anti-4-Ethyl-4-methyl-1-phenylhexa-1,5-dien-3-ol (247e)  
The title compound was prepared according to GP 8 utilizing 15 mg 
Ni(dppm)Br2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc 
iodide (50 mmol, 20 mol% each). These materials were suspended in 
0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 M in dichloromethane, 
12.5 mmol, 5.0 mol%) were added. After stirring for additional 10 min at ambient temperature, 
52 mg 4,4,5,5-tetramethyl-2-(3-methylenepentyl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq 
each) were added. The reaction mixture was stirred 2 d at ambient temperature. Then, 33 mg 
cinnamaldehyde were added and stirring was continued for another day. After general workup 
and purification by FC (n-pentane/Et2O 12:1) 4-ethyl-4-methyl-1-phenylhexa-1,5-dien-3-ol 
(247e) was obtained as syn/anti mixture (23:77) in 67% yield (36 mg, 0.167 mmol) as colorless 
oil. The product mixture contained 11 mg (20%) of unreacted cinnamaldehyde which could not 
be removed by multiple column chromatography. 
1H NMR (300 MHz, CDCl3) δ 7.59 – 7.21 (m, 5H, CHar), 6.60 (d, J = 15.8 Hz, 1H, CHolef), 
6.21 (dd, J = 15.9, 7.4 Hz, 1H, CHolef), 5.82 (dd, J = 17.6, 10.9 Hz, 1H, CHolef), 5.27 (dd, J = 
10.8, 1.4 Hz, 1H, CHolef), 5.11 (dd, J = 17.6, 1.5 Hz, 1H, CHolef), 4.00 (d, J = 7.3 Hz, 1H, CH), 
1.71 (s, 1H, OH), 1.47 (q, J = 7.4 Hz, 2H, CH2), 0.99 (s, 3H, CH3), 0.83 (t, J = 7.5 Hz, 3H, 
CH3). 
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13C NMR (75 MHz, CDCl3) δ 152.8 (CHolef), 143.8 (Cq, ar), 131.4 (CHolef), 128.9 (CHar), 128.7 
(CHar), 127.8 (CHar), 126.7 (CHolef), 115.8 (CH2, olef), 78.6 (CH), 45.7 (Cq), 30.1 (CH2), 16.8 
(CH3), 8.4 (CH3). 
Resolved signals of the minor diastereomer syn-4-ethyl-4-methyl-1-phenylhexa-1,5-dien-3-ol: 
1H NMR (300 MHz, CDCl3) δ 6.59 (d, J = 15.8 Hz, 1H, CHolef), 5.22 (dd, J = 10.9, 1.5 Hz, 1H, 
CHolef), 5.08 (dd, J = 17.5, 1.5 Hz, 1H, CHolef), 1.06 (s, 3H, CH3), 0.84 (t, J = 7.5 Hz, 3H, CH3).  
The NMR spectroscopic data are in accordance with the literature.174 
anti-3-Ethyl-3-methylundec-1-en-4-ol (247f) 
The title compound was prepared according to GP 8 utilizing 
15 mg Ni(dppm)Br2 (25 mmol, 10 mol%), 3.3 mg zinc powder 
and 16 mg zinc iodide (50 mmol, 20 mol% each). These 
materials were suspended in 0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution 
(0.125 M in dichloromethane, 12.5 mmol, 5.0 mol%) were added. After stirring for additional 
10 min at ambient temperature, 53 mg 4,4,5,5-tetramethyl-2-(3-methylenepentyl)-1,3,2-
dioxaborolane (0.25 mmol, 1.0 eq each) were added. The reaction mixture was stirred overnight 
at ambient temperature. Then, 32 mg octanal were added and stirring was continued for another 
day. After general workup and purification by FC (n-pentane/Et2O 30:1) 3-ethyl-3-
methylundec-1-en-4-ol (247f) was obtained as syn/anti mixture (31:69) in 52% yield (28 mg, 
0.131 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.73 (dd, J = 17.6, 10.9 Hz, 1H, CHolef), 5.20 (dd, J = 10.9, 1.6 
Hz, 1H, CHolef), 5.04 (dd, J = 17.6, 1.6 Hz, 1H, CHolef), 3.27 (d, J = 10.0 Hz, 1H, CH), 1.59 – 
1.37 (m, 2H, CH2), 1.28 (s, 12H, CH2), 0.92 (s, 3H, CH3), 0.88 (t, J = 7.0 Hz, 3H, CH3), 0.79 
(t, J = 7.5 Hz, 3H, CH3).  
13C NMR (75 MHz, CDCl3) δ 144.4 (CHolef), 115.3 (CH2, olef), 78.1 (CH), 45.4 (Cq), 32.03 
(CH2), 31.1 (CH2), 29.9 (CH2), 29.78 (CH2), 29.7 (CH2), 29.5 (CH2), 27.3 (CH2), 16.4 (CH3), 
14.2 (CH3), 8.5 (CH3). 
IR (neat) = 3405, 2959, 2922, 2873, 2855, 1461, 1413, 1378, 1308, 1119, 1038, 911, 683, 442. 
HRMS (EI) calculated for C14H28O: m/z = 212.2140; found m/z = 212.2151. 
 
5. Experimental Section 
188 
 
Resolved signals of the minor diastereomer syn-3-ethyl-3-methylundec-1-en-4-ol: 
1H NMR (300 MHz, CDCl3) δ 5.68 (dd, J = 17.6, 10.9 Hz, 1H), 5.14 (dd, J = 11.0, 1.5 Hz, 1H), 
4.99 (dd, J = 17.6, 1.6 Hz, 1H), 3.29 (d, J = 10.2 Hz, 1H), 0.96 (s, 3H), 0.81 (t, J = 7.5 Hz, 3H). 
13C NMR (75 MHz, CDCl3) δ 143.7 (CHolef), 114.6 (CH2, olef), 45.1 (Cq), 32.00 (CH2), 29.80 
(CH2), 27.2 (CH2), 17.4 (CH3), 8.4 (CH3). 
anti-2-Methyl-1,2-diphenylbut-3-en-1-ol (247g)  
The title compound was prepared according to GP 8 utilizing 14 mg 
Ni(dppe)Cl2 (25 mmol, 10 mol%), 3.3 mg zinc powder and 16 mg zinc iodide 
(50 mmol, 20 mol% each). These materials were suspended in 0.15 mL 
acetonitrile and 0.1 mL of the HPPh2 solution (0.125 M in acetonitrile, 12.5 mmol, 5.0 mol%) 
were added. At ambient temperature 27 mg benzaldehyde and 65 mg 4,4,5,5-tetramethyl-2-(3-
phenylbut-3-en-1-yl)-1,3,2-dioxaborolane (0.25 mmol, 1.0 eq each) were added. The reaction 
mixture was stirred overnight at 80 °C. After general workup and purification by FC (n-
pentane/Et2O 8:1) 2-methyl-1,2-diphenylbut-3-en-1-ol (247g) was obtained as syn/anti mixture 
(3:97) in 63% yield (38 mg, 0.158 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.10 (m, 10H, CHar), 6.61 – 6.51 (m, 1H, CHolef), 5.34 – 
5.31 (m, 1H, CHolef), 5.14 – 5.07 (m, 2H, CHolef + CH), 2.05 (s, 1H, OH), 1.30 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 148.9 (CHolef), 141.2 (Cq, ar), 140.3 (Cq, ar), 128.5 (CHar), 128.1 
(CHar), 127.6 (CHar), 127.5 (CHar), 127.4 (CHar), 126.7 (CHar), 115.8 (CH2, olef), 80.5 (CH), 50.5 
(Cq), 20.8 (CH3). 
The NMR spectroscopic data are in accordance with the literature.165 
(E/Z)-3-Phenylhept-5-enal (248a)  
The title compound was prepared according to a modified GP 8 
utilizing 27 mg Ni(dppp)Cl2 (50 mmol, 10 mol%), 6.6 mg zinc powder 
and 32 mg zinc iodide (100 mmol, 20 mol% each). These materials were suspended in 0.3 mL 
dichloromethane and 0.2 mL of the HPPh2 solution (0.125 M in dichloromethane, 25 mmol, 
5.0 mol%) were added. After cooling to −40 °C, 66 mg cinnamaldehyde and 91 mg 2-(but-3-
en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.5 mmol, 1.0 eq each) were added. The 
reaction mixture was stirred for 6 h at − °C. Then, 0.5 mL anhydrous THF were added as 
well as 380 mg [18]-crown-6 (1.48 mmol, 3.0 eq) and 39 mg potassium hydride (0.99 mmol, 
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2.0 eq). The reaction mixture was stirred overnight at ambient temperature before being 
quenched with water. The aqueous layer was extracted with Et2O. The organic layer was 
washed with brine, dried over MgSO4, filtered and the solvent was evaporated. After 
purification by FC (n-pentane/Et2O 10:1) 3-phenylhept-5-enal (248a) was obtained as E/Z 
mixture (90:10) in 47% yield (43 mg, 0.230 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 9.66 (t, J = 2.0 Hz, 1H, CHO), 7.32 – 7.16 (m, 5H, CHar), 5.49 
– 5.40 (m, 1H, CHolef), 5.32 – 5.25 (m, 1H, CHolef), 3.27 – 3.21 (m, 1H, CH), 2.74 (dd, J = 6.3, 
2.2 Hz, 1H, CH2), 2.70 (dd, J = 8.3, 2.2 Hz, 1H, CH2), 2.39 – 2.26 (m, 2H, CH2), 1.62 (dd, J = 
6.4, 1.0 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 202.2 (CHO), 143.9 (Cq, ar), 128.7 (CHar), 128.1 (CHolef), 127.6 
(CHolef), 49.4 (CH2), 40.4 (CH), 40.0 (CH2), 18.0 (CH3). 
IR (neat) 3062, 2916, 2722, 1722, 1686, 1494, 1452, 1377, 967, 758, 699, 537. 
HRMS (EI) calculated for C13H16O: m/z = 188.1201; found m/z = 188.1211. 
Resolved signals of the minor isomer (Z)-3-phenylhept-5-enal: 
1H NMR (300 MHz, CDCl3) δ 9.68 (t, J = 2.1 Hz, 1H, CHO), 1.54 (d, J = 6.8 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 202.0 (CHO), 143.8 (Cq, ar), 128.7 (CHar), 128.0 (CHolef), 127.5 
(CHolef), 49.5 (CH2), 18.1 (CH3). 
6-Methyl-3-phenylhept-5-enal (248b)  
The title compound was prepared according to a modified GP 8 
utilizing 14 mg Ni(dppp)Cl2 (25 mmol, 10 mol%), 3.3 mg zinc powder 
and 16 mg zinc iodide (50 mmol, 20 mol% each). These materials were 
suspended in 0.15 mL dichloromethane and 0.1 mL of the HPPh2 solution (0.125 m in 
dichloromethane, 12.5 mmol, 5.0 mol%) were added. After stirring for additional 10 min at 
ambient temperature, 49 mg 4,4,5,5-tetramethyl-2-(3-methylbut-3-en-1-yl)-1,3,2-
dioxaborolane (0.25 mmol, 1.0 eq) were added. The reaction mixture was stirred overnight at 
ambient temperature. Then, 33 mg cinnamaldehyde (0.25 mmol, 1.0 eq), 0.5 mL anhydrous 
THF were added as well as 182 mg [18]-crown-6 (0.69 mmol, 3.0 eq) and 19 mg potassium 
hydride (0.46 mmol, 2.0 eq). The reaction mixture was stirred overnight at ambient temperature 
before being quenched with water. The aqueous layer was extracted with Et2O. The organic 
layer was washed with brine, dried over MgSO4, filtered and the solvent was evaporated. After 
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purification by FC (n-pentane/Et2O 10:1) 6-methyl-3-phenylhept-5-enal (248b) was obtained 
in 23% yield (12 mg, 0.060 mmol) as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 9.66 (t, J = 2.0 Hz, 1H, CHO), 7.33 – 7.18 (m, 5H, CHar), 5.04 
(t, J = 7.0 Hz, 1H, CHolef), 3.27 – 3.18 (m, 1H, CH), 2.74 – 2.70 (m, 2H, CH2), 2.40 – 2.27 (m, 
2H, CH2), 1.66 (s, 3H, CH3), 1.54 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 202.1 (CHO), 134.2 (Cq, ar), 128.7 (CHar), 127.6 (CHar), 126.7 
(CHar), 121.7 (CHar), 49.5 (CH2), 40.7 (CH), 35.5 (CH2), 25.9 (CH3), 18.0 (CH3). 
IR (neat) 2967, 2914, 2782, 2251, 1722, 1495, 1452, 1377, 910, 731, 699, 541. 
HRMS (EI) calculated for C14H18O: m/z = 202.1400; found m/z = 202.1342. 
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5.6 Cobalt-Catalyzed Reductive Cyclization 
(E)-Trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-en-1-yl)silane (268)  
According to a procedure of Stupp,131 15.4 mL s-BuLi (1.3 M in n-hexane, 
20.0 mmol, 1.0 eq) and 3.0 mL TMEDA (20.0 mmol, 1.0 eq) were dissolved in 20 mL 
anhydrous THF. Then, 3.2 mL allyl bromide (20 mmol, 1.0 eq) were added at −78 °C. The 
reaction was stirred at −40 °C for 2 h. A solution of 4.0 mL iPrOBpin (20.0 mmol, 1.0 eq) in 
5.0 mL anhydrous THF was precooled to −78 °C before being added to the reaction mixture. 
The reaction was stirred overnight at ambient temperature and then quenched with aqueous 
NH4Cl solution. The aqueous layer was extracted three times with Et2O, the organic layer was 
dried over MgSO4, filtered and the solvent was evaporated. After purification by FC 
(n-pentane/Et2O 25:1) (E)-trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-
en-1-yl)silane (268) was obtained in 48% yield (2.27 g, 9.50 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 6.07 (dt, J = 18.5, 7.5 Hz, 1H, CHolef), 5.63 (d, J = 18.5 Hz, 1H, 
CHolef), 1.80 (d, J = 7.0 Hz, 2H, CH2), 1.24 (s, 12H, CH3, pin), 0.03 (s, 9H, Si(CH3)3). 
13C NMR (75 MHz, CDCl3) δ 142.0 (CHolef), 130.7 (CHolef), 83.2 (CH2), 24.7 (CH3, pin), –1.1 
(Si(CH3)3).   
The NMR spectroscopic data are in accordance with the literature.131 
(1-Bromoallyl)trimethylsilane (272)  
According to a procedure of Gennari,175 10.4 mL n-BuLi (2.5 M in n-hexane, 
24.0 mmol, 1.2 eq) were added to a solution of diisopropylamine (3.64 mL, 
26 mmol, 1.3 eq) in 6 mL anhydrous THF at –78 °C. After stirring at 0 °C for 30 min, the 
solution was added to a mixture of allyl bromide (2.08 mL, 24 mmol, 1.2 eq) and TMSCl 
(2.52 mL, 20 mmol, 1.0 eq) in 5 mL anhydrous THF at –78 °C. After stirring for 1 h, the 
reaction was quenched with aqueous NH4Cl solution. The aqueous phase was extracted three 
times with n-pentane. The combined organic layers were dried over MgSO4, filtered and the 
solvent was evaporated. The crude product was purified by FC (n-pentane) to give 
(1-bromoallyl)trimethylsilane (272) in 78% yield (30.03 g, 15.69 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.91 (dt, J = 16.5, 9.8 Hz, 1H, CHolef), 5.16 (dd, J = 16.5, 1.2 Hz, 
1H, CHolef), 5.03 (d, J = 10.0 Hz, 1H, CHolef), 3.80 (d, J = 9.6 Hz, 1H, BrCH), 0.14 (s, 9H, 
Si(CH3)3). 
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13C NMR (75 MHz, CDCl3) δ 138.9 (CHolef), 114.7 (CHolef), 43.5 (BrCH), –1.1 (Si(CH3)3).   
The NMR spectroscopic data are in accordance with the literature.175 
(Z)-1-Bromo-2-(buta-1,3-dien-1-yl)benzene (273)  
According to a procedure of Jiang,130 740 mg CrCl2 were suspended in 10 mL 
anhydrous THF by sonication for 10 min. The slurry was cooled to 0°C before 
a solution of 0.7 mL 2-bromobenzaldehyde (6.0 mmol, 1.2 eq) and 966 mg (1-
bromoallyl)trimethylsilane (6.0 mmol, 1.0 eq) in 10 mL anhydrous THF were added. The 
reaction mixture was stirred for 3 h at ambient temperature. A color change from grayish green 
to dark red-brown was observed. 26 mL MeOH were used to quench the reaction followed by 
addition of 50 mL 6 M aqueous KOH solution. The reaction was stirred overnight at ambient 
temperature. n-Pentane was then added, and the layers were separated. The slimy aqueous layer 
was extracted three times with n-pentane. The combined organic layers were dried over MgSO4, 
filtered and the solvent was evaporated. The crude product was purified by FC (n-pentane) to 
give (Z)-1-bromo-2-(buta-1,3-dien-1-yl)benzene (273) in 54% yield (568 mg, 2.72 mmol) as 
colorless liquid.  
1H NMR (300 MHz, CDCl3) δ 7.59 (dd, J = 8.0, 0.8 Hz, 1H, CHar), 7.36 (dd, J = 9.3, 1.6 Hz, 
1H, CHar), 7.29 (dt, J = 8.1, 0.9 Hz, 1H, CHar), 7.13 (dt, J = 7.5, 1.7 Hz, 1H, CHar), 6.66 (dt, J 
= 16.9, 10.8 Hz, 1H, CHolef), 6.51 (d, J = 11.3 Hz, 1H, CHolef), 6.36 (t, J = 11.1 Hz, 1H, CHolef), 
5.41 (d, J = 16.8 Hz, 1H, CHolef), 5.24 (d, J = 10.2 Hz, 1H, CHolef).  
13C NMR (75 MHz, CDCl3) δ 137.4 (Cq, ar), 132.9 (CHar), 132.8 (CHar), 131.9 (CHolef), 131.3 
(CHolef), 130.0 (CHolef), 128.8 (CHar), 127.1 (CHar), 124.1 (Cq, ar), 120.5 (CH2, olef). 
IR (neat) 3085, 3057, 3027, 2922, 1819, 1592, 1465, 1427, 1116, 1026, 1002, 907, 838, 812, 
780, 752, 733, 695, 654. 
HRMS (EI)  calculated for C10H9Br: m/z = 207.9888; found m/z = 207.9883.  
(Z)-2-(Buta-1,3-dien-1-yl)benzaldehyde (Z-262)  
Under argon atmosphere, 345 mg LiCl (8.15 mmol, 3.0 eq) and 568 mg (Z)-1-
bromo-2-(buta-1,3-dien-1-yl)benzene (2.72 mmol, 1.0 eq) were dissolved in 
15 mL anhydrous THF before being cooled to −78 °C. 1.3 mL n-BuLi (2.5 M 
in n-hexane, 3.26 mmol, 1.2 eq) were added and the reaction mixture was stirred for 30 min at 
−78 °C. 15 mL ethyl formate were added and the reaction was warmed to ambient temperature. 
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The reaction was quenched with aqueous NH4Cl solution and the aqueous layer was extracted 
three times with Et2O. The combined organic layers were washed with brine, dried over MgSO4, 
filtered and the solvent was evaporated. The crude product was purified by FC (n-pentane/Et2O 
7:1) to give (Z)-2-(buta-1,3-dien-1-yl)benzaldehyde (Z-262) in 49% yield (210 mg, 1.33 mmol) 
as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 10.21 (s, 1H, CHO), 7.90 (d, J = 7.8 Hz, 1H, CHar), 7.57 (dt, 
J = 7.5, 1.2 Hz, 1H, CHar), 7.43 (t, J = 7.5 Hz, 1H, CHar), 7.34 (d, J = 7.5 Hz, 1H, CHar), 6.88 
(t, J = 10.1 Hz, 1H, CHolef), 6.54 – 6.44 (m, 1H, CHolef), 5.43 – 5.39 (m, 1H, CHolef), 5.22 (d, 
J = 9.8 Hz, 1H, CHolef). 
13C NMR (75 MHz, CDCl3) δ 192.4 (C=O), 140.1 (Cq, ar), 133.97 (CHolef), 133.93 (CHolef), 
133.7 (CHar), 132.6 (Cq, ar), 131.1 (CHar), 129.8 (CHar), 127.9 (CHar), 127.1 (CHolef), 121.1 (CH2, 
olef).  
IR (neat) 2843, 2746, 1691, 1595, 1562, 1429, 1294, 1270, 1393, 1294, 1270, 1198, 1004, 910, 
860, 833, 806, 758, 651, 634. 
HRMS (EI) calculated for C11H10O: m/z = 158.0732; found m/z = 158.0724.  
(E)-2-(Buta-1,3-dien-1-yl)benzaldehyde (E-262)  
Under argon atmosphere, 194 mg magnesium turnings (8.00 mmol, 1.2 eq) 
were suspended in 16 mL anhydrous THF. Three drops 1,2-dibromoethane 
were added and the reaction was stirred at 40 °C until an exothermic reaction 
was observed. Then, 1.39 g (E)-1-bromo-2-(buta-1,3-dien-1-yl)benzene (6.67 mmol, 1.0 eq) 
were added and the reaction was heated to reflux overnight. After cooling the reaction mixture 
to 45 °C, 0.8 mL DMF (10.0 mmol, 1.5 eq) were added and the reaction mixture was stirred 
overnight at ambient temperature. Aqueous NH4Cl solution was added and the aqueous layer 
was extracted three times with Et2O. The combined organic layers were dried over MgSO4, 
filtered and the solvent was evaporated. The crude product was purified by FC (n-pentane/Et2O 
8:1) to give (E)-2-(buta-1,3-dien-1-yl)benzaldehyde (E-262) in 58% yield (2.02 g, 12.8 mmol) 
as colorless oil.  
1H NMR (300 MHz, CDCl3) δ 10.27 (s, 1H, CHO), 7.80 (dd, J = 7.7, 1.1 Hz, 1H, CHar), 7.61(d, 
J = 7.6 Hz, 1H, CHar), 7.57 – 7.38 (m, 2H, CHar + CHolef), 6.74 (dd, J = 15.4, 10.6 Hz, 1H, 
CHolef), 6.59 (dt, J = 16.7, 10.1 Hz, 1H, CHolef), 5.40 (d, J = 16.6 Hz, 1H, CHolef), 5.27 (d, J = 
10.1 Hz, 1H, CHolef). 
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13C NMR (75 MHz, CDCl3) δ 192.6 (C=O), 139.7 (Cq, ar), 137.1 (CHolef), 134.8 (CHolef), 133.8 
(CHar), 132.9 (Cq, ar), 132.2 (CHar), 128.6 (CHar), 127.8 (CHar), 127.1 (CHolef), 119.7 (CH2, olef). 
The NMR spectroscopic data are in accordance with the literature.176 
1-Bromo-2-((1Z,3E)-penta-1,3-dien-1-yl)benzene (294) 
The title compound was prepared according to GP 6. First, 5.93 g E-
crotyltriphenylphosphonium bromide (14.9 mmol, 1.2 eq) and 1.67 g 
potassium tert-butoxide (14.9 mmol, 1.2 eq) were suspended in 30 mL Et2O 
at 0 °C. After stirring for 1 h at ambient temperature, 1.45 mL 2-bromobenzaldehyde 
(12.4 mmol, 1.0 eq) were added dropwise and the mixture was stirred overnight. Aqueous 
NH4Cl solution was added and the aqueous layer was extracted three times with Et2O. The 
combined organic layers were dried over MgSO4, filtered, adsorbed on silica gel and the solvent 
was evaporated. The adsorbed crude product was purified by FC (n-pentane) to give 1-bromo-
2-((1Z/E,3E)-penta-1,3-dien-1-yl)benzene (294) as Z/E mixture (64:36) in 68% yield (2.27 g, 
10.2 mmol) as colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.51 (dd, J = 8.0, 1.0 Hz, 1H, CHar), 7.32 (dd, J = 7.6, 1.8 Hz, 
1H, CHar), 7.22 (td, J = 7.4, 1.0 Hz, 1H, CHar), 7.00 (td, J = 7.5, 1.7 Hz, 1H, CHar), 6.74 – 6.54 
(m, 1H, CHolef), 6.33 – 6.19 (m, 2H, CHolef), 5.90 – 5.79 (m, 1H, CHolef), 1.70 (dd, J = 6.0, 1.2 
Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 137.4 (Cq, ar), 133.1 (CHar), 132.2 (CHar), 131.9 (CHar), 131.8 
(CHar), 128.4 (CHolef), 128.3 (CHolef), 127.5 (CHolef), 126.4 (CHolef), 123.8 (Cq, ar), 18.6 (CH3). 
IR (neat) 3026, 2911, 1645, 1466, 1433, 1375, 1115, 1043, 1023, 985, 943, 867, 824, 761, 739, 
725, 670, 652, 621, 580. 
HRMS (EI) calculated for C11H11Br: m/z = 222.0044; found m/z = 222.0043.  
Resolved signals of the minor isomer 1-bromo-2-((1E,3E)-penta-1,3-dien-1-yl)benzene: 
1H NMR (300 MHz, CDCl3) δ 7.46 (dt, J = 8.0, 1.2 Hz, 1H, CHar), 5.66 – 5.55 (m, 1H, CHolef), 
1.77 (dd, J = 7.2, 1.3 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 128.6 (CHolef), 126.9 (CHolef), 22.5 (CH3).  
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2-((1Z,3E)-Penta-1,3-dien-1-yl)benzaldehyde (274) 
Under argon atmosphere, 296 mg magnesium turnings (12.2 mmol, 1.2 eq) 
were suspended in 30 mL anhydrous THF. Three drops 1,2-dibromoethane 
were added and the reaction was stirred at 40 °C until an exothermic reaction 
was observed. Then, 2.26 g 1-bromo-2-((1Z/E,3E)-penta-1,3-dien-1-yl)benzene (10.2 mmol, 
1.0 eq) were added and the reaction was heated to reflux overnight. After cooling the reaction 
mixture to 45 °C, 1.2 mL DMF (15.2 mmol, 1.5 eq) were added and the reaction mixture was 
stirred overnight at ambient temperature. Aqueous NH4Cl solution was added and the aqueous 
layer was extracted three times with Et2O. The combined organic layers were dried over 
MgSO4, filtered and the solvent was evaporated. The crude product was purified by FC (n-
pentane/Et2O 8:1) to give 2-((1Z/E,3E)-penta-1,3-dien-1-yl)benzaldehyde (274) as Z/E mixture 
(76:24) in 51% yield (887 mg, 5.16 mmol) as colorless oil. 
1H NMR (500 MHz, CDCl3) δ 10.21 (s, 1H, CHO), 7.90 (dd, J = 7.5, 0.8 Hz, 1H, CHar), 7.56 
(dt, J = 8.1, 1.1 Hz, 1H, CHar), 7.42 – 7.33 (m, 2H, CHar), 6.69 (d, J = 11.6 Hz, 1H, CHolef), 
6.44 (t, J = 11.6 Hz, 1H, CHolef), 6.21 – 6.16 (m, 1H, CHolef), 5.95 – 5.88 (m, 1H, CHolef), 1.73 
(d, J = 7.1 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 192.5 (CHO), 140.8 (Cq, ar), 134.2 (CHolef), 133.8 (CHolef), 133.6 
(CHolef), 131.0 (CHar), 129.2 (CHar), 127.5 (CHar), 127.2 (CHar), 123.6 (CHolef), 18.49 (CH3). 
IR (neat) 3026, 2930, 2854, 2730, 1724, 1693, 1645, 1595, 1561, 1479, 1447, 1392, 1292, 
1269, 1196, 1159, 1068, 986, 948, 933, 863, 822, 761, 729, 702, 659, 636, 611. 
HRMS (EI)  calculated for C12H12O: m/z = 172.0888; found m/z = 172.0897.  
Resolved signals of the minor isomer 2-((1E,3E)-penta-1,3-dien-1-yl)benzaldehyde:  
1H NMR (500 MHz, CDCl3) δ 10.27 (s, 1H, CHO), 7.78 (d, J = 7.6 Hz, 1H, CHar), 7.49 (t, J = 
7.5 Hz, 1H, CHar), 6.72 (d, J = 15.4 Hz, 1H, CHolef), 6.34 – 6.28 (m, 1H, CHolef), 1.84 (d, J = 
6.0 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 192.6 (CHO), 132.7 (CHolef), 134.8 (CHolef), 131.8 (CHolef), 
129.6 (CHar), 127.1 (CHar), 126.9 (CHolef), 125.3 (CHar), 18.53 (CH3). 
6,7-Dihydro-5H-benzo[7]annulen-5-ol (266) 
The title compound was prepared according to GP 9 utilizing 30 mg 
Co(dppe)Br2 (50 mmol, 10 mol%) and 50 mg zinc powder (0.75 mmol, 
150 mol%). After 10 min, 80 mg (Z)-2-(buta-1,3-dien-1-yl)benzaldehyde 
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(0.505 mmol, 1.0 eq) were added at ambient temperature and the reaction was stirred for 24 h 
at ambient temperature. The crude product mixture was directly purified by FC (n-pentane/Et2O 
4:1) to give 6,7-dihydro-5H-benzo[7]annulen-5-ol (266) in 91% yield (72 mg, 0.460 mmol) as 
colorless sticky solid. The product contained 6,9-dihydro-5H-benzo[7]annulen-5-ol (266’) as 
by-product with an isomeric ratio 266:266’ of 86:14 which was determined by GC/MS and 1H 
NMR analysis. 
1H NMR (300 MHz, CDCl3) δ 7.44 – 7.41 (m, 1H, CHar), 7.27 – 7.18 (m, 3H, CHar), 6.41 (d, J 
= 12.1 Hz, 1H, CHolef), 5.95 (dt, J = 12.1, 4.6 Hz, 1H, CHolef), 4.89 (d, J = 7.2 Hz, 1H, CH), 
2.57 – 2.47 (m, 2H, CH2), 2.27 – 2.08 (m, 2H, CH2), 1.96 (s, 1H, OH).  
13C NMR (75 MHz, CDCl3) δ 142.7 (Cq, ar), 134.2 (Cq, ar), 131.6 (CHolef), 131.6 (CHar), 129.5 
(CHolef), 127.5 (CHar), 126.9 (CHar), 126.7 (CHar), 73.5 (CH), 34.0 (CH2), 26.9 (CH2).  
IR (neat) 3356, 3017, 2926, 2891, 1657, 1485, 1448, 1425, 1342, 1289, 1255, 1199, 1174, 
1107, 1044, 781, 763, 731, 655. 
HRMS (EI)  calculated for C11H12O: m/z = 160.0883; found m/z = 160.0875.  
Resolved signals of the minor isomer 6,9-dihydro-5H-benzo[7]annulen-5-ol: 
1H NMR (300 MHz, CDCl3) δ 7.48 (d, J = 7.5 Hz, 1H, CHar), 7.08 (d, J = 7.4 
Hz, 1H, CHar), 5.81 – 5.73 (m, 1H, CHolef), 5.55 – 5.48 (m, 1H, CHolef), 5.36 (d, 
J = 11.1 Hz, CH), 3.64 (dt, J = 17.1, 3.2 Hz, 1H, CH2), 3.27 (dd, J = 16.9, 7.3 
Hz, 1H, CH2), 2.71 – 2.65 (m, 1H, CH2), 2.44 – 2.32 (m, 1H, CH2), 1.98 (s, 1H, OH). 
13C NMR (75 MHz, CDCl3) δ 143.4 (Cq, ar), 138.7 (Cq, ar), 132.6 (CHar), 128.3 (CHar), 127.1 
(CHar), 126.1 (CHolef), 123.8 (CHolef), 70.5 (CH), 38.1 (CH2), 33.7 (CH2). 
6-Methyl-6,7-dihydro-5H-benzo[7]annulen-5-ol (275) and  6-Methyl-6,9-dihydro-5H-
benzo[7]annulen-5-ol (275’) 
The title compound was prepared according to GP 9 utilizing 30 mg 
Co(dppe)Br2 (50 mmol, 10 mol%) and 50 mg zinc powder (0.75 mmol, 
150 mol%). After 10 min, 86 mg 2-((1Z,3E)-penta-1,3-dien-1-
yl)benzaldehyde (0.500 mmol, 1.0 eq) were added at ambient temperature and the reaction was 
stirred for 24 h at ambient temperature. The crude product mixture was directly purified by FC 
(n-pentane/Et2O 4:1) to give 6-methyl-6,7-dihydro-5H-benzo[7]annulen-5-ol (275) in 40% 
yield (34 mg, 0.105 mmol) as colorless oil. The product contained 6-methyl-6,9-dihydro-5H-
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benzo[7]annulen-5-ol (275’) as by-product with an isomeric ratio 275:275’ of 74:26 which was 
determined by GC/MS and 1H NMR analysis. 
1H NMR (300 MHz, CDCl3) δ 7.41 – 7.38 (m, 1H, CHar), 7.34 – 7.23 (m, 3H, CHar), 6.46 (d, J 
= 12.0 Hz, 1H, CHolef), 5.94 (dt, J = 12.2, 5.1 Hz, 1H, CHolef), 4.74 (d, J = 3.8 Hz, 1H, CH), 
2.53 – 2.36 (m, 3H, CH + CH2), 1.92 (d, J = 5.0 Hz, 1H, OH), 1.11 (d, J = 6.3 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 141.4 (Cq, ar), 135.6 (Cq, ar), 134.6 (CHar), 131.5 (CHolef), 129.1 
(CHolef), 128.5 (CHar), 127.7 (CHar), 127.0 (CHar), 78.7 (CH), 37.1 (CH), 34.5 (CH2), 19.3 
(CH3).  
IR (neat) 3393, 3015, 2958, 2883, 1449, 1422, 1243, 1032, 971, 947, 776, 753, 708, 609, 570. 
HRMS (ESI)  calculated for C12H14OLi
+: m/z = 181.1205; found m/z = 181.1203.  
Resolved signals of the minor isomer 6-methyl-6,9-dihydro-5H-benzo[7]annulen-5-ol: 
1H NMR (300 MHz, CDCl3) δ 7.43 – 7.41 (d, J = 7.3 Hz, 1H, CHar), 5.75 – 
5.69 (m, 1H, CHolef), 5.47 – 5.41 (m, 1H, CHolef), 3.60 (dq, J = 17.0, 2.5 Hz, 
1H, CH), 3.24 (dd, J = 16.9, 7.1 Hz, 1H, CH2), 0.85 (d, J = 7.1 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 141.1 (Cq, ar), 135.7 (Cq, ar), 131.2 (CHar), 130.7 
(CHolef), 130.0 (CHolef), 129.7 (CHar), 127.6 (CHar), 39.5 (CH), 32.8 (CH2), 17.6 (CH3). 
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5.7 Synthesis of Deuterated Compounds 
Octan-1,1-d2-1-ol (295-d2)  
590 mg lithium aluminum deuteride (14.0 mmol, 2.0 eq) were 
suspended in 100 mL anhydrous THF and 1.11 g ethyl octanoate 
(7.00 mmol, 1.0 eq) were added at 0 °C. The reaction mixture was stirred for 1 h at ambient 
temperature. It was then quenched with 0.6 mL water, 0.6 mL aqueous NaOH (15 w-%) and 
0.2 mL water. The mixture was filtered, the precipitate was rinsed thoroughly with Et2O and 
the filtrate was evaporated to give octan-1,1-d2-1-ol (295-d2) in 96% yield (890 mg, 6.73 mmol) 
as colorless oil and quantitative deuterium incorporation. 
1H NMR (300 MHz, CDCl3) δ 1.55 (d, J = 6.9 Hz, 2H, CH2), 1.36 – 1.20 (m, 11H, CH2 + OH), 
0.88 (t, J = 6.9 Hz, 3H, CH3). 
2H NMR (46 MHz, CHCl3) δ 3.41 (s, 2D, CD2OH). 
13C NMR (75 MHz, CDCl3) δ 32.8 (CH2), 32.0 (CH2), 29.5 (CH2), 29.4 (CH2), 25.9 (CH2), 
22.8 (CH2), 14.2 (CH3). CD2OH not detectable. 
IR (neat) 3333, 2956, 2924, 2854, 2190, 2093, 1464, 1378, 1296, 1185, 1131, 1091, 1073, 967, 
907, 722, 650. 
HRMS (EI) calculated for C8H15D2: m/z = 114.1456; found m/z = 114.3774. 
1-Bromooctane-1,1-d2 (296-d2)  
Under argon atmosphere, 890 mg octan-1,1-d2-1-ol (6.73 mmol, 
1.0 eq) and 3.55 g CBr4 (10.1 mmol, 1.5 eq) were dissolved in 
20 mL anhydrous dichloromethane. Then, 2.65 g PPh3 (10.1 mmol, 1.5 eq) were added in three 
portions. The reaction mixture was stirred at ambient temperature for 1 h. Another 1.5 eq of 
PPh3 were added and the mixture was stirred for another hour. The crude product mixture was 
adsorbed on silica. After purification by FC (n-pentane) 1-bromooctane-1,1-d2 (296-d2) was 
obtained in 76% yield (997 mg, 5.11 mmol) as colorless oil and quantitative deuterium 
incorporation.  
1H NMR (300 MHz, CDCl3) δ 1.84 (t, J = 7.9 Hz, 2H, CH2), 1.46 – 1.38 (m, 2H, CH2), 1.37 – 
1.28 (m, 8H, CH2), 0.89 (t, J = 7.2 Hz, 3H, CH3). 
2H NMR (46 MHz, CHCl3) δ 3.18 (s, 2D, CD2OH). 
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13C NMR (75 MHz, CDCl3) δ 32.8 (CH2), 31.9 (CH2), 29.3 (CH2), 28.9 (CH2), 28.3 (CH2), 
22.8 (CH2), 14.2 (CH3).CD2Br not detectable. 
IR (neat) 2955, 2924, 2855, 2156, 1464, 1378, 1115, 993, 957, 927, 911, 723, 675, 607, 541. 
HRMS (EI) calculated for C8H15D2Br: m/z = 194.06392; found m/z = 194.06347. 
Dec-1-ene-3,3-d2 (297-d2)  
According to a procedure of Oshima,177 111 mg Ni(dppp)Cl2 
(205 mm, 10 mol%) and 220 mg vinylbromide (2.05 mmol, 1.0 eq) 
were dissolved in anhydrous THF under argon atmosphere. In a second flask under argon 
atmosphere, 60 mg magnesium turnings (2.46 mmol, 1.2 eq) and 400 mg bromooctane-1,1-d2 
(2.05 mmol, 1.0 eq) were suspended in anhydrous THF and stirred for 5 h at ambient 
temperature. The Grignard solution was then transferred into the first flask containing the nickel 
catalyst and vinylbromide. The reaction was stirred for 5 h at 35 °C. It was filtered through a 
short pad of silica. After purification by vacuum distillation (15 mbar, 67 °C) dec-1-ene-3,3-d2 
(297-d2) was obtained in 46% yield (132 mg, 0.93 mmol) as colorless oil and quantitative 
deuterium incorporation. As byproduct hexadecane-8,8,9,9-d4 was obtained in 45% yield 
(216 mg, 0.93 mmol). 
1H NMR (300 MHz, CDCl3) δ 5.80 (dd, J = 17.1, 10.2 Hz, 1H, CHolef), 4.98 (dd, J = 17.1, 2.2 
Hz, 1H, CH2, olef), 4.92 (dd, J = 10.2, 2.2 Hz, 1H, CH2, olef), 1.27 (br s, 12H, CH2), 0.88 (t, J = 
7.1 Hz, 3H, CH3). 
2H NMR (46 MHz, CHCl3) δ 1.82 (s, 2D, CD2OH). 
13C NMR (75 MHz, CDCl3) δ 139.4 (CHolef), 114.3 (CH2, olef), 34.3 (CH2), 32.1 (CH2), 29.6 
(CH2), 29.4 (CH2), 29.3 (CH2), 29.0 (CH2), 22.8 (CD2), 14.2 (CH3). 
IR (neat) 2958, 2922, 2854, 2180, 2092, 1673, 1465, 1412, 1377, 1339, 1260, 1146, 1059, 993, 
967, 909, 845, 722. 
HRMS (EI) calculated for C10H18D2: m/z = 142.16905; found m/z = 142.16886. 
2-Phenylacetic-2,2-d2 acid (298-d2)  
According to a procedure of Gao,23 5.44 g phenylacetic acid (40 mmol, 
1.0 eq) were dissolved in 10 mL of a solution containing 40 w-% NaOD in 
deuterium oxide (97.6 mmol, 2.3 eq). The reaction mixture was heated for 
12 h to 100 °C, was then cooled to ambient temperature and acidified with 2 M aqueous HCl to 
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pH 2. The aqueous layer was extracted three times with dichloromethane, the organic layer was 
dried over MgSO4, filtered and the solvent was removed under reduced pressure to give 
2-phenylacetic-2,2-d2 acid (298-d2) in quantitative yield (5.52 g, 39.9 mmol) as a white solid 
and 95% deuterium incorporation.   
1H NMR (300 MHz, CDCl3) δ 11,79 (br s, 1H, COOH), 7.37 – 7.28 (m, 5H, CHar). 
2H NMR (77 MHz, CHCl3) δ 3.65 (s, 2D, CD2). 
13C NMR (75 MHz, CDCl3) δ 178.3 (COOH), 133.3 (Cq, ar), 129.5 (CHar), 128.8 (CHar), 127.5 
(CHar), 40.7 (quin, J = 19.7 Hz, CD2).  
The NMR spectroscopic data are in accordance with the literature.23 
 2-Phenylethan-2,2-d2-1-ol (299-d2)  
According to a procedure of Gao,23 under argon atmosphere, 1.23 g lithium 
aluminum hydride (32.6 mmol, 1.5 eq) in 40 mL anhydrous was added 
dropwise 3.00 g phenylacetic-2,2-d2 acid (21.7 mmol, 1.0 eq)  in 40 mL 
anhydrous THF. The reaction mixture was stirred 1 h at ambient temperature. It was then 
quenched with 0.5 M aqueous HCl. The mixture was filtered, and the precipitate was thoroughly 
rinsed with EtOAc. The organic layer was washed with water and brine, dried over MgSO4, and 
the solvent was evaporated. After purification by FC (n-pentane/Et2O 4:1) 2-phenylethan-2,2-
d2-1-ol (299-d2) was obtained in 99% yield (2.67 g, 21.5 mmol) as colorless oil and 95% 
deuterium incorporation. 
1H NMR (300 MHz, CDCl3) δ 7.34 (t, J = 7.8 Hz, 2H, CHar), 7.28 – 7.24 (m, 3H, CHar), 3.87 
(d, J = 6.0 Hz, 2H, CH2OH), 1.68 (br s, 1H, OH). 
2H NMR (77 MHz, CHCl3) δ 4.29 (s, 2D, CD2). 
13C NMR (75 MHz, CDCl3) δ 138.6 (Cq, ar), 129.1 (CHar), 128.7 (CHar), 126.5 (CHar), 60.5 
(CH2OH), 38.8 (quin, J = 19.1 Hz, CD2).  
The NMR spectroscopic data are in accordance with the literature.23 
(Allyl-1,1-d2)benzene (17-d2)  
According to a procedure of Gao,23 1.60 g pyridinium chlorochromate 
(7.50 mmol, 1.5 eq) and 7.5 g silica were suspended in 15 mL anhydrous 
dichloromethane and 0.62 g 2-phenylethan-2,2-d2-1-ol (5.00 mmol, 1.0 eq) in 
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10 mL anhydrous dichloromethane were added. The reaction mixture was stirred 5 h at ambient 
temperature. The mixture was filtered through a short pad of silica gel and the precipitate was 
washed with Et2O. The solvent was evaporated. The aldehyde was then used for a subsequent 
Wittig reaction following the standard protocol of GP 6. After purification by FC (n-pentane) 
(allyl-1,1-d2)benzene (17-d2) was obtained in 37% yield (220 mg, 1.83 mmol) as colorless 
liquid and 88% deuterium incorporation. 
1H NMR (300 MHz, CDCl3) δ 7.32 – 7.18 (m, 5H, CHar), 6.02 – 5.92 (m, 1H, CHolef), 5.11 – 
5.06 (m, 2H, CH2, olef), 3.39 (br s, 0.24 H, CH2). 
2H NMR (77 MHz, CHCl3) δ 3.40 (s, 1D, CD2). 
13C NMR (75 MHz, CDCl3) δ 137.5 (CHolef), 128.7 (CHar), 128.6 (CHar), 126.2 (CHar), 115.9 
(CH2, olef). Cq, ar and CD2 not detectable. 
The NMR spectroscopic data are in accordance with the literature.23 
(E)-(Prop-1-en-1-yl-1,2,3-d3)benzene (18-d)   
The title compound was prepared according to a modified GP 1 
utilizing 31 mg Ni(dppp)Br2 (50.0 mmol, 10 mol%), 6.6 mg zinc 
powder (100 mmol, 20 mol%), 32.0 mg zinc iodide (100 mmol, 
20 mol%) in 0.25 mL anhydrous dichloromethane. Note, that diphenylphosphine was NOT 
used! 60 mg (allyl-1,1-d2)benzene (0.25 mmol, 1.0 eq) were added after 10 min. The reaction 
mixture was stirred 24 h at ambient temperature. After general workup (E)-(prop-1-en-1-yl-
1,2,3-d3)benzene (18-d) was obtained in 68% yield (41.0 mg, 0.341 mmol) as colorless oil and 
58% remaining deuterium at position 1, 12% deuterium incorporation at position 2, and 76% 
deuterium incorporation at position 3. 
1H NMR (300 MHz, CDCl3) δ 7.35 – 7.29 (m, 4H, CHar), 7.22 – 7.17 (m, 1H, CHar), 6.42 (d, J 
= 15.9 Hz, 0.42 H, CHolef), 6.32 – 6.20 (m, 0.88 H, CHolef), 1.88 (d, J = 6.3 Hz, 2.24 H, CH2D). 
2H NMR (77 MHz, CHCl3) δ 6.46 (br s, 1D, CDolef), 6.30 (br s, 0.24 D, CDolef), 1.92 (br s, 
1.28 D, CH2D). 
13C NMR (75 MHz, CDCl3) δ 138.1 (d, J = 4.9 Hz, Cq, ar), 131.2 (CHolef), 128.6 (CHar), 126.9 
(CHar), 125.9 (CHar), 125.8 (d, J = 8.9 Hz, CHolef), 18.6 (br s, CH2D). 
The NMR spectroscopic data are in accordance with the literature.23 
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N-Allyl-N-d-benzamide (72e-d)  
Under argon atmosphere, 386 mg N-allylbenzamide (2.40 mmol, 1.0 eq) 
were dissolved in 5.0 mL ahydrous THF and cooled to −78 °C. 1.5 mL n-
BuLi (1.6 M in n-hexane, 2.40 mmol, 1.0 eq) were added and the reaction 
mixture was stirred for 1 h at −78 °C. The reaction was quenched with 0.1 mL D2O (4.80 mmol, 
2.0 eq) and the aqueous layer was extracted with EtOAc, dried over Na2SO4, filtered and the 
solvent was evaporated to give deutero-N-allylbenzamide (72e-d) in 69% yield (296 mg, 
1.66 mmol) as colorless oil. 
1H NMR (300 MHz, DMSO-d6) δ 7.90 – 7.85 (m, 2H, CHar), 7.56 – 7.43 (m, 3H, CHar), 5.96 
– 5.83 (m, 1H, CHolef), 5.17 (dq, J = 15.4, 1.8 Hz, 1H, CHolef), 5.07 (dq, J = 10.2, 1.7 Hz, 1H, 
CHolef), 3.89 (dt, J = 5.1, 1.6 Hz, 2H, CH2). 
2H NMR (46 MHz, DMSO) δ 8.95 (br s, ND). 
13C NMR (75 MHz, CDCl3) δ 167.5 (C=O), 134.7 (Cq, ar), 134.3 (CHolef), 131.6 (CHar), 128.7 
(CHar), 127.1 (CHar), 116.8 (CH2, olef), 42.6 (CH2). 
IR (neat) 3064, 2917, 2476, 1626, 1577, 1451, 1437, 1412, 1274, 1186, 1158, 1141, 1075, 989, 
946, 917, 845, 800, 707, 690, 668, 631, 617, 547, 494. 
HRMS (ESI)  calculated for C10H10ODNa
+: m/z = 185.0734; found m/z = 185.0767.  
Deutero-(Z/E)-2-(Buta-1,3-dien-1-yl)benzaldehyde (262-d) 
Under argon atmosphere, 0.70 g 1-bromo-2-(buta-1,3-dienyl)benzene 
(3.30 mmol, 1.0 eq) and 420 mg LiCl (9.90 mmol, 3.0 eq) were suspended 
in 20 mL anhydrous THF and cooled to −78 °C. 2.5 mL n-BuLi (1.6 M in n-
hexane, 4.00 mmol, 1.2 eq) were added and the reaction was stirred for 30 min at −78 °C. Then, 
0.76 mL DMF-d7 (9.90 mmol, 3.0 eq) were added and the reaction was stirred for another 
15 min. It was then quenched with aqueous NH4Cl. The aqueous layer was extracted three times 
with Et2O. The organic layer was dried over MgSO4, filtered and the solvent was evaporated to 
give deutero-(Z/E)-2-(buta-1,3-dien-1-yl)benzaldehyde (262-d) as Z/E mixture (86:14) as a 
colorless oil. The product was used without further purification. 
1H NMR (300 MHz, CDCl3) δ 7.89 (dd, J = 7.8, 0.9 Hz, 1H, CHar), 7.55 (dt, J = 7.5, 1.2 Hz, 
1H, CHar), 7.41 (t, J = 7.6 Hz, 1H, CHar), 7.32 (d, J = 7.6 Hz, 1H, CHar), 6.86 (d, J = 10.4 Hz, 
1H, CHolef), 6.50 – 6.43 (m, 2H, CHolef), 5.41 – 5.38 (m, 1H, CHolef), 5.21 (d, J = 9.7 Hz, 1H, 
CHolef). 
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2H NMR (77 MHz, CHCl3) δ 10.24 (s, 1D, CDO). 
13C NMR (125 MHz, CDCl3) δ 191.9 (t, J = 27.2 Hz, DC=O), 140.0 (Cq, ar), 133.9 (CHolef), 
133.6 (CHar), 132.0 (Cq, ar), 132.5 (CHolef), 131.0 (CHar), 129.6 (CHar), 127.75 (CHar), 127.0 
(CHolef), 121.0 (CH2, olef). 
IR (neat) 2928, 2111, 1675, 1649, 1598, 1563, 1431, 1213, 1006, 911, 797, 756, 702, 647. 
HRMS (ESI)  calculated for C11H9ODLi
+: m/z = 166.0954; found m/z = 166.0959.  
Resolved signals of the minor isomer deutero-(E)-2-(buta-1,3-dien-1-yl)benzaldehyde: 
1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.7 Hz, 1H, CHar), 7.60 (d, J = 8.1 Hz, 1H, CHar), 
6.62 – 6.53 (m, 2H, CHolef). 
2H NMR (77 MHz, CHCl3) δ 10.30 (s, 1D, CDO). 
13C NMR (125 MHz, CDCl3) δ 139.7 (Cq, ar), 134.7 (CHolef), 133.2 (CHar), 130.8 (CHar), 130.4 
(CHar), 127.69 (CHar), 127.1 (CHolef), 119.7 (CH2, olef). 
6,7-Dihydro-5H-benzo[7]annulen-5-d-5-ol (266-d) 
The title compound was prepared according to GP 9 utilizing 30 mg 
Co(dppe)Br2 (50 mmol, 10 mol%) and 50 mg zinc powder (0.75 mmol, 
150 mol%). After 10 min, 80 mg deutero-(Z)-2-(buta-1,3-dien-1-
yl)benzaldehyde (0.505 mmol, 1.0 eq) were added at ambient temperature and the reaction was 
stirred for 24 h at ambient temperature. The crude product mixture was directly purified by FC 
(n-pentane/Et2O 4:1) to give 6,7-dihydro-5H-benzo[7]annulen-5-d-5-ol (266-d) in 54% yield 
(43 mg, 0.273 mmol) as colorless sticky solid. The product contained and  6,9-dihydro-5H-
benzo[7]annulen-5-d-5-ol (266’-d) as by-product with an isomeric ratio 266-d:266’-d of 85:15 
which was determined by GC/MS and 1H NMR analysis. 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.42 (m, 1H, CHar), 7.28 – 7.18 (m, 3H, CHar), 6.41 (d, J 
= 12.1 Hz, 1H, CHolef), 5.94 (dt, J = 12.1, 4.6 Hz, 1H, CHolef), 2.61 – 2.52 (m, 1H, CH2), 2.50 
– 2.43 (m, 1H, CH2), 2.23 – 2.17 (m, 1H, CH2), 2.12 – 2.08 (m, 1H, CH2), 1.91 (s, 1H, OH).  
2H NMR (77 MHz, CHCl3) δ 4.90 (s, 1D, CDOH). 
13C NMR (125 MHz, CDCl3) δ 142.7 (Cq, ar), 134.3 (Cq, ar), 132.6 (CHolef), 131.6 (CHar), 129.5 
(CHolef), 127.5 (CHar), 127.0 (CHar), 126.8 (CHar), 72.9 (t, J = 44.2 Hz, CDOH), 33.9 (CH2), 
26.8 (CH2).  
IR (neat) 3373, 2926, 1659, 1446, 1255, 1117, 1078, 1060, 947, 908, 778, 762, 730, 575. 
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HRMS (ESI) calculated for C11H12ONa
+: m/z = 184.0849; found m/z = 184.1004.  
Resolved signals of the minor isomer 6,9-dihydro-5H-benzo[7]annulen-5-d-5-ol: 
1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.5 Hz, 1H, CHar), 7.08 (d, J = 7.4 Hz, 
1H, CHar), 5.80 – 5.71 (m, 1H, CHolef), 5.58 – 5.49 (m, 1H, CHolef), 3.27 (m, 1H, 
CH2), 2.70 – 2.66 (m, 1H, CH2), 2.01 (s, 1H, OH). 
13C NMR (125 MHz, CDCl3) δ 128.3 (CHar), 127.1 (CHar), 126.1 (CHolef), 123.8 (CHolef), 33.7 
(CH2). 
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5.8 Abbreviations 
Å Ångström 
Ac acetyl 
acac acetyl acetonate 
Alk alkyl 
Ar aryl 
atm atmospheric pressure 
BARF tetrakis[3,5-bis(trifluoromethyl)-phenyl]borate  
bdpp pentane-2,4-diylbis(biphenyl-4-phosphine) 
BINAP 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl 
B.O. bond order (German: Bindungsordnung) 
Boc tert-butoxy carbamate 
Bn benzyl 
Bu butyl 
BuLi butyllithium 
Cbz Carboxybenzyl 
cf. compare 
cod cyclooctadiene 
CV cyclic voltammetry 
Cy cyclohexyl 
d dublet, day 
 delta, chemical shift 
dArpp pentane-2,4-diylbis(bis(4-methoxyphenyl)-4-phosphine) 
DCE 1,2-dichloroethane 
de diasteremeric excess 
DFT density functional theory 
DIBAL diisobutyl aluminum hydride 
DMAP 4-dimethylaminopyridine 
DMB 2,3-dimethylbuta-1,3-diene 
DME dimethoxyethane 
DMF N,N-dimethyl formamide 
DMPU 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO dimethylsulfoxide 
5. Experimental Section 
206 
 
d(o-Tol)pp 1,3-bis(di-o-tolylphosphinyl)propane 
dppb 1,2-bis(diphenylphosphino)butane 
dppe 1,2-bis(diphenylphosphino)ethane 
dppm 1,2-bis(diphenylphosphino)methane 
dppp 1,2-bis(diphenylphosphino)propane 
dpppBuEt (2-butyl-2-ethylpropane-1,3-di-yl)bis(biphenyl-4-phosphine) 
dpppMe2 (2,2-dimethylpropane-1,3-diyl)bis(biphenyl-4-phosphine) 
d.r. diastereomeric ratio 
E 
E1/2 
energy 
half-wave potential 
ee enantiomeric excess 
EI electron impact ionization 
EPR electron paramagnetic resonance  
eq equivalents 
equat. equatorial 
e.r. enatiomeric ratio 
ESI electron spray ionization 
EWG electron withdrawing group 
FC flash column chromatography 
Fc/Fc+ ferrocene/ferrocenium 
FG functional group 
FID flame ionization detector 
FT Fourier transform 
GC gas chromatograph(y) 
GC/MS gas chromatograph coupled with a mass-selective detector 
GP general procedure 
h hour 
HAT hydrogen atom transfer 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
HV high vacuum 
Hz Hertz 
I current, nuclear spin 
ie isomeric excess 
5. Experimental Section 
207 
 
IMes 1,3-bis(2,4,6-trimethylphenyl)imidazole 
i.r. isomeric ratio 
IR infrared 
IS internal standard 
J coupling constant 
JvW Jacobi von Wangelin 
K Kelvin 
KR kinetic resolution 
L ligand 
LG leaving group 
m meta 
M molar 
[M] metal complex 
Me-DuPHOS (−)-1,2-bis[(2R,5R)-2,5-dimethylphospholano]benzene 
Mes mesityl 
min minute 
MS mass-selective detector 
MTBE methyl tert-butyl ether 
m/z mass-to-charge ratio 
 wavenumber 
n.d. not detectable 
n.i. not isolated 
NMR nuclear magnetic resonance 
o ortho 
o/n overnight 
p para 
PCC pyridinium chlorochromate 
PG protecting group 
Ph phenyl 
pin pinacolyl 
ppm part per million 
Pr propyl 
py-imin (E)-2-((pyridin-2-ylmethylene)-amino)ethan-1-amine 
R rest 
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® registered trademark 
RCM ring closing metathesis 
r.r. regioisomeric ratio 
rt room (ambient) temperature  
saltBu/tBu (R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamin 
SHOP Shell Higher Olefin Process 
s.m. starting material 
t tertiary, time 
T temperature 
TBA tetrabutylammonium 
TBS tert-butyl dimethyl silyl 
Tf triflyl 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMEDA tetramethyl ethylene diamine 
TMS trimethylsilyl 
Tol tolyl 
Tos tosyl 
(R)-TRIP (R)-3,3′-bis(2,4,6triisopropyl-phen-yl)-1,1′-binaphthyl-2,2′-diyl 
hydrogenphosphate 
TS transition state 
u unit (kg/C for m/z) 
üN overnight; German: über Nacht  
ZPE zero-point energy 
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5.9 NMR Spectra of Selected Compounds 
(Z)-tert-Butyldimethyl(tetradeca-9,13-dien-1-yloxy)silane (185) 
 
1H NMR (500 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(Z)-Tetradeca-9,13-dien-1-ol (284) 
 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
 
5. Experimental Section 
211 
 
(Z)-Tetradeca-9,13-dien-1-yl Acetate (184) 
 
1H NMR (500 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(9Z,12Z)-Tetradeca-9,12-dien-1-yl Acetate (165) 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(Z)-N-(Prop-1-en-1-yl)benzamide (72e) 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(Z)-4-Bromo-N-(prop-1-en-1-yl)benzamide (72i) 
 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
 
5. Experimental Section 
215 
 
tert-Butyl (Z)-prop-1-en-1-ylcarbamate (204a) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(E)-1-(Prop-1-en-1-yl)pyrrolidin-2-one (210a) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(Z)-3-(But-2-en-1-yl)oxazolidin-2-one (219) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
 
5. Experimental Section 
218 
 
4,4,5,5-Tetramethyl-2-(3-methylenepentyl)-1,3,2-dioxaborolane (231) 
 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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syn-2-Methyl-1-phenylbut-3-en-1-ol (112) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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syn-2-Ethyl-1-phenylbut-3-en-1-ol (237) 
 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (125 MHz, CDCl3). 
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Artemisia Alcohol (247c) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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anti-2-Ethyl-2-methyl-1-phenylbut-3-en-1-ol (130) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (125 MHz, CDCl3). 
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(Z)-1-Bromo-2-(buta-1,3-dien-1-yl)benzene (273) 
 
1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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(Z)-2-(Buta-1,3-dien-1-yl)benzaldehyde (262) 
 
 1H NMR (300 MHz, CDCl3). 
 
13C NMR (75 MHz, CDCl3). 
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6,7-Dihydro-5H-benzo[7]annulen-5-ol (266) and  6,9-Dihydro-5H-benzo[7]annulen-5-ol 
(266‘) 
 
1H NMR (300 MHz, CDCl3). 
13C NMR (125 MHz, CDCl3). 
6. References 
226 
 
6. References 
(1)  Takeda, T. Modern Carbonyl Olefination, Wiley-VCH, Weinheim, 2004. 
(2)  a) Yan, M.; Jin, T.; Ishikawa, Y.; Minato, T.; Fujita, T.; Chen, L.-Y.; Bao, M.; Asao, N.;  
Chen, M.-W.; Yamamoto, Y. J. Am. Chem. Soc. 2012, 134, 17536–17542; b) Trost, B. M.; 
Ball, Z. T.; Jöge, T. J. Am. Chem. Soc. 2002, 124, 7922–7923; c) Shen, R.; Chen, T.; Zhao, 
Y.; Qiu, R.; Zhou, Y.; Yin, S.; Wang, X.; Goto, M.; Han, L.-B. J. Am. Chem. Soc. 2011, 
133, 17037–17044; d) Richmond, E.; Moran, J. J. Org. Chem. 2015, 80, 6922–6929; e) 
Mäsing, F.; Nüsse, H.; Klingauf, J.; Studer, A. Org. Lett. 2017, 19, 2658–2661; f) Fu, S.; 
Chen, N.-Y.; Liu, X.; Shao, Z.; Luo, S.-P.; Liu, Q. J. Am. Chem. Soc. 2016, 138, 8588–
8594. 
(3) Oestreich, M. The Mizoroki–Heck Reaction; John Wiley & Sons, Chichester, UK, 2009. 
(4) Grubbs, R. H., Ed. Handbook of metathesis; Wiley-VCH, Weinheim, Germany, 2010. 
(5) Larsen, C. R.; Grotjahn, D. B. Top. Catal. 2010, 53, 1015–1018. 
(6) a) Hilt, G. ChemCatChem 2014, 6, 2484–2485; b) Colquhoun, H. M.; Holton, J.; Thompson, 
D. J.; Twigg, M. V. Isomerization of Alkenes. In New Pathways for Organic Synthesis; 
Colquhoun, H. M.; Holton, J.; Thompson, D. J.; Twigg, M. V., Eds.; Springer US: Boston, 
MA, 1984, pp 173–193; c) Chen, X.; Qiu, S.; Wang, S.; Wang, H.; Zhai, H. Org. Biomol. 
Chem. 2017, 15, 6349–6352.  
(7) Biswas, S. Comments on Inorg. Chem. 2015, 35, 300–330. 
(8) Vasseur, A.; Bruffaerts, J.; Marek, I. Nature Chem. 2016, 8, 209–219. 
(9) Crabtree, R. H. The organometallic chemistry of the transition metals, 4th edition; Wiley-
Interscience, Hoboken, N.J., 2005. 
(10) Sawyer, K. R.; Glascoe, E. A.; Cahoon, J. F.; Schlegel, J. P.; Harris, C. B. 
Organometallics 2008, 27, 4370–4379. 
(11) Sommer, H.; Juliá-Hernández, F.; Martin, R.; Marek, I. ACS central science 2018, 4, 
153–165. 
(12) Biswas, S.; Huang, Z.; Choliy, Y.; Wang, D. Y.; Brookhart, M.; Krogh-Jespersen, K.; 
Goldman, A. S. J. Am. Chem. Soc. 2012, 134, 13276–13295. 
(13) Wille, A.; Tomm, S.; Frauenrath, H. Synthesis 1998, 305–308. 
(14) Larionov, E.; Li, H.; Mazet, C. Chem. Commun. 2014, 50, 9816–9826. 
(15)   Kurosawa, H.; Yamamoto, A., Eds. Fundamentals of Molecular Catalysis. Current 
Methods in Inorganic Chemistry, Vol. 3; Elsevier Science & Technology, 2003. 
(16) a) Larsen, C. R.; Erdogan, G.; Grotjahn, D. B. J. Am. Chem. Soc. 2014, 136, 1226–1229; 
b) Larsen, C. R.; Grotjahn, D. B. J. Am. Chem. Soc. 2012, 134, 10357–10360. 
(17) a) Krompiec, S.; Kuźnik, N.; Penczek, R.; Rzepa, J.; Mrowiec-Białoń, J. J. Molec. 
Catal. A 2004, 219, 29–40; b) Mamone, P.; Grünberg, M. F.; Fromm, A.; Khan, B. A.; 
Gooßen, L. J. Org. Lett. 2012, 14, 3716–3719; c) Becica, J.; Glaze, O. D.; Wozniak, D. I.; 
Dobereiner, G. E. Organometallics 2018, 37, 482–490.  
(18) Krompiec, S.; Krompiec, M.; Penczek, R.; Ignasiak, H. Coord. Chem. Rev. 2008, 252, 
1819–1841. 
6. References 
227 
 
(19) Orchin, M. The Homogeneous Catalytic Isomerization of Olefins by Transition Metal 
Complexes, in Advances in catalysis and related subjects; Academic Press: New York, 
1966. 
(20) Lochow, C. F.; Miller, R. G. J. Org. Chem. 1976, 41, 3020–3022. 
(21)   a) Kanai, H. J. Chem. Soc., Chem. Commun. 1972, 203; b) Kanai, H.; Kushi, K.; 
Sakanoue, K.; Kishimoto, N. Bull. Chem. Soc. Jpn. 1980, 53, 2711–2715.  
(22) Lim, H. J.; Smith, C. R.; RajanBabu, T. V. J. Org. Chem. 2009, 74, 4565–4572. 
(23) Wu, Q.; Wang, L.; Jin, R.; Kang, C.; Bian, Z.; Du, Z.; Ma, X.; Guo, H.; Gao, L. Eur. J. 
Org. Chem. 2016, 5415–5422. 
(24) Mintsaeya, V. J. Catal. 1980, 66, 412–423. 
(25) Cowherd, F. G.; Rosenberg, J. L. von. J. Am. Chem. Soc. 1969, 91, 2157–2158. 
(26) Mayer, M.; Welther, A.; Jacobi von Wangelin, A. ChemCatChem 2011, 3, 1567–1571. 
(27) Jennerjahn, R.; Jackstell, R.; Piras, I.; Franke, R.; Jiao, H.; Bauer, M.; Beller, M. 
ChemSusChem 2012, 5, 734–739. 
(28) Kobayashi, T.; Yorimitsu, H.; Oshima, K. Chemistry, Asian J. 2009, 4, 1078–1083. 
(29)   Crossley, S. W. M.; Barabé, F.; Shenvi, R. A. J. Am. Chem. Soc. 2014, 136, 16788–
16791. 
(30) Liu, X.; Zhang, W.; Wang, Y.; Zhang, Z.-X.; Jiao, L.; Liu, Q. J. Am. Chem. Soc. 2018, 
140, 6873–6882. 
(31) Chen, C.; Dugan, T. R.; Brennessel, W. W.; Weix, D. J.; Holland, P. L. J. Am. Chem. 
Soc. 2014, 136, 945–955. 
(32) Schmidt, A.; Nödling, A. R.; Hilt, G. Angew. Chem. Int. Ed. 2015, 54, 801–804. 
(33) Schmidt, A., Entwicklung und Anwendung Übergangsmetall-katalysierter 
Isomerisierungsreaktionen und Kobalt-katalysierte Umsetzungen von 1,3,5-Hexatrienen, 
Dissertation, Philipps-Universität Marburg, Marburg, 2015. 
(34) Taskinen, E. J. Chem. Soc., Perkin Trans. 2 2001, 1824–1834. 
(35) Ahlsten, N.; Bartoszewicz, A.; Martín-Matute, B. Dalton Trans. 2012, 41, 1660–1670. 
(36)   Paulson, E. R.; Grotjahn, D. B., Isomerization and Hydrogenation of Alkenes, in 
Encyclopedia of Inorganic and Bioinorganic Chemistry; John Wiley & Sons, Ltd: 
Chichester, UK, 2011. 
(37) Goetz, R. W.; Orchin, M. J. Am. Chem. Soc. 1963, 85, 1549–1550. 
(38) van der Drift, R. C.; Bouwman, E.; Drent, E. Journal of Organometallic Chemistry 
2002, 650, 1–24. 
(39) Xia, T.; Wei, Z.; Spiegelberg, B.; Jiao, H.; Hinze, S.; de Vries, J. G. Chemistry 2018, 
24, 4043–4049. 
(40) a) Uma, R.; Gouault, N.; Crévisy, C.; Grée, R. Tetrahedron Letters 2003, 44, 6187–
6190; b) Petrignet, J.; Roisnel, T.; Grée, R. Chemistry 2007, 13, 7374–7384; c) Cuperly, D.; 
Crévisy, C.; Grée, R. J. Org. Chem. 2003, 68, 6392–6399; d) Crévisy, C.; Wietrich, M.; Le 
Boulaire, V.; Uma, R.; Grée, R. Tetrahedron Letters 2001, 42, 395–398. 
(41) a) Cuperly, D.; Crévisy, C.; Grée, R. Synlett 2004, 93–96; b) Cuperly, D.; Petrignet, J.; 
Crévisy, C.; Grée, R. Chemistry 2006, 12, 3261–3274. 
6. References 
228 
 
(42) Frauenrath, H.; Brethauer, D.; Reim, S.; Maurer, M.; Raabe, G. Angew. Chem. Int. Ed. 
2001, 40, 177–179. 
(43) Krompiec, S.; Pigulla, M.; Kuźnik, N.; Krompiec, M.; Marciniec, B.; Chadyniak, D.; 
Kasperczyk, J. J. Molec. Catal. A 2005, 225, 91–101. 
(44) Neugnot, B.; Cintrat, J.-C.; Rousseau, B. Tetrahedron 2004, 60, 3575–3579. 
(45) Tani, K.; Yamagata, T.; Akutagawa, S.; Kumobayashi, H.; Taketomi, T.; Takaya, H.; 
Miyashita, A.; Noyori, R.; Otsuka, S. J. Am. Chem. Soc. 1984, 106, 5208–5217. 
(46) Alcaide, B.; Almendros, P.; Alonso, J. M. Chemistry 2006, 12, 2874–2879. 
(47) Stille, J. K.; Becker, Y. J. Org. Chem. 1980, 45, 2139–2145. 
(48) Sergeyev, S.; Hesse, M. ChemInform 2002, 33, 83. 
(49) Sergeyev, S. A.; Hesse, M. HCA 2003, 86, 750–755. 
(50) Halli, J.; Kramer, P.; Bechthold, M.; Manolikakes, G. Adv. Synth. Catal. 2015, 357, 
3321–3324. 
(51) Wang, L.; Liu, C.; Bai, R.; Pan, Y.; Lei, A. Chem. Commun. 2013, 49, 7923–7925. 
(52) Richmond, E.; Khan, I. U.; Moran, J. Chemistry 2016, 22, 12274–12277. 
(53) Juliá-Hernández, F.; Moragas, T.; Cornella, J.; Martin, R. Nature 2017, 545, 84–88. 
(54)   a) Grotjahn, D. B.; Larsen, C. R.; Erdogan, G. Top Catal 2014, 57, 1483–1489; b) 
Grotjahn, D. B.; Larsen, C. R.; Gustafson, J. L.; Nair, R.; Sharma, A. J. Am. Chem. Soc. 
2007, 129, 9592–9593.  
(55) Noyori, R. Chem. Soc. Rev. 1989, 18, 187. 
(56)  Bhaduri, S.; Mukesh, D. Homogeneous catalysis: Mechanisms and industrial 
applications; Wiley-Interscience, Hoboken, N.J., 2002. 
(57) a) Li, T.; Jones, W. D. Organometallics 2011, 30, 547–555; b) Tolman, C. A.; 
McKinney, R. J.; Seidel, W. C.; Druliner, J. D.; Stevens, W. R. Homogeneous Nickel-
Catalyzed Olefin Hydrocyanation, in Advances in catalysis, Academic Press: Orlando, 
1985, pp 1–46. 
(58) Cornils, B.; Herrmann, W. A., Eds. Applied homogeneous catalysis with organometallic 
compounds: A comprehensive handbook in three volumes, 2nd edition, Wiley-VCH, 
Weinheim, 2002. 
(59) van Leeuwen, P. W. N. M.; Chadwick, J. C. Homogeneous catalysts: Activity - stability 
- deactivation, Wiley, Chicheseter, 2011. 
(60) Vilches-Herrera, M.; Domke, L.; Börner, A. ACS Catal. 2014, 4, 1706–1724. 
(61) Wiest, O.; Wu, Y. Computational Organometallic Chemistry, 1st edition; Springer-
Verlag, Berlin, 2012. 
(62) Kluwer, A. M.; Krafft, M. J.; Hartenbach, I.; Bruin, B. de; Kaim, W. Top Catal 2016, 
59, 1787–1792. 
(63) Azran, J.; Orchin, M. Organometallics 1984, 3, 197–199. 
(64) Mooibroek, T. J.; Wenker, E. C. M.; Smit, W.; Mutikainen, I.; Lutz, M.; Bouwman, E. 
Inorganic chemistry 2013, 52, 8190–8201. 
(65) He, Y.; Cai, Y.; Zhu, S. J. Am. Chem. Soc. 2017, 139, 1061–1064. 
6. References 
229 
 
(66) a) Buslov, I.; Becouse, J.; Mazza, S.; Montandon-Clerc, M.; Hu, X. Angew. Chem. Int. 
Ed. 2015, 54, 14523–14526; b) Bair, J. S.; Schramm, Y.; Sergeev, A. G.; Clot, E.; 
Eisenstein, O.; Hartwig, J. F. J. Am. Chem. Soc. 2014, 136, 13098–13101.  
(67) Zhou, F.; Zhu, J.; Zhang, Y.; Zhu, S. Angew. Chem. Int. Ed. 2018, 57, 4058–4062. 
(68) Xiao, J.; He, Y.; Ye, F.; Zhu, S. Chemistry 2018, 4, 1645–1657. 
(69) Dobereiner, G. E.; Erdogan, G.; Larsen, C. R.; Grotjahn, D. B.; Schrock, R. R. ACS 
Catal. 2014, 4, 3069–3076. 
(70) Schmidt, B.; Hauke, S.; Mühlenberg, N. Synthesis 2014, 1648–1658. 
(71) Kobayashi, T.; Arisawa, M.; Shuto, S. Org. Biomol. Chem. 2011, 9, 1219–1224. 
(72) a) Hemelaere, R.; Carreaux, F.; Carboni, B. Eur. J. Org. Chem. 2015, 2470–2481; b) 
Hemelaere, R.; Carreaux, F.; Carboni, B. Chemistry 2014, 20, 14518–14523.  
(73)   a) Obligacion, J. V.; Chirik, P. J. J. Am. Chem. Soc. 2013, 135, 19107–19110; b) 
Scheuermann, M. L.; Johnson, E. J.; Chirik, P. J. Org. Lett. 2015, 17, 2716–2719. 
(74) Yamamoto, Y.; Kurihara, K.; Yamada, A.; Takahashi, M.; Takahashi, Y.; Miyaura, N. 
Tetrahedron 2003, 59, 537–542. 
(75) Miura, T.; Nishida, Y.; Morimoto, M.; Murakami, M. J. Am. Chem. Soc. 2013, 135, 
11497–11500. 
(76) Horino, Y.; Aimono, A.; Abe, H. Org. Lett. 2015, 17, 2824–2827. 
(77) Horino, Y.; Sugata, M.; Mutsuura, I.; Tomohara, K.; Abe, H. Org. Lett. 2017, 19, 5968–
5971. 
(78) Ely, R. J.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 2534–2535. 
(79) Sušnik, P.; Hilt, G. Organometallics 2014, 33, 5907–5910. 
(80) Erver, F.; Hilt, G. Org. Lett. 2012, 14, 1884–1887. 
(81) Erver, F.; Kuttner, J. R.; Hilt, G. J. Org. Chem. 2012, 77, 8375–8385. 
(82) Fiebig, L.; Kuttner, J.; Hilt, G.; Schwarzer, M. C.; Frenking, G.; Schmalz, H.-G.; 
Schäfer, M. J. Org. Chem. 2013, 78, 10485–10493. 
(83) Hilt, G. Chem. Rec. 2014, 14, 386–396. 
(84) Kuttner, J. R.; Hilt, G. Macromolecules 2014, 47, 5532–5541. 
(85) Pünner, F.; Schieven, J.; Hilt, G. Org. Lett. 2013, 15, 4888–4891. 
(86) Hilt, G. Eur. J. Org. Chem. 2012, 4441–4451. 
(87) Hilt, G.; Du Mesnil, F.-X.; Lüers, S. Angew. Chem. Int. Ed. 2001, 40, 387–389. 
(88) Kersten, L.; Hilt, G. Adv. Synth. Catal. 2012, 354, 863–869. 
(89) Schmidt, A.; Hilt, G. Org. Lett. 2013, 15, 2708–2711. 
(90) Bohn, M. A.; Schmidt, A.; Hilt, G.; Dindaroğlu, M.; Schmalz, H.-G. Angew. Chem. Int. 
Ed. 2011, 50, 9689–9693. 
(91) Pünner, F.; Schmidt, A.; Hilt, G. Angew. Chem. Int. Ed.2012, 51, 1270–1273. 
(92) Schmidt, A.; Hilt, G. Chem. Asian J. 2014, 9, 2407–2410. 
(93) a) Pellissier, H.; Clavier, H. Chem. Rev. 2014, 114, 2775–2823; b) RajanBabu, T. V. 
Synlett 2009, 853–885; c) Timsina, Y. N.; Sharma, R. K.; RajanBabu, T. V. Chem. Sci. 
6. References 
230 
 
2015, 6, 3994–4008; d) RajanBabu, T. V. Chem. Rev. 2003, 103, 2845–2860; e) Sharma, R. 
K.; RajanBabu, T. V. J. Am. Chem. Soc. 2010, 132, 3295–3297.  
(94) Hilt, G.; Danz, M.; Treutwein, J. Org. Lett. 2009, 11, 3322–3325. 
(95) Arndt, M.; Dindaroğlu, M.; Schmalz, H.-G.; Hilt, G. Org. Lett. 2011, 13, 6236–6239. 
(96) Ballmann, M.; Weber, F.; Sattler, L.; Hilt, G. Synthesis 2018, 1711–1720. 
(97) Chen, Q.-A.; Kim, D. K.; Dong, V. M. J. Am. Chem. Soc. 2014, 136, 3772–3775. 
(98) Oonishi, Y.; Mori, M.; Sato, Y. Synthesis 2007, 2323–2336. 
(99) Kim, D. K.; Riedel, J.; Kim, R. S.; Dong, V. M. J. Am. Chem. Soc. 2017, 139, 10208–
10211. 
(100) Yang, J.; Yoshikai, N. J. Am. Chem. Soc. 2014, 136, 16748–16751. 
(101) Yang, J.; Rérat, A.; Lim, Y. J.; Gosmini, C.; Yoshikai, N. Angew. Chem. Int. Ed. 2017, 
56, 2449–2453. 
(102) Weber, F. Stereoselektive Nickel-katalysierte Isomerisierung terminaler Alkene und 
Untersuchungen zur Synthese von Vitamin A, Master Thesis, Philipps-Universität Marburg, 
Marburg, 2014. 
(103) Weber, F.; Schmidt, A.; Röse, P.; Fischer, M.; Burghaus, O.; Hilt, G. Org. Lett. 2015, 
17, 2952–2955. 
(104) Bard, A. J.; Faulkner, L. R. Electrochemical methods: Fundamentals and applications, 
2nd edition; Wiley, Hoboken, N.J., 2001. 
(105) Scholz, F.; Bond, A. M., Electroanalytical Methods: Guide to Experiments and 
Applications, 2nd edition, Springer-Verlag, Berlin, 2010. 
(106) Laskowski, C. A.; Hillhouse, G. L. J. Am. Chem. Soc. 2008, 130, 13846–13847. 
(107) Carter, E.; Murphy, D. M. Top. Catal. 2015, 58, 759–768. 
(108) a) Gilbert, B. C.; Carter, E. Electron paramagnetic resonance: A review of the recent 
literature; A specialist periodical report, Royal Society of Chemistry, Cambridge, 2015; b) 
Carter, E.; Murphy, D. M. Homogeneous catalytic transformations investigated by EPR 
spectroscopy, in Electron paramagnetic resonance. A review of the recent literature, Royal 
Society of Chemistry, Cambridge, 2015.  
(109) Schwab, M. M.; Himmel, D.; Kacprzak, S.; Radtke, V.; Kratzert, D.; Weis, P.; Wernet, 
M.; Peter, A.; Yassine, Z.; Schmitz, D.; Scheidt, E.-W.; Scherer, W.; Weber, S.; Feuerstein, 
W.; Breher, F.; Higelin, A.; Krossing, I. Chemistry 2018, 24, 918–927. 
(110) Grigoryev, E. I.; Weber, F.; Hilt, G.; Berger, R. Org. Chem. Front. 2018, submitted. 
(111) Lee, W.-C.; Wang, C.-H.; Lin, Y.-H.; Shih, W.-C.; Ong, T.-G. Org. Lett. 2013, 15, 
5358–5361. 
(112) Kohlmeyer, C. Untersuchungen zu in situ Folgereaktionen der Nickel-katalysierten 
Isomerisierung funktionalisierter 1-Alkene, Master-Thesis, Philipps-Universität Marburg, 
Marburg, 2016. 
(113) Busacca, C. A.; Lorenz, J. C.; Grinberg, N.; Haddad, N.; Hrapchak, M.; Latli, B.; Lee, 
H.; Sabila, P.; Saha, A.; Sarvestani, M.; Shen, S.; Varsolona, R.; Wei, X.; Senanayake, C. 
H. Org. Lett. 2005, 7, 4277–4280. 
(114) Herbert, M. B.; Marx, V. M.; Pederson, R. L.; Grubbs, R. H. Angew. Chem. Int. Ed. 
2013, 52, 310–314. 
6. References 
231 
 
(115) a) Kasymzhanova, M.; Abdukakharov, V. S.; Kamaev, F. G.; Abduvakhabov, A. A. 
Chem. Nat. Compd. 1989, 25, 708–713; b) Odinokov, V. N. Chem. Nat. Compd. 2000, 36, 
11–39.  
(116) Marner, F.-J.; Jaenicke, L. Chem. Ber. 1975, 108, 2202–2211. 
(117) Ortiz, A.; Quesada, A.; Sanchez, A. J. Chem. Ecol. 2004, 30, 991–1000. 
(118) Organ, M. G.; Ghasemi, H. J. Org. Chem. 2004, 69, 695–700. 
(119)   Bieber, L. W.; da Silva, M. F. Tetrahedron Lett. 2007, 48, 7088–7090. 
(120)   Liu, H.-J.; Browne, E. N. C. Can. J. Chem. 1978, 56, 306–307. 
(121) a) Hilt, G.; Lüers, S. Synthesis 2002, 609–618; b) Hilt, G.; Galbiati, F. Synlett 2005, 
829–833.  
(122)   Thiedemann, B.; Schmitz, C. M. L.; Staubitz, A. J. Org. Chem. 2014, 79, 10284–10295. 
(123)   Weber, F.; Steinlandt, P.; Ballmann, M.; Hilt, G. Synthesis 2016, 49, 440–450. 
(124)   Steinlandt; P. Nickel-katalysierte, (Z)-selektive Isomerisierung von N-Allylamiden und 
N,O-Allylcarbamaten, Bachelor Thesis, Philipps-Universität Marburg, Marburg, 2016. 
(125)   Weber, F.; Ballmann, M.; Kohlmeyer, C.; Hilt, G. Org. Lett. 2016, 18, 548–551. 
(126) Kohlmeyer, C. Untersuchungen zu in situ Folgereaktionen der Nickel-katalysierten 
Isomerisierung funktionalisierter 1-Alkene, Master-Thesis, Philipps-Universität Marburg, 
Marburg, 2016. 
(127) Alam, R.; Raducan, M.; Eriksson, L.; Szabó, K. J. Org. Lett. 2013, 15, 2546–2549. 
(128)   Hoffmann, R. W.; Landmann, B. Chem. Ber. 1986, 119, 1039–1053. 
(129)   Ballmann; M. Nickel-katalysierte Isomerisierung von Homoallylboronsäureestern und 
in situ Allylborierung, Bachelor Thesis, Philipps-Universität Marburg, Marburg, 2015. 
(130) Zhu, S.; Guo, Z.; Huang, Z.; Jiang, H. Chemistry 2014, 20, 2425–2430. 
(131) Sato, K.; Ji, W.; Palmer, L. C.; Weber, B.; Barz, M.; Stupp, S. I. J. Am. Chem. Soc. 
2017, 139, 8995–9000. 
(132)   Feismann, K. Cobalt-katalysierte reduktive Cyclisierung arylsubstituierter 1,3-Diene, 
Carl von Ossietzky-Universität Oldenburg, Oldenburg, 2018. 
(133)   Mehdi, M.; Djurdjevic, S.; Green, J. Synlett 2015, 26, 2408–2412. 
(134)   Lee, S. H.; Silva Elipe, M. V.; Arora, J. S.; Blair, I. A. Chem. Res. Toxicol. 2005, 18, 
566–578. 
(135) Diab, L.; Smejkal, T.; Geier, J.; Breit, B. Angew. Chem. Int. Ed. 2009, 48, 8022–8026. 
(136) Zhu, H.; Wickenden, J. G.; Campbell, N. E.; Leung, J. C. T.; Johnson, K. M.; Sammis, 
G. M. Org. Lett. 2009, 11, 2019–2022. 
(137)   a) Marshall, J. A.; Hinkle, K. W. J. Org. Chem. 1997, 62, 5989–5995; b) Cryle, M. J.; 
Hayes, P. Y.; de Voss, J. J. Chemistry 2012, 18, 15994–15999.  
(138)   Jönsson, S.; Liljefors, T.; Hansson, B. S. J. Chem. Ecol. 1992, 18, 637–657. 
(139) Ehrlich, G.; Hassfeld, J.; Eggert, U.; Kalesse, M. Chemistry 2008, 14, 2232–2247. 
(140) Moslin, R. M.; Jamison, T. F. J. Org. Chem. 2007, 72, 9736–9745. 
(141) a) Björkling, F.; Norin, T.; Unelius, R. Synthetic Communications 1985, 15, 463–472; 
b) Decodts, G.; Dressaire, G.; Langlois, Y. Synthesis 1979, 510–513;  
6. References 
232 
 
(142) Henderson, A. R.; Stec, J.; Owen, D. R.; Whitby, R. J. Chem. Commun.2012, 48, 3409–
3411. 
(143) Pavlyuk, O.; Teller, H.; McMills, M. C. Tetrahedron Lett. 2009, 50, 2716–2718. 
(144) Sarkar, S. de; Studer, A. Org. Lett. 2010, 12, 1992–1995. 
(145) Teller, H.; Corbet, M.; Mantilli, L.; Gopakumar, G.; Goddard, R.; Thiel, W.; Fürstner, 
A. J. Am. Chem. Soc. 2012, 134, 15331–15342. 
(146) Tarantino, K. T.; Miller, D. C.; Callon, T. A.; Knowles, R. R. J. Am. Chem. Soc. 2015, 
137, 6440–6443. 
(147) Moon, N. G.; Harned, A. M. Tetrahedron Lett. 2013, 54, 2960–2963. 
(148) Xu, G.; Micklatcher, M.; Silvestri, M. A.; Hartman, T. L.; Burrier, J.; Osterling, M. C.; 
Wargo, H.; Turpin, J. A.; Buckheit, R. W.; Cushman, M. J. Med. Chem. 2001, 44, 4092–
4113. 
(149) Ohmura, N.; Nakamura, A.; Hamasaki, A.; Tokunaga, M. Eur. J. Org. Chem. 2008, 
5042–5045. 
(150) Lin, S.; Yang, Z.-Q.; Kwok, B. H. B.; Koldobskiy, M.; Crews, C. M.; Danishefsky, S. 
J. J. Am. Chem. Soc. 2004, 126, 6347–6355. 
(151) Formentín, P.; Gimeno, N.; Steinke, J. H. G.; Vilar, R. J. Org. Chem. 2005, 70, 8235–
8238. 
(152) Marsh, B. J.; Heath, E. L.; Carbery, D. R. Chem. Commun. 2011, 47, 280–282. 
(153) Guennouni, N.; Lhermitte, F.; Cochard, S.; Carboni, B. Tetrahedron 1995, 51, 6999–
7018. 
(154) Murray, S. A.; Green, J. C.; Tailor, S. B.; Meek, S. J. Angew. Chem. Int. Ed. 2016, 55, 
9065–9069. 
(155) Moiseenkov, A. M.; Czeskis, B. A.; Ivanova, N. M.; Nefedov, O. M. Org. Prep. Proc. 
Int. 1990, 22, 215–227. 
(156)   Molander, G. A.; Petrillo, D. E. Org. Lett. 2008, 10, 1795–1798. 
(157)   Gao, M.; Thorpe, S. B.; Santos, W. L. Org. Lett. 2009, 11, 3478–3481. 
(158)   Sasaki, Y.; Zhong, C.; Sawamura, M.; Ito, H. J. Am. Chem. Soc. 2010, 132, 1226–1227. 
(159) Gao, M.; Thorpe, S. B.; Kleeberg, C.; Slebodnick, C.; Marder, T. B.; Santos, W. L. J. 
Org. Chem. 2011, 76, 3997–4007. 
(160) Jiang, S.; Agoston, G. E.; Chen, T.; Cabal, M.-P.; Turos, E. Organometallics 1995, 14, 
4697–4709. 
(161)   Kim, I. S.; Ngai, M.-Y.; Krische, M. J. J. Am. Chem. Soc. 2008, 130, 6340–6341. 
(162)   Nowrouzi, F.; Thadani, A. N.; Batey, R. A. Org. Lett. 2009, 11, 2631–2634. 
(163)   Arkivoc 2003, 52. 
(164)   Kim, I. S.; Han, S. B.; Krische, M. J. J. Am. Chem. Soc. 2009, 131, 2514–2520. 
(165)   Denmark, S. E.; Fu, J.; Lawler, M. J. J. Org. Chem. 2006, 71, 1523–1536. 
(166)   Gao, X.; Townsend, I. A.; Krische, M. J. J. Org. Chem. 2011, 76, 2350–2354. 
(167)   Russo, V.; Herron, J. R.; Ball, Z. T. Org. Lett. 2010, 12, 220–223. 
6. References 
233 
 
(168)   de Sio, V.; Massa, A.; Scettri, A. Org. Biomol. Chem. 2010, 8, 3055–3059. 
(169) a) Fang, G. Y.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 46, 359–362; b) Hayashi, 
T.; Matsumoto, Y.; Kiyoi, T.; Ito, Y.; Kohra, S.; Tominaga, Y.; Hosomi, A. Tetrahedron 
Lett. 1988, 29, 5667–5670. 
(170) Smith, A. B.; Kim, W.-S.; Tong, R. Org. Lett. 2010, 12, 588–591. 
(171) a) Bower, J. F.; Skucas, E.; Patman, R. L.; Krische, M. J. J. Am. Chem. Soc. 2007, 129, 
15134–15135; b) Skucas, E.; Bower, J. F.; Krische, M. J. J. Am. Chem. Soc. 2007, 129, 
12678–12679. 
(172) Han, S. B.; Kim, I. S.; Han, H.; Krische, M. J. J. Am. Chem. Soc. 2009, 131, 6916–6917. 
(173) Jadhav, P. K.; Bhat, K. S.; Perumal, P. T.; Brown, H. C. J. Org. Chem. 1986, 51, 432–
439. 
(174)   Nishigaichi, Y.; Takuwa, A. Tetrahedron Lett. 1999, 40, 109–112. 
(175) Zanato, C.; Pignataro, L.; Ambrosi, A.; Hao, Z.; Trigili, C.; Díaz, J. F.; Barasoain, I.; 
Gennari, C. Eur. J. Org. Chem. 2011, 2643–2661. 
(176) Yeh, K.-L.; Liu, B.; Lai, Y.-T.; Li, C.-W.; Liu, R.-S. J. Org. Chem. 2004, 69, 4692–
4694. 
(177) Fujita, K.; Yorimitsu, H.; Shinokubo, H.; Oshima, K. J. Am. Chem. Soc. 2004, 126, 
6776–6783. 
 
 
 
